WorldWideScience

Sample records for platinum-based doublet chemotherapy

  1. SEROTONIN METABOLISM FOLLOWING PLATINUM-BASED CHEMOTHERAPY COMBINED WITH THE SEROTONIN TYPE-3 ANTAGONIST TROPISETRON

    NARCIS (Netherlands)

    SCHRODER, CP; VANDERGRAAF, WTA; KEMA, IP; GROENEWEGEN, A; SLEIJFER, DT; DEVRIES, EGE

    1995-01-01

    The administration of platinum-based chemotherapy induces serotonin release from the enterochromaffin cells, causing nausea and vomiting. This study was conducted to evaluate parameters of serotonin metabolism following platinum-based chemotherapy given in combination with the serotonin type-3

  2. Metabolic response assessment with 18F-FDG-PET/CT is superior to modified RECIST for the evaluation of response to platinum-based doublet chemotherapy in malignant pleural mesothelioma

    Energy Technology Data Exchange (ETDEWEB)

    Kanemura, Shingo [Department of Respiratory Medicine, Hyogo College of Medicine, 1-1 Mukogawa-cho, Nishinomiya, Hyogo 663-8501 (Japan); Kuribayashi, Kozo, E-mail: kuririn@hyo-med.ac.jp [Department of Respiratory Medicine, Hyogo College of Medicine, 1-1 Mukogawa-cho, Nishinomiya, Hyogo 663-8501 (Japan); Funaguchi, Norihiko [Department of Respiratory Medicine, Murakami Memorial Hospital, Asahi University, 3-23 Hashimoto-cho, Gifu 500-8523 (Japan); Shibata, Eisuke; Mikami, Koji [Department of Respiratory Medicine, Hyogo College of Medicine, 1-1 Mukogawa-cho, Nishinomiya, Hyogo 663-8501 (Japan); Doi, Hiroshi [Department of Radiology, Hyogo College of Medicine, 1-1 Mukogawa-cho, Nishinomiya, Hyogo 663-8501 (Japan); Kitajima, Kazuhiro [Division of Nuclear Medicine and PET center, Department of Radiology, Hyogo College of Medicine, 1-1 Mukogawa-cho, Nishinomiya, Hyogo 663-8501 (Japan); Hasegawa, Seiki [Department of Thoracic Surgery, Hyogo College of Medicine, 1-1 Mukogawa-cho, Nishinomiya, Hyogo 663-8501 (Japan); Nakano, Takashi [Department of Respiratory Medicine, Hyogo College of Medicine, 1-1 Mukogawa-cho, Nishinomiya, Hyogo 663-8501 (Japan)

    2017-01-15

    Highlights: • 18F-FDG-PET/CT and mRESIST were used for tumour responsiveness evaluation in MPM. • 29% of mRESIST stable disease (SD) patients were metabolic non-responders. • Disease control rate was 93.9% and metabolic response rate was 71.9%. • Progressive metabolic disease patients had lower time to progression. • MRESIST stable disease (SD) patients should be further screened by 18F-FDG-PET/CT. - Abstract: Purpose: Efficient monitoring of tumor responsiveness to chemotherapy is essential to mitigate high mortality risks and cytotoxic effects of chemotherapeutics. However, there is no consensus on the most suitable diagnostic technique/parameters for assessing response to chemotherapy in malignant pleural mesothelioma (MPM). We compared the tumor responsiveness of MPM patients as assessed using modified RECIST (mRECIST) criteria and integrated 18F-FDG-PET/CT. Methods: Histologically confirmed MPM patients (N = 82) who were treated with three cycles of cisplatin and pemetrexed, or carboplatin and pemetrexed, were included. mRECIST and integrated 18F-FDG-PET/CT were used to evaluate MPM tumor response to chemotherapy. Metabolic non-responders were defined as those with a 25% or greater increase in SUVmax compared with the previous value. Time to progression (TTP) and overall survival (OS) were compared between metabolic-responders and non-responders. Results: After three cycles of chemotherapy, 62(75.6%) of the patients were classified as having SD, 15 (18%) with partial remission (PR), and 5 (6%) with progressive disease (PD), based on mRECIST criteria. The cumulative median OS was 728.0 days (95% confidence interval [CI]: 545.9–910.1) and cumulative median TTP was 365.0 days (95% CI: 296.9–433.1). For the 82 patients, the disease control rate was 93.9%, whereas the metabolic response rate was only 71.9% (p < 0.001). All PD and PR patients were found to be metabolic responders on 18F-FDG-PET/CT; however, among the 62mRECIST SD patients, 18 (29

  3. Prevention of blood transfusion with intravenous iron in gynecologic cancer patients receiving platinum-based chemotherapy.

    Science.gov (United States)

    Athibovonsuk, Punnada; Manchana, Tarinee; Sirisabya, Nakarin

    2013-12-01

    To compare the efficacy of intravenous iron and oral iron for prevention of blood transfusions in gynecologic cancer patients receiving platinum-based chemotherapy. Sixty-four non anemic gynecologic cancer patients receiving adjuvant platinum-based chemotherapy were stratified and randomized according to baseline hemoglobin levels and chemotherapy regimen. The study group received 200mg of intravenous iron sucrose immediately after each chemotherapy infusion. The control group received oral ferrous fumarate at a dose of 200mg three times a day. Complete blood count was monitored before each chemotherapy infusion. Blood transfusions were given if hemoglobin level was below 10mg/dl. There were 32 patients in each group. No significant differences in baseline hemoglobin levels and baseline characteristics were demonstrated between both groups. Nine patients (28.1%) in the study group and 18 patients (56.3%) in the control group required blood transfusion through 6 cycles of chemotherapy (p=0.02). Fewer median number of total packed red cell units were required in the study group compared to the control group (0 and 0.5 unit, respectively, p=0.04). Serious adverse events and hypersensitivity reactions were not reported. However, constipation was significantly higher in the control group (3.1% and 40.6%, p=gynecologic cancer patients receiving platinum-based chemotherapy, associated with less constipation than the oral formulation. © 2013 Elsevier Inc. All rights reserved.

  4. Major Clinical Impact of Platinum-Based Chemotherapy in a Patient with a Borderline Ovarian Cancer

    Directory of Open Access Journals (Sweden)

    Jian Chen

    2009-09-01

    Full Text Available A patient with extensive and painful chest wall involvement from a metastatic borderline cancer of the ovary was treated with a carboplatin plus paclitaxel chemotherapy regimen. She achieved a rather dramatic improvement of pain control, a significant biochemical response with 75% reduction of the CA-125 antigen level, but only limited radiographic tumor regression. This experience emphasizes the potential clinical utility of platinum-based cytotoxic chemotherapy in the setting of symptomatic advanced borderline ovarian cancer.

  5. Platinum-based chemotherapy with or without thoracic radiation therapy in patients with unresectable thymic carcinoma

    International Nuclear Information System (INIS)

    Nakamura, Yoichi; Kunitoh, Hideo; Kubota, Kaoru

    2000-01-01

    Thymic carcinoma is a rare mediastinal neoplasm with poor prognosis. Although the clinical benefit of chemotherapy for thymic carcinoma is controversial, cisplatin-based chemotherapy with or without radiation therapy is ordinarily adopted in advanced cases. We evaluated the clinical outcome of platinum-based chemotherapy with or without radiation therapy in unresectable thymic carcinoma patients. Ten patients with unresectable thymic carcinoma were treated with platinum-based chemotherapy with or without radiation therapy in the National Cancer Center Hospital between 1989 and 1998. We reviewed the histological type, treatment, response and survival of these patients. Four of the 10 patients responded to chemotherapy and both the median progression-free survival period and the median response duration were 6.0 months. The median survival time was 11.0 months. There was no relationship between histological classification and prognosis. Platinum-based chemotherapy with or without thoracic radiation is, regardless of tumor histology, marginally effective in advanced thymic carcinoma patients, giving only a modest tumor response rate and short response duration and survival. (author)

  6. Pharmacogenetic predictors of toxicity to platinum based chemotherapy in non-small cell lung cancer patients.

    Science.gov (United States)

    Pérez-Ramírez, Cristina; Cañadas-Garre, Marisa; Alnatsha, Ahmed; Villar, Eduardo; Delgado, Juan Ramón; Faus-Dáder, María José; Calleja-Hernández, Miguel Ÿngel

    2016-09-01

    Platinum-based chemotherapy is the standard treatment for NSCLC patients with EGFR wild-type, and as alternative to failure to EGFR inhibitors. However, this treatment is aggressive and most patients experience grade 3-4 toxicities. ERCC1, ERCC2, ERCC5, XRCC1, MDM2, ABCB1, MTHFR, MTR, SLC19A1, IL6 and IL16 gene polymorphisms may contribute to individual variation in toxicity to chemotherapy. The aim of this study was to evaluate the effect of these polymorphisms on platinum-based chemotherapy in NSCLC patients. A prospective cohorts study was conducted, including 141 NSCLC patients. Polymorphisms were analyzed by PCR Real-Time with Taqman(®) probes and sequencing. Patients with ERCC1 C118T-T allele (p=0.00345; RR=26.05; CI95%=4.33, 515.77) and ERCC2 rs50872-CC genotype (p=0.00291; RR=4.06; CI95%=1.66, 10.65) had higher risk of general toxicity for platinum-based chemotherapy. ERCC2 Asp312Asn G-alelle, ABCB1 C1236T-TT and the IL1B rs12621220-CT/TT genotypes conferred a higher risk to present multiple adverse events. The subtype toxicity analysis also revealed that ERCC2 rs50872-CC genotype (p=0.01562; OR=3.23; CI95%=1.29, 8.82) and IL16 rs7170924-T allele (p=0.01007; OR=3.19; CI95%=1.35, 7.97) were associated with grade 3-4 hematological toxicity. We did not found the influence of ERCC1 C8092A, ERCC2 Lys751Gln, ERCC2 Asp312Asn, ERCC5 Asp1104His, XRCC1 Arg194Trp, MDM2 rs1690924, ABCB1 C3435T, ABCB1 Ala893Ser/Thr, MTHFR A1298C, MTHFR C677T, IL1B rs1143623, IL1B rs16944, and IL1B rs1143627 on platinum-based chemotherapy toxicity. In conclusion, ERCC1 C118T, ERCC2 rs50872, ERCC2 Asp312Asn, ABCB1 C1236T, IL1B rs12621220 and IL16 rs7170924 polymorphisms may substantially act as prognostic factors in NSCLC patients treated with platinum-based chemotherapy. Copyright © 2016 Elsevier Ltd. All rights reserved.

  7. Efficacy of tegafur-uracil in advanced urothelial cancer patients after the treatment failure of platinum-based chemotherapy.

    Science.gov (United States)

    Maolake, Aerken; Izumi, Kouji; Takahashi, Rie; Itai, Shingo; Machioka, Kazuaki; Yaegashi, Hiroshi; Nohara, Takahiro; Kitagawa, Yasuhide; Kadono, Yoshifumi; Konaka, Hiroyuki; Mizokami, Atsushi; Namiki, Mikio

    2015-03-01

    Platinum-based chemotherapy is the first-line treatment for advanced urinary tract urothelial cancers. However, the optimal second-line treatment is unclear. Although tegafur-uracil is sometimes used for advanced urothelial cancer patients after the treatment failure of platinum-based chemotherapy, there is little evidence regarding its use as a second-line treatment. Advanced urothelial cancer patients previously treated with platinum-based chemotherapy were retrospectively analyzed. Overall survival (OS) was compared between patients with and without tegafur-uracil treatment. Thirty-one patients (27 and 4 patients with and without tegafur-uracil treatment, respectively) were analyzed. OS from the last day of the final chemotherapy course was better in patients with tegafur-uracil treatment than in those without (p<0.001, 358 and 66.5 days of the median survival time, respectively). Tegafur-uracil may be a candidate for the secondary treatment of advanced urothelial cancer patients after the treatment failure of platinum-based chemotherapy. Copyright© 2015 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved.

  8. Six versus fewer planned cycles of first-line platinum-based chemotherapy for non-small-cell lung cancer

    DEFF Research Database (Denmark)

    Rossi, Antonio; Chiodini, Paolo; Sun, Jong-Mu

    2014-01-01

    BACKGROUND: Platinum-based chemotherapy is the standard first-line treatment for patients with advanced non-small-cell lung cancer. However, the optimum number of treatment cycles remains controversial. Therefore, we did a systematic review and meta-analysis of individual patient data to compare ...

  9. Randomized pharmacokinetic study comparing subcutaneous and intravenous palonosetron in cancer patients treated with platinum based chemotherapy.

    Directory of Open Access Journals (Sweden)

    Belen Sadaba

    Full Text Available Palonosetron is a potent second generation 5- hydroxytryptamine-3 selective antagonist which can be administered by either intravenous (IV or oral routes, but subcutaneous (SC administration of palonosetron has never been studied, even though it could have useful clinical applications. In this study, we evaluate the bioavailability of SC palonosetron.Patients treated with platinum-based chemotherapy were randomized to receive SC or IV palonosetron, followed by the alternative route in a crossover manner, during the first two cycles of chemotherapy. Blood samples were collected at baseline and 10, 15, 30, 45, 60, 90 minutes and 2, 3, 4, 6, 8, 12 and 24 h after palonosetron administration. Urine was collected during 12 hours following palonosetron. We compared pharmacokinetic parameters including AUC0-24h, t1/2, and Cmax observed with each route of administration by analysis of variance (ANOVA.From October 2009 to July 2010, 25 evaluable patients were included. AUC0-24h for IV and SC palonosetron were respectively 14.1 and 12.7 ng × h/ml (p=0.160. Bioavalability of SC palonosetron was 118% (95% IC: 69-168. Cmax was lower with SC than with IV route and was reached 15 minutes following SC administration.Palonosetron bioavailability was similar when administered by either SC or IV route. This new route of administration might be specially useful for outpatient management of emesis and for administration of oral chemotherapy.ClinicalTrials.gov NCT01046240.

  10. Safety and feasibility of fasting in combination with platinum-based chemotherapy

    International Nuclear Information System (INIS)

    Dorff, Tanya B.; Groshen, Susan; Garcia, Agustin; Shah, Manali; Tsao-Wei, Denice; Pham, Huyen; Cheng, Chia-Wei; Brandhorst, Sebastian; Cohen, Pinchas; Wei, Min; Longo, Valter; Quinn, David I.

    2016-01-01

    Short-term starvation prior to chemotherapy administration protects mice against toxicity. We undertook dose-escalation of fasting prior to platinum-based chemotherapy to determine safety and feasibility in cancer patients. 3 cohorts fasted before chemotherapy for 24, 48 and 72 h (divided as 48 pre-chemo and 24 post-chemo) and recorded all calories consumed. Feasibility was defined as ≥ 3/6 subjects in each cohort consuming ≤ 200 kcal per 24 h during the fast period without excess toxicity. Oxidative stress was evaluated in leukocytes using the COMET assay. Insulin, glucose, ketones, insulin-like growth factor-1 (IGF-1) and IGF binding proteins (IGFBPs) were measured as biomarkers of the fasting state. The median age of our 20 subjects was 61, and 85 % were women. Feasibility criteria were met. Fasting-related toxicities were limited to ≤ grade 2, most commonly fatigue, headache, and dizziness. The COMET assay indicated reduced DNA damage in leukocytes from subjects who fasted for ≥48 h (p = 0.08). There was a non-significant trend toward less grade 3 or 4 neutropenia in the 48 and 72 h cohorts compared to 24 h cohort (p = 0.17). IGF-1 levels decreased by 30, 33 and 8 % in the 24, 48 and 72 h fasting cohorts respectively after the first fasting period. Fasting for 72 h around chemotherapy administration is safe and feasible for cancer patients. Biomarkers such as IGF-1 may facilitate assessment of differences in chemotherapy toxicity in subgroups achieving the physiologic fasting state. An onging randomized trial is studying the effect of 72 h of fasting. Clinicaltrials.gov: NCT00936364, registered propectively on July 9, 2009. The online version of this article (doi:10.1186/s12885-016-2370-6) contains supplementary material, which is available to authorized users

  11. Safety and feasibility of fasting in combination with platinum-based chemotherapy.

    Science.gov (United States)

    Dorff, Tanya B; Groshen, Susan; Garcia, Agustin; Shah, Manali; Tsao-Wei, Denice; Pham, Huyen; Cheng, Chia-Wei; Brandhorst, Sebastian; Cohen, Pinchas; Wei, Min; Longo, Valter; Quinn, David I

    2016-06-10

    Short-term starvation prior to chemotherapy administration protects mice against toxicity. We undertook dose-escalation of fasting prior to platinum-based chemotherapy to determine safety and feasibility in cancer patients. 3 cohorts fasted before chemotherapy for 24, 48 and 72 h (divided as 48 pre-chemo and 24 post-chemo) and recorded all calories consumed. Feasibility was defined as ≥ 3/6 subjects in each cohort consuming ≤ 200 kcal per 24 h during the fast period without excess toxicity. Oxidative stress was evaluated in leukocytes using the COMET assay. Insulin, glucose, ketones, insulin-like growth factor-1 (IGF-1) and IGF binding proteins (IGFBPs) were measured as biomarkers of the fasting state. The median age of our 20 subjects was 61, and 85 % were women. Feasibility criteria were met. Fasting-related toxicities were limited to ≤ grade 2, most commonly fatigue, headache, and dizziness. The COMET assay indicated reduced DNA damage in leukocytes from subjects who fasted for ≥48 h (p = 0.08). There was a non-significant trend toward less grade 3 or 4 neutropenia in the 48 and 72 h cohorts compared to 24 h cohort (p = 0.17). IGF-1 levels decreased by 30, 33 and 8 % in the 24, 48 and 72 h fasting cohorts respectively after the first fasting period. Fasting for 72 h around chemotherapy administration is safe and feasible for cancer patients. Biomarkers such as IGF-1 may facilitate assessment of differences in chemotherapy toxicity in subgroups achieving the physiologic fasting state. An onging randomized trial is studying the effect of 72 h of fasting. NCT00936364 , registered propectively on July 9, 2009.

  12. Correlation of Serum Cystatin C with Glomerular Filtration Rate in Patients Receiving Platinum-Based Chemotherapy

    Directory of Open Access Journals (Sweden)

    Ernesta Cavalcanti

    2016-01-01

    Full Text Available Objectives. Serum cystatin C seems to be an accurate marker of glomerular filtration rate (GFR compared to serum creatinine. The aim of this work was to explore the possibility of using serum cystatin C instead of serum creatinine to early predict renal failure in cancer patients who received platinum based chemotherapy. Design and Methods. Serum creatinine, serum cystatin C concentrations, and GFR were determined simultaneously in 52 cancer patients received carboplatin-based or cisplatin-based chemotherapy. Serum creatinine was assayed on Cobas C6000-Roche, serum cystatin C assay was performed on AIA 360-Tosoh, and GFR was determined in all patients, before the first cycle of chemotherapy and before the subsequent administrations. Results. In the overall series, for the prediction of a fall of GFR < 80 mL/min/1.73 m2, the AUC of the ROC curve for cystatin C was 0,667 and the best threshold was 1.135 mg/L (sensitivity 90.5%, specificity 61.1%. For a GFR fall < 60 mL/min/1.73 m2, the AUC of ROC curve for cystatin C was 74.3% and the best threshold was 1.415 mg/L (sensitivity 66.7%, specificity 73.2%. Conclusions. Baseline cystatin C values were not able to predict renal failure during subsequent treatment. In conclusion, serum cystatin C is not a reliable early marker to efficiently predict renal failure in patients receiving chemotherapy.

  13. Meta-Analysis on Pharmacogenetics of Platinum-Based Chemotherapy in Non Small Cell Lung Cancer (NSCLC) Patients

    Science.gov (United States)

    Yin, Ji-Ye; Huang, Qiong; Zhao, Ying-Chun; Zhou, Hong-Hao; Liu, Zhao-Qian

    2012-01-01

    Aim To determine the pharmacogenetics of platinum-based chemotherapy in Non Small Cell Lung Cancer (NSCLC) patients. Methods Publications were selected from PubMed, Cochrane Library and ISI Web of Knowledge. A meta-analysis was conducted to determine the association between genetic polymorphisms and platinum-based chemotherapy by checking odds ratio (OR) and 95% confidence interval (CI). Results Data were extracted from 24 publications, which included 11 polymorphisms in 8 genes for meta-analysis. MDR1 C3435T (OR = 1.97, 95% CI: 1.11–3.50, P = 0.02), G2677A/T (OR = 2.61, 95% CI: 1.44–4.74, P = 0.002) and GSTP1 A313G (OR = 0.32, 95% CI: 0.17–0.58, P = 0.0002) were significantly correlated with platinum-based chemotherapy in Asian NSCLC patients. Conclusion Attention should be paid to MDR1 C3435T, G2677A/T and GSTP1 A313G for personalized chemotherapy treatment for NSCLC patients in Asian population in the future. PMID:22761669

  14. Multicenter retrospective study of cetuximab plus platinum-based chemotherapy for recurrent or metastatic oral squamous cell carcinoma.

    Science.gov (United States)

    Yanamoto, Souichi; Umeda, Masahiro; Kioi, Mitomu; Kirita, Tadaaki; Yamashita, Tetsuro; Hiratsuka, Hiroyoshi; Yokoo, Satoshi; Tanzawa, Hideki; Uzawa, Narikazu; Shibahara, Takahiko; Ota, Yoshihide; Kurita, Hiroshi; Okura, Masaya; Hamakawa, Hiroyuki; Kusukawa, Jingo; Tohnai, Iwai

    2018-03-01

    The purpose of this study was to assess the efficacy and safety of cetuximab plus platinum-based chemotherapy for patients specifically diagnosed with recurrent or metastatic oral squamous cell carcinoma (OSCC). We conducted a multicenter retrospective observational study of patients who underwent first-line cetuximab plus platinum-based chemotherapy between December 2012 and June 2015. 65 patients received weekly cetuximab (week 1, 400 mg/m 2 ; subsequent weeks, 250 mg/m 2 ) plus a maximum of six 3-weekly cycles of cisplatin (80 or 100 mg/m 2 , day 1) or carboplatin (at an area under the curve of 5 mg/mL/min as a 1-h intravenous infusion on day 1) and 5-fluorouracil (800 or 1000 mg/m 2 /day, days 1-4). Patients with stable disease who received cetuximab plus platinum-based chemotherapy continued to receive cetuximab until disease progression or unacceptable toxicities, whichever occurred first. The median follow-up was 10.5 (range 1.2-34.2) months. The best overall response and the disease control rates were 46.2 and 67.7%, respectively. The median overall survival and progression-free survival rates were 12.1 and 7.8 months, respectively. The most common grades 3-4 adverse events were skin rash (9.2%) followed by leukopenia (6.2%). None of the adverse events were fatal. The results of our multicenter retrospective study, which was the largest of its kind to date, suggest that first-line cetuximab plus platinum-based chemotherapy is suitable and well-tolerated for the systemic therapy of recurrent or metastatic OSCC.

  15. Renal function and urological complications after radical hysterectomy with postoperative radiotherapy and platinum-based chemotherapy for cervical cancer.

    Science.gov (United States)

    Okadome, Masao; Saito, Toshiaki; Kitade, Shoko; Ariyoshi, Kazuya; Shimamoto, Kumi; Kawano, Hiroyuki; Minami, Kazuhito; Nakamura, Motonobu; Shimokawa, Mototsugu; Okushima, Kazuhiro; Kubo, Yuichiro; Kunitake, Naonobu

    2018-02-01

    We aimed to clarify renal functional changes long term and serious urological complications in women with cervical cancer who undergo radical hysterectomy followed by pelvic radiotherapy and/or platinum-based chemotherapy to treat the initial disease. Data on 380 women who underwent radical hysterectomy at the National Kyushu Cancer Center from January 1997 to December 2013 were reviewed. Main outcome measures were the estimated glomerular filtration rate (eGFR) and monitored abnormal urological findings. Postoperative eGFR was significantly lower than preoperative eGFR in 179 women with surgery alone and in 201 women with additional pelvic radiotherapy and/or chemotherapy (both P types of univariate analyses for eGFR reduction in women after treatment showed that older age, advanced stage, pelvic radiotherapy, and platinum-based chemotherapy were significant variables on both analyses. Two types of multivariate analyses showed that platinum-based chemotherapy or pelvic radiotherapy were associated with impaired renal function (odds ratio 1.96, 95% confidence interval 1.08-3.54 and odds ratio 2.85, 95% confidence interval 1.12-7.24, for the respective analyses). There was a higher rate of bladder wall thickening in women with pelvic radiotherapy had than those without it (17.4% vs. 2.7%, P chemotherapy and/or postoperative pelvic radiotherapy. Serious and life-threatening urological complications are rare, but surgeons should be aware of the possibility during the long follow-up. © The Author 2017. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

  16. Real-world hospital costs for nonchemotherapy drugs and nondrug care associated with platinum-based doublets in the first-line setting for advanced nonsquamous non-small-cell lung cancer in Chinese patients: a retrospective cohort study

    Directory of Open Access Journals (Sweden)

    Chen JH

    2016-04-01

    Full Text Available Jianhua Chen,1 Shengqi Wu,2 Chenping Hu,3 Yicheng Yang,4 Narayan Rajan,5 Yun Chen,4 Canjuan Yang,6 Jianfeng Li,6 Wendong Chen7 1Department of Medical Oncology, 2Department of Research and Education, Hunan Province Tumor Hospital, 3Department of Respiratory, Xiangya Hospital, Central South University, Changsha, Hunan, 4Lilly Suzhou Pharmaceutical Co., Ltd. Shanghai Branch, Shanghai, People's Republic of China; 5Global Health Outcomes Research, Eli Lilly and Co, Indianapolis, IN, USA; 6Division of Health Outcome Research, Normin Health Changsha Representative Office, Changsha, Hunan, People's Republic of China; 7Normin Health, Toronto, ON, Canada Objective: The objective of this study was to compare hospital costs per treatment cycle (HCTC for nonchemotherapy drugs and nondrug care associated with platinum-based doublets in the first-line setting for advanced nonsquamous non-small-cell lung cancer (AdvNS-NSCLC in Chinese patients. Methods: Patients receiving platinum-based doublets in the first-line setting for AdvNS-NSCLC from 2010 to 2012 in two Chinese tertiary hospitals were identified to create the retrospective study cohort. Propensity score methods were used to create matched treatment groups for head-to-head comparisons on HCTC between pemetrexed–platinum and other platinum-based doublets. Multiple linear regression analyses were performed to rank studied platinum-based doublets for their associations with the log10 scale of HCTC for nonchemotherapy drugs and nondrug care. Results: Propensity score methods created matched treatment groups for pemetrexed–platinum versus docetaxel–platinum (61 pairs, paclitaxel–platinum (39 pairs, gemcitabine–platinum (93 pairs, and vinorelbine–platinum (73 pairs, respectively. Even though the log10 scale of HCTC for nonchemotherapy drugs and nondrug care associated with pemetrexed–platinum was ranked lowest in all patients (coefficient –0.174, P=0.015, which included patients experiencing

  17. Adenosine triphosphate-based chemotherapy response assay (ATP-CRA)-guided platinum-based 2-drug chemotherapy for unresectable nonsmall-cell lung cancer.

    Science.gov (United States)

    Moon, Yong Wha; Choi, Sung Ho; Kim, Yong Tai; Sohn, Joo Hyuk; Chang, Joon; Kim, Se Kyu; Park, Moo Suk; Chung, Kyung Young; Lee, Hyoun Ju; Kim, Joo-Hang

    2007-05-01

    The study investigated correlations between adenosine triphosphate / chemotherapy response assay (ATP-CRA) and clinical outcomes after ATP-CRA-guided platinum-based chemotherapy for unresectable nonsmall-cell lung cancer (NSCLC). The authors performed an in vitro chemosensitivity test, ATP-CRA, to evaluate the chemosensitivities of anticancer drugs such as cisplatin, carboplatin, paclitaxel, docetaxel, gemcitabine, and vinorelbine for chemonaive, unresectable NSCLC. The cell death rate was determined by measuring the intracellular ATP levels of drug-exposed cells compared with untreated controls. A sensitive drug was defined as a drug producing 30% or more reduction in ATP compared with untreated controls. Assay-guided platinum-based 2-drug chemotherapy was given to patients with pathologically confirmed NSCLC. Thirty-four patients were enrolled. Thirty tumor specimens were obtained by bronchoscopic biopsies and 4 obtained surgically. The median age was 61 years and 27 patients had an Eastern Cooperative Oncology Group (ECOG) performance status of 0-1. The response rate was 43.8%. At a median follow-up period of 16.9 months, the median progression-free and overall survivals were 3.6 and 11.2 months, respectively. Patients were dichotomized into the platinum-sensitive (S; 20 patients) and resistant (R; 14 patients) groups. The positive/negative predictive values were 61.1% and 78.6% with a predictive accuracy of 68.8%. Although without significant differences in pretreatment parameters, the S-group showed better clinical response (P=.036), longer progression-free survival (P=.060), and longer overall survival (P=.025). Despite using bronchoscopic biopsied specimens, ATP-CRA and clinical outcomes correlated well after assay-guided platinum-based 2-drug chemotherapy for unresectable NSCLC. There was a favorable response and survival in the platinum-sensitive vs resistant groups. Copyright (c) 2007 American Cancer Society

  18. Platinum-based chemotherapy followed by radiation therapy of locally advanced nasopharyngeal cancer; A retrospective analysis of 39 cases

    Energy Technology Data Exchange (ETDEWEB)

    Fountzilas, G.; Danilidis, J.; Kosmidis, P.; Srihar, K.S.; Kalogera-Fountzila, A.; Nicolaou, A.; Makrantonakis, P.; Banis, K.; Dimitriadis, A.; Sombolos, K.; Zaramboukas, T.; Themelis, C.; Vritsios, A.; Tourkantonis, A. (Ahepa Univ. Hospital, Thessaloniki (Greece) Metaxa Cancer Hospital, Piraeaus (Greece) Miami School of Medicine and VA Hospital, FL (United States). Sylvester Comprehensive Cancer Center)

    1991-01-01

    A retrospective analysis was performed of 39 patients with locally advanced nasopharyngeal cancer treated with combined chemotherapy and radiation therapy during the last five years at our departments. There were 26 men and 13 women with median age 55 (24-75) years. Histology was squamous cell carcinoma in 6 patients and undifferentiated carcinoma in the remaining 33 patients. Induction chemotherapy consisted of either regimen A (cisplating 100 mg/m{sup 2} day 1, 5-FU 1000 mg/m{sup 2} days 2-6 as continuous infusion, bleomycin 15 mg days 15 and 29 i.m., mitomycin 4 mg/m{sup 2} day 22 and hydroxyurea 1000 mg/m{sup 2} daily days 23-27) or regimen B (carboplatin 300 mg/m{sup 2} day 1, 5-FU 1000 mg/m{sup 2} days 1-5 as continuous infusion and methotrexate 1.2 g/m{sup 2} day 14 with leucovorin rescue). After completion of induction chemotherapy 13 patients (33%) had complete remission (CR) and 19 (49%) partial remission (PR). The CR rate was increased after radiation therapy to 72%. Survival rates were 88% at 12 and 78% at 24 months. Median time to progression was 29.5 months. In conclusion, induction chemotherapy with a platinum-based regimen followed by radiation therapy achieved a high rate of local control. If the treatment also prolongs survival must, however, be studied by randomized trials. (orig.).

  19. Association of well-characterized lung cancer lncRNA polymorphisms with lung cancer susceptibility and platinum-based chemotherapy response.

    Science.gov (United States)

    Gong, Wei-Jing; Yin, Ji-Ye; Li, Xiang-Ping; Fang, Chao; Xiao, Di; Zhang, Wei; Zhou, Hong-Hao; Li, Xi; Liu, Zhao-Qian

    2016-06-01

    Long non-coding RNAs (lncRNAs) play important roles in carcinogenesis and drug efficacy. Platinum-based chemotherapy is first-line treatment for lung cancer chemotherapy. In this study, we aimed to investigate the association of well-characterized lung cancer lncRNA genetic polymorphisms with the lung cancer susceptibility and platinum-based chemotherapy response. A total of 498 lung cancer patients and 213 healthy controls were recruited in the study. Among them, 467 patients received at least two cycles of platinum-based chemotherapy. Thirteen polymorphisms in HOXA distal transcript antisense RNA (HOTTIP), HOX transcript antisense intergenic RNA (HOTAIR), H19, CDKN2B antisense RNA 1 (ANRIL), colon cancer-associated transcript 2 (CCAT2), metastasis-associated lung adenocarcinoma transcript 1 (MALAT1), and maternally expressed gene 3 (MEG3) genes were genotyped by allele-specific MALDI-TOF mass spectrometry. We found that patients with HOTTIP rs5883064 C allele or rs1859168 A allele had increased lung cancer risk (P = 0.01, P = 0.01, respectively). CCAT2 rs6983267 (P = 0.02, adenocarcinoma) and H19 rs2107425 (P = 0.02, age under 50 years) showed strong relationship with lung cancer susceptibility. CCAT2 rs6983267, H19 rs2839698, MALAT1 rs619586, and HOTAIR rs7958904 were associated with platinum-based chemotherapy response in dominant model ((P = 0.02, P = 0.04, P = 0.04, P = 0.01, respectively). ANRIL rs10120688 (P = 0.02, adenocarcinoma) and rs1333049 (P = 0.04, small-cell lung cancer), H19 rs2107425 (P = 0.02, small-cell lung cancer) and HOTAIR rs1899663 (P = 0.03, male; P = 0.03, smoker) were associated with response to platinum-based chemotherapy. HOTTIP, CCAT2, H19, HOTAIR, MALATI, ANRIL genetic polymorphisms were significantly associated with lung cancer susceptibility or platinum-based chemotherapy response. They may be potential clinical biomarkers to predict lung cancer risk and platinum-based

  20. Icotinib versus docetaxel used in lung adenocarcinoma patients who failed platinum-based chemotherapy: a retrospective study.

    Science.gov (United States)

    He, Wei; Zhang, Yan; Xiong, Yu; Dai, Feng-Juan; Fan, Qing-Xia

    2016-01-01

    The efficacy and safety of epidermal growth factor receptor tyrosine kinase inhibitors have been studied worldwide. However, there are few reports directly comparing the efficacy and safety between icotinib and docetaxel as second-line treatment in lung adenocarcinoma patients who have failed platinum-based chemotherapy. This article offers insight into this field. A total of 137 patients with stage III or IV lung adenocarcinoma who had progressed on first-line platinum-based therapies and received icotinib or docetaxel therapy between October 2011 and February 2013 were retrospectively reviewed. Patients in the icotinib group received oral icotinib at a dose of 125 mg tid, while patients in the docetaxel group received infusion docetaxel at a dose of 75 mg/m(2) on day 1 of every 21 days (four to six cycles) until disease progression or unacceptable toxicity occurred after which best supportive care was given. There was no statistically significant difference in the objective response rate (23.3% vs 12.5%, P=0.103), progression-free survival (121 days vs 106 days, P=0.083), and overall survival (307 days vs 254 days, P=0.070) between the two groups. As compared to the docetaxel group, the disease control rate (75.3% vs 54.7%, P=0.011) was significantly better in the icotinib group. In the icotinib group, the most common adverse events were rash (35.62%) and diarrhea (24.66%), whereas in the docetaxel group, elevation of transaminase (37.50%), leukopenia (50.00%), and anemia (54.69%) were the most common. Icotinib had similar efficacy and a lower adverse events rate in epidermal growth factor receptor-unselected patients as compared to docetaxel, thereby making it an effective second-line therapy option for lung adenocarcinoma.

  1. The role of adjuvant platinum-based chemotherapy in esophagogastric cancer patients who received neoadjuvant chemotherapy prior to definitive surgery.

    Science.gov (United States)

    Saunders, John H; Bowman, Christopher R; Reece-Smith, Alex M; Pang, Vincent; Dorrington, Matthew S; Mumtaz, Errum; Soomro, Irshad; Kaye, Philip; Madhusudan, Srinivasan; Parsons, Simon L

    2017-06-01

    For patients with operable esophagogastric cancer, peri-operative chemotherapy confers a significant overall survival benefit compared to surgery alone, however only 30-40% of patients demonstrate histopathological response. It is unclear whether those with no neoadjuvant chemotherapy response should go onto receive adjuvant chemotherapy, as no further benefit may be conferred. Esophagogastric cancers were prospectively captured with associated histopathological tumor regression grades following neoadjuvant chemotherapy. This cohort was then interrogated for clinico-pathological and survival outcomes. Following neoadjuvant chemotherapy and surgery, patients with chemotherapy responsive cancers, who were administered adjuvant chemotherapy gained a significant overall survival benefit. Multivariate Cox analysis, demonstrated a final adjusted hazard ratio for adjuvant therapy of 0.509; (95%CI 0.28-0.93); P = 0.028. In contrast, patients with non-responsive tumors, who underwent adjuvant chemotherapy, did not show any survival benefit. Chemotherapy toxicity was prevalent and contributed to only half of patients receiving adjuvant chemotherapy. These results suggest the benefit of the adjuvant portion of chemotherapy is limited to those who demonstrate a histopathological response to neoadjuvant chemotherapy. The administration of the adjuvant portion of chemotherapy to patients without a response to neoadjuvant chemotherapy may not provide any survival benefit, while potentially causing increased morbidity. © 2017 Wiley Periodicals, Inc.

  2. Treatment outcome in performance status 2 advanced NSCLC patients administered platinum-based combination chemotherapy

    DEFF Research Database (Denmark)

    Helbekkmo, Nina; Aasebø, Ulf; Sundstrøm, Stein H

    2008-01-01

    BACKGROUND: There is no consensus regarding chemotherapy to patients with advanced NSCLC (ANSCLC) and performance status (PS) 2. Using data from a national multicenter study comparing two third-generation carboplatin-based regimens in ANSCLC patients, we evaluated the outcome of PS 2 patients....... PATIENTS AND METHODS: The 123 PS 2 patients were compared to 309 PS 0/1 patients regarding survival, quality of life (QOL) and treatment toxicity. RESULTS: PS 2 patients had lower haemoglobin, lower global QOL and more pain, nausea/vomiting and dyspnea at inclusion. 68% of PS 2 patients received three...... chemotherapy courses vs. 85% in the PS 0/1 group (PPS 2 group, 4.5 vs. 8.9 months and 10% vs. 37% (PPS 2 patients needed blood transfusions (P=0.03) and hospitalization (PPS 2 patients had better relief of pain and dyspnea...

  3. Cost-effectiveness of adding cetuximab to platinum-based chemotherapy for first-line treatment of recurrent or metastatic head and neck cancer.

    Directory of Open Access Journals (Sweden)

    Malek B Hannouf

    Full Text Available To assess the cost effectiveness of adding cetuximab to platinum-based chemotherapy in first-line treatment of patients with recurrent or metastatic head and neck squamous cell carcinoma (HNSCC from the perspective of the Canadian public healthcare system.We developed a Markov state transition model to project the lifetime clinical and economic consequences of recurrent or metastatic HNSCC. Transition probabilities were derived from a phase III trial of cetuximab in patients with recurrent or metastatic HNSCC. Cost estimates were obtained from London Health Sciences Centre and the Ontario Case Costing Initiative, and expressed in 2011 CAD. A three year time horizon was used. Future costs and health benefits were discounted at 5%.In the base case, cetuximab plus platinum-based chemotherapy compared to platinum-based chemotherapy alone led to an increase of 0.093 QALY and an increase in cost of $36,000 per person, resulting in an incremental cost effectiveness ratio (ICER of $386,000 per QALY gained. The cost effectiveness ratio was most sensitive to the cost per mg of cetuximab and the absolute risk of progression among patients receiving cetuximab.The addition of cetuximab to standard platinum-based chemotherapy in first-line treatment of patients with recurrent or metastatic HNSCC has an ICER that exceeds $100,000 per QALY gained. Cetuximab can only be economically attractive in this patient population if the cost of cetuximab is substantially reduced or if future research can identify predictive markers to select patients most likely to benefit from the addition of cetuximab to chemotherapy.

  4. Piroxicam and intracavitary platinum-based chemotherapy for the treatment of advanced mesothelioma in pets: preliminary observations

    Directory of Open Access Journals (Sweden)

    Citro Gennaro

    2008-05-01

    Full Text Available Abstract Malignant Mesothelioma is an uncommon and very aggressive tumor that accounts for 1% of all the deaths secondary to malignancy in humans. Interestingly, this neoplasm has been occasionally described in companion animals as well. Aim of this study was the preclinical evaluation of the combination of piroxicam with platinum-based intracavitary chemotherapy in pets. Three companion animals have been treated in a three years period with this combination. Diagnosis was obtained by ultrasonographic exam of the body cavities that evidenced thickening of the mesothelium. A surgical biopsy further substantiated the diagnosis. After drainage of the malignant effusion from the affected cavity, the patients received four cycles of intracavitary CDDP at the dose of 50 mg/m2 every three weeks if dogs or four cycles of intracavitary carboplatin at the dose of 180 mg/m2 (every 3 weeks if cats, coupled with daily administration of piroxicam at the dose of 0.3 mg/kg. The therapy was able to arrest the effusion in all patients for variable remission times: one dog is still in remission after 3 years, one dog died of progressive disease after 8 months and one cat died due to progressive neoplastic growth after six months, when the patient developed a mesothelial cuirass. The combination showed remarkable efficacy at controlling the malignant effusion secondary to MM in our patients and warrants further investigations.

  5. Piroxicam and intracavitary platinum-based chemotherapy for the treatment of advanced mesothelioma in pets: preliminary observations

    Science.gov (United States)

    Spugnini, Enrico P; Crispi, Stefania; Scarabello, Alessandra; Caruso, Giovanni; Citro, Gennaro; Baldi, Alfonso

    2008-01-01

    Malignant Mesothelioma is an uncommon and very aggressive tumor that accounts for 1% of all the deaths secondary to malignancy in humans. Interestingly, this neoplasm has been occasionally described in companion animals as well. Aim of this study was the preclinical evaluation of the combination of piroxicam with platinum-based intracavitary chemotherapy in pets. Three companion animals have been treated in a three years period with this combination. Diagnosis was obtained by ultrasonographic exam of the body cavities that evidenced thickening of the mesothelium. A surgical biopsy further substantiated the diagnosis. After drainage of the malignant effusion from the affected cavity, the patients received four cycles of intracavitary CDDP at the dose of 50 mg/m2 every three weeks if dogs or four cycles of intracavitary carboplatin at the dose of 180 mg/m2 (every 3 weeks) if cats, coupled with daily administration of piroxicam at the dose of 0.3 mg/kg. The therapy was able to arrest the effusion in all patients for variable remission times: one dog is still in remission after 3 years, one dog died of progressive disease after 8 months and one cat died due to progressive neoplastic growth after six months, when the patient developed a mesothelial cuirass. The combination showed remarkable efficacy at controlling the malignant effusion secondary to MM in our patients and warrants further investigations. PMID:18577247

  6. Icotinib versus docetaxel used in lung adenocarcinoma patients who failed platinum-based chemotherapy: a retrospective study

    Directory of Open Access Journals (Sweden)

    He W

    2016-07-01

    Full Text Available Wei He, Yan Zhang, Yu Xiong, Feng-juan Dai, Qing-xia Fan The Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, People’s Republic of China Background: The efficacy and safety of epidermal growth factor receptor tyrosine kinase inhibitors have been studied worldwide. However, there are few reports directly comparing the efficacy and safety between icotinib and docetaxel as second-line treatment in lung adenocarcinoma patients who have failed platinum-based chemotherapy. This article offers insight into this field.Methods: A total of 137 patients with stage III or IV lung adenocarcinoma who had progressed on first-line platinum-based therapies and received icotinib or docetaxel therapy between October 2011 and February 2013 were retrospectively reviewed. Patients in the icotinib group received oral icotinib at a dose of 125 mg tid, while patients in the docetaxel group received infusion docetaxel at a dose of 75 mg/m2 on day 1 of every 21 days (four to six cycles until disease progression or unacceptable toxicity occurred after which best supportive care was given.Results: There was no statistically significant difference in the objective response rate (23.3% vs 12.5%, P=0.103, progression-free survival (121 days vs 106 days, P=0.083, and overall survival (307 days vs 254 days, P=0.070 between the two groups. As compared to the docetaxel group, the disease control rate (75.3% vs 54.7%, P=0.011 was significantly better in the icotinib group. In the icotinib group, the most common adverse events were rash (35.62% and diarrhea (24.66%, whereas in the docetaxel group, elevation of transaminase (37.50%, leukopenia (50.00%, and anemia (54.69% were the most common.Conclusion: Icotinib had similar efficacy and a lower adverse events rate in epidermal growth factor receptor-unselected patients as compared to docetaxel, thereby making it an effective second-line therapy option for lung adenocarcinoma

  7. Elevated serum levels of vascular endothelial growth factor predict a poor prognosis of platinum-based chemotherapy in non-small cell lung cancer

    Directory of Open Access Journals (Sweden)

    Zang JL

    2017-01-01

    Full Text Available Jialan Zang,1–3,* Yong Hu,1,2,* Xiaoyue Xu,1,2 Jie Ni,1,2 Dali Yan,1,2 Siwen Liu,4 Jieyu He,5 Jing Xue,4 Jianzhong Wu,4 Jifeng Feng2 1The Fourth Clinical School of Nanjing Medical University, 2Department of Chemotherapy, Nanjing Medical University Affiliated Cancer Hospital, Nanjing, 3Department of Oncology, The First Hospital of Harbin City, Harbin, 4Center of Clinical Laboratory, Nanjing Medical University Affiliated Cancer Hospital, 5Department of Public Health, Southeast University, Nanjing, People’s Republic of China *These authors contributed equally to this work Aim: This study was designed to investigate the predictive and prognostic values of serum vascular endothelial growth factor (VEGF level in non-small cell lung cancer (NSCLC patients treated with platinum-based chemotherapy. Methods: Patients’ peripheral blood samples were collected prior to chemotherapy and after 1 week of the third cycle of combination chemotherapy. Serum VEGF levels were evaluated through Luminex multiplex technique. Between September 2011 and August 2015, a total of 135 consecutive advanced or recurrent histologically verified NSCLC patients were enrolled in the study. Moreover, all the patients received platinum-based combination chemotherapy as a first-line treatment. Results: No significant associations were found between pretreatment serum VEGF levels and clinical characteristics, such as sex (P=0.0975, age (P=0.2522, stage (P=0.1407, lymph node metastasis (P=0.6409, tumor location (P=0.3520, differentiated degree (P=0.5608, pathological (histological type (P=0.4885, and response to treatment (P=0.9859. The VEGF load per platelet (VEGFPLT levels were not correlated with sex, age, primary tumor site, and pathological type in NSCLC patients (all P>0.05. The median survival time of progression-free survival (PFS was 6.407 and 5.29 months in the low and high groups, respectively, when using 280 pg/mL VEGF level as the cutoff point (P=0.024. Conclusion

  8. Improvement of a predictive model in ovarian cancer patients submitted to platinum-based chemotherapy: implications of a GST activity profile.

    Science.gov (United States)

    Pereira, Deolinda; Assis, Joana; Gomes, Mónica; Nogueira, Augusto; Medeiros, Rui

    2016-05-01

    The success of chemotherapy in ovarian cancer (OC) is directly associated with the broad variability in platinum response, with implications in patients survival. This heterogeneous response might result from inter-individual variations in the platinum-detoxification pathway due to the expression of glutathione-S-transferase (GST) enzymes. We hypothesized that GSTM1 and GSTT1 polymorphisms might have an impact as prognostic and predictive determinants for OC. We conducted a hospital-based study in a cohort of OC patients submitted to platinum-based chemotherapy. GSTM1 and GSTT1 genotypes were determined by multiplex PCR. GSTM1-null genotype patients presented a significantly longer 5-year survival and an improved time to progression when compared with GSTM1-wt genotype patients (log-rank test, P = 0.001 and P = 0.013, respectively). Multivariate Cox regression analysis indicates that the inclusion of genetic information regarding GSTM1 polymorphism increased the predictive ability of risk of death after OC platinum-based chemotherapy (c-index from 0.712 to 0.833). Namely, residual disease (HR, 4.90; P = 0.016) and GSTM1-wt genotype emerged as more important predictors of risk of death (HR, 2.29; P = 0.039; P = 0.036 after bootstrap). No similar effect on survival was observed regarding GSTT1 polymorphism, and there were no statistically significant differences between GSTM1 and GSTT1 genotypes and the assessed patients' clinical-pathological characteristics. GSTM1 polymorphism seems to have an impact in OC prognosis as it predicts a better response to platinum-based chemotherapy and hence an improved survival. The characterization of the GSTM1 genetic profile might be a useful molecular tool and a putative genetic marker for OC clinical outcome.

  9. Comparison of clinical outcome after first-line platinum-based chemotherapy in different types of KRAS mutated advanced non-small-cell lung cancer.

    Science.gov (United States)

    Mellema, Wouter W; Masen-Poos, Lucie; Smit, Egbert F; Hendriks, Lizza E L; Aerts, Joachim G; Termeer, Arien; Goosens, Martijn J; Smit, Hans J M; van den Heuvel, Michel M; van der Wekken, Anthonie J; Herder, Gerarda J M; Krouwels, Frans H; Stigt, Jos A; van den Borne, Ben E E M; Haitjema, Tjeerd J; Staal-Van den Brekel, Agnes J; van Heemst, Robbert C; Pouw, Ellen; Dingemans, Anne-Marie C

    2015-11-01

    As suggested by in-vitro data, we hypothesize that subtypes of KRAS mutated non-small cell lung cancer (NSCLC) respond differently to chemotherapy regimens. Patients with advanced NSCLC and known KRAS mutation, treated with first-line platinum-based chemotherapy, were retrieved from hospital databases. to investigate overall response rate (ORR), progression free survival (PFS) and overall survival (OS) between different types of platinum-based chemotherapy per type of KRAS mutation. 464 patients from 17 hospitals, treated between 2000 and 2013, were included. The majority of patients had stage IV disease (93%), had a history of smoking (98%) and known with an adenocarcinoma (91%). Most common types of KRAS mutation were G12C (46%), G12V (20%) and G12D (10%). Platinum was combined with pemetrexed (n=334), taxanes (n=68) or gemcitabine (n=62). Patients treated with taxanes had a significant improved ORR (50%) compared to pemetrexed (21%) or gemcitabine (25%; pchemotherapy had best ORR. Response to chemotherapy regimens was different in types of KRAS mutation. Especially patients with G12V had better response to taxane treatment. Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

  10. S-1 monotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck after progression on platinum-based chemotherapy

    International Nuclear Information System (INIS)

    Yokota, Tomoya; Onozawa, Yusuke; Boku, Narikazu

    2011-01-01

    Platinum compounds play pivotal roles in treatment for squamous cell carcinoma of the head and neck. The objective was to evaluate the efficacy of S-1 monotherapy in patients with recurrent or metastatic squamous cell carcinoma of the head and neck after failure of platinum-based chemotherapy. We retrospectively analyzed 39 consecutive patients with recurrent or metastatic squamous cell carcinoma of the head and neck who received S-1 monotherapy after failure of platinum-based chemotherapy or chemoradiotherapy at the Shizuoka Cancer Center between August 2003 and October 2010. S-1 was given orally twice daily (80 mg/m 2 /day) for 28 days followed by a 14-day rest. The median follow-up period in survivors was 31.5 months. Among 38 patients with measurable lesions, 9 (24%) showed partial response and 15 (39%) showed stable disease. The median progression-free survival was 4.9 months and the median overall survival was 13.2 months. The median progression-free survival for oropharyngeal cancer (n=7) was significantly longer than for other cancers (n=32) (14.9 vs. 4.7 months, P=0.035). The response rate in patients with a recurrence-free interval since the last platinum administration >6.0 months was significantly better than with a recurrence-free interval 6.0 months also showed a significantly better progression-free survival (6.0 vs. 2.6 months, P=0.045). The frequency of Grade 3/4 toxicities was less than 10%. S-1 monotherapy shows promising signs of efficacy and tolerability in patients with recurrent or metastatic squamous cell carcinoma of the head and neck after failure of platinum-based chemotherapy in this retrospective cohort and warrants further investigation in this population. (author)

  11. Evaluation of point plaster therapy with ginger powder in preventing nausea and vomiting occurred after platinum-based interventional chemotherapy in patients with primary or metastatic liver cancer

    International Nuclear Information System (INIS)

    Lu Haiyan; Yang Yang; Meng Zhiqiang; Chen Leihua

    2010-01-01

    Objective: To evaluate the point plaster therapy with ginger powder combined with ondansetron hydrochloride in preventing nausea and vomiting usually occurred after platinum-based interventional chemotherapy in patients with primary or metastatic liver cancer, and to compared its effectiveness with that by using ondansetron hydrochloride only. Method: Sixty-two patients with primary or metastatic liver cancer, who were scheduled to receive platinum-based interventional chemotherapy, were randomly and equally divided into two groups with 31 cases in each group. The patients in the study group (n = 31) were given point plaster therapy, i.e. externally applying ginger powder (20 g) to the point of Shenque, for four days together with arterial infusion of ondansetron hydrochloride (8 mg) during interventional procedure,while the patients in the control group (n = 31) were given point plaster therapy with placebo (potato powder) together with arterial infusion of ondansetron hydrochloride (8 mg) during interventional procedure. The questionnaire of INVR (index form for evaluating nausea and vomiting) was used to assess the effectiveness, and the results were compared between two groups. Results: The incidence of nausea and vomiting in study group was significantly lower than that in control group at all observed points of time during the period of 0 -72 hours after the treatment (P 0.05). After the treatment the scores of nausea, vomiting and retching in the study group were 0.45, 0.25 and 0.19 respectively, while these in the control group were 2.77, 0.87 and 0.97 respectively, the differences between two groups were statistically significant (P < 0.05). Conclusion: The external application of ginger powder to points of Shenque can markedly decrease the incidence and severity of nausea and vomiting after platinum-based interventional chemotherapy in patients with primary or metastatic liver cancer. (authors)

  12. Predictive value of XPD polymorphisms on platinum-based chemotherapy in non-small cell lung cancer: a systematic review and meta-analysis.

    Directory of Open Access Journals (Sweden)

    Mantang Qiu

    Full Text Available BACKGROUND: The correlation between xeroderma pigmentosum group D (XPD polymorphisms (Lys751Gln and Asp312Asn and clinical outcomes of non-small cell lung cancer (NSCLC patients, who received platinum-based chemotherapy (Pt-chemotherapy, is still inconclusive. This meta-analysis was aimed to systematically review published evidence and ascertain the exact role of XPD polymorphisms. METHODS: Databases of MEDLINE and EMBASE were searched up to April 2013 to identify eligible studies. A rigorous quality assessment of eligible studies was conducted according the Newcastle-Ottawa Quality Assessment Scales. The relationship between XPD polymorphisms and response to Pt-chemotherapy and survival was analyzed. RESULTS: A total of 22 eligible studies were included and analyzed in this meta-analysis. The overall analysis suggested that the XPD Lys751Gln polymorphism was not associated with response to Pt-chemotherapy or survival. However, the XPD 312Asn allele was significantly associated with poor response to Pt-chemotherapy compared with the Asp312 allele (Asn vs. Asp: OR = 0.435, 95% CI: 0.261-0.726. Additionally, the variant genotype of XPD Asp312Asn polymorphism was associated with favorable survival in Caucasian (AspAsn vs. AspAsp: HR = 0.781, 95% CI: 0.619-0.986 but unfavorable survival in Asian (AspAsn+AsnAsn vs. AspAsp: HR = 1.550, 95% CI: 1.038-2.315. CONCLUSIONS: These results suggest that XPD Asp312Asn polymorphism may function as a predictive biomarker on platinum-based chemotherapy in NSCLC and further studies are warranted.

  13. An aCGH classifier derived from BRCA1-mutated breast cancer and benefit of high-dose platinum-based chemotherapy in HER2-negative breast cancer patients

    NARCIS (Netherlands)

    Vollebergh, M. A.; Lips, E. H.; Nederlof, P. M.; Wessels, L. F. A.; Schmidt, M. K.; van Beers, E. H.; Cornelissen, S.; Holtkamp, M.; Froklage, F. E.; de Vries, E. G. E.; Schrama, J. G.; Wesseling, J.; van de Vijver, M. J.; van Tinteren, H.; de Bruin, M.; Hauptmann, M.; Rodenhuis, S.; Linn, S. C.

    Patients and methods: We evaluated this classifier in stage III breast cancer patients, who had been randomly assigned between adjuvant high-dose platinum-based (HD-PB) chemotherapy, a DSB-inducing regimen, and conventional anthracycline-based chemotherapy. Additionally, we assessed BRCA1 loss

  14. Polymorphisms in XPD gene could predict clinical outcome of platinum-based chemotherapy for non-small cell lung cancer patients: a meta-analysis of 24 studies.

    Directory of Open Access Journals (Sweden)

    Qin Qin

    Full Text Available OBJECTIVE: Xeroderma pigmentosum group D (XPD is an essential gene involved in the nucleotide excision repair (NER pathway. Two commonly studied single nucleotide polymorphisms (SNPs of XPD (Lys751Gln, A>C, rs13181; Asp312Asn, G>A, rs1799793 are implicated in the modulation of DNA repair capacity, thus related to the responses to platinum-based chemotherapy. Here we performed a meta-analysis to better evaluate the association between the two XPD SNPs and clinical outcome of platinum-based chemotherapy in non-small cell lung cancer (NSCLC patients. METHODS: A comprehensive search of PubMed database was conducted to identify relevant articles. Primary outcomes included objective response (i.e., complete response + partial response vs. stable disease + progressive disease, progression-free survival (PFS and overall survival (OS. The pooled and 95% confidence intervals (CIs of ORs (odds ratios and HRs (hazard ratios were estimated using the fixed or random effect model. RESULTS: Twenty-four studies were eligible according to the inclusion criteria. None of the XPD Lys751Gln/Asp312Asn polymorphisms was associated with objective response, PFS or OS in NSCLC patients treated with platinum drugs. However, in stratified analysis by ethnicity, the XPD Lys751Gln (A>C polymorphism was not significantly associated with increased response in Caucasians (OR=1.35, 95%CI=1.0-1.83, P=0.122 for heterogeneity but was associated with decreased PFS in Asians (HR=1.39, 95%CI=1.07-1.81, P=0.879 for heterogeneity. Furthermore, a statistically significant difference existed in the estimates of effect between the two ethnicities (P=0.014 for TR; PC may have inverse predictive and prognostic role in platinum-based treatment of NSCLC according to different ethnicities. Further studies are needed to validate our findings.

  15. Clinical Significance of Long Non-Coding RNA CASC8 rs10505477 Polymorphism in Lung Cancer Susceptibility, Platinum-Based Chemotherapy Response, and Toxicity

    Directory of Open Access Journals (Sweden)

    Lei Hu

    2016-05-01

    Full Text Available Long non-coding RNA (lncRNA CASC8 rs10505477 polymorphism has been identified to be related to risk of many kinds of cancers, such as colorectal cancer, gastric cancer, and invasive ovarian cancer, and it may be involved in the prognosis of gastric cancer patients who have received platinum-based chemotherapy after surgical treatment. So far, there is no study investigating the clinical significance of lncRNA CASC8 rs10505477 in lung cancer susceptibility and treatment. In this study, we genotyped 498 lung cancer patients and 213 healthy control subjects to explore the correlation between the rs10505477 polymorphism and lung cancer risk in a Chinese population. Among the 498 patients, 467 were selected for the chemotherapy response and toxicity study. We found that the single nucleotide polymorphisms (SNP rs10505477 was greatly related to lung cancer risk in male and adenocarcinoma subgroups in recessive model (adjusted OR = 0.51, 95%CI = 0.29–0.90, p = 0.02; adjusted OR = 0.52, 95%CI = 0.30–0.89, p = 0.02, respectively. It was also closely correlated with platinum-based chemotherapy response in dominant model (adjusted OR = 1.58, 95%CI = 1.05–2.39, p = 0.03. Additionally, we observed that CASC8 rs10505477 polymorphism was significantly relevant to severe hematologic toxicity in non-small-cell lung cancer (NSCLC subgroup in dominant model (adjusted OR = 0.59, 95%CI = 0.35–0.98, p = 0.04 and in additive model (adjusted OR = 0.62, 95%CI = 0.43–0.90, p = 0.01. Furthermore, it was found that rs10505477 polymorphism was greatly associated with gastrointestinal toxicity in SCLC and cisplatin subgroups in dominant model (adjusted OR = 7.82, 95%CI = 1.36–45.07, p = 0.02; adjusted OR = 1.94, 95%CI = 1.07–3.53, p = 0.03, respectively. Thus, lncRNA CASC8 rs10505477 could serve as a possible risk marker for diagnosing lung cancer, and could be used to forecast the response and toxicity of platinum-based treatment in lung cancer patients.

  16. The association between COX-2 polymorphisms and hematologic toxicity in patients with advanced non-small-cell lung cancer treated with platinum-based chemotherapy.

    Directory of Open Access Journals (Sweden)

    Fei Zhou

    Full Text Available BACKGROUND AND OBJECTIVE: Overexpression of COX-2 is proved to contribute to tumor promotion and carcinogenesis through stimulating cell proliferation, inhibiting apoptosis and enhancing the invasiveness of cancer cells. Apoptosis-related molecules are potential predictive markers for survival and toxicity in platinum treatment. This study aimed at investigating the association between COX-2 polymorphisms and the occurrence of grade 3 or 4 toxicity in advanced non-small cell lung cancer patients treated with platinum-based chemotherapy. MATERIALS AND METHODS: Two hundred and twelve patients with inoperable stage IIIB-IV NSCLC received first-line chemotherapy between 2007 and 2009 were recruited in this study. Four functional COX-2 polymorphisms were genotyped by PCR-based restriction fragment length polymorphism (RFLP methods. RESULTS: The incidence of grade 3 or 4 hematologic toxicity was significantly higher in G allele carriers of the COX-2 rs689466 (-1195G/A polymorphism compared with wild-type homozygotes AA (P value = 0.008; odds ratio, 2.47; 95% confidence internal, 1.26-4.84 and the significance still existed after the Bonferroni correction. Statistically significant difference was also found in grade 3 or 4 leukopenia (P value = 0.010; OR = 2.82; 95%CI = 1.28-6.20. No other significant association was observed between genotype and toxicity in the study. The haplotype analysis showed that the haplotype AGG was associated with a reduced risk of grade 3 or 4 hematologic and leukopenia toxicity (P value = 0.009; OR = 0.59; 95%CI = 0.39-0.88 and P value = 0.025; OR = 0.61; 95%CI = 0.39-0.94, respectively while the haplotype GGG was associated with an increased risk of grade 3 or 4 hematologic and leukopenia toxicity (P value = 0.009; OR = 1.71; 95%CI = 1.14-2.56 and P value = 0.025; OR = 1.65; 95%CI  = 1.06-2.57, respectively. CONCLUSION: This investigation for the first time

  17. Treatment of dogs with oral melanoma by hypofractionated radiation therapy and platinum-based chemotherapy (1987-1997).

    Science.gov (United States)

    Freeman, Kim P; Hahn, Kevin A; Harris, F Dee; King, Glen K

    2003-01-01

    This retrospective study in 39 dogs with incompletely resected oral melanoma examined the efficacy of hypofractionated radiation therapy and platinum-containing chemotherapy. All dogs were completely staged, with the majority of dogs classified as stage 1. Dogs received 6 weekly fractions of 6-gray (Gy) megavoltage irradiation with a cobalt-60 unit or a 4-MeV (megaelectron volts) linear accelerator. Dogs received cisplatin (10-30 mg/m2 IV) or carboplatin (90 mg/m2 IV) chemotherapy 60 minutes before radiation delivery. Durations of local control, metastasis-free survival time, and overall survival time were recorded. By the Kaplan-Meier method, 15% of the dogs had local recurrence within a median time of 139 days. Fifty-one percent of the dogs developed metastatic disease within a median time of 311 days (range, 24-2, 163 days). Median survival time for all 39 dogs was 363 days. The combined use of chemotherapy and radiation therapy in this protocol provided local control consistent with previous studies. Low-dose chemotherapy was used with the intent of enhancing radiation therapy for the local control of an incompletely excised tumor. Survival times were longer than previously reported for dogs with oral malignant melanoma. Additional studies are required to determine whether these results were due to the effects of chemotherapy on microscopic disease or the enhanced local control provided by chemoradiation therapy.

  18. The predictive value of 53BP1 and BRCA1 mRNA expression in advanced non-small-cell lung cancer patients treated with first-line platinum-based chemotherapy

    Science.gov (United States)

    Bonanno, Laura; Costa, Carlota; Majem, Margarita; Sanchez, Jose Javier; Gimenez-Capitan, Ana; Rodriguez, Ignacio; Vergenegre, Alain; Massuti, Bartomeu; Favaretto, Adolfo; Rugge, Massimo; Pallares, Cinta; Taron, Miquel; Rosell, Rafael

    2013-01-01

    Platinum-based chemotherapy is the standard first-line treatment for non-oncogene-addicted non-small cell lung cancers (NSCLCs) and the analysis of multiple DNA repair genes could improve current models for predicting chemosensitivity. We investigated the potential predictive role of components of the 53BP1 pathway in conjunction with BRCA1. The mRNA expression of BRCA1, MDC1, CASPASE3, UBC13, RNF8, 53BP1, PIAS4, UBC9 and MMSET was analyzed by real-time PCR in 115 advanced NSCLC patients treated with first-line platinum-based chemotherapy. Patients expressing low levels of both BRCA1 and 53BP1 obtained a median progression-free survival of 10.3 months and overall survival of 19.3 months, while among those with low BRCA1 and high 53BP1 progression-free survival was 5.9 months (P <0.0001) and overall survival was 8.2 months (P=0.001). The expression of 53BP1 refines BRCA1-based predictive modeling to identify patients most likely to benefit from platinum-based chemotherapy. PMID:24197907

  19. Comparison of clinical outcome after first-line platinum-based chemotherapy in different types of KRAS mutated advanced non-small-cell lung cancer

    NARCIS (Netherlands)

    Mellema, Wouter W.; Masen-Poos, Lucie; Smit, Egbert F.; Hendriks, Lizza E. L.; Aerts, Joachim G.; Termeer, Arien; Goosens, Martijn J.; Smit, Hans J. M.; van den Heuvel, Michel M.; Wekken, van der Anthonie J.; Herder, Gerarda J. M.; Krouwels, Frans H.; Stigt, Jos A.; van den Borne, Ben E. E. M.; Haitjema, Tjeerd J.; Staal-Van den Brekel, Agnes J.; van Heemst, Robbert C.; Pouw, Ellen; Dingemans, Anne-Marie C.

    2015-01-01

    Objectives: As suggested by in-vitro data, we hypothesize that subtypes of ICRAS mutated non-small cell lung cancer (NSCLC) respond differently to chemotherapy regimens. Methods: Patients with advanced NSCLC and known KRAS mutation, treated with first-line platinumbased chemotherapy, were retrieved

  20. A matched-pair comparison of intensity-modulated radiation therapy with cetuximab versus intensity-modulated radiation therapy with platinum-based chemotherapy for locally advanced head neck cancer

    International Nuclear Information System (INIS)

    Huang, J.; Baschnagel, A.M.; Chen, P.; Ye, H.; Krauss, D.; Gustafson, G.; Jaiyesmi, I.; Folbe, M.; Akervall, J.

    2014-01-01

    We retrospectively compared the efficacy of intensity-modulated radiotherapy (IMRT) and cetuximab (IMRT/cetuximab) versus IMRT and platinum-based chemotherapy (IMRT/platinum) for locally advanced head neck squamous cell carcinoma (LAHNSCC). Thirty-one IMRT/cetuximab patients were matched 1:2 with 62 IMRT/platinum patients according to primary site and clinical stage. The primary endpoint was locoregional recurrence (LRR), and secondary endpoints included distant metastasis (DM), cause-specific survival (CSS), and overall survival (OS). Because of inherent selection bias, the IMRT/cetuximab cohort was significantly older and with a higher Charlson Comorbidity Index. IMRT/cetuximab and IMRT/platinum did not have significantly different LRR and DM (33 vs. 23% at 2 years, P=0.22; 17 vs. 11% at 2 years, P=0.40; respectively). IMRT/cetuximab had significantly worse CSS and OS (67 vs. 84%, P=0.04; 58 vs. 83%, P=0.001; respectively). However, for the subset of elderly patients ≥65 years old, there is no difference between the two cohorts for all endpoints (all P=NS). IMRT/platinum should remain the preferred choice of chemoradiotherapy for LAHNSCC, but IMRT/cetuximab may be a reasonable alternative for elderly patients. (author)

  1. Benefit-Risk Summary of Nivolumab for Patients With Metastatic Squamous Cell Lung Cancer After Platinum-Based Chemotherapy: A Report From the US Food and Drug Administration.

    Science.gov (United States)

    Kazandjian, Dickran; Khozin, Sean; Blumenthal, Gideon; Zhang, Lijun; Tang, Shenghui; Libeg, Meredith; Kluetz, Paul; Sridhara, Rajeshwari; Keegan, Patricia; Pazdur, Richard

    2016-01-01

    Metastatic squamous non-small-cell lung cancer (SQ NSCLC) is a serious and life-threatening malignant condition with unmet medical need. In late December 2014, the US Food and Drug Administration (FDA) obtained the data monitoring committee report of a planned interim analysis of a trial in second-line SQ NSCLC (CM017) that demonstrated an overall survival benefit for patients treated with nivolumab compared with docetaxel. In that trial, 272 patients with metastatic SQ NSCLC patients had been randomized to receive nivolumab (n = 135) or docetaxel (n = 137). Median overall survival was 9.2 months for patients randomized to nivolumab and 6.0 months for those randomized to docetaxel (hazard ratio, 0.59; 95% CI, 0.44-0.79; P chemotherapy. The approval provides an important treatment option for these patients, affecting routine care and clinical trials.

  2. Cetuximab plus platinum-based chemotherapy in head and neck squamous cell carcinoma: a retrospective study in a single comprehensive European cancer institution.

    Directory of Open Access Journals (Sweden)

    Ramon Andrade de Mello

    Full Text Available BACKGROUND: The use of cetuximab in combination with platinum (P plus 5-fluorouracil (F has previously been demonstrated to be effective in the treatment of metastatic squamous cell cancer of head and neck (SCCHN. We investigated the efficacy and outcome of this protocol as a first-line treatment for patients with recurrent or metastatic disease. We evaluated overall-survival (OS, progression-free-survival (PFS, overall response rate (ORR and the treatment toxicity profile in a retrospective cohort. PATIENTS AND METHODS: This study enrolled 121 patients with untreated recurrent or metastatic SCCHN. The patients received PF+ cetuximab every 3 weeks for a maximum of 6 cycles. Patients with stable disease who received PF+ cetuximab continued to receive cetuximab until disease progressed or unacceptable toxic effects were experienced, whichever occurred first. RESULTS: The median patient age was 53 (37-78 years. The patient cohort was 86.8% male. The addition of cetuximab to PF in the recurrent or metastatic setting provided an OS of 11 months (Confidential Interval, CI, 95%, 8.684-13.316 and PFS of 8 months (CI 95%, 6.051-9.949. The disease control rate was 48.9%, and the ORR was 23.91%. The most common grade 3 or 4 adverse events in the PF+ cetuximab regimen were febrile neutropenia (5.7%, skin rash (3.8% and mucosistis (3.8%. CONCLUSIONS: The results of this study suggest that cetuximab plus platinum-fluorouracil chemotherapy is a good option for systemic treatment in advanced SSCHN patients. This regimen has a well-tolerated toxicity profile.

  3. Oxaliplatin-Based Doublets Versus Cisplatin or Carboplatin-Based Doublets in the First-Line Treatment of Advanced Nonsmall Cell Lung Cancer.

    Science.gov (United States)

    Yu, Jing; Xiao, Jing; Yang, Yifan; Cao, Bangwei

    2015-07-01

    The efficacy and toxicity of oxaliplatin-based versus carboplatin/cisplatin-based doublets in patients with previously untreated nonsmall cell lung cancer (NSCLC) have been compared.We searched published randomized controlled trials of oxaliplatin-based or carboplatin/cisplatin-based medications for NSCLC. A fixed effect model was used to analyze outcomes which were expressed as the hazard ratio for overall survival (OS) and time-to-progression (TTP), relative risk, overall response rate (ORR), disease control rate (DCR), 1-year survival, and the odds ratios for toxicity were pooled.Eight studies involving 1047 patients were included. ORR tended to favor carboplatin/cisplatin but the effect was not significantly different compared with oxaliplatin doublets (P = 0.05). The effects of OS, TTP, DCR, and 1-year survival between the 2 regimens were comparable. Oxaliplatin doublets caused less grade 3/4 leukocytopenia and neutropenia. Grades 3 to 4 nonhematological toxicities and grades 3 to 4 hematological toxicities showed little difference between oxaliplatin doublets and carboplatin/cisplatin doublets.Meta-analysis shows that the efficacy of oxaliplatin doublets is similar to that of other currently used platinum doublets. The lack of significant differences in the statistic analysis does not preclude genuine differences in clinical efficacy, because higher diversities between the studies covered differences between the 2 groups in each study. Oxaliplatin combined with a third-generation agent should be considered for use as alternative chemotherapy in patients who cannot tolerate conventional platinum-based regimens because the toxicity profile is much more favorable.

  4. High plasma exposure to pemetrexed leads to severe hyponatremia in patients with advanced non small cell lung cancer receiving pemetrexed-platinum doublet chemotherapy

    International Nuclear Information System (INIS)

    Gota, Vikram; Kavathiya, Krunal; Doshi, Kartik; Gurjar, Murari; Damodaran, Solai E; Noronha, Vanita; Joshi, Amit; Prabhash, Kumar

    2014-01-01

    Pemetrexed-platinum doublet therapy is a standard treatment for stage IIIb/IV nonsquamous non small cell lung cancer (NSCLC). While the regimen is associated with several grade ≥3 toxicities, hyponatremia is not a commonly reported adverse effect. Here we report an unusually high incidence of grade ≥3 hyponatremia in Indian patients receiving pemetrexed-platinum doublet, and the pharmacological basis for this phenomenon. Forty-six patients with advanced NSCLC were enrolled for a bioequivalence study of two pemetrexed formulations. All patients received the pemetrexed-platinum doublet for six cycles followed by single-agent pemetrexed maintenance until progression. Pharmacokinetic blood samples were collected at predefined time points during the first cycle and the concentration-time profile of pemetrexed was investigated by noncompartmental analysis. Hyponatremic episodes were investigated with serum electrolytes, serum osmolality, urinary sodium, and urine osmolality. Sixteen of 46 patients (35%) had at least one episode of grade ≥3 hyponatremia. Twenty-four episodes of grade ≥3 hyponatremia were observed in 200 cycles of doublet chemotherapy. Plasma exposure to pemetrexed was significantly higher in patients with high-grade hyponatremia than in those with low-grade or no hyponatremia (P=0.063 and P=0.001, respectively). Pemetrexed clearance in high-grade hyponatremia was quite low compared with normal and low-grade hyponatremia (P=0.001 and P=0.055, respectively). Median pemetrexed exposure in this cohort was much higher than that reported in the literature from Western studies. Higher exposure to pemetrexed is associated with grade ≥3 hyponatremia. The pharmacogenetic basis for higher exposure to pemetrexed in Indian patients needs further investigation

  5. Predictors of pulmonary toxicity in limited stage small cell lung cancer patients treated with induction chemotherapy followed by concurrent platinum-based chemotherapy and 70 Gy daily radiotherapy: CALGB 30904.

    Science.gov (United States)

    Salama, Joseph K; Pang, Herbert; Bogart, Jeffrey A; Blackstock, A William; Urbanic, James J; Hogson, Lydia; Crawford, Jeffrey; Vokes, Everett E

    2013-12-01

    Standard therapy for limited stage small cell lung cancer (L-SCLC) is concurrent chemotherapy and radiotherapy followed by prophylactic cranial radiotherapy. Predictors of post chemoradiotherapy pulmonary toxicity in limited stage (LS) small cell lung cancer (SCLC) patients are not well defined. Current guidelines are derived from non-small cell lung cancer regimens, and do not account for the unique biology of this disease. Therefore, we analyzed patients on three consecutive CALGB LS-SCLC trials treated with concurrent chemotherapy and daily high dose radiotherapy (70 Gy) to determine patient and treatment related factors predicting for post-treatment pulmonary toxicity. Patients treated on CALGB protocols 39808, 30002, 30206 investigating two cycles of chemotherapy followed by concurrent chemotherapy and 70 Gy daily thoracic radiation therapy were pooled. Patient, tumor, and treatment related factors were evaluated to determine predictors of grade 3–5 pulmonary toxicities after concurrent chemoradiotherapy. 100 patients were included. No patient experienced grade 4–5 post-treatment pulmonary toxicity. Patients who experienced post-treatment pulmonary toxicity were more likely to be older (median age 69 vs 60, p = 0.09) and have smaller total lung volumes (2565 cc vs 3530 cc, p = 0.05).). Furthermore,exposure of larger volumes of lung to lower (median V5 = 70%, p = 0.09, median V10 = 63%, p = 0.07), inter-mediate (median V20 = 50, p = 0.04) and high (median V60 = 25%, p = 0.01) doses of radiation were all associated with post-treatment grade 3 pulmonary toxicity, as was a larger mean lung radiation dose(median 31 Gy) p = 0.019. Post-treatment pulmonary toxicity following the completion of 2 cycles of chemotherapy followed by concurrent chemotherapy and high dose daily radiation therapy was uncommon. Care should be taken to minimize mean lung radiation exposure, as well as volumes of low, intermediate and high doses of radiation.

  6. Adenosine triphosphate-based chemotherapy response assay (ATP-CRA)-guided versus empirical chemotherapy in unresectable non-small cell lung cancer.

    Science.gov (United States)

    Moon, Yong Wha; Sohn, Joo Hyuk; Kim, Yong Tai; Chang, Hyun; Jeong, Jae Heon; Lee, Young Joo; Chang, Joon; Kim, Se Kyu; Jung, Minkyu; Hong, Soojung; Choi, Sung Ho; Kim, Joo-Hang

    2009-10-01

    We retrospectively compared adenosine triphosphate-based chemotherapy response assay (ATP-CRA)-guided and empirical chemotherapies for unresectable non-small cell lung cancer (NSCLC) in this case-control study. Unresectable NSCLC patients receiving ATP-CRA-guided platinum-based doublets as first-line therapy were enrolled as cases (n=27; 14 platinum-sensitive and 13 platinum-resistant patients). Performance status, stage, and chemotherapeutic regimen-matched patients receiving empirical chemotherapy were selected from the retrospective database as controls (n=93) in a case to control ratio of approximately 1:3. Response rate and survival (progression-free; overall) in both groups were not significantly different. However, the platinum-sensitive subgroup by ATP-CRA showed a higher response rate than the empirical group (71 versus 38%; p=0.023) with a trend toward longer progression-free survival (8.7 versus 4.8 months for platinum-sensitive versus empirical; p=0.223) and overall survival (not reached versus 12.6 months for platinum-sensitive versus empirical for p=0.134). ATP-CRA may be helpful in selecting platinum-responsive patients in unresectable NSCLC. We consider that nonplatinum doublets in platinum-resistant patients by ATP-CRA may be a more adapted approach than platinum-based doublets in future clinical trials.

  7. Intraperitoneal cisplatin versus no further treatment : 8-year results of EORTC 55875, a randomized phase III study in ovarian cancer patients with a pathologically complete remission after platinum-based intravenous chemotherapy

    NARCIS (Netherlands)

    Piccart, MJ; Floquet, A; Scarfone, G; Willemse, PHB; Emerich, J; Vergote, [No Value; Giurgea, L; Coens, C; Awada, A; Vermorken, JB

    2003-01-01

    First-line intravenous chemotherapy (CT) following debulking surgery is associated with prolonged survival, in particular in patients who achieve a pathological complete remission (pCR) at second-look surgery but in whom a high rate of relapses still occurs. Between 1988 and 1997, 153 patients in

  8. Time-Series Modeling and Simulation for Comparative Cost-Effective Analysis in Cancer Chemotherapy: An Application to Platinum-Based Regimens for Advanced Non-small Cell Lung Cancer.

    Science.gov (United States)

    Chisaki, Yugo; Nakamura, Nobuhiko; Yano, Yoshitaka

    2017-01-01

    The purpose of this study was to propose a time-series modeling and simulation (M&S) strategy for probabilistic cost-effective analysis in cancer chemotherapy using a Monte-Carlo method based on data available from the literature. The simulation included the cost for chemotherapy, for pharmaceutical care for adverse events (AEs) and other medical costs. As an application example, we describe the analysis for the comparison of four regimens, cisplatin plus irinotecan, carboplatin plus paclitaxel, cisplatin plus gemcitabine (GP), and cisplatin plus vinorelbine, for advanced non-small cell lung cancer. The factors, drug efficacy explained by overall survival or time to treatment failure, frequency and severity of AEs, utility value of AEs to determine QOL, the drugs' and other medical costs in Japan, were included in the model. The simulation was performed and quality adjusted life years (QALY) and incremental cost-effectiveness ratios (ICER) were calculated. An index, percentage of superiority (%SUP) which is the rate of the increased cost vs. QALY-gained plots within the area of positive QALY-gained and also below some threshold values of the ICER, was calculated as functions of threshold values of the ICER. An M&S process was developed, and for the simulation example, the GP regimen was the most cost-effective, in case of threshold values of the ICER=$70000/year, the %SUP for the GP are more than 50%. We developed an M&S process for probabilistic cost-effective analysis, this method would be useful for decision-making in choosing a cancer chemotherapy regimen in terms of pharmacoeconomic.

  9. Adjuvant Chemotherapy Improves the Probability of Freedom From Recurrence in Patients With Resected Stage IB Lung Adenocarcinoma.

    Science.gov (United States)

    Hung, Jung-Jyh; Wu, Yu-Chung; Chou, Teh-Ying; Jeng, Wen-Juei; Yeh, Yi-Chen; Hsu, Wen-Hu

    2016-04-01

    The benefit of adjuvant chemotherapy remains controversial for patients with stage IB non-small-cell lung cancer (NSCLC). This study investigated the effect of adjuvant chemotherapy and the predictors of benefit from adjuvant chemotherapy in patients with stage IB lung adenocarcinoma. A total of 243 patients with completely resected pathologic stage IB lung adenocarcinoma were included in the study. Predictors of the benefits of improved overall survival (OS) or probability of freedom from recurrence (FFR) from platinum-based adjuvant chemotherapy in patients with resected stage IB lung adenocarcinoma were investigated. Among the 243 patients, 70 (28.8%) had received platinum-based doublet adjuvant chemotherapy. A micropapillary/solid-predominant pattern (versus an acinar/papillary-predominant pattern) was a significantly worse prognostic factor for probability of FFR (p = 0.033). Although adjuvant chemotherapy (versus surgical intervention alone) was not a significant prognostic factor for OS (p = 0.303), it was a significant prognostic factor for a better probability of FFR (p = 0.029) on multivariate analysis. In propensity-score-matched pairs, there was no significant difference in OS between patients who received adjuvant chemotherapy and those who did not (p = 0.386). Patients who received adjuvant chemotherapy had a significantly better probability of FFR than those who did not (p = 0.043). For patients with a predominantly micropapillary/solid pattern, adjuvant chemotherapy (p = 0.033) was a significant prognostic factor for a better probability of FFR on multivariate analysis. Adjuvant chemotherapy is a favorable prognostic factor for the probability of FFR in patients with stage IB lung adenocarcinoma, particularly in those with a micropapillary/solid-predominant pattern. Copyright © 2016 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

  10. Chemotherapy

    Science.gov (United States)

    ... nurse can help you balance the risks of chemotherapy against the potential benefits. It is important to note that the information provided here is basic and does not take the place of professional advice. If you have any questions ... Publication Quimioterapia (Chemotherapy) Una publicación de ...

  11. Randomized Adjuvant Chemotherapy of EGFR-Mutated Non-Small Cell Lung Cancer Patients with or without Icotinib Consolidation Therapy.

    Science.gov (United States)

    Feng, Siyang; Wang, Yuanyuan; Cai, Kaican; Wu, Hua; Xiong, Gang; Wang, Haofei; Zhang, Ziliang

    2015-01-01

    Epidermal growth factor receptor (EGFR) mutations occur in up to 50% of Asian patients with non-small cell lung cancer (NSCLC). Treatment of advanced NSCLC patients with EGFR-tyrosine kinase inhibitor (EGFR-TKI) confers a significant survival benefit. This study assessed the efficacy and safety of chemotherapy with or without icotinib in patients undergoing resection of stage IB to ⅢA EGFR-mutated NSCLC. Patients with surgically resected stage IB (with high risk factors) to ⅢA EGFR-mutated NSCLC were randomly assigned (1:1) to one of two treatment plans. One group received four cycles of platinum-based doublet chemotherapy every three weeks, and the other group received platinum-based chemotherapy supplemented with consolidation therapy of orally administered icotinib (125 mg thrice daily) two weeks after chemotherapy. The icotinib treatment continued for four to eight months, or until the occurrence of disease relapse, metastasis or unacceptable icotinib or chemotherapy toxicity. The primary endpoint was disease-free survival (DFS). 41 patients were enrolled between Feb 9, 2011 and Dec 17, 2012. 21 patients were assigned to the combined chemotherapy plus icotinib treatment group, while 20 patients received chemotherapy only. DFS at 12 months was 100% for icotinib-treated patients and 88.9% for chemotherapy-only patients (p = 0. 122). At 18 months DFS for icotinib-treated vs. chemotherapy-only patients was 95.2% vs. 83.3% (p = 0. 225), respectively, and at 24 months DFS was 90.5% vs. 66.7% (p = 0. 066). The adverse chemotherapy effects predominantly presented as gastrointestinal reactions and marrow suppression, and there was no significant difference between the two treatment groups. Patients in the chemotherapy plus icotinib treatment group showed favorable tolerance to oral icotinib. The results suggest that chemotherapy plus orally icotinib displayed better DFS compared with chemotherapy only, yet the difference in DFS was not significant. We would think

  12. Randomized Adjuvant Chemotherapy of EGFR-Mutated Non-Small Cell Lung Cancer Patients with or without Icotinib Consolidation Therapy.

    Directory of Open Access Journals (Sweden)

    Siyang Feng

    Full Text Available Epidermal growth factor receptor (EGFR mutations occur in up to 50% of Asian patients with non-small cell lung cancer (NSCLC. Treatment of advanced NSCLC patients with EGFR-tyrosine kinase inhibitor (EGFR-TKI confers a significant survival benefit. This study assessed the efficacy and safety of chemotherapy with or without icotinib in patients undergoing resection of stage IB to ⅢA EGFR-mutated NSCLC.Patients with surgically resected stage IB (with high risk factors to ⅢA EGFR-mutated NSCLC were randomly assigned (1:1 to one of two treatment plans. One group received four cycles of platinum-based doublet chemotherapy every three weeks, and the other group received platinum-based chemotherapy supplemented with consolidation therapy of orally administered icotinib (125 mg thrice daily two weeks after chemotherapy. The icotinib treatment continued for four to eight months, or until the occurrence of disease relapse, metastasis or unacceptable icotinib or chemotherapy toxicity. The primary endpoint was disease-free survival (DFS.41 patients were enrolled between Feb 9, 2011 and Dec 17, 2012. 21 patients were assigned to the combined chemotherapy plus icotinib treatment group, while 20 patients received chemotherapy only. DFS at 12 months was 100% for icotinib-treated patients and 88.9% for chemotherapy-only patients (p = 0. 122. At 18 months DFS for icotinib-treated vs. chemotherapy-only patients was 95.2% vs. 83.3% (p = 0. 225, respectively, and at 24 months DFS was 90.5% vs. 66.7% (p = 0. 066. The adverse chemotherapy effects predominantly presented as gastrointestinal reactions and marrow suppression, and there was no significant difference between the two treatment groups. Patients in the chemotherapy plus icotinib treatment group showed favorable tolerance to oral icotinib.The results suggest that chemotherapy plus orally icotinib displayed better DFS compared with chemotherapy only, yet the difference in DFS was not significant. We would

  13. Randomized Phase III Trial of Erlotinib versus Docetaxel in Patients with Advanced Squamous Cell Non-Small Cell Lung Cancer Failing First-Line Platinum-Based Doublet Chemotherapy Stratified by VeriStrat Good versus VeriStrat Poor. The European Thoracic Oncology Platform (ETOP) EMPHASIS-lung Trial

    NARCIS (Netherlands)

    Peters, Solange; Stahel, Rolf A.; Dafni, Urania; Ponce Aix, Santiago; Massuti, Bartomeu; Gautschi, Oliver; Coate, Linda; Lopez Martin, Ana; van Heemst, Robbert; Berghmans, Thierry; Meldgaard, Peter; Cobo Dols, Manuel; Garde Noguera, Javier; Curioni-Fontecedro, Alessandra; Rauch, Daniel; Mark, Michael T.; Cuffe, Sinead; Biesma, Bonne; van Henten, Arjen M. J.; Juan Vidal, Oscar; Palmer Sanchez, Ramon; Villa Guzman, Jose Carlos; Collado Martin, Ricardo; Peralta, Sergio; Insa, Amelia; Summers, Yvonne; Lang, Istvan; Horgan, Anne; Ciardiello, Fortunato; de Hosson, Sander; Pieterman, Remge; Groen, Harry J. M.; van den Berg, Paul M.; Zielinski, Christoph C.; Kuruvilla, Yojena Chittazhathu Kurian; Gasca-Ruchti, Adriana; Kassapian, Marie; Novell, Silvia; Torri, Valter; Tsourti, Zoi; Gregorc, Vanesa; Smit, Egbert F.

    Introduction: Docetaxel and erlotinib are registered second line treatments for wild-type EGFR NSCLC. Previous studies suggested a predictive value of the VeriStrat test in second line therapy of NSCLC, classifying patients as either VeriStrat good or VeriStrat poor. EMPHASIS-lung aimed at exploring

  14. The retreatment of carboplatin via high-dose intraperitoneal chemotherapy in patients with a history of a hypersensitivity reaction

    NARCIS (Netherlands)

    Kerkhof, M.H.; Ruiz Zapata, A.M.; Bril, H.; Bleeker, M.C.G.; Belien, J.A.M.; Stoop, R.; Helder, M.N.

    2014-01-01

    A hypersensitivity reaction attributed to platinum-based chemotherapy is a relatively common occurrence. Hyperthermic intraperitoneal chemotherapy potentially facilitates the safe retreatment of platinum therapy following this complication. We describe 3 ovarian cancer patients who were successfully

  15. Origins of inert Higgs doublets

    Directory of Open Access Journals (Sweden)

    Thomas W. Kephart

    2016-05-01

    Full Text Available We consider beyond the standard model embedding of inert Higgs doublet fields. We argue that inert Higgs doublets can arise naturally in grand unified theories where the necessary associated Z2 symmetry can occur automatically. Several examples are discussed.

  16. Feasibility Study of Sequentially Alternating EGFR-TKIs and Chemotherapy for Patients with Non-small Cell Lung Cancer.

    Science.gov (United States)

    Takemura, Yoshizumi; Chihara, Yusuke; Morimoto, Yoshie; Tanimura, Keiko; Imabayashi, Tatsuya; Seko, Yurie; Kaneko, Yoshiko; Date, Koji; Ueda, Mikio; Arimoto, Taichiro; Iwasaki, Yoshinobu; Takayama, Koichi

    2018-04-01

    The purpose of this trial was to evaluate the feasibility and efficacy of alternating platinum-based doublet chemotherapy with epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) in patients with EGFR-mutant non-small cell lung cancer (NSCLC). Chemotherapy-naive patients with advanced NSCLC harboring an EGFR mutation were enrolled. All patients underwent induction chemotherapy by sequentially alternating pemetrexed/cisplatin/bevacizumab and EGFR-TKIs followed by maintenance therapy with pemetrexed/bevacizumab and EGFR-TKIs. The primary outcome was the completion rate of the induction therapy. Eighteen eligible patients were enrolled between May 2011 and March 2016. The completion rate of induction therapy was 72.2% (13/18). Unfortunately, one patient developed grade 4 acute renal injury, but no other serious complications concerning this protocol were observed. Furthermore, diarrhea, rashes, and hematological adverse effects were mild. The completion rate of induction therapy was promising. Alternating chemotherapy and EGFR-TKIs should be further investigated regarding feasibility and efficacy. Copyright© 2018, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

  17. The effectiveness and safety of platinum-based pemetrexed and platinum-based gemcitabine treatment in patients with malignant pleural mesothelioma.

    Science.gov (United States)

    Ak, Guntulu; Metintas, Selma; Akarsu, Muhittin; Metintas, Muzaffer

    2015-07-09

    .470). The treatment was generally well tolerated, and the side effects were similar in both groups. The study indicates that platinum-based gemcitabine is effective and a safe schema in malignant pleural mesothelioma. Further research should include large randomized phase III trials comparing these agents.

  18. Semialigned two Higgs doublet model

    Science.gov (United States)

    Haba, Naoyuki; Umeeda, Hiroyuki; Yamada, Toshifumi

    2018-02-01

    In the left-right symmetric model based on S U (2 )L×S U (2 )R×U (1 )B -L gauge symmetry, there appear heavy neutral scalar particles mediating quark flavor changing neutral currents (FCNCs) at tree level. We consider a situation where such FCNCs give the only sign of the left-right model while WR gauge boson is decoupled, and name it "semialigned two Higgs doublet model" because the model resembles a two Higgs doublet model with mildly aligned Yukawa couplings to quarks. We predict a correlation among processes induced by quark FCNCs in the model, and argue that future precise calculation of meson-antimeson mixings and C P violation therein may hint at the semialigned two Higgs doublet model and the left-right model behind it.

  19. Shaping and characteristics of doublet plasmas in Doublet III

    International Nuclear Information System (INIS)

    Ohkawa, T.

    1979-10-01

    The shaping and plasma characteristics of doublet plasmas in Doublet III with high-Z limiters are described. Typical steady-state parameters at B/sub T/ = 24 kG are I/sub p/ = 1.5 MA, V/sub loop/ = 1.6 V, T/sub e/(O) = 1.0 keV, anti n/sub e/ = 4 x 10 13 cm -3 , Z/sub eff/ = 2, q(O) approx. 1 and tau /sub E//sup e/(O) = 20 msec. Electron energy confinement and maximum plasma density are in agreement with standard circular tokamak empirical scaling laws. Chromium and molybdenum appear to be the dominant high-Z plasma contaminants, with relative concentrations of approx. 10/sub -4/. The central power balance does not appear to be dominated by high-Z impurity radiation

  20. Titanium gettering in Doublet III

    International Nuclear Information System (INIS)

    de Grassie, J.S.; Callis, R.; Campbell, G.

    1980-08-01

    The application of mild titanium gettering in the Doublet III tokamak has led to a significant improvement in the obtainable operating regimes and discharge parameters for all of the many plasma cross-sectional shapes studied. With gettering, low-Z impurities and radiated power are greatly reduced. The maximum line averaged electron density has increased 50% (anti n/sub e max/ approx. 1 x 10 20 /m 3 ), corresponding to a Murakami coefficient of nearly 6

  1. Phase III trial comparing vinflunine with docetaxel in second-line advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy

    DEFF Research Database (Denmark)

    Krzakowski, Maciej; Ramlau, Rodryg; Jassem, Jacek

    2010-01-01

    To compare vinflunine (VFL) to docetaxel in patients with stage IIIB/IV non-small-cell lung cancer (NSCLC) who have experienced treatment failure with first-line platinum-based chemotherapy.......To compare vinflunine (VFL) to docetaxel in patients with stage IIIB/IV non-small-cell lung cancer (NSCLC) who have experienced treatment failure with first-line platinum-based chemotherapy....

  2. Doublet method for very fast autocoding

    Directory of Open Access Journals (Sweden)

    Berman Jules J

    2004-09-01

    Full Text Available Abstract Background Autocoding (or automatic concept indexing occurs when a software program extracts terms contained within text and maps them to a standard list of concepts contained in a nomenclature. The purpose of autocoding is to provide a way of organizing large documents by the concepts represented in the text. Because textual data accumulates rapidly in biomedical institutions, the computational methods used to autocode text must be very fast. The purpose of this paper is to describe the doublet method, a new algorithm for very fast autocoding. Methods An autocoder was written that transforms plain-text into intercalated word doublets (e.g. "The ciliary body produces aqueous humor" becomes "The ciliary, ciliary body, body produces, produces aqueous, aqueous humor". Each doublet is checked against an index of doublets extracted from a standard nomenclature. Matching doublets are assigned a numeric code specific for each doublet found in the nomenclature. Text doublets that do not match the index of doublets extracted from the nomenclature are not part of valid nomenclature terms. Runs of matching doublets from text are concatenated and matched against nomenclature terms (also represented as runs of doublets. Results The doublet autocoder was compared for speed and performance against a previously published phrase autocoder. Both autocoders are Perl scripts, and both autocoders used an identical text (a 170+ Megabyte collection of abstracts collected through a PubMed search and the same nomenclature (neocl.xml, containing over 102,271 unique names of neoplasms. In side-by-side comparison on the same computer, the doublet method autocoder was 8.4 times faster than the phrase autocoder (211 seconds versus 1,776 seconds. The doublet method codes 0.8 Megabytes of text per second on a desktop computer with a 1.6 GHz processor. In addition, the doublet autocoder successfully matched terms that were missed by the phrase autocoder, while the

  3. Microwave Ablation in Combination with Chemotherapy for the Treatment of Advanced Non-Small Cell Lung Cancer

    Energy Technology Data Exchange (ETDEWEB)

    Wei, Zhigang, E-mail: weizhigang321321@163.com; Ye, Xin, E-mail: yexintaian@aliyun.com; Yang, Xia, E-mail: yangxjinan@163.com; Zheng, Aimin, E-mail: am-zheng@163.com; Huang, Guanghui, E-mail: hgh3612@163.com; Li, Wenhong, E-mail: wenghong-li@163.com; Ni, Xiang, E-mail: asuka2521@hotmail.com; Wang, Jiao; Han, Xiaoying, E-mail: mylittlecarol@sina.com [Shandong Provincial Hospital Affiliated to Shandong University, Department of Oncology (China)

    2015-02-15

    PurposeTo verify whether microwave ablation (MWA) used as a local control treatment had an improved outcome regarding advanced non-small cell lung cancer (NSCLC) when combined with chemotherapy.MethodsThirty-nine patients with histologically verified advanced NSCLC and at least one measurable site other than the ablative sites were enrolled. Primary tumors underwent MWA followed by platinum-based doublet chemotherapy. Modified response evaluation criteria in solid tumors (mRECIST) and RECIST were used to evaluate therapeutic response. Complications were assessed using the National Cancer Institute Common Toxicity Criteria (version 3.0).ResultsMWA was administered to 39 tumors in 39 patients. The mean and median diameters of the primary tumor were 3.84 cm and 3.30 cm, respectively, with a range of 1.00–9.00 cm. Thirty-three (84.6 %) patients achieved a partial response. No correlation was found between MWA efficacy and clinicopathologic characteristics. For chemotherapy, 11 patients (28.2 %) achieved a partial response, 18 (46.2 %) showed stable disease, and 10 (25.6 %) had progressive disease. The overall objective response rate and disease control rate were 28.2 and 74.4 %, respectively. The median progression-free survival time was 8.7 months (95 % CI 5.5–11.9). The median overall survival time was 21.3 months (95 % CI 17.0–25.4). Complications were observed in 22 (56.4 %) patients, and grade 3 adverse events were observed in 3 (7.9 %) patients.ConclusionsPatients with advanced NSCLC could benefit from MWA in combination with chemotherapy. Complications associated with MWA were common but tolerable.

  4. Structure of matrix metalloproteinase-3 with a platinum-based inhibitor.

    Science.gov (United States)

    Belviso, Benny Danilo; Caliandro, Rocco; Siliqi, Dritan; Calderone, Vito; Arnesano, Fabio; Natile, Giovanni

    2013-06-18

    An X-ray investigation has been performed with the aim of characterizing the binding sites of a platinum-based inhibitor (K[PtCl3(DMSO)]) of matrix metalloproteinase-3 (stromelysin-1). The platinum complex targets His224 in the S1' specificity loop, representing the first step in the selective inhibition process (PDB ID code 4JA1).

  5. The role of support and promoter on the oxidation of sulfur dioxide using platinum based catalysts

    DEFF Research Database (Denmark)

    Koutsopoulos, Sotiris; Rasmussen, Søren Birk; Eriksen, Kim Michael

    2006-01-01

    The catalytic oxidation of SO2 to SO3 was studied over platinum based catalysts in the absence and the presence of dopants. The active metal was supported on silica gel or titania (anatase) by impregnation. The activities of the silica supported catalysts were found to follow the order PtRh/SiO2 ...

  6. THROMBOCYTOSIS AS PROGNOSTIC FACTOR FOR SURVIVAL IN PATIENTS WITH ADVANCED NON SMALL CELL LUNG CANCER TREATED WITH FIRST- LINE CHEMOTHERAPY.

    Directory of Open Access Journals (Sweden)

    Deyan Davidov

    2014-12-01

    Full Text Available Objective: The aim of this study was to evaluate elevated platelet count as a prognostic factor for survival in patients with advanced (stage IIIB/ IV non- small cell lung cancer (NSCLC receiving first- line chemotherapy. Methods: From 2005 to 2009 three hundreds forty seven consecutive patients with stage IIIB or IV NSCLC, treated in Department of Medical Oncology, UMHAT "Dr Georgi Stranski" entered the study. The therapeutic regimens included intravenous administration of platinum- based doublets. Survival analysis was evaluated by Kaplan- Meier test. The influence of pretreatment thrombocytosis as prognostic factor for survival was analyzed using multivariate stepwise Cox regression analyses. Results: Elevated platelet counts were found in 78 patients. The overall survival for patients without elevated platelet counts was 9,6 months versus 6,9 months for these with thrombocytosis. In multivariate analysis as independent poor prognostic factors were identified: stage, performance status and elevated platelet counts. Conclusions: These results indicated that platelet counts as well as some clinical pathologic characteristics could be useful prognostic factors in patients with unresectable NSCLC.

  7. Higgs properties in the Stealth Doublet Model

    Directory of Open Access Journals (Sweden)

    Wouda Glenn

    2013-11-01

    Full Text Available I present a model with two scalar doublets and a softly broken ℤ2 symmetry, where only one of the doublets gets a vacuum expectation value and couples to fermions at tree-level. The softly broken ℤ2 symmetry leads to interesting phenomenology such as mixing between the two doublets and a charged scalar H± which can be light and dominantly decays into Hγ. The model can also naturally reproduce an enhanced γγ signal of the newly observed Higgs boson at the LHC with mass 125 GeV.

  8. Vacuum stability in neutrinophilic Higgs doublet model

    International Nuclear Information System (INIS)

    Haba, Naoyuki; Horita, Tomohiro

    2011-01-01

    A neutrinophilic Higgs model has tiny vacuum expectation value (VEV), which can naturally explain tiny masses of neutrinos. There is a large energy scale hierarchy between a VEV of the neutrinophilic Higgs doublet and that of usual standard model-like Higgs doublet. In this Letter we at first analyze vacuum structures of Higgs potential in both supersymmetry (SUSY) and non-SUSY neutrinophilic Higgs models, and next investigate a stability of this VEV hierarchy against radiative corrections. We will show that the VEV hierarchy is stable against radiative corrections in both Dirac neutrino and Majorana neutrino scenarios in both SUSY and non-SUSY neutrinophilic Higgs doublet models.

  9. Multistage electrodeposition of supported platinum-based nanostructured systems for electrocatalytic applications

    CSIR Research Space (South Africa)

    Mkwizu, TS

    2011-05-01

    Full Text Available .R. Modibedi and Mkhulu K. Mathe* *kmathe@csir.co.za 219th ECS Meeting, 1 ? 6 May, 2011, Montreal, Canada Multistage Electrodeposition of Supported Platinum-based Nanostructured Systems for Electrocatalytic Applications Overview ? Acknowledgements... of constituent elements of the given electrode surface. ? Applications areas: Fuel cells, electrochemical sensors, electrolyzers Introduction e- A B 5 Introduction Atomic-level processes during electrocatalysis www...

  10. Nanoengineering of Ruthenium and Platinum-based Nanocatalysts by Continuous-Flow Chemistry for Renewable Energy Applications

    KAUST Repository

    AlYami, Noktan Mohammed

    2017-01-01

    This thesis presents an integrated study of nanocatalysts for heterogenous catalytic and electrochemical processes using pure ruthenium (Ru) with mixed-phase and platinum-based nanomaterials synthesized by continuous-flow chemistry. There are three

  11. TP53 status and taxane-platinum versus platinum-based therapy in ovarian cancer patients: A non-randomized retrospective study

    Directory of Open Access Journals (Sweden)

    Markowska Janina

    2008-01-01

    Full Text Available Abstract Background Taxane-platinum therapy (TP has replaced platinum-based therapy (PC or PAC, DNA damaging chemotherapy in the postoperative treatment of ovarian cancer patients; however, it is not always effective. TP53 protein plays a differential role in response to DNA-damaging agents and taxanes. We sought to define profiles of patients who benefit the most from TP and also of those who can be treated with PC. Methods We compared the effectiveness of PC/PAC (n = 253 and TP (n = 199 with respect to tumor TP53 accumulation in ovarian cancer patients with FIGO stage IIB-IV disease; this was a non-randomized retrospective study. Immunohistochemical analysis was performed on 452 archival tumors; univariate and multivariate analysis by the Cox's and logistic regression models was performed in all patients and in subgroups with [TP53(+] and without TP53 accumulation [TP53(-]. Results The advantage of taxane-platinum therapy over platinum-based therapy was seen in the TP53(+, and not in the TP53(- group. In the TP53(+ group taxane-platinum therapy enhanced the probability of complete remission (p = .018, platinum sensitivity (p = .014, platinum highly sensitive response (p = .038 and longer survival (OS, p = .008. Poor tumor differentiation diminished the advantage from taxane-platinum therapy in the TP53(+ group. In the TP53(- group PC/PAC was at least equally efficient as taxane-platinum therapy and it enhanced the chance of platinum highly sensitive response (p = .010. However, in the TP53(- group taxane-platinum therapy possibly diminished the risk of death in patients over 53 yrs (p = .077. Among factors that positively interacted with taxane-platinum therapy in some analyses were endometrioid and clear cell type, FIGO III stage, bulky residual tumor, more advanced age of patient and moderate tumor differentiation. Conclusion Our results suggest that taxane-platinum therapy is particularly justified in patients with TP53(+ tumors or older

  12. The development of platinum-based alloys and their thermodynamic database

    OpenAIRE

    Cornish L.A.; Hohls J.; Hill P.J.; Prins S.; Süss R.; Compton D.N.

    2002-01-01

    A series of quaternary platinum-based alloys have been demonstrated to exhibit the same two-phase structure as Ni-based superalloys and showed good mechanical properties. The properties of ternary alloys were a good indication that the quaternary alloys, with their better microstructure, will be even better. The quaternary alloy composition has been optimised at Pt84:Al11:Ru2:Cr3 for the best microstructure and hardness. Work has begun on establishing a thermodynamic database for Pt-Al-Ru-Cr ...

  13. Structural insights into microtubule doublet interactions inaxonemes

    Energy Technology Data Exchange (ETDEWEB)

    Downing, Kenneth H.; Sui, Haixin

    2007-06-06

    Coordinated sliding of microtubule doublets, driven by dynein motors, produces periodic beating of the axoneme. Recent structural studies of the axoneme have used cryo-electron tomography to reveal new details of the interactions among some of the multitude of proteins that form the axoneme and regulate its movement. Connections among the several sets of dyneins, in particular, suggest ways in which their actions may be coordinated. Study of the molecular architecture of isolated doublets has provided a structural basis for understanding the doublet's mechanical properties that are related to the bending of the axoneme, and has also offered insight into its potential role in the mechanism of dynein activity regulation.

  14. Excision repair cross-complementation group 1 (ERCC1) in platinum-based treatment of non-small cell lung cancer with special emphasis on carboplatin: a review of current literature

    DEFF Research Database (Denmark)

    Vilmar, A.; Sorensen, J.B.

    2009-01-01

    on carboplatin based on the current literature. Research on the development of a reliable methodology is warranted followed by validation in large, prospective, randomized trials as ERCC1 may possibly play an important role as tumour marker in tailored chemotherapy for NSCLC Udgivelsesdato: 2009/5......-complementation group 1 (ERCC1) has shown potential as a predictive marker in patients with NSCLC treated with cisplatin-based chemotherapy. Carboplatin has gained widespread use in the treatment of advanced NSCLC and its mechanisms of action are likely similar to that of cisplatin. MATERIALS AND METHODS: A literature...... review on ERCC1 was conducted as predictor in NSCLC patients receiving platinum-based treatment with emphasis on carboplatin. English language publications from January 1996 to February 2008 were eligible and data on methodology and outcome were recorded. RESULTS: Eight preclinical articles, 25 clinical...

  15. Doublet Tracer Testing in Klamath Falls, Oregon

    Energy Technology Data Exchange (ETDEWEB)

    Gudmundsson, J.S.; Johnson, S.E.; Horne, R.N.; Jackson, P. B. [Pet. Eng. Dept., Stanford University; Culver, G.G. [Geo-Heat Center, Oregon Institute of Technology, Klamath Falls, OR

    0001-01-01

    A tracer test was carried out in a geothermal doublet system to study the injection behavior of a developed reservoir known to be fractured. The doublet produces about 320 gpm of 160 degrees Fahrenheit water that is used for space heating and then injected; the wells are spaced 250 ft apart. Tracer breakthrough was observed in 2 hours and 45 minutes in the production well, indicating fracture flow. However, the tracer concentrations were low and indicated porous media flow; the tracers mixed with a reservoir volume much larger than a fracture.

  16. Doublet Tracer Testing in Klamath Falls, Oregon

    Energy Technology Data Exchange (ETDEWEB)

    Gudmundsson, J S; Johnson, S E; Horne, R N; Jackson, P B [Pet. Eng. Dept., Stanford University; Culver, G G [Geo-Heat Center, Oregon Institute of Technology, Klamath Falls, OR

    0000-12-30

    A tracer test was carried out in a geothermal doublet system to study the injection behavior of a developed reservoir known to be fractured. The doublet produces about 320 gpm of 160 degrees Fahrenheit water that is used for space heating and then injected; the wells are spaced 250 ft apart. Tracer breakthrough was observed in 2 hours and 45 minutes in the production well, indicating fracture flow. However, the tracer concentrations were low and indicated porous media flow; the tracers mixed with a reservoir volume much larger than a fracture.

  17. DNA interaction with platinum-based cytostatics revealed by DNA sequencing.

    Science.gov (United States)

    Smerkova, Kristyna; Vaculovic, Tomas; Vaculovicova, Marketa; Kynicky, Jindrich; Brtnicky, Martin; Eckschlager, Tomas; Stiborova, Marie; Hubalek, Jaromir; Adam, Vojtech

    2017-12-15

    The main mechanism of action of platinum-based cytostatic drugs - cisplatin, oxaliplatin and carboplatin - is the formation of DNA cross-links, which restricts the transcription due to the disability of DNA to enter the active site of the polymerase. The polymerase chain reaction (PCR) was employed as a simplified model of the amplification process in the cell nucleus. PCR with fluorescently labelled dideoxynucleotides commonly employed for DNA sequencing was used to monitor the effect of platinum-based cytostatics on DNA in terms of decrease in labeling efficiency dependent on a presence of the DNA-drug cross-link. It was found that significantly different amounts of the drugs - cisplatin (0.21 μg/mL), oxaliplatin (5.23 μg/mL), and carboplatin (71.11 μg/mL) - were required to cause the same quenching effect (50%) on the fluorescent labelling of 50 μg/mL of DNA. Moreover, it was found that even though the amounts of the drugs was applied to the reaction mixture differing by several orders of magnitude, the amount of incorporated platinum, quantified by inductively coupled plasma mass spectrometry, was in all cases at the level of tenths of μg per 5 μg of DNA. Copyright © 2017 Elsevier Inc. All rights reserved.

  18. Prevention of chemotherapy-induced peripheral neuropathy by the small-molecule inhibitor pifithrin-mu

    NARCIS (Netherlands)

    Krukowski, Karen; Nijboer, Cora H.; Huo, XiaoJiao; Kavelaars, Annemieke; Heijnen, Gobi J.

    2015-01-01

    Chemotherapy-induced peripheral neuropathy (CIPN) is a common side effect of cancer treatment. It is the most frequent cause of dose reduction or treatment discontinuation in patients treated for cancer with commonly used drugs including taxanes and platinum-based compounds. No FDA-approved

  19. Clinical practice of adjuvant chemotherapy in patients with early-stage epithelial ovarian cancer

    NARCIS (Netherlands)

    Frielink, Lindy M J; Pijlman, Brenda M; Ezendam, N.P.M.; Pijnenborg, Johanna M A

    2016-01-01

    BACKGROUND: Adjuvant platinum-based chemotherapy improves survival in women with early-stage epithelial ovarian cancer (EOC). Yet, there is a wide variety in clinical practice. METHODS: All patients diagnosed with FIGO I and IIa EOC (2006-2010) in the south of the Netherlands were analyzed. The

  20. Clinical Practice of Adjuvant Chemotherapy in Patients with Early-Stage Epithelial Ovarian Cancer

    NARCIS (Netherlands)

    Frielink, L.M.; Pijlman, B.M.; Ezendam, N.P.; Pijnenborg, J.M.A.

    2016-01-01

    BACKGROUND: Adjuvant platinum-based chemotherapy improves survival in women with early-stage epithelial ovarian cancer (EOC). Yet, there is a wide variety in clinical practice. METHODS: All patients diagnosed with FIGO I and IIa EOC (2006-2010) in the south of the Netherlands were analyzed. The

  1. Chemotherapy for intracranial ependymoma in adults

    International Nuclear Information System (INIS)

    Gramatzki, Dorothee; Roth, Patrick; Felsberg, Jörg; Hofer, Silvia; Rushing, Elisabeth J.; Hentschel, Bettina; Westphal, Manfred; Krex, Dietmar; Simon, Matthias; Schnell, Oliver; Wick, Wolfgang; Reifenberger, Guido; Weller, Michael

    2016-01-01

    Ependymal tumors in adults are rare, accounting for less than 4 % of primary tumors of the central nervous system in this age group. The low prevalence of intracranial ependymoma in adults limits the ability to perform clinical trials. Therefore, treatment decisions are based on small, mostly retrospective studies and the role of chemotherapy has remained unclear. We performed a retrospective study on 17 adult patients diagnosed with intracranial World Health Organisation grade II or III ependymoma, who were treated with chemotherapy at any time during the disease course. Benefit from chemotherapy was estimated by applying Macdonald criteria. Progression-free (PFS) and overall survival (OS) were calculated from start of chemotherapy, using the Kaplan-Meier method. Eleven patients had supratentorial and 6 infratentorial tumors. Ten patients were treated with temozolomide (TMZ), 3 with procarbazine/lomustine/vincristine (PCV), 3 with platinum-based chemotherapy and 1 patient received epirubicin/ifosfamide. Response rates were as follows: TMZ 8/10 stable disease; PCV 3/3 stable disease; platinum-based chemotherapy 1/3 partial response; epirubicin/ifosfamide 1/1 complete response. PFS rates at 6, 12 and 24 months were 52.9, 35.3 and 23.5 %. OS rates at 6, 12 and 24 months were 82.4, 82.4 and 70.1 %. There was no indication for a favourable prognostic role of O 6 -methylguanyl-DNA-methyltransferase (MGMT) promoter methylation which was detected in 3/12 investigated tumors. Survival outcomes in response to chemotherapy in adult intracranial ependymoma patients vary substantially, but individual patients may respond to any kind of chemotherapy. There were too few patients to compare survival data between chemotherapeutic subgroups. The online version of this article (doi:10.1186/s12885-016-2323-0) contains supplementary material, which is available to authorized users

  2. Symmetries for SM Alignment in multi-Higgs Doublet Models

    CERN Document Server

    Pilaftsis, Apostolos

    2016-01-01

    We derive the complete set of maximal symmetries for Standard Model (SM) alignment that may occur in the tree-level scalar potential of multi-Higgs Doublet Models, with $n > 2$ Higgs doublets. Our results generalize the symmetries of SM alignment, without decoupling of large mass scales or fine-tuning, previously obtained in the context of two-Higgs Doublet Models.

  3. On doublet composite schemes of leptons and quarks

    International Nuclear Information System (INIS)

    Pirogov, Yu.F.

    1981-01-01

    All simplest doublet composite schemes are classified. Four different doublet schemes are shown to be available. A new scheme with charge doublet Q=(2/3, -1/3) rather advantageous as compared with the previous ones is being considered. Some difficulties in interpreting the colour as an effective symmetry are pointed out [ru

  4. The development of platinum-based alloys and their thermodynamic database

    Directory of Open Access Journals (Sweden)

    Cornish L.A.

    2002-01-01

    Full Text Available A series of quaternary platinum-based alloys have been demonstrated to exhibit the same two-phase structure as Ni-based superalloys and showed good mechanical properties. The properties of ternary alloys were a good indication that the quaternary alloys, with their better microstructure, will be even better. The quaternary alloy composition has been optimised at Pt84:Al11:Ru2:Cr3 for the best microstructure and hardness. Work has begun on establishing a thermodynamic database for Pt-Al-Ru-Cr alloys, and further work will be done to enhance the mechanical and oxidation properties of the alloys by adding small amounts of other elements to the base composition of Pt84:Al11:Ru2:Cr3.

  5. Intratumoral chemotherapy for lung cancer: re-challenge current targeted therapies

    Directory of Open Access Journals (Sweden)

    Hohenforst-Schmidt W

    2013-07-01

    through passive transport within the tumor. Recent advances have enhanced the diffusion of pharmaceuticals through active transport by using pharmaceuticals designed to target the genome of tumors. In the present study, five patients with non-small cell lung cancer epidermal growth factor receptor (EGFR negative stage IIIa–IV International Union Against Cancer 7 (UICC-7, and with Eastern Cooperative Oncology Group (ECOG 2 scores were administered platinum-based doublet chemotherapy using combined intratumoral-regional and intravenous route of administration. Cisplatin analogues were injected at 0.5%–1% concentration within the tumor lesion and proven malignant lymph nodes according to pretreatment histological/cytological results and the concentration of systemic infusion was decreased to 70% of a standard protocol. This combined intravenous plus intratumoral-regional chemotherapy is used as a first line therapy on this short series of patients. To the best of our knowledge this is the first report of direct treatment of involved lymph nodes with cisplatin by endobronchial ultrasound drug delivery with a needle without any adverse effects. The initial overall survival and local response are suggestive of a better efficacy compared to established doublet cisplatin–based systemic chemotherapy in (higher standard concentrations alone according to the UICC 7 database expected survival. An extensive search of the literature was performed to gather information of previously published literature of intratumoral chemo-drug administration and formulation for this treatment modality. Our study shows a favorable local response, more than a 50% reduction, for a massive tumor mass after administration of five sessions of intratumoral chemotherapy plus two cycles of low-dose intravenous chemotherapy according to our protocol. These encouraging results (even in very sick ECOG 2 patients with central obstructive non-small cell lung cancer having a worse prognosis and quality of

  6. Adjuvant chemotherapy for endometrial cancer after hysterectomy

    Science.gov (United States)

    Johnson, Nick; Bryant, Andrew; Miles, Tracie; Hogberg, Thomas; Cornes, Paul

    2014-01-01

    Background Endometrial adenocarcinoma (womb cancer) is a malignant growth of the lining (endometrium) of the womb (uterus). It is distinct from sarcomas (tumours of the uterine muscle). Survival depends the risk of microscopic metastases after surgery. Adjuvant (postoperative) chemotherapy improves survival from some other adenocarcinomas, and there is evidence that endometrial cancer is sensitive to cytotoxic therapy. This systematic review examines the effect of chemotherapy on survival after hysterectomy for endometrial cancer. Objectives To assess efficacy of adjuvant (postoperative) chemotherapy for endometrial cancer. Search methods We searched the Cochrane Central Register of Controlled Trials (CENTRAL, The Cochrane Library 2010, Issue 3), MEDLINE and EMBASE up to August 2010, registers of clinical trials, abstracts of scientific meetings, reference lists of included studies and contacted experts in the field. Selection criteria Randomised controlled trials (RCTs) comparing adjuvant chemotherapy with any other adjuvant treatment or no other treatment. Data collection and analysis We used a random-effects meta-analysis to assess hazard ratios (HR) for overall and progression-free survival and risk ratios (RR) to compare death rates and site of initial relapse. Main results Five RCTs compared no additional treatment with additional chemotherapy after hysterectomy and radiotherapy. Four trials compared platinum based combination chemotherapy directly with radiotherapy. Indiscriminate pooling of survival data from 2197 women shows a significant overall survival advantage from adjuvant chemotherapy (RR (95% CI) = 0.88 (0.79 to 0.99)). Sensitivity analysis focused on trials of modern platinum based chemotherapy regimens and found the relative risk of death to be 0.85 ((0.76 to 0.96); number needed to treat for an additional beneficial outcome (NNT) = 25; absolute risk reduction = 4% (1% to 8%)). The HR for overall survival is 0.74 (0.64 to 0.89), significantly

  7. Concurrent platinum-based chemotherapy and hyperfractionated radiotherapy with late intensification in advanced head and neck cancer

    International Nuclear Information System (INIS)

    Glicksman, Arvin S.; Wanebo, Harold J.; Slotman, Gus; Liu Li; Landmann, Christine; Clark, Jeffrey; Zhu, Timothy C.; Lohri, Andreas; Probst, Rudolf

    1997-01-01

    Purpose: To determine whether a course of hyperfractionated radiation therapy concomitant with escalated radiosensitizing platinum compounds can be administered with acceptable morbidity and achieve a high rate of loco-regional control for Stage III and IV head and neck cancer and whether the patients can be tumor free at the primary site after initial therapy and cured by the additional chemoradiation without radical resection of the primary tumor. Methods and Materials: Patients with Stage III/IV head and neck cancer were treated in this multicenter Phase II Study with 1.8 Gy fraction radiotherapy for 2 weeks, with escalation to 1.2 Gy b.i.d. hyperfractionation to 46.8 Gy. Concomitant continuous infusion cisplatinum (CDDP) 20 mg per meter square on day 1 to 4 and 22 to 25 was given. Reassessment by biopsy of primary and nodes was done. Patients with a complete response continued with hyperfractionated radiotherapy to 75.6 Gy with simultaneous carboplatinum (Carbo), 25 mg per meter square b.i.d. for 12 consecutive treatment days. Patients with residual disease at 46.8 Gy required curative surgery. Seventy-four patients were treated at the three institutions; 20 were Stage III and 54 were Stage IV. All patients had daily mouth care, nutritional, and psychosocial support. Results: This regime was well tolerated. Eighty-five percent of toxicities were Grade 1 or 2 and there was only one Grade 4 hematologic toxicity. Late toxicities included xerostomia in 25 patients, dysplasia in 18, and mild speech impediment in 11. Biopsies of primary site were done after the first course of treatment in 59 patients. Neck dissections were performed in 35 patients. Forty-four of 59 (75%) primary sites and 16 of 35 (46%) lymph nodes had pathologically complete response (CR). Of the 74 patients, only 12 required surgical resection of the primary site. Thirty-five of the 50 node positive patients had neck dissections, 16 of these were CRs at surgery. At 4 years (median follow-up of 26 months), disease-specific survival is 63%. The actuarial survival for all patients is 51%. Patients with pathological CR after initial treatment have disease specific survival of 73% at 4 years vs. 48% of patients with partial response (PR) only. Conclusion: This study, developed on the basis of radiobiological and cell kinetic precepts, produced results that compare favorably with other reports of management of patients with advanced head and neck cancer. In comparison with our previous study, these results are comparable, not impressively better. The associated morbidity was somewhat worse

  8. Doublet III beamline: as-built

    International Nuclear Information System (INIS)

    Harder, C.R.; Holland, M.M.; Parker, J.W.; Gunn, J.; Resnick, L.

    1980-03-01

    In order to fully exploit Doublet III capabilities and to study new plasma physics regimes, a Neutral Beam Injector System has been constructed. Initially, a two beamline system will supply 7 MW of heat to the plasma. The system is currently being expanded to inject approx. 20 MW of power (6 beamlines). Each beamline is equipped with two Lawrence Berkeley Laboratory type rectangular ion sources with 10 cm x 40 cm extraction grids. These sources will accelerate hydrogen ions to 80 keV, with extracted beam currents in excess of 80 A per source expected. The first completed source is currently being tested and conditioned on the High Voltage Test Stand at Lawrence Livermore Laboratory. This paper pictorially reviews the as-built Doublet III neutral beamline with emphasis on component relation and configuration relative to spatial and source imposed design constraints

  9. Effective Field Theory with Two Higgs Doublets

    CERN Document Server

    Crivellin, Andreas; Procura, Massimiliano

    2016-01-01

    In this article we extend the effective field theory framework describing new physics effects to the case where the underlying low-energy theory is a Two-Higgs-Doublet model. We derive a complete set of independent operators up to dimension six assuming a $Z_2$-invariant CP-conserving Higgs potential. The effects on Higgs and gauge boson masses, mixing angles in the Higgs sector as well as couplings to fermions and gauge bosons are computed. At variance with the case of a single Higgs doublet, we find that pair production of SM-like Higgses, arising through dimension-six operators, is not fixed by fermion-fermion-Higgs couplings and can therefore be sizable.

  10. Doublet III: status and future plans

    International Nuclear Information System (INIS)

    Rawls, J.M.

    1980-04-01

    A synopsis is presented of the experimental results from the ohmic heating phase of Doublet III, with emphasis on the production of good target plasmas for the upcoming neutral beam injection phase. The program plan for the device over the life of the US-Japan cooperative program is discussed, as is the status of the preliminary investigation into replacing the present vacuum vessel by one better suited for ETF simulation

  11. Two Higgs doublets in SO(10) model

    International Nuclear Information System (INIS)

    Asatryan, G.M.

    1989-01-01

    An SO(10) grand unification model is suggested with two light Higgs doublets, whose vacuum expectation values are connected with the SU(2) L xU(1) Y electroweak group breaking. Taking into account the naturality condition associated with absence of flavor changing neutral currents, a certain form of the quark mass matrices. As a result, the proton lifetime in the SO(10) model turns to be strongly restrained

  12. Doublet III construction and engineering test

    International Nuclear Information System (INIS)

    Anon.

    1979-01-01

    Progress during FY-78 on the construction and operation of the Doublet III is reported. Detailed discussions about the installation and testing of various components and subsystems, including the B-coil, E-coil, F-coils and support structure, vacuum vessel, vacuum pumping system, limiter, thermal insulation blanket, control system, B-coil power system, E-coil power system, F-coil power system, and motor-generator, are presented. A brief review of the engineering test operation is given

  13. Can the ''doublet-triplet splitting'' problem be solved without doublet-triplet splitting?

    International Nuclear Information System (INIS)

    Dvali, G.R.

    1992-03-01

    We consider a new possible mechanism for the natural solution of the doublet-triplet splitting problem in SUSY GUTs. In contrast to the usually discussed scenarios, in our case the GUT symmetry breaking does not provide any splitting between the Higgs doublet and the triplet masses. The weak doublet and its colour triplet partner both remain light, but the triplet automatically occurs decoupled from the quark and lepton superfields and cannot induce proton decay. The advantage of the above scenarios is the absence at the GUT scale of the baryon number violating the tree level d = 5 and d = 6 operators via the colour-triple exchange. It is shown that in flipped SU(5) GUT they do not appear at any scale. In the SO(10) model, such operators can be induced after SUSY breaking but are strongly suppressed. (author). 22 refs, 2 figs

  14. Urinary excretion of platinum, arsenic and selenium of cancer patients from the Antofagasta region in Chile treated with platinum-based drugs

    Directory of Open Access Journals (Sweden)

    Román Domingo A

    2012-04-01

    Full Text Available Abstract Background Arsenic exposure increases the risk of non-cancerous and cancerous diseases. In the Antofagasta region in Chile, an established relationship exists between arsenic exposure and the risk of cancer of the bladder, lung and skin. Platinum-based drugs are first-line treatments, and many works recognise selenium as a cancer-fighting nutrient. We characterised the short-term urinary excretion amounts of arsenic, selenium and platinum in 24-h urine samples from patients with lung cancer and those with cancer other than lung treated with cisplatin or/and carboplatin. As - Se - Pt inter-element relationships were also investigated. Results The amounts of platinum excreted in urine were not significantly different between patients with lung cancer and those with other cancers treated with cisplatin, despite the significant variation in platinum amounts supplied from platinum-based drugs. In general, the analytical amounts of excreted selenium were greater than those for arsenic, which could imply that platinum favours the excretion of selenium. For other types of cancers treated with drugs without platinum, excretion of selenium was also greater than that of arsenic, suggesting an antagonist selenium-anti-cancer drug relationship. Conclusions Regards the baseline status of patients, the analytical amounts of excreted Se is greater than those for As, particularly, for cisplatin chemotherapy. This finding could imply that for over the As displacement Pt favours the excretion of Se. The analytical amounts of excreted Se were greater than those for As, either with and without Pt-containing drugs, suggesting an antagonist Se-anti-cancer drug relationship. However, it seemed that differences existed between As - Se - Pt inter-element associations in patients treated for lung cancer in comparison with those treated for cancer other than lung. Therefore, knowledge obtained in this work, can contribute to understanding the arsenic cancer

  15. The parity doublet model with fluctuations

    Energy Technology Data Exchange (ETDEWEB)

    Weyrich, Johannes; Smekal, Lorenz von [TU Darmstadt (Germany); Strodthoff, Nils [Universitaet Heidelberg (Germany)

    2014-07-01

    In the 1970s the Walecka model and the chiral Walecka model were developed and have since been studied intensively. It was noted early on, however, that the chiral model leads to massless Lee-Wick nuclear matter in the chirally restored phase. A promising variant to describe nuclear matter and chiral symmetry restoration consistently is the parity doublet model (or mirror model). It has already been treated in a mean field (MF) approach with promising results. This is motivation for us to to examine this model with functional renormalization group (FRG) methods, hence including full mesonic fluctuations.

  16. Structure of potentials with N Higgs doublets

    International Nuclear Information System (INIS)

    Nishi, C. C.

    2007-01-01

    Extensions of the standard model with N Higgs doublets are simple extensions presenting a rich mathematical structure. An underlying Minkowski structure emerges from the study of both variable space and parameter space. The former can be completely parametrized in terms of two future lightlike Minkowski vectors with spatial parts forming an angle whose cosine is -(N-1) -1 . For the parameter space, the Minkowski parametrization enables one to impose sufficient conditions for bounded below potentials, characterize certain classes of local minima, and distinguish charge breaking vacua from neutral vacua. A particular class of neutral minima presents a degenerate mass spectrum for the physical charged Higgs bosons

  17. Platinum-Based Drugs Differentially Affect the Ultrastructure of Breast Cancer Cell Types

    Directory of Open Access Journals (Sweden)

    Shadia Al-Bahlani

    2017-01-01

    Full Text Available Breast cancer (BC is the most common cause of cancer-related death worldwide. Although platinum-based drugs (PBDs are effective anticancer agents, responsive patients eventually become resistant. While resistance of some cancers to PBDs has been explored, the cellular responses of BC cells are not studied yet. Therefore, we aim to assess the differential effects of PBDs on BC ultrastructure. Three representative cells were treated with different concentrations and timing of Cisplatin, Carboplatin, and Oxaliplatin. Changes on cell surface and ultrastructure were detected by scanning (SEM and transmission electron microscope (TEM. In SEM, control cells were semiflattened containing microvilli with extending lamellipodia while treated ones were round with irregular surface and several pores, indicating drug entry. Prolonged treatment resembled distinct apoptotic features such as shrinkage, membrane blebs, and narrowing of lamellipodia with blunt microvilli. TEM detected PBDs’ deposits that scattered among cellular organelles inducing structural distortion, lumen swelling, chromatin condensation, and nuclear fragmentation. Deposits were attracted to fat droplets, explained by drug hydrophobic properties, while later they were located close to cell membrane, suggesting drug efflux. Phagosomes with destructed organelles and deposits were detected as defending mechanism. Understanding BC cells response to PBDs might provide new insight for an effective treatment.

  18. 2HDM portal for Singlet-Doublet Dark Matter

    OpenAIRE

    Arcadi, Giorgio

    2018-01-01

    We present an extensive analysis of a model in which the (Majorana) Dark Matter candidate is a mixture between a SU(2) singlet and two SU(2) doublets. This kind of setup takes the name of singlet-doublet model. We will investigate in detail an extension of this model in which the Dark Matter sector interactions with a 2-doublet Higgs sector enforcing the complementarity between Dark Matter phenomenology and searches of extra Higgs bosons.

  19. New final doublets and power densities for the international linear ...

    Indian Academy of Sciences (India)

    Abstract. In this paper we use current and proposed final doublet magnet technologies to reoptimise the interaction region of the international linear collider and reduce the power losses. The result is a set of three new final doublet layouts with improved beam transport properties. The effect of localised power deposition and ...

  20. The possible mass region for shears bands and chiral doublets

    Energy Technology Data Exchange (ETDEWEB)

    Meng, J [Institute of Physical and Chemical Research, Wako, Saitama (Japan); Frauendorf, S

    1998-03-01

    The Tilted Axis Cranking (TAC) theory is reviewed. The recent progress of TAC for triaxial deformed nuclei is reported. More emphasis has been paid to the new discovered phenomena - chiral doublets and their explanation. The possible mass region for the shears bands and chiral doublets and their experimental signature are discussed. (author)

  1. Scalar production in models with 1 and 2 Higgs doublets

    International Nuclear Information System (INIS)

    Campos Carvalho, F.L. de.

    1991-03-01

    A standard electroweak interaction model is studied based on the introduction of an additional scalar doublet which rises two neutral scalars, one pseudoscalar and two charged scalars. The doublet introduction gives the possibility to implement constraints issued by the supersymmetry, restricting therefore those scalar masses. (L.C.J.A.)

  2. Progress in Personalizing Chemotherapy for Bladder Cancer

    Directory of Open Access Journals (Sweden)

    James S. Chang

    2012-01-01

    Full Text Available Platinum-based chemotherapy is commonly used for the treatment of locally advanced and metastatic bladder cancer. However, there are currently no methods to predict chemotherapy response in this disease setting. A better understanding of the biology of bladder cancer has led to developments of molecular biomarkers that may help guide clinical decision making. These biomarkers, while promising, have not yet been validated in prospective trials and are not ready for clinical applications. As alkylating agents, platinum drugs kill cancer cells mainly through induction of DNA damage. A microdosing approach is currently being tested to determine if chemoresistance can be identified by measuring platinum-induced DNA damage using highly sensitive accelerator mass spectrometry technology. The hope is that these emerging strategies will help pave the road towards personalized therapy in advanced bladder cancer.

  3. The Doublet III neutral beam injector cryosystem

    International Nuclear Information System (INIS)

    Langhorn, A.R.

    1984-01-01

    This chapter describes neutral beam injection into the Doublet III tokamak for plasma heating experiments. Cryopanels employed in the beamline vacuum pumping system are force flow cooled to 3.8 K by a closed loop refrigeration system. Topics considered include beamline description, cryosystem description, system characteristics, and operational history. Evaluation of the first beamline was carried out using a 25 L/h liquefier and a unique reliquefaction heat exchanger to permit subatmospheric operation and panel flow rates of 140 L/h. The system was upgraded for three beamline operation by substitution of a 100 L/h liquefier and more cryogen storage capacity. It is concluded that the cryosystem gives stable operation of three beamline cryopanel arrays with little operator intervention

  4. Partially natural Two Higgs Doublet Models

    Energy Technology Data Exchange (ETDEWEB)

    Draper, Patrick [Department of Physics, University of California,Broida Hall, Santa Barbara, CA 93106 (United States); Haber, Howard E. [Santa Cruz Institute for Particle Physics, University of California,1156 High Street, Santa Cruz, CA 95064 (United States); Kavli Institute for Theoretical Physics, University of California,Kohn Hall, Santa Barbara, CA 93106 (United States); Ruderman, Joshua T. [Center for Cosmology and Particle Physics, Department of Physics, New York University,4 Washington Pl. New York, NY 10003 (United States)

    2016-06-21

    It is possible that the electroweak scale is low due to the fine-tuning of microscopic parameters, which can result from selection effects. The experimental discovery of new light fundamental scalars other than the Standard Model Higgs boson would seem to disfavor this possibility, since generically such states imply parametrically worse fine-tuning with no compelling connection to selection effects. We discuss counterexamples where the Higgs boson is light because of fine-tuning, and a second scalar doublet is light because a discrete symmetry relates its mass to the mass of the Standard Model Higgs boson. Our examples require new vectorlike fermions at the electroweak scale, and the models possess a rich electroweak vacuum structure. The mechanism that we discuss does not protect a small CP-odd Higgs mass in split or high-scale supersymmetry-breaking scenarios of the MSSM due to an incompatibility between the discrete symmetries and holomorphy.

  5. The impact of reduction of doublet well spacing on the Net Present Value and the life time of fluvial Hot Sedimentary Aquifer doublets

    DEFF Research Database (Denmark)

    Willems, C. J. L.; Nick, H. M.; Goense, T.

    2017-01-01

    This paper evaluates the impact of reduction of doublet well spacing, below the current West Netherlands Basin standard of 1000 - 1500 m, on the Net Present Value (NPV) and the life time of fluvial Hot Sedimentary Aquifer (HSA) doublets. First, a sensitivity analysis is used to show the possible ...... the potential and risks of HSA doublets. This factor significantly affects doublet life time and net energy production of the doublet....

  6. Efficacy of chemotherapy after first-line gefitinib therapy in EGFR mutation-positive advanced non-small cell lung cancer-data from a randomized Phase III study comparing gefitinib with carboplatin plus paclitaxel (NEJ002).

    Science.gov (United States)

    Miyauchi, Eisaku; Inoue, Akira; Kobayashi, Kunihiko; Maemondo, Makoto; Sugawara, Shunichi; Oizumi, Satoshi; Isobe, Hiroshi; Gemma, Akihiko; Saijo, Yasuo; Yoshizawa, Hirohisa; Hagiwara, Koichi; Nukiwa, Toshihiro

    2015-07-01

    Epidermal growth factor receptor tyrosine kinase inhibitors are effective as first-line therapy for advanced non-small cell lung cancer patients harboring epidermal growth factor receptor mutations. However, it is unknown whether second-line platinum-based chemotherapy after epidermal growth factor receptor tyrosine kinase inhibitor therapy could lead to better outcomes. We evaluated the efficacy of second-line platinum-based chemotherapy after gefitinib for advanced non-small cell lung cancers harboring epidermal growth factor receptor mutations (the NEJ002 study). Seventy-one non-small cell lung cancers, treated with gefitinib as first-line therapy and then receiving platinum-based chemotherapy as second-line therapy were evaluated in NEJ002. Patients were evaluated for antitumor response to second-line chemotherapy by computed tomography according to the criteria of the Response Evaluation Criteria in Solid Tumors group (version 1.0). Of the 71 patients receiving platinum-based chemotherapy after first-line gefitinib, a partial response was documented in 25.4% (18/71), stable disease in 43.7% (31/71) and progression of disease in 21.1% (15/71). The objective response and disease control rates were 25.4% (18/71) and 69% (49/71), respectively. There was no significant difference between first- and second-line chemotherapy in objective response and disease control rates for advanced non-small cell lung cancer harboring activating epidermal growth factor receptor mutations. In the analysis of epidermal growth factor receptor mutation types, the objective responses of deletions in exon 19 and a point mutation in exon 21 (L858R) were 27.3% (9/33) and 28.1% (9/32), respectively, but these differences between objective response rates were not significant. The efficacy of second-line platinum-based chemotherapy followed at progression by gefitinib was similar to first-line platinum-based chemotherapy, and epidermal growth factor receptor mutation types did not influence

  7. Molecular mechanisms for synergistic effect of proteasome inhibitors with platinum-based therapy in solid tumors.

    Science.gov (United States)

    Chao, Angel; Wang, Tzu-Hao

    2016-02-01

    The successful development of the proteasome inhibitor bortezomib as an anticancer drug has improved survival in patients with multiple myeloma. With the emergence of the newly US Food and Drug Administration-approved proteasome inhibitor carfilzomib, ongoing trials are investigating this compound and other proteasome inhibitors either alone or in combination with other chemotherapy drugs. However, in solid tumors, the efficacy of proteasome inhibitors has not lived up to expectations. Results regarding the potential clinical efficacy of bortezomib combined with other agents in the treatment of solid tumors are eagerly awaited. Recent identification of the molecular mechanisms (involving apoptosis and autophagy) by which bortezomib and cisplatin can overcome chemotherapy resistance and sensitize tumor cells to anticancer therapy can provide insights into the development of novel therapeutic strategies for patients with solid malignancies. Copyright © 2016. Published by Elsevier B.V.

  8. Chemotherapy treatment is associated with altered PD-L1 expression in lung cancer patients

    DEFF Research Database (Denmark)

    Rojkó, Lívia; Reiniger, Lilla; Téglási, Vanda

    2018-01-01

    Objectives: While the predictive value of programmed cell death ligand-1 (PD-L1) protein expression for immune checkpoint inhibitor therapy of lung cancer has been extensively studied, the impact of standard platinum-based chemotherapy on PD-L1 or programmed cell death-1 (PD-1) expression is unkn...... expression of TC in a subset of patients, therefore, rebiopsy and re-evaluation of PD-L1 expression may be necessary for the indication of immune checkpoint inhibitor therapy.......Objectives: While the predictive value of programmed cell death ligand-1 (PD-L1) protein expression for immune checkpoint inhibitor therapy of lung cancer has been extensively studied, the impact of standard platinum-based chemotherapy on PD-L1 or programmed cell death-1 (PD-1) expression...... is unknown. The aim of this study was to determine the changes in PD-L1 expression of tumor cells (TC) and immune cells (IC), in PD-1 expression of IC, and in the amount of stromal mononuclear cell infiltration after platinum-based chemotherapy in patients with lung cancer. Materials and methods: We...

  9. Flow Injection Analysis with Electrochemical Detection for Rapid Identification of Platinum-Based Cytostatics and Platinum Chlorides in Water

    Directory of Open Access Journals (Sweden)

    Marketa Kominkova

    2014-02-01

    Full Text Available Platinum-based cytostatics, such as cisplatin, carboplatin or oxaliplatin are widely used agents in the treatment of various types of tumors. Large amounts of these drugs are excreted through the urine of patients into wastewaters in unmetabolised forms. This phenomenon leads to increased amounts of platinum ions in the water environment. The impacts of these pollutants on the water ecosystem are not sufficiently investigated as well as their content in water sources. In order to facilitate the detection of various types of platinum, we have developed a new, rapid, screening flow injection analysis method with electrochemical detection (FIA-ED. Our method, based on monitoring of the changes in electrochemical behavior of analytes, maintained by various pH buffers (Britton-Robinson and phosphate buffer and potential changes (1,000, 1,100 and 1,200 mV offers rapid and cheap selective determination of platinum-based cytostatics and platinum chlorides, which can also be present as contaminants in water environments.

  10. A New Linearization Technique Using Multi-sinh Doublet

    Directory of Open Access Journals (Sweden)

    CEHAN, V.

    2009-06-01

    Full Text Available In this paper a new linearization technique using multi-sinh doublet, implemented with a second generation current conveyor is presented. This new linearization technique is compared with the one based on multi-tanh doublets with linearization series connected diodes on the branches. The comparative study of the two linearization techniques is carried out using both dynamic range analysis, expressed by linearity error and the THD value calculation of output current, and the noise behavior of the two analyzed doublets. For the multi-sinh linearization technique proposed in the paper a method which assures the increase of the dynamic range, keeping the transconductance value constant is presented. This is done by using two design parameters: the number of series connected diodes N, which specifies the desired linear operating range and the k emitters areas ratio of the input stage transistors, which establishes the transconductance value. In the paper is also shown that if the transconductances of the two analyzed doublets are identical, and for the same values of N and k parameters, respectively, the current consumption of the multi-sinh doublet is always smaller than for the multi-tanh doublet.

  11. Astragalus-containing Traditional Chinese Medicine, with and without prescription based on syndrome differentiation, combined with chemotherapy for advanced non-small-cell lung cancer: a systemic review and meta-analysis.

    Science.gov (United States)

    Wang, S F; Wang, Q; Jiao, L J; Huang, Y L; Garfield, D; Zhang, J; Xu, L

    2016-06-01

    Traditional Chinese Medicine (tcm) is used in China as part of the treatment for non-small-cell lung cancer (nsclc) and often includes prescription of herbal therapy based on syndrome differentiation. Studies of various Astragalus-based Chinese medicines combined with platinum-based chemotherapy in the treatment of lung cancer are popular in East Asia, particularly in China. The aim of the present study was to perform a systematic review and meta-analysis comparing platinum-based chemotherapy alone with platinum-based chemotherapy plus Astragalus-based Chinese botanicals, with and without prescription based on syndrome differentiation, as first-line treatment for advanced nsclc. We searched the Chinese Biomedical Literature database, the China National Knowledge Internet, the VIP Chinese Science and Technology Periodicals Database, PubMed, embase, the Cochrane databases, and abstracts presented at meetings of the American Society of Clinical Oncology, the World Conference on Lung Cancer, the European Society for Medical Oncology, and the Chinese Society of Clinical Oncology for all eligible studies. Endpoints were overall survival; 1-year, 2-year, and 3-year survival rates; performance status; overall response rate; and grade 3 or 4 adverse events. Subgroup analyses based on herbal formulae individualized using syndrome differentiation or on oral or injection patent medicines were performed using the Stata software application (version 11.0: StataCorp LP, College Station, TX, U.S.A.) and a fixed-effects or random-effects model in case of heterogeneity. Results are expressed as a hazard ratio (hr) or relative risk (rr), with corresponding 95% confidence intervals (cis). Seventeen randomized studies with scores on the Jadad quality scale of 2 or more, representing 1552 patients, met the inclusion criteria. Compared with platinum-based chemotherapy alone, the addition of Astragalus-based tcm to chemotherapy was associated with significantly increased overall survival

  12. Is There a Survival Benefit of First-Line Epidermal Growth Factor Receptor Tyrosine-Kinase Inhibitor Monotherapy Versus Chemotherapy in Patients with Advanced Non-Small-Cell Lung Cancer?: A Meta-Analysis.

    Science.gov (United States)

    Guetz, Gaetan Des; Landre, Thierry; Uzzan, Bernard; Chouahnia, Kader; Nicolas, Patrick; Morere, Jean-François

    2016-02-01

    Tyrosine-kinase inhibitors (TKIs) markedly improve progression-free survival (PFS) of patients with advanced non-small-cell lung cancer (NSCLC) mutated for epidermal growth factor receptor (EGFR). Results on overall survival (OS) are less clear-cut. We performed a publication-based meta-analysis to address further this issue. We did a PubMed query using keywords simultaneously (lung neoplasm, tyrosine kinase inhibitors, epidermal growth factor receptor mutation, survival, and randomized controlled trials). We also searched for relevant abstracts in annual proceedings of ASCO, ESMO, and WCLC meetings. We cross-checked all references from all eligible articles. Only phase III randomized controlled trials comparing TKI monotherapy and platinum-based doublet chemotherapy in first-line treatment of metastatic or advanced NSCLC were included. We used EasyMA software to perform statistical analyses. A random effect model was used in case of heterogeneity between studies (and a fixed effect model in absence of heterogeneity). The eight eligible studies included 2962 patients (780 males, 2182 females, mostly Asian, median age 60 years), 2909 adenocarcinomas (98 %), 1739 mutated tumors (897 exon 19 deletion, 699 L858 mutation), 448 stage IIIB, and 2222 stage IV (75 %) tumours and 2453 never smokers (83 %). Four studies assessed gefitinib, two studies assessed erlotinib, and two studies assessed afatinib. Chemotherapies were doublets including a platinum salt. All studies included patients with EGFR mutations, but six studies included only EGFR mutated patients. OS was similar among patients who first received TKI or chemotherapy (HR 0.98, 95 % CI 0.87-1.10, fixed effect model). Conversely, compared with chemotherapy, EGFR TKIs significantly improved PFS in patients with EGFR-mutated tumours (HR 0.37, 95 % CI 0.29-0.49, random effect model). Concerning side effects, rash (RR 6.29, 95 % CI 4.05-9.77), diarrhoea (RR 3.51, 95 % CI 2.15-5.75), stomatitis (RR 3.57, 95 % CI 1

  13. CP violation conditions in N-Higgs-doublet potentials

    International Nuclear Information System (INIS)

    Nishi, C. C.

    2006-01-01

    Conditions for CP violation in the scalar potential sector of general N-Higgs-doublet models are analyzed from a group theoretical perspective. For the simplest two-Higgs-doublet model potential, a minimum set of conditions for explicit and spontaneous CP violation is presented. The conditions can be given a clear geometrical interpretation in terms of quantities in the adjoint representation of the basis transformation group for the two doublets. Such conditions depend on CP-odd pseudoscalar invariants. When the potential is CP invariant, the explicit procedure to reach the real CP-basis and the explicit CP transformation can also be obtained. The procedure to find the real basis and the conditions for CP violation are then extended to general N-Higgs-doublet model potentials. The analysis becomes more involved and only a formal procedure to reach the real basis is found. Necessary conditions for CP invariance can still be formulated in terms of group invariants: the CP-odd generalized pseudoscalars. The problem can be completely solved for three Higgs-doublets

  14. SEM method for direct visual tracking of nanoscale morphological changes of platinum based electrocatalysts on fixed locations upon electrochemical or thermal treatments

    Energy Technology Data Exchange (ETDEWEB)

    Zorko, Milena [National Institute of Chemistry, Hajdrihova 19, Ljubljana (Slovenia); Centre of Excellence for Low-Carbon Technologies, Hajdrihova 19, Ljubljana (Slovenia); Jozinović, Barbara [Centre of Excellence for Low-Carbon Technologies, Hajdrihova 19, Ljubljana (Slovenia); Bele, Marjan [National Institute of Chemistry, Hajdrihova 19, Ljubljana (Slovenia); Centre of Excellence for Low-Carbon Technologies, Hajdrihova 19, Ljubljana (Slovenia); Hodnik, Nejc, E-mail: nejc.hodnik@ki.si [National Institute of Chemistry, Hajdrihova 19, Ljubljana (Slovenia); Gaberšček, Miran [National Institute of Chemistry, Hajdrihova 19, Ljubljana (Slovenia); Centre of Excellence for Low-Carbon Technologies, Hajdrihova 19, Ljubljana (Slovenia)

    2014-05-01

    A general method for tracking morphological surface changes on a nanometer scale with scanning electron microscopy (SEM) is introduced. We exemplify the usefulness of the method by showing consecutive SEM images of an identical location before and after the electrochemical and thermal treatments of platinum-based nanoparticles deposited on a high surface area carbon. Observations reveal an insight into platinum based catalyst degradation occurring during potential cycling treatment. The presence of chloride clearly increases the rate of degradation. At these conditions the dominant degradation mechanism seems to be the platinum dissolution with some subsequent redeposition on the top of the catalyst film. By contrast, at the temperature of 60 °C, under potentiostatic conditions some carbon corrosion and particle aggregation was observed. Temperature treatment simulating the annealing step of the synthesis reveals sintering of small platinum based composite aggregates into uniform spherical particles. The method provides a direct proof of induced surface phenomena occurring on a chosen location without the usual statistical uncertainty in usual, random SEM observations across relatively large surface areas. - Highlights: • A new SEM method for observations of identical locations. • Nanoscale morphological consecutive changes on identical locations. • Electrochemical and thermal treatments on platinum based nanoparticles. • Potential cycling induces platinum dissolution with redeposition on top of the film. • At 1.4 V vs. RHE and 60 °C carbon corrosion and particle aggregation is observed.

  15. Two-Higgs-doublet models with Minimal Flavour Violation

    International Nuclear Information System (INIS)

    Carlucci, Maria Valentina

    2010-01-01

    The tree-level flavour-changing neutral currents in the two-Higgs-doublet models can be suppressed by protecting the breaking of either flavour or flavour-blind symmetries, but only the first choice, implemented by the application of the Minimal Flavour Violation hypothesis, is stable under quantum corrections. Moreover, a two-Higgs-doublet model with Minimal Flavour Violation enriched with flavour-blind phases can explain the anomalies recently found in the ΔF = 2 transitions, namely the large CP-violating phase in B s mixing and the tension between ε K and S ψKS .

  16. Adjuvant chemotherapy for elderly patients with stage I non-small-cell lung cancer ≥4 cm in size: an SEER-Medicare analysis.

    Science.gov (United States)

    Malhotra, J; Mhango, G; Gomez, J E; Smith, C; Galsky, M D; Strauss, G M; Wisnivesky, J P

    2015-04-01

    The role of adjuvant chemotherapy for non-small-cell lung cancer (NSCLC) stage I patients with tumors size ≥4 cm is not well established in the elderly. We identified 3289 patients with stage I NSCLC (T2N0M0 and tumor size ≥4 cm) who underwent lobectomy from the Surveillance, Epidemiology and End Results (SEER)-Medicare linked database diagnosed from 1992 to 2009. Overall survival and rates of serious adverse events (defined as those requiring admission to hospital) were compared between patients treated with resection alone, platinum-based adjuvant chemotherapy, or postoperative radiation (PORT) with or without adjuvant chemotherapy. Propensity scores for receiving each treatment were calculated and survival analyses were conducted using inverse probability weights based on the propensity score. Overall, 84% patients were treated with resection alone, 9% received platinum-based adjuvant chemotherapy, and 7% underwent PORT with or without adjuvant chemotherapy. Adjusted analysis showed that adjuvant chemotherapy [hazard ratio (HR), 0.82; 95% confidence interval (CI) 0.68-0.98] was associated with improved survival compared with resection alone. Conversely, the use of PORT with or without adjuvant chemotherapy (HR 1.91; 95% CI 1.64-2.23) was associated with worse outcomes. Patients receiving adjuvant chemotherapy had more serious adverse events compared with those treated with resection alone, with neutropenia (odds ratio, 21.2; 95% CI 5.8-76.6) being most significant. No significant difference was observed in rates of fever, cytopenias, nausea, and renal dysfunction. Platinum-based adjuvant chemotherapy is associated with reduced mortality and increased serious adverse events in elderly patients with stage I NSCLC and tumor size ≥4 cm. © The Author 2015. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For permissions, please email: journals.permissions@oup.com.

  17. Precision lifetime measurements of Ar II 4p doublet levels

    International Nuclear Information System (INIS)

    Marger, D.; Schmoranzer, H.

    1990-01-01

    The lifetimes of the Ar II 4p doublet fine-structure levels 4p 2 D 0 5/2 , 4p' 2 F 0 5/2 and 4p' 2 F 0 7/2 were measured by beam-dye laser spectroscopy. The experimental uncertainty was reduced to below 1%. (orig.)

  18. Origin and phenomenology of weak-doublet spin-1 bosons

    International Nuclear Information System (INIS)

    Chizhov, M.V.; Dvali, Gia

    2011-01-01

    We study phenomenological consequences of the Standard Model extension by the new spin-1 fields with the internal quantum numbers of the electroweak Higgs doublets. We show, that there are at least three different classes of theories, all motivated by the hierarchy problem, which predict appearance of such vector weak-doublets not far from the weak scale. The common feature for all the models is the existence of an SU(3) W gauge extension of the weak SU(2) W group, which is broken down to the latter at some energy scale around TeV. The Higgs doublet then emerges as either a pseudo-Nambu-Goldstone boson of a global remnant of SU(3) W , or as a symmetry partner of the true eaten-up Goldstone boson. In the third class, the Higgs is a scalar component of a high-dimensional SU(3) W gauge field. The common phenomenological feature of these theories is the existence of the electroweak doublet vectors (Z * ,W * ), which in contrast to well-known Z ' and W ' bosons posses only anomalous (magnetic moment type) couplings with ordinary light fermions. This fact leads to some unique signatures for their detection at the hadron colliders.

  19. Separation of the 1+ /1- parity doublet in 20Ne

    Science.gov (United States)

    Beller, J.; Stumpf, C.; Scheck, M.; Pietralla, N.; Deleanu, D.; Filipescu, D. M.; Glodariu, T.; Haxton, W.; Idini, A.; Kelley, J. H.; Kwan, E.; Martinez-Pinedo, G.; Raut, R.; Romig, C.; Roth, R.; Rusev, G.; Savran, D.; Tonchev, A. P.; Tornow, W.; Wagner, J.; Weller, H. R.; Zamfir, N.-V.; Zweidinger, M.

    2015-02-01

    The (J , T) = (1 , 1) parity doublet in 20Ne at 11.26 MeV is a good candidate to study parity violation in nuclei. However, its energy splitting is known with insufficient accuracy for quantitative estimates of parity violating effects. To improve on this unsatisfactory situation, nuclear resonance fluorescence experiments using linearly and circularly polarized γ-ray beams were used to determine the energy difference of the parity doublet ΔE = E (1-) - E (1+) = - 3.2(± 0.7) stat(-1.2+0.6)sys keV and the ratio of their integrated cross sections Is,0(+) /Is,0(-) = 29(± 3) stat(-7+14)sys. Shell-model calculations predict a parity-violating matrix element having a value in the range 0.46-0.83 eV for the parity doublet. The small energy difference of the parity doublet makes 20Ne an excellent candidate to study parity violation in nuclear excitations.

  20. Generation of deviation parameters for amino acid singlets, doublets ...

    Indian Academy of Sciences (India)

    We present a new method, secondary structure prediction by deviation parameter (SSPDP) for predicting the secondary structure of proteins from amino acid sequence. Deviation parameters (DP) for amino acid singlets, doublets and triplets were computed with respect to secondary structural elements of proteins based on ...

  1. Development of thermal fractures in two Dutch geothermal doublets

    NARCIS (Netherlands)

    Loeve, D.; Veldkamp, J.G.; Peters, E.; Wees, J.D.A.M. van

    2015-01-01

    In the production well of a low-enthalpy geothermal doublet hot water is pumped from reservoirs at about 50-1007deg;C. After passing through a heat exchanger, the cold water is re-injected at about 20-357deg;C in the injection well into the reservoir, which initially has the same temperature as the

  2. The influence of reservoir heterogeneities on geothermal doublet performance

    NARCIS (Netherlands)

    Doddema, Leon

    2012-01-01

    SUMMARY The current main problem with deep geothermal energy in the Netherlands is the uncertainty in terms of attainable flow rate and life time. The goal of this research is therefore modeling a geothermal doublet in a heterogeneous reservoir, using a

  3. Doublet III neutral beam multi-stream command language system

    International Nuclear Information System (INIS)

    Campbell, L.; Garcia, J.R.

    1983-01-01

    A multi-stream command language system was developed to provide control of the dual source neutral beam injectors on the Doublet III experiment at GA Technologies Inc. The Neutral Beam command language system consists of three parts: compiler, sequencer, and interactive task. The command language, which was derived from the Doublet III tokamak command language, POPS, is compiled, using a recursive descent compiler, into reverse polish notation instructions which then can be executed by the sequencer task. The interactive task accepts operator commands via a keyboard. The interactive task directs the operation of three input streams, creating commands which are then executed by the sequencer. The streams correspond to the two sources within a Doublet III neutral beam, plus an interactive stream. The sequencer multiplexes the execution of instructions from these three streams. The instructions include reads and writes to an operator terminal, arithmetic computations, intrinsic functions such as CAMAC input and output, and logical instructions. The neutral beam command language system was implemented using Modular Computer Systems (ModComp) Pascal and consists of two tasks running on a ModComp Classic IV computer. The two tasks, the interactive and the sequencer, run independently and communicate using shared memory regions. The compiler runs as an overlay to the interactive task when so directed by operator commands. The system is succesfully being used to operate the three neutral beams on Doublet III

  4. Isomer shifts of the octupole doublet in muonic 207Pb

    International Nuclear Information System (INIS)

    Budick, B.; Anigstein, R.; Kast, J.W.

    1980-01-01

    Isomer shifts in the doublet 5/2 + , 7/2 + levels in muonic 207 Pb have been measured. The shifts are essentially the same as in the core 3 - collective state. They support the hypothesis that the octupole vibration does not conserve volume. (orig.)

  5. Optimization of an electrostatic quadrupole doublet focusing systems

    Energy Technology Data Exchange (ETDEWEB)

    Hussein, Oday A., E-mail: oah@sc.nahrainuniv.edu.iq [Department of Physics, College of Science, Al-Nahrain University, Baghdad (Iraq); Sise, Omer [Department of Science Education, Faculty of Education, Suleyman Demirel University, Isparta (Turkey)

    2017-05-15

    Highlights: • The imaging properties of an electrostatic quadrupole doublet lens were analyzed with the aid of computer simulation. • The optimal electrode voltages which lead to stigmatic image in both planes of the quadrupole doublet lens with minimum spot size at position sensitive detector (PSD) were found for two operation modes: point-to-point focusing and parallel-to-point focusing. • The imaging properties of are very sensitive to the lunching angle of the electron-beam. - Abstract: The imaging properties of an electrostatic quadrupole doublet lens were analyzed with the aid of computer simulation. The optimal electrode voltages which lead to stigmatic image in both planes of the quadrupole doublet lens with minimum spot size at position sensitive detector (PSD) were found for two operation modes: point-to-point focusing and parallel-to-point focusing. The optical properties as: Magnifications, spot sizes in the image plane and aberration figures were discussed. The results showed that the focusing of the lens was strong in the xy-plane in comparison with the focusing in the xz-plane. The distortion of the image was greater when the image position will be close to the lens in comparison with object position. Also, the imaging properties were very sensitive to the lunching angle of the electron-beam.

  6. Measurements of Narrow Mg II Associated Absorption Doublets with ...

    Indian Academy of Sciences (India)

    2016-01-27

    Jan 27, 2016 ... The measurement of the variations of absorption lines over time is a good method to study the physical conditions of absorbers. In this paper, we measure the variations of the line strength of 36 narrow Mg II2796, 2803 associated absorption doublets, which are imprinted on 31 quasar spectra with two ...

  7. Outcomes in 24 selected patients with stage IVB cervical cancer and excellent performance status treated with radiotherapy and chemotherapy

    International Nuclear Information System (INIS)

    Zighelboim, Israel; Taylor, Nicholas P.; Powell, Matthew A.; Gibb, Randall K.; Rader, Janet S.; Mutch, David G.; Grigsby, Perry W.

    2006-01-01

    We sought to review outcomes in patients with stage IVB carcinoma of the cervix treated with irradiation in combination with chemotherapy. We report outcomes of 24 consecutive patients with good performance status treated from 1998 to 2005. Most of these patients underwent concurrent irradiation with platinum-based chemotherapy. Some patients received subsequent systemic chemotherapy. All patients underwent external beam radiotherapy; 7 patients (29%) had additional high-dose-rate and 12 (50%) low-dose-rate brachytherapy. Two patients (8%) received an intensity modulated radiation therapy (IMRT) boost instead of brachytherapy. The mean dose to point A was variable (73.9±19.2 Gy). Twenty patients (83%) received radio-sensitizing platinum-based chemotherapy, and the remaining had radiotherapy alone. Seven patients (29%) had further combination chemotherapy. Therapy was well tolerated. The overall survival was 44% at 36 months and 22% at 5 years. Patients with stage IVB cervical cancer have mostly been treated with palliative intent. With the advent of concurrent chemoradiation, we have treated many of these cases with aggressive combination therapy. In this series, the use of radiotherapy and multiagent chemotherapy in patients with stage IVB cervical carcinoma and good performance status was well tolerated and resulted in higher survival rates than previously reported. (author)

  8. Temporal changes of the inner core from waveform doublets

    Science.gov (United States)

    Yang, Y.; Song, X.

    2017-12-01

    Temporal changes of the Earth's inner core have been detected from earthquake waveform doublets (repeating sources with similar waveforms at the same station). Using doublets from events up to the present in the South Sandwich Island (SSI) region recorded by the station COLA (Alaska), we confirmed systematic temporal variations in the travel time of the inner-core-refracted phase (PKIKP, the DF branch). The DF phase arrives increasingly earlier than outer core phases (BC and AB) by rate of approximately 0.07 s per decade since 1970s. If we assume that the temporal change is caused by a shift of the lateral gradient from the inner core rotation as in previous studies, we estimate the rotation rate of 0.2-0.4 degree per year. We also analyzed the topography of the inner core boundary (ICB) using SSI waveform doublets recorded by seismic stations in Eurasia and North America with reflected phase (PKiKP) and refracted phases. There are clear temporal changes in the waveforms of doublets for PKiKP under Africa and Central America. In addition, for doublets recorded by three nearby stations (AAK, AML, and UCH), we observed systematic change in the relative travel time of PKiKP and PKIKP. The temporal change of the (PKiKP - PKIKP) differential time is always negative for the event pairs if both events are before 2007, while it fluctuates to positive if the later event occurs after 2007. The rapid temporal changes in space and time may indicate localized processes (e.g., freezing and melting) of the ICB in the recent decades under Africa. We are exploring 4D models consistent with the temporal changes.

  9. Tumor-infiltrating lymphocytes predict response to chemotherapy in patients with advance non-small cell lung cancer.

    Science.gov (United States)

    Liu, Hui; Zhang, Tiantuo; Ye, Jin; Li, Hongtao; Huang, Jing; Li, Xiaodong; Wu, Benquan; Huang, Xubing; Hou, Jinghui

    2012-10-01

    Accumulating preclinical evidence suggests that anticancer immune responses contribute to the success of chemotherapy. The predictive significance of tumor-infiltrating lymphocytes (TILs) for response to neoadjuvant chemotherapy in non-small cell lung cancer (NSCLC) remains unknown. The aim of this study was to investigate the prognostic and predictive value of TIL subtypes in patients with advanced NSCLC treated with platinum-based chemotherapy. In total, 159 patients with stage III and IV NSCLC were retrospectively enrolled. The prevalence of CD3(+), CD4(+), CD8(+) and Foxp3(+) TILs was assessed by immunohistochemistry in tumor tissue obtained before chemotherapy. The density of TILs subgroups was treated as dichotomous variables using the median values as cutoff. Survival curves were estimated by the Kaplan-Meier method, and differences in overall survival between groups were determined using the Log-rank test. Prognostic effects of TIL subsets density were evaluated by Cox regression analysis. The presence of CD3(+), CD4(+), CD8(+), and FOXP3(+) TILs was not correlated with any clinicopathological features. Neither the prevalence of TILs nor combined analysis displayed obvious prognostic performances for overall survival in Cox regression model. Instead, higher FOXP3(+)/CD8(+) ratio in tumor sites was an independent factor for poor response to platinum-based chemotherapy in overall cohort. These findings suggest that immunological CD8(+) and FOXP3(+)Tregs cell infiltrate within tumor environment is predictive of response to platinum-based neoadjuvant chemotherapy in advanced NSCLC patients. The understanding of the clinical relevance of the microenvironmental immunological milieu might provide an important clue for the design of novel strategies in cancer immunotherapy.

  10. Germline single nucleotide polymorphisms associated with response of urothelial carcinoma to platinum-based therapy: the role of the host.

    LENUS (Irish Health Repository)

    Gallagher, D J

    2013-09-01

    Variations in urothelial carcinoma (UC) response to platinum chemotherapy are common and frequently attributed to genetic and epigenetic variations of somatic DNA. We hypothesized that variations in germline DNA may contribute to UC chemosensitivity.

  11. SEM method for direct visual tracking of nanoscale morphological changes of platinum based electrocatalysts on fixed locations upon electrochemical or thermal treatments.

    Science.gov (United States)

    Zorko, Milena; Jozinović, Barbara; Bele, Marjan; Hodnik, Nejc; Gaberšček, Miran

    2014-05-01

    A general method for tracking morphological surface changes on a nanometer scale with scanning electron microscopy (SEM) is introduced. We exemplify the usefulness of the method by showing consecutive SEM images of an identical location before and after the electrochemical and thermal treatments of platinum-based nanoparticles deposited on a high surface area carbon. Observations reveal an insight into platinum based catalyst degradation occurring during potential cycling treatment. The presence of chloride clearly increases the rate of degradation. At these conditions the dominant degradation mechanism seems to be the platinum dissolution with some subsequent redeposition on the top of the catalyst film. By contrast, at the temperature of 60°C, under potentiostatic conditions some carbon corrosion and particle aggregation was observed. Temperature treatment simulating the annealing step of the synthesis reveals sintering of small platinum based composite aggregates into uniform spherical particles. The method provides a direct proof of induced surface phenomena occurring on a chosen location without the usual statistical uncertainty in usual, random SEM observations across relatively large surface areas. Copyright © 2014 Elsevier B.V. All rights reserved.

  12. A search for close-mass lepton doublet

    International Nuclear Information System (INIS)

    Riles, J.K.

    1989-04-01

    Described is a search for a heavy charged lepton with an associated neutrino of nearly the same mass, together known as a close-mass lepton doublet. The search is conducted in e + e/sup/minus// annihilation data taken with the Mark II detector at a center-of-mass energy of 29 GeV. In order to suppress contamination from conventional two-photon reactions, the search applies a novel, radiative-tagging technique. Requiring the presence of an isolated, energetic photon allows exploration for lepton doublets with a mass splitting smaller than that previously accessible to experiment. No evidence for such a new lepton has been found, enabling limits to be placed on allowed mass combinations. Mass differences as low as 250-300 MeV are excluded for charged lepton masses up to 10 GeV. 78 refs., 64 figs., 8 tabs

  13. Scalar dark matter in leptophilic two-Higgs-doublet model

    Science.gov (United States)

    Bandyopadhyay, Priyotosh; Chun, Eung Jin; Mandal, Rusa

    2018-04-01

    Two-Higgs-Doublet Model of Type-X in the large tan ⁡ β limit becomes leptophilic to allow a light pseudo-scalar A and thus provides an explanation of the muon g - 2 anomaly. Introducing a singlet scalar dark matter S in this context, one finds that two important dark matter properties, nucleonic scattering and self-annihilation, are featured separately by individual couplings of dark matter to the two Higgs doublets. While one of the two couplings is strongly constrained by direct detection experiments, the other remains free to be adjusted for the relic density mainly through the process SS → AA. This leads to the 4τ final states which can be probed by galactic gamma ray detections.

  14. Design study of a new vacuum vessel for Doublet III

    International Nuclear Information System (INIS)

    Rawls, J.M.; Davis, L.G.; Anderson, P.M.

    1980-10-01

    The principal thrust of the project was to examine a single design in enough depth to gain confidence in the feasibility and desirability of specific design features. However, a valuable spin-off of the project was to develop information of a more generic character to aid in future studies of possibilities for Doublet III. For example, we now feel that Doublet III can be reconfigured with any of a variety of new vacuum vessels, poloidal coil sets, and auxiliary heating systems within three years of project initiation, a period that is short compared to the time scale for developing a completely new facility. In addition, this can be accomplished at a fraction of the cost required to develop a comparable facility

  15. Power systems for the Doublet III 2-MW ECH system

    International Nuclear Information System (INIS)

    Remsen, D.B. Jr.

    1981-10-01

    A system providing 5 second pulses at 60 GHz from ten 200 kW gyrotrons is being prepared for electron cyclotron heating experiments on Doublet III. The power supply for the gyrotron system is a power supply currently under construction by Universal Voltronics Corporation for the Doublet III neutral beam power supply, and is to have the option of reverse polarity (negative) to fill the needs of the system of ten gyrotons operating in parallel. The output of this power supply is 80 kV at 100A for 5 second pulses with good regulation. The output pulse rise and fall times and fault protection response time are all compatible with the gyrotron requirements

  16. ATLAS diboson excesses from the stealth doublet model

    Directory of Open Access Journals (Sweden)

    Wei Chao

    2016-02-01

    Full Text Available The ATLAS Collaboration has reported excesses in diboson invariant mass searches of new resonances around 2 TeV, which might be a prediction of new physics around that mass range. We interpret these results in the context of a modified stealth doublet model where the extra Higgs doublet has a Yukawa interaction with the first generation quarks, and show that the heavy CP-even Higgs boson can naturally explain the excesses in the WW and ZZ channels with a small Yukawa coupling, ξ∼0.15, and a tiny mixing angle with the SM Higgs boson, α∼0.05. Furthermore, the model satisfies constraints from colliders and electroweak precision measurements.

  17. Metronomic chemotherapy.

    Science.gov (United States)

    Mutsaers, Anthony J

    2009-08-01

    Chemotherapy drugs are usually administered at doses that are high enough to result in an obligatory break period to allow for the observation of potential side effects and institution of supportive care, if required. In recent years, efforts to administer chemotherapy on a more continuous basis, with a much shorter break period, or none at all, have received increased interest, and the practice has come to be known as metronomic chemotherapy. The basis for success with this currently investigational approach may be rooted in continuous drug exposure to susceptible cancer cells, inhibition of tumor blood vessel growth-a process known as tumor angiogenesis, and/or alterations in tumor immunology. Increased benefit also appears to occur when metronomic chemotherapy is used in combination with newer, targeted antiangiogenic agents, and therefore represents a promising approach to combination therapy, particularly as targeted oncology drugs make their way into veterinary oncology applications. There is still much to be learned in this field, especially with regard to optimization of the proper drugs, dose, schedule, and tumor applications. However, the low cost, ease of administration, and acceptable toxicity profiles potentially associated with this therapeutic strategy make metronomic chemotherapy protocols attractive and suitable to veterinary applications. Preliminary clinical trial results have now been reported in both human and veterinary medicine, including adjuvant treatment of canine splenic hemangiosarcoma and incompletely resected soft tissue sarcoma, and, further, more powerful studies are currently ongoing.

  18. Localized excitations in superconducting point contacts: probing the Andreev doublet

    International Nuclear Information System (INIS)

    Bretheau, L.

    2013-01-01

    The Josephson effect describes the coherent coupling between superconductors and the resulting supercurrent. Microscopically, it arises from the existence of discrete quasiparticle states, localized at the weak link, the Andreev bound states. They come in doublets in each conduction channel of the weak link, with energies symmetric about the Fermi energy and opposite supercurrents. Each Andreev doublet gives rise to four states: the ground state |-> and the excited state |+>, with even parity, and the excited odd states |↑> and |↓>. Is it possible to address and control Andreev doublets? This thesis describes two sets of experiments designed to answer this question using the most basic Josephson element, a one-atom contact between two superconducting electrodes. In a first experiment, we have observed and characterized the excited odd states |↑> and |↓>. As expected for a spin-degenerate system, they do not carry supercurrent. In this experiment the excitation was uncontrolled and resulted from trapping of spurious quasiparticles. We have measured the lifetime of the odd states: under some condition, it is found to exceed 100 μs. The second experiment is a photon-absorption spectroscopy of the Andreev doublet. It was performed by using a Josephson junction as an integrated on-chip microwave emitter and detector. The observed Andreev transitions correspond to excitation from the ground state |->to the excited even state |+>, and are well accounted for by our quantum model. This result opens the way to coherent manipulation of this two level system. The direct observation of the excited Andreev state, either by quasiparticle-injection or photon-absorption, strongly supports the mesoscopic theory of the Josephson effect. It shows that in addition to the phase difference, each channel of a Josephson weak link possesses an internal fermionic degree of freedom. It could be used to code information in a novel type of superconducting qubit. (author) [fr

  19. Vortex solutions in two-Higgs-doublet systems

    International Nuclear Information System (INIS)

    Bimonte, G.; Lozano, G.

    1994-04-01

    We analyze the existence of string-like defects in a two-Higgs-doublet system having SU(2) x U(1) y x U(1) y , as gauge group. We are able to show that, when certain relations among the parameters hold, these configurations satisfy a set of first order differential equations (Bogomol'nyi equations) and their energy is proportional to their topological charge. (author). 12 refs

  20. Doublet vs. FODO structure: beam dynamics and layout

    CERN Document Server

    Eshraqi, M; CERN. Geneva. BE Department

    2010-01-01

    A FoDo (singlet) structure is designed for the CERN Superconducting Proton LINAC. This architecture is compared to the baseline (doublet) architecture of SPL on the basis of its beam dynamics performance and the required investment. The sensitivity of both layouts to quadrupole gradient errors and misalignment is checked and a correction scheme for beam steering is proposed. Finally a single quad beam dilution scheme is studied and designed for the pilot beam dump.

  1. Standard model fermion hierarchies with multiple Higgs doublets

    International Nuclear Information System (INIS)

    Solaguren-Beascoa Negre, Ana

    2016-01-01

    The hierarchies between the Standard Model (SM) fermion masses and mixing angles and the origin of neutrino masses are two of the biggest mysteries in particle physics. We extend the SM with new Higgs doublets to solve these issues. The lightest fermion masses and the mixing angles are generated through radiative effects, correctly reproducing the hierarchy pattern. Neutrino masses are generated in the see-saw mechanism.

  2. Nomogram-based Prediction of Overall Survival in Patients with Metastatic Urothelial Carcinoma Receiving First-line Platinum-based Chemotherapy

    DEFF Research Database (Denmark)

    Necchi, Andrea; Sonpavde, Guru; Lo Vullo, Salvatore

    2017-01-01

    BACKGROUND: The available prognostic models for overall survival (OS) in patients with metastatic urothelial carcinoma (UC) have been derived from clinical trial populations of cisplatin-treated patients. OBJECTIVE: To develop a new model based on real-world patients. DESIGN, SETTING, AND PARTICI...

  3. Doublet III neutral beam multi-stream command language system

    International Nuclear Information System (INIS)

    Campbell, L.; Garcia, J.R.

    1983-12-01

    A multi-stream command language system was developed to provide control of the dual source neutral beam injectors on the Doublet III experiment at GA Technologies Inc. The Neutral Beam command language system consists of three parts: compiler, sequencer, and interactive task. The command language, which was derived from the Doublet III tokamak command language, POPS, is compiled, using a recursive descent compiler, into reverse polish notation instructions which then can be executed by the sequencer task. The interactive task accepts operator commands via a keyboard. The interactive task directs the operation of three input streams, creating commands which are then executed by the sequencer. The streams correspond to the two sources within a Doublet III neutral beam, plus an interactive stream. The sequencer multiplexes the execution of instructions from these three streams. The instructions include reads and writes to an operator terminal, arithmetic computations, intrinsic functions such as CAMAC input and output, and logical instructions. The neutral beam command language system was implemented using Modular Computer Systems (ModComp) Pascal and consists of two tasks running on a ModComp Classic IV computer

  4. A Phase II Study of Weekly Docetaxel as Second-Line Chemotherapy in Patients With Metastatic Urothelial Carcinoma.

    Science.gov (United States)

    Kim, Young Saing; Lee, Soon Il; Park, Se Hoon; Park, Silvia; Hwang, In Gyu; Lee, Sang-Cheol; Sun, Jong-Mu; Lee, Jeeyun; Lim, Ho Yeong

    2016-02-01

    The present multicenter phase II study evaluated the efficacy and safety of weekly docetaxel as second-line chemotherapy for metastatic urothelial carcinoma. Weekly docetaxel was well tolerated but demonstrated modest activity, with a response rate of 6%, a median progression-free survival (PFS) of 1.4 months, and a median overall survival (OS) of 8.3 months. The dichotomy between PFS and OS was likely associated with subsequent platinum-based chemotherapy received by 58% of the patients. Docetaxel is commonly used for second-line therapy for metastatic urothelial carcinoma (UC). However, myelosuppression is a substantial concern when the traditional 3-week docetaxel cycle is used. The present multicenter phase II study evaluated the efficacy and safety of weekly docetaxel as second-line chemotherapy for metastatic UC. Patients with progression after previous platinum-based chemotherapy for advanced or metastatic disease were treated with docetaxel 30 mg/m(2) on days 1 and 8 every 21 days. The primary endpoint was the response rate. The study enrolled 31 patients. Their median age was 64 years (range, 40-79 years). An Eastern Cooperative Oncology Group performance status of 1, liver metastasis, and a hemoglobin level chemotherapy had been administered for metastatic disease in 29 patients (94%). Although fatigue (13%) and anorexia (6%) were the most frequently observed grade 3 to 4 toxicities, the safety profiles were generally mild and manageable. Two patients (6%) achieved an objective response, which was maintained for 3.0 to 7.8 months. Eight patients experienced disease stabilization (disease control rate, 32%). The median progression-free survival (PFS) and overall survival (OS) were 1.4 months (95% confidence interval [CI], 1.3-1.6) and 8.3 months (95% CI, 5.9-10.6), respectively. A relatively long OS was associated with further salvage platinum-based chemotherapy (n = 18, 58%) showing an encouraging activity (response rate, 44%; median PFS, 4.0 months

  5. Nanoengineering of Ruthenium and Platinum-based Nanocatalysts by Continuous-Flow Chemistry for Renewable Energy Applications

    KAUST Repository

    AlYami, Noktan Mohammed

    2017-04-15

    This thesis presents an integrated study of nanocatalysts for heterogenous catalytic and electrochemical processes using pure ruthenium (Ru) with mixed-phase and platinum-based nanomaterials synthesized by continuous-flow chemistry. There are three major challenges to the application of nanomaterials in heterogenous catalytic reactions and electrocatalytic processes in acidic solution. These challenges are the following: (i) controlling the size, shape and crystallography of nanoparticles to give the best catalytic properties, (ii) scaling these nanoparticles up to a commercial quantity (kg per day) and (iii) making stable nanoparticles that can be used catalytically without degrading in acidic electrolytes. Some crucial limitations of these nanostructured materials in energy conversion and storage applications were overcome by continuous-flow chemistry. By using a continuous-flow reactor, the creation of scalable nanoparticle systems was achieved and their functionality was modified to control the nanoparticles’ physical and chemical characteristics. The nanoparticles were also tested for long-term stability, to make sure these nanoparticles were feasible under realistic working conditions. These nanoparticles are (1) shape- and crystallography-controlled ruthenium (Ru) nanoparticles, (2) size-controlled platinum-metal (Pt-M= nickel (Ni) & copper (Cu)) nanooctahedra (while maintaining morphology) and (3) core-shell platinum@ruthenium (Pt@Ru) nanoparticles where an ultrathin ruthenium shell was templated onto the platinum core. Thus, a complete experimental validation of the formation of a scalable amount of these nanoparticles and their catalytic activity and stability towards the oxygen evolution reaction (OER) in acid medium, hydrolysis of ammonia borane (AB) along with plausible explanations were provided.

  6. The impact of reduction of doublet well spacing on the Net Present Value and the life time of fluvial Hot Sedimentary Aquifer doublets

    NARCIS (Netherlands)

    Willems, C.J.L.; Maghami Nick, Hamidreza M.; Bruhn, D.F.

    This paper evaluates the impact of reduction of doublet well spacing, below the current West Netherlands Basin standard of 1000 to 1500 m, on the Net Present Value (NPV) and the life time of fluvial Hot Sedimentary Aquifer (HSA) doublets. First, a sensitivity analysis is used to show the possible

  7. Development of XFCT imaging strategy for monitoring the spatial distribution of platinum-based chemodrugs: Instrumentation and phantom validation

    Energy Technology Data Exchange (ETDEWEB)

    Kuang Yu [Department of Radiation Oncology and Molecular Imaging Program at Stanford (MIPS), Stanford University School of Medicine, Stanford, California 94305-5847 and Medical Physics Program, University of Nevada, Las Vegas, Nevada 89154-3037 (United States); Pratx, Guillem; Bazalova, Magdalena; Qian Jianguo; Meng Bowen; Xing Lei [Department of Radiation Oncology and Molecular Imaging Program at Stanford (MIPS), Stanford University School of Medicine, Stanford, California 94305-5847 (United States)

    2013-03-15

    Purpose: Developing an imaging method to directly monitor the spatial distribution of platinum-based (Pt) drugs at the tumor region is of critical importance for early assessment of treatment efficacy and personalized treatment. In this study, the authors investigated the feasibility of imaging platinum (Pt)-based drug distribution using x-ray fluorescence (XRF, a.k.a. characteristic x ray) CT (XFCT). Methods: A 5-mm-diameter pencil beam produced by a polychromatic x-ray source equipped with a tungsten anode was used to stimulate emission of XRF photons from Pt drug embedded within a water phantom. The phantom was translated and rotated relative to the stationary pencil beam in a first-generation CT geometry. The x-ray energy spectrum was collected for 18 s at each position using a cadmium telluride detector. The spectra were then used for the K-shell XRF peak isolation and sinogram generation for Pt. The distribution and concentration of Pt were reconstructed with an iterative maximum likelihood expectation maximization algorithm. The capability of XFCT to multiplexed imaging of Pt, gadolinium (Gd), and iodine (I) within a water phantom was also investigated. Results: Measured XRF spectrum showed a sharp peak characteristic of Pt with a narrow full-width at half-maximum (FWHM) (FWHM{sub K{alpha}1}= 1.138 keV, FWHM{sub K{alpha}2}= 1.052 keV). The distribution of Pt drug in the water phantom was clearly identifiable on the reconstructed XRF images. Our results showed a linear relationship between the XRF intensity of Pt and its concentrations (R{sup 2}= 0.995), suggesting that XFCT is capable of quantitative imaging. A transmission CT image was also obtained to show the potential of the approach for providing attenuation correction and morphological information. Finally, the distribution of Pt, Gd, and I in the water phantom was clearly identifiable in the reconstructed images from XFCT multiplexed imaging. Conclusions: XFCT is a promising modality for monitoring

  8. Maximum entropy technique in the doublet structure analysis

    International Nuclear Information System (INIS)

    Belashev, B.Z.; Panebrattsev, Yu.A.; Shakhaliev, Eh.I.; Soroko, L.M.

    1998-01-01

    The Maximum Entropy Technique (MENT) for solution of the inverse problems is explained. The effective computer program for resolution of the nonlinear equations system encountered in the MENT has been developed and tested. The possibilities of the MENT have been demonstrated on the example of the MENT in the doublet structure analysis of noisy experimental data. The comparison of the MENT results with results of the Fourier algorithm technique without regularization is presented. The tolerant noise level is equal to 30% for MENT and only 0.1% for the Fourier algorithm

  9. Random phase approximation: from Giant to Intra-doublet resonances

    International Nuclear Information System (INIS)

    Amusia, M.Ya.

    2004-01-01

    We discuss here the history and current achievements of one of the most powerful approaches of 20th century physics--the random phase approximation (RPA) that permits us to study collective or multiparticle effects in atoms, nuclei, molecules and clusters, as well as in quantum liquids. We concentrate on RPA application to studies of isolated atoms where it permits one to disclose the collective multielectron nature of so-called Giant resonances and predict a number of others, like Interference and Intra-doublet resonances. We present general theory as well as results of concrete calculations for a number of atoms

  10. Random phase approximation: from Giant to Intra-doublet resonances

    Energy Technology Data Exchange (ETDEWEB)

    Amusia, M.Ya. E-mail: amusia@vms.huji.ac.il

    2004-06-01

    We discuss here the history and current achievements of one of the most powerful approaches of 20th century physics--the random phase approximation (RPA) that permits us to study collective or multiparticle effects in atoms, nuclei, molecules and clusters, as well as in quantum liquids. We concentrate on RPA application to studies of isolated atoms where it permits one to disclose the collective multielectron nature of so-called Giant resonances and predict a number of others, like Interference and Intra-doublet resonances. We present general theory as well as results of concrete calculations for a number of atoms.

  11. Strong electron correlation in photoionization of spin-orbit doublets

    International Nuclear Information System (INIS)

    Amusia, M.Ya.; Chernysheva, L.V.; Manson, S.T.; Msezane, A.M.; Radojevic, V.

    2002-01-01

    A new and explicitly many-body aspect of the 'leveraging' of the spin-orbit interaction is demonstrated, spin-orbit activated interchannel coupling, which can significantly alter the photoionization cross section of a spin-orbit doublet. As an example, it is demonstrated via a modified version of the spin-polarized random phase approximation with exchange, that a recently observed unexplained structure in the Xe 3d 5/2 photoionization cross section [A. Kivimaeki et al., Phys. Rev. A 63, 012716 (2000)] is entirely due to this effect. Similar features are predicted for Cs 3d 5/2 and Ba 3d 5/2

  12. Vector boson fusion in the inert doublet model

    Science.gov (United States)

    Dutta, Bhaskar; Palacio, Guillermo; Restrepo, Diego; Ruiz-Álvarez, José D.

    2018-03-01

    In this paper we probe the inert Higgs doublet model at the LHC using vector boson fusion (VBF) search strategy. We optimize the selection cuts and investigate the parameter space of the model and we show that the VBF search has a better reach when compared with the monojet searches. We also investigate the Drell-Yan type cuts and show that they can be important for smaller charged Higgs masses. We determine the 3 σ reach for the parameter space using these optimized cuts for a luminosity of 3000 fb-1 .

  13. Re-derived overclosure bound for the inert doublet model

    Science.gov (United States)

    Biondini, S.; Laine, M.

    2017-08-01

    We apply a formalism accounting for thermal effects (such as modified Sommerfeld effect; Salpeter correction; decohering scatterings; dissociation of bound states), to one of the simplest WIMP-like dark matter models, associated with an "inert" Higgs doublet. A broad temperature range T ˜ M/20 . . . M/104 is considered, stressing the importance and less-understood nature of late annihilation stages. Even though only weak interactions play a role, we find that resummed real and virtual corrections increase the tree-level overclosure bound by 1 . . . 18%, depending on quartic couplings and mass splittings.

  14. An evaluation of interferences in heat production from low enthalpy geothermal doublets systems

    DEFF Research Database (Denmark)

    Willems, Cees J. L.; Nick, Hamidreza M.; Weltje, Gert Jan

    2017-01-01

    Required distance between doublet systems in low enthalpy geothermal heat exploitation is often not fully elucidated. The required distance aims to prevent negative interference influencing the utilisation efficiency of doublet systems. Currently production licence areas are often issued based...... and minimal required production temperature. The results of this study can be used to minimize negative interference or optimise positive interference aiming at improving geothermal doublet deployment efficiency. (C) 2017 The Authors. Published by Elsevier Ltd....

  15. Molecular architecture of axonemal microtubule doublets revealedby cryo-electron tomography

    Energy Technology Data Exchange (ETDEWEB)

    Sui, Haixin; Downing, Kenneth H.

    2006-05-22

    The axoneme, which forms the core of eukaryotic flagella and cilia, is one of the largest macromolecular machines with a structure that is largely conserved from protists to mammals. Microtubule doublets are structural components of axonemes containing a number of proteins besides tubulin, and are usually found in arrays of nine doublets arranged around two singlet microtubules. Coordinated sliding of adjacent doublets, which involves a host of other proteins in the axoneme, produces periodic beating movements of the axoneme. We have obtained a 3D density map of intact microtubule doublets using cryo-electron tomography and image averaging. Our map, with a resolution of about 3 nm, provides insights into locations of particular proteins within the doublets and the structural features of the doublets that define their mechanical properties. We identify likely candidates for several of these non-tubulin components of the doublets. This work offers novel insight on how tubulin protofilaments and accessory proteins attach together to form the doublets and provides a structural basis for understanding doublet function in axonemes.

  16. Electroweak phase transition in two Higgs doublet models

    International Nuclear Information System (INIS)

    Cline, J.M.; Lemieux, P.

    1997-01-01

    We reexamine the strength of the first-order phase transition in the electroweak theory supplemented by an extra Higgs doublet. The finite-temperature effective potential V eff is computed to one-loop order, including the summation of ring diagrams, to study the ratio φ c /T c of the Higgs field VEV to the critical temperature. We make a number of improvements over previous treatments, including a consistent treatment of Goldstone bosons in V eff , an accurate analytic approximation to V eff valid for any mass-to-temperature ratios, and use of the experimentally measured top quark mass. For two-Higgs-doublet models, we identify a significant region of parameter space where φ c /T c is large enough for electroweak baryogenesis, and we argue that this identification should persist even at higher orders in perturbation theory. In the case of the minimal supersymmetric standard model, our results indicate that the extra Higgs bosons have little effect on the strength of the phase transition. copyright 1997 The American Physical Society

  17. Material failures observed in Doublet III neutral beamlines

    International Nuclear Information System (INIS)

    Bailey, E.W.; Colleraine, A.; Doll, D.; Grunloh, H.; Kim, J.; Langhorn, A.; Thurgood, B.

    1983-12-01

    The Doublet III neutral beam injectors consist of three separable spools two meters in diameter by four meters long overall when assembled. Contained within these spools are the neutralizers, ion dumps, deflecting magnet, calorimeter dumps, cryogenic panels and beam scraping collimators 3,7. To date three beamlines are in operation on Doublet III, and the beams have accumulated operating time of approximately 32 months, with the oldest having been in operation for 18 months. During this time operation of DIII with the neutral beam sources has demonstrated the following: 7.8 MW injected neutrals from three beamlines (6 sources), high β (4.5%), and non-circular plasma shape. The sources have also exhibited a very reliable injected shot history 4, 5, 6, 8. Material failures encountered during the operation of DIII N.B. injectors and the solutions to these failures are described. Failures include cracking of the neutralizer exit collimator due to heating cycles, failure of cyropanel support rods due to cooling cycles, failure of the sliding drive of the moveable calorimeter due to friction

  18. Material failures observed in the Doublet III neutral beamlines

    International Nuclear Information System (INIS)

    Bailey, E.W.; Colleraine, A.; Doll, D.; Grunloh, H.; Kim, J.; Langhorn, A.; Thurgood, B.

    1983-01-01

    The Doublet III neutral beam injectors consist of three separable spools two meters in diameter by four meters long overall when assembled. Contained within these spools are the neutralizers, ion dumps, deflecting magnet, calorimeter dumps, cryogenic panels and beam scraping collimators. To date three beamlines are in operation on Doublet III, and the beams have accumulated operating time of approximately 32 months, with the oldest having been in operation for 18 months. During this time operation of DIII with the neutral beam sources has demonstrated the following: 7.8 MW injected neutrals from three beamlines (6 sources), high β (4.5%), and non-circular plasma shape. The sources have also exibited a very reliable injected shot history. Material failures encountered during the operation of DIII N.B. injectors and the solutions to these failures are described. Failures include cracking of the neutralizer exit collimator due to heating cycles, failure of cyropanel support rods due to cooling cycles, failure of the sliding drive of the moveable calorimeter due to friction

  19. LHC phenomenology of composite 2-Higgs doublet models

    Energy Technology Data Exchange (ETDEWEB)

    De Curtis, Stefania [University of Florence, Department of Physics and Astronomy, Sesto Fiorentino (Italy); INFN, Sezione di Firenze (Italy); Moretti, Stefano; Yagyu, Kei; Yildirim, Emine [University of Southampton, School of Physics and Astronomy, Southampton (United Kingdom)

    2017-08-15

    We investigate the phenomenology of Composite 2-Higgs doublet models (C2HDMs) of various Yukawa types based on the global symmetry breaking SO(6) → SO(4) x SO(2). The kinetic part and the Yukawa Lagrangian are constructed in terms of the pseudo Nambu-Goldstone Boson (pNGB) matrix and a 6-plet of fermions under SO(6). The scalar potential is assumed to be the same as that of the Elementary 2-Higgs doublet model (E2HDM) with a softly broken discrete Z{sub 2} symmetry. We then discuss the phenomenological differences between the E2HDM and C2HDM by focusing on the deviations from standard model (SM) couplings of the discovered Higgs state (h) as well as on the production cross sections and branching ratios (BRs) at the large Hadron collider (LHC) of extra Higgs bosons. We find that, even if the same deviation in the hVV (V = W,Z) coupling is assumed in the two scenarios, there appear significant differences between the E2HDM and C2HDM from the structure of the Yukawa couplings, so that production and decay features of extra Higgs bosons can be used to distinguish between the two scenarios. (orig.)

  20. Precise predictions within the two-Higgs-doublet model

    International Nuclear Information System (INIS)

    Altenkamp, Lukas

    2017-01-01

    We consider the Two-Higgs-Doublet Model (THDM) where the Standard Model (SM) field content is extended by adding a further Higgs-boson doublet. This results in five Higgs bosons, two CP-even, one CP-odd and a charged Higgs boson and it's anti-particle. In order to provide accurate and reliable predictions within this model, next-to-leading order calculations are necessary. To this end, we perform a renormalization procedure and adopt four new renormalization schemes. The counterterm Feynman rules as well as the renormalization conditions are implemented into an FeynArts model file, yielding the possibility to generate amplitudes and squared matrix elements for arbitrary processes which is a major contribution to the automation of higher-order calculations. As an application we investigate the decay of a light, CP-even, SM-like Higgs boson into four fermions in the THDM. To this end, we extend the program Prophecy4f and compute the partial decay widths for different benchmark scenarios. For all investigated scenarios, we observe that the THDM widths are bounded by the SM widths and that the deviations are larger at higher order. The renormalization group equations have been solved in order to investigate the renormalization scale dependence which gives an estimate of the theoretical uncertainty arising due to the truncation of the perturbation series. By comparing the results of different renormalization schemes we determine for which parameter regions each scheme provides reliable predictions.

  1. Collisional broadening of alkali doublets by helium perturbers

    Energy Technology Data Exchange (ETDEWEB)

    Mullamphy, D F T [School of Mathematics, Physics and Information Technology, James Cook University, Townsville 4811 (Australia); Peach, G [Department of Physics and Astronomy, University College London WC1E 6BT (United Kingdom); Venturi, V [School of Mathematics, Physics and Information Technology, James Cook University, Townsville 4811 (Australia); Whittingham, I B [School of Mathematics, Physics and Information Technology, James Cook University, Townsville 4811 (Australia); Gibson, S J [School of Mathematics, Physics and Information Technology, James Cook University, Townsville 4811 (Australia)

    2007-03-28

    We report results for the Lorentzian profiles of the Li I, Na I and K I doublets and the Na I subordinate doublet broadened by helium perturbers for temperatures up to 3000 K. They have been obtained from a fully quantum-mechanical close-coupling description of the colliding atoms, the Baranger theory of line shapes and new ab initio potentials for the alkali-helium interaction. For all lines except the 769.9 nm K I line, the temperature dependence of the widths over the range 70 {<=} T {<=} 3000 K is accurately represented by the power law form w = aT{sup bb} with 0.38 < b < 0.43. The 769.9 nm K I line has this form for 500 {<=} T {<=} 3000 K with b having the higher value of 0.49. Although the shifts have a more complex temperature dependence, they all have the general feature of increasing with temperature above T {approx} 500 K apart from the 769.9 K I line whose shift decreases with temperature.

  2. Energy confinement in Doublet III with high-Z limiters

    Energy Technology Data Exchange (ETDEWEB)

    Marcus, F.B.; Adcock, S.J.; Baker, D.R.; Blau, F.P.; Brooks, N.H.; Chase, R.P.; DeBoo, J.C.; Ejima, S.; Fairbanks, E.S.; Fisher, R.K.

    1980-02-01

    This report describes the experimental measurements and data analysis techniques used to evaluate the energy confinement in noncircular plasmas produced in Doublet III. Major aspects of the confinement measurements and analysis techniques are summarized. Machine parameters, diagnostic systems and discharge parameters relavent to the confinement measurements are given. Magnetic analysis techniques used to determine the plasma shape are reviewed. Scaling of the on-axis values of electron temperature, confinement time and Z/sub eff/ with plasma density is presented. Comparison with scaling results from other circular tokamaks is discussed. Numerical and analytic techniques developed for calculating the plasma energy confinement time and self-consistent profiles of density, temperature, current, and flux in non-circular geometries are described. These techniques are applied to the data and used to determine the central and global electron energy confinement time for a typical doublet plasma. Additional aspects of the confinement such as the radial dependence of the electron thermal conductivity and the estimated ion temperature are explored with the aid of a non-circular transport simulation code. The results of the confinement measurements are summarized and discussed. A brief summary of the theoretically expected effects of noncircularity on plasma confinement is included for reference as Appendix I.

  3. Emulsion sheet doublets as interface trackers for the OPERA experiment

    International Nuclear Information System (INIS)

    Anokhina, A; Aoki, S; Ariga, A; Arrabito, L; Autiero, D; Brugiere, T; Chaussard, L; Badertscher, A; Bay, F; Greggio, F Bersani; Bertolin, A; Besnier, M; Bick, D; Bozza, C; Brugnera, R; Carrara, E; Brunetti, G; Buontempo, S; Cazes, A; Chernyavsky, M

    2008-01-01

    New methods for efficient and unambiguous interconnection between electronic position sensitive detectors and target units based on nuclear photographic emulsion films have been developed. The application to the OPERA experiment, that aims at detecting ν μ ν τ oscillations in the CNGS neutrino beam, is reported in this paper. In order to reduce background due to latent tracks collected before installation in the detector, on-site large-scale treatments of the emulsions (''refreshing'') have been applied. Changeable Sheet (CSd) packages, each made of a doublet of emulsion films, have been designed, assembled and coupled to the OPERA target units (''ECC bricks''). A device has been built to print X-ray spots for accurate interconnection both within the CSd and between the CSd and the related ECC brick. Sample emulsion films have been extensively scanned with state-of-the-art automated optical microscopes. Efficient track-matching and powerful background rejection have been achieved in tests with electronically tagged penetrating muons. Further improvement of in-doublet film alignment was obtained by matching the pattern of low-energy electron tracks. The commissioning of the overall OPERA alignment procedure is in progress

  4. Doublet III neutral beam injector test tank cryopanel design

    International Nuclear Information System (INIS)

    Doll, D.W.; Kamperschroer, J.H.; Arend, P.V.

    1980-03-01

    A simple condensing cryopanel has been designed for the Doublet III neutral beam test tank with a 320,000 liters per second pumping capacity for hydrogen. This maintains a vacuum in the test tank which simulates the Doublet III vessel, 1.3 x 10 -3 Pa (approx.10 -5 torr). The hydrogen gas load comes from the beam striking the test tank calorimeter and amounts to about 7.2 torr liters per second. The cryopanel is cylindrical shaped with a liquid helium (LHe) surface that pumps through liquid nitrogen (LN) cooled aluminum chevrons located in squirrel-cage fashion around the inside surface of the cylinder. The LHe cooled surface is a smooth cylinder 2.09m in diameter by .69m long with LHe flowing in a approx. 1mm annular space between concentric cylinders. The chevrons which are not blackened are cooled from each end with LN flowing in ring manifolds that serve as the primary cryopanel structure. The LHe is force fed at 55.2 kPa remaining in the liquid phase through the panel. External heat exchanger capability permits use of helium at 3.8 to 4.2 0 K. Normal operating flow rate is 1.4 g/sec for a heat load expected to be 12.2 W total

  5. Precise predictions within the two-Higgs-doublet model

    Energy Technology Data Exchange (ETDEWEB)

    Altenkamp, Lukas

    2017-02-21

    We consider the Two-Higgs-Doublet Model (THDM) where the Standard Model (SM) field content is extended by adding a further Higgs-boson doublet. This results in five Higgs bosons, two CP-even, one CP-odd and a charged Higgs boson and it's anti-particle. In order to provide accurate and reliable predictions within this model, next-to-leading order calculations are necessary. To this end, we perform a renormalization procedure and adopt four new renormalization schemes. The counterterm Feynman rules as well as the renormalization conditions are implemented into an FeynArts model file, yielding the possibility to generate amplitudes and squared matrix elements for arbitrary processes which is a major contribution to the automation of higher-order calculations. As an application we investigate the decay of a light, CP-even, SM-like Higgs boson into four fermions in the THDM. To this end, we extend the program Prophecy4f and compute the partial decay widths for different benchmark scenarios. For all investigated scenarios, we observe that the THDM widths are bounded by the SM widths and that the deviations are larger at higher order. The renormalization group equations have been solved in order to investigate the renormalization scale dependence which gives an estimate of the theoretical uncertainty arising due to the truncation of the perturbation series. By comparing the results of different renormalization schemes we determine for which parameter regions each scheme provides reliable predictions.

  6. The flavor-locked flavorful two Higgs doublet model

    Science.gov (United States)

    Altmannshofer, Wolfgang; Gori, Stefania; Robinson, Dean J.; Tuckler, Douglas

    2018-03-01

    We propose a new framework to generate the Standard Model (SM) quark flavor hierarchies in the context of two Higgs doublet models (2HDM). The `flavorful' 2HDM couples the SM-like Higgs doublet exclusively to the third quark generation, while the first two generations couple exclusively to an additional source of electroweak symmetry breaking, potentially generating striking collider signatures. We synthesize the flavorful 2HDM with the `flavor-locking' mechanism, that dynamically generates large quark mass hierarchies through a flavor-blind portal to distinct flavon and hierarchon sectors: dynamical alignment of the flavons allows a unique hierarchon to control the respective quark masses. We further develop the theoretical construction of this mechanism, and show that in the context of a flavorful 2HDM-type setup, it can automatically achieve realistic flavor structures: the CKM matrix is automatically hierarchical with | V cb | and | V ub | generically of the observed size. Exotic contributions to meson oscillation observables may also be generated, that may accommodate current data mildly better than the SM itself.

  7. Electric dipole moments in two-Higgs-doublet models

    Energy Technology Data Exchange (ETDEWEB)

    Jung, Martin [Institut für Physik, Technische Universität Dortmund,Otto-Hahn-Str. 4, D-44221 Dortmund (Germany); Pich, Antonio [IFIC, Universitat de València - CSIC,Apt. Correos 22085, E-46071 València (Spain)

    2014-04-10

    Electric dipole moments are extremely sensitive probes for additional sources of CP violation in new physics models. Specifically, they have been argued in the past to exclude new CP-violating phases in two-Higgs-doublet models. Since recently models including such phases have been discussed widely, we revisit the available constraints in the presence of mechanisms which are typically invoked to evade flavour-changing neutral currents. To that aim, we start by assessing the necessary calculations on the hadronic, nuclear and atomic/molecular level, deriving expressions with conservative error estimates. Their phenomenological analysis in the context of two-Higgs-doublet models yields strong constraints, in some cases weakened by a cancellation mechanism among contributions from neutral scalars. While the corresponding parameter combinations do not yet have to be unnaturally small, the constraints are likely to preclude large effects in other CP-violating observables. Nevertheless, the generically expected contributions to electric dipole moments in this class of models lie within the projected sensitivity of the next-generation experiments.

  8. Clinical Practice of Adjuvant Chemotherapy in Patients with Early-Stage Epithelial Ovarian Cancer.

    Science.gov (United States)

    Frielink, Lindy M J; Pijlman, Brenda M; Ezendam, Nicole P M; Pijnenborg, Johanna M A

    2016-01-01

    Adjuvant platinum-based chemotherapy improves survival in women with early-stage epithelial ovarian cancer (EOC). Yet, there is a wide variety in clinical practice. All patients diagnosed with FIGO I and IIa EOC (2006-2010) in the south of the Netherlands were analyzed. The percentage of patients that received adjuvant chemotherapy was determined as well as the comprehensiveness of staging and outcome. Forty percent (54/135) of the patients with early-stage EOC received adjuvant chemotherapy. Treatment with adjuvant chemotherapy was associated with FIGO stage, clear-cell histology and nonoptimal staging. Optimal staging was achieved in 50%, and nonoptimal staging was associated with advanced age, comorbidity and treatment in a non-referral hospital. Overall, there was no difference in outcome between patients with and without adjuvant chemotherapy. Yet, in grade 3 tumors, adjuvant chemotherapy seems beneficial. Selective treatment of patients with early-stage EOC might reduce adjuvant chemotherapy without compromising outcome. © 2016 S. Karger AG, Basel.

  9. Blood transfusion reduction with intravenous iron in gynecologic cancer patients receiving chemotherapy.

    Science.gov (United States)

    Dangsuwan, Penkae; Manchana, Tarinee

    2010-03-01

    To compare the incidence of repeated red blood cell (RBC) transfusion in anemic gynecologic cancer patients receiving platinum-based chemotherapy comparing intravenous and oral iron. Forty-four anemic gynecologic cancer patients (hemoglobin level below 10 mg/dl) who required RBC transfusion were stratified and randomized according to baseline hemoglobin levels and chemotherapy regimen. Study group received 200 mg of intravenous iron sucrose and control group received oral ferrous sulphate 600 mg/day. RBC transfusion requirement in the consecutive cycle of chemotherapy was the primary outcome. Quality of life was evaluated by validated Thai version of the Functional Assessment of Cancer Therapy-Anemia (FACT-An). In a total of the 44 patients, there were 22 patients in each group. Five patients (22.7%) in the study group and 14 patients (63.6%) in the control group required RBC transfusion in consecutive cycle of chemotherapy (p=0.01). No significant difference in baseline hemoglobin and hematocrit levels was demonstrated in both groups. Significantly higher mean hemoglobin and hematocrit levels after treatment were reported in the study group (10.0+/-0.8 g/dl and 30.5+/-2.4%) than the control group (9.5+/-0.9 g/dl and 28.4+/-2.7%). No significant change of total FACT-An scores was noted between before and after treatment in both groups. No serious adverse events were reported and there was no significant difference among adverse events between both groups. Intravenous iron is an alternative treatment for anemic gynecologic cancer patients receiving platinum-based chemotherapy and reduces the incidence of RBC transfusion without serious adverse events.

  10. Elve Doublets: The Ionospheric Fingerprints of Compact Intracloud Discharges

    Science.gov (United States)

    da Silva, C. L.; Marshall, R. A.; Pasko, V. P.

    2015-12-01

    Compact intracloud discharges (CIDs) persist to date as one of the most mysterious lightning manifestations. CIDs are known to be the strongest natural sources of radio-frequency radiation on Earth. At VHF frequencies, approximately above 30 MHz, their emitted power is ten times stronger than that of other lightning processes. The well-known strength of CIDs in VHF contrasts with the lack of substantial optical measurements. CID's VLF/LF electric field change waveforms resemble one full cycle of a distorted sine function, with the first half-cycle being (a few times) larger-amplitude and shorter-duration than the second. For this reason CIDs have been dubbed narrow bipolar events (NBEs). NBE waveshapes are strikingly similar to the largest initial breakdown pulses (IBPs) that occur during the earlier stages of a conventional lightning flash, called classic IBPs. The similarity between classic IBP and NBE far-field waveforms, combined with the fact that positive-polarity NBEs frequently appear as the first event in an otherwise regular positive intracloud discharge, may be indicative that the source of these two E-field pulse types share the same physical mechanism inside thunderclouds [da Silva and Pasko, JGR, 120, 4989-5009, 2015]. In this presentation, we introduce a novel way to investigate CIDs. We show evidence that CIDs can produce an unique ionospheric signature, named "elve doublets". These signatures are characterized by a pair of elves separated in time by 80-160 microseconds. Our analysis combines fast photometric elve data, equivalent-transmission-line models to describe the dynamics of CID source currents, and FDTD modeling of electromagnetic wave propagation in the Earth-ionosphere waveguide accounting for its nonlinear interaction with the lower ionosphere [Marshall et al., GRL, 42, 2015, doi:10.1002/2015GL064862]. We show that typical (negative-polarity) CID altitudes, between 14-22 km, explain the time delay observed in elve doublets, where the

  11. Beta and current limits in the Doublet III tokamak

    International Nuclear Information System (INIS)

    Strait, E.J.; Chu, M.S.; Jahns, G.L.

    1986-04-01

    Neutral-beam heated discharges in Doublet III exhibit an operational beta limit, β/sub T/(%) less than or equal to 3.5 I(MA)/a(m)B(T), in good agreement with several theoretical predictions for ideal external kink or ballooning modes. These theories predict that the β limit has no explicit dependence on plasma shape (for nominal dee shapes). This aspect of the theory was confirmed in Doublet III by varying the elongation (kappa) from 1.0 to 1.6 and the triangularity (delta) from -0.1 to 0.9 and finding in all cases the same β limit. The maximum achievable beta thus depends on the minimum achievable value of the safety factor q. In Doublet III, the operational current limit is given by q greater than or equal to 1.7 for limiter-defined discharges and q greater than or equal to 2.7 for separatrix-defined discharges. Operation with q approx.2 was achieved for 1.0 less than or equal to kappa less than or equal to 1.6. Both β and q limits are characterized by major disruptions which usually terminate the discharge. In both cases, the disruptions often have a precursor oscillation with toroidal mode number n = 1, poloidal mode number m = 2 or 3, a frequency of zero to a few kHz, and a growth time on the order of a millisecond. These observations suggest that the proximate cause of these disruptions is a kink or tearing mode, pressure-driven in one case and current-driven in the other. Theoretical analyses of discharges at both limits will be compared. Modes with a high toroidal mode number, 3 less than or equal to n less than or equal to 5, and ballooning character have been observed near the β/sub T/ limit. These modes do not appear to be closely connected with the disruptions. Heating efficiency, ΔW/ΔP, remains constant up to the limiting disruption. Fishbone modes appear to be mainly a feature of high β/sub p/ operation and not connected to the β/sub T/ limit

  12. Identification of the IGF1/PI3K/NF κB/ERK gene signalling networks associated with chemotherapy resistance and treatment response in high-grade serous epithelial ovarian cancer

    International Nuclear Information System (INIS)

    Koti, Madhuri; Evans, Kenneth; Feilotter, Harriet E; Park, Paul C; Squire, Jeremy A; Gooding, Robert J; Nuin, Paulo; Haslehurst, Alexandria; Crane, Colleen; Weberpals, Johanne; Childs, Timothy; Bryson, Peter; Dharsee, Moyez

    2013-01-01

    Resistance to platinum-based chemotherapy remains a major impediment in the treatment of serous epithelial ovarian cancer. The objective of this study was to use gene expression profiling to delineate major deregulated pathways and biomarkers associated with the development of intrinsic chemotherapy resistance upon exposure to standard first-line therapy for ovarian cancer. The study cohort comprised 28 patients divided into two groups based on their varying sensitivity to first-line chemotherapy using progression free survival (PFS) as a surrogate of response. All 28 patients had advanced stage, high-grade serous ovarian cancer, and were treated with standard platinum-based chemotherapy. Twelve patient tumours demonstrating relative resistance to platinum chemotherapy corresponding to shorter PFS (< eight months) were compared to sixteen tumours from platinum-sensitive patients (PFS > eighteen months). Whole transcriptome profiling was performed using an Affymetrix high-resolution microarray platform to permit global comparisons of gene expression profiles between tumours from the resistant group and the sensitive group. Microarray data analysis revealed a set of 204 discriminating genes possessing expression levels which could influence differential chemotherapy response between the two groups. Robust statistical testing was then performed which eliminated a dependence on the normalization algorithm employed, producing a restricted list of differentially regulated genes, and which found IGF1 to be the most strongly differentially expressed gene. Pathway analysis, based on the list of 204 genes, revealed enrichment in genes primarily involved in the IGF1/PI3K/NF κB/ERK gene signalling networks. This study has identified pathway specific prognostic biomarkers possibly underlying a differential chemotherapy response in patients undergoing standard platinum-based treatment of serous epithelial ovarian cancer. In addition, our results provide a pathway context for

  13. On the connectivity anisotropy in fluvial Hot Sedimentary Aquifers and its influence on geothermal doublet performance

    DEFF Research Database (Denmark)

    Willems, Cees J.L.; Nick, Hamid; Donselaar, Marinus E.

    2017-01-01

    This study finds that the geothermal doublet layout with respect to the paleo flow direction in fluvial sedimentary reservoirs could significantly affect pump energy losses. These losses can be reduced by up to 10% if a doublet well pair is oriented parallel to the paleo flow trend compared...

  14. Types of chemotherapy

    Science.gov (United States)

    ... this page: //medlineplus.gov/ency/patientinstructions/000910.htm Types of chemotherapy To use the sharing features on this page, ... cancer.org/treatment/treatments-and-side-effects/treatment-types/chemotherapy/how-chemotherapy-drugs-work.html . Updated February 15, ...

  15. Graphite limiter and armour damage in Doublet III

    International Nuclear Information System (INIS)

    McKelvey, T.; Taylor, T.; Trester, P.

    1983-01-01

    Graphite coated with TiC has been used extensively in Doublet III for limiters and neutral beam armour. Performance of these components has been superior to that of the metal components previously used. Damage to the coated graphite has occurred and can be classified into three categories: (1) gross failure of the graphite due to thermal stresses induced by the combination of high applied energy fluxes and mechanical restraint, (2) surface failure of the graphite due to runaway electron impingement, and (3) loss of TiC coating due to arcing, sputtering, vaporization and spalling, primarily during plasma disruptions and other abnormal plasma conditions. Design improvements are being continually implemented to minimize this damage and its consequences. (author)

  16. Impurity studies and discharge cleaning in Doublet III

    International Nuclear Information System (INIS)

    Marcus, F.B.

    1979-10-01

    The goal of present and next generation tokamak experiments is to produce high-density, high-purity plasmas during high-power, extended-duration discharges. Plasma discharges with Z/sub eff/ values near unity and low concentrations of medium and high-Z metallic impurities have been obtained in Doublet III using a combination of low-power hydrogen discharge cleaning, gas puffing, precise plasma shape and position control, and high-Z limiters. Analysis of the first wall surface and residual gas impurities confirmed that clean conditions have been achieved. The high-Z limiters showed very limited amounts of melting or arcing. The progress of the wall cleaning process was monitored by three diagnostic techniques: Auger electron spectroscopy of metallic samples at the vessel wall, residual gas analysis, and the resistivity of full power discharges

  17. A two-Higgs-doublet model facing experimental hints

    Directory of Open Access Journals (Sweden)

    Crivellin Andreas

    2016-01-01

    Full Text Available Physics beyond the Standard Model has so far eluded our experimental probes. Nevertheless, a number of interesting anomalies have accumulated that can be taken as hints towards new physics: BaBar, Belle, and LHCb have found deviations of approximately 3:8σ in B → Dτν and B → D*τν; the anomalous magnetic moment of the muon differs by about 3σ from the theoretic prediction; the branching ratio for τ → μνν is about 2σ above the Standard Model expectation; and CMS and ATLAS found hints for a non-zero decay rate of h → μτ at 2.6σ. Here we consider these processes within a lepton-specific two-Higgs doublet model with additional non-standard Yukawa couplings and show how (and which of these excesses can be accommodated.

  18. Controlled flavour changing neutral couplings in two Higgs Doublet models

    Energy Technology Data Exchange (ETDEWEB)

    Alves, Joao M.; Branco, Gustavo C.; Nebot, Miguel [Instituto Superior Tecnico (IST), Lisboa Univ., Departamento de Fisica e Centro de Fisica Teorica de Particulas (CFTP), Lisboa (Portugal); Botella, Francisco J.; Cornet-Gomez, Fernando [Universitat de Valencia-CSIC, Departament de Fisica Teorica y IFIC, Burjassot (Spain)

    2017-09-15

    We propose a class of two Higgs doublet models where there are flavour changing neutral currents (FCNC) at tree level, but under control due to the introduction of a discrete symmetry in the full Lagrangian. It is shown that in this class of models, one can have simultaneously FCNC in the up and down sectors, in contrast to the situation encountered in the renormalisable and minimal flavour violating 2HDM models put forward by Branco et al. (Phys Lett B 380:119, 1996). The intensity of FCNC is analysed and it is shown that in this class of models one can respect all the strong constraints from experiment without unnatural fine-tuning. It is pointed out that the additional sources of flavour and CP violation are such that they can enhance significantly the generation of the Baryon asymmetry of the Universe, with respect to the standard model. (orig.)

  19. Emulsion sheet doublets as interface trackers for the OPERA experiment

    CERN Document Server

    Anokhina, A.; Ariga, A.; Arrabito, L.; Autiero, D.; Badertscher, A.; Bay, F.; Greggio, F.Bersani; Bertolin, A.; Besnier, M.; Bick, D.; Bozza, C.; Brugiere, T.; Brugnera, R.; Brunetti, G.; Buontempo, S.; Carrara, E.; Cazes, A.; Chaussard, L.; Chernyavsky, M.; Chiarella, V.; Chon-Sen, N.; Chukanov, A.; Consiglio, L.; Cozzi, M.; Cuha, V.; Dal Corso, F.; D'Amato, G.; D'Ambrosio, N.; De Lellis, G.; Declais, Y.; De Serio, M.; Di Capua, F.; Di Ferdinando, D.; Di Giovanni, A.; Di Marco, N.; Di Troia, C.; Dmitrievski, S.; Dominjon, A.; Dracos, Marcos; Duchesneau, D.; Dusini, S.; Ebert, J.; Egorov, O.; Enikeev, R.; Ereditato, Antonio; Esposito, L.S.; Favier, J.; Felici, G.; Ferber, T.; Fini, R.; Frekers, D.; Fukuda, T.; Galkin, V.I.; Galkin, V.A.; Garfagnini, A.; Giacomelli, G.; Giorgini, M.; Goellnitz, C.; Goldberg, J.; Golubkov, D.; Gornushkin, Y.; Grella, G.; Grianti, F.; Guler, M.; Gusev, G.; Gustavino, C.; Hagner, Caren; Hara, T.; Hierholzer, M.; Hiramatsu, S.; Hoshino, Kaoru; Ieva, M.; Jakovcic, K.; Janicsko Csathy, J.; Janutta, B.; Jollet, C.; Juget, F.; Kawai, T.; Kazuyama, M.; Kim, S.H.; Knuesel, J.; Kodama, K.; Komatsu, M.; Kose, U.; Kreslo, I.; Laktineh, I.; Lazzaro, C.; Lenkeit, J.; Ljubicic, A.; Longhin, Andrea; Lutter, G.; Manai, K.; Mandrioli, G.; Marotta, A.; Marteau, J.; Matsuo, T.; Matsuoka, H.; Mauri, N.; Meisel, F.; Meregaglia, A.; Messina, M.; Migliozzi, P.; Mikado, S.; Miyamoto, S.; Monacelli, Piero; Morishima, Kunihiro; Moser, U.; Muciaccia, Maria Teresa; Naganawa, N.; Naka, T.; Nakamura, M.; Nakamura, T.; Nakano, T.; Nikitina, V.; Niwa, K.; Nonoyama, Y.; Ogawa, S.; Osedlo, V.; Ossetski, D.; Paoloni, A.; Park, B.D.; Park, I.G.; Pastore, A.; Patrizii, L.; Pennacchio, E.; Pessard, H.; Pilipenko, V.; Pistillo, C.; Polukhina, N.; Pozzato, M.; Pretzl, Klaus P.; Publichenko, P.; Pupilli, F.; Roganova, T.; Rosa, G.; Rostovtseva, I.; Rubbia, A.; Russo, A.; Ryazhskaya, O.; Ryzhikov, D.; Sato, O.; Sato, Y.; Saveliev, V.; Sazhina, G.; Schembri, A.; Scotto Lavina, L.; Shibuya, H.; Simone, S.; Sioli, Max; Sirignano, C.; Sirri, G.; Song, J.S.; Spinetti, M.; Stanco, L.; Starkov, N.; Stipcevic, M.; Strauss, T.; Strolin, Paolo Emilio; Sugonyaev, V.; Taira, Y.; Takahashi, S.; Tenti, M.; Terranova, F.; Tezuka, I.; Tioukov, V.; Tolun, P.; Tsarev, V.; Tufanli, S.; Ushida, N.; Vilain, P.; Vladimirov, M.; Votano, L.; Vuilleumier, J.L.; Wilquet, G.; Wonsak, B.; Wurtz, J.; Yoon, C.S.; Yoshida, J.; Zaitsev, Y.; Zemskova, S.; Zghiche, Amina; Zimmermann, R.

    2008-01-01

    New methods for efficient and unambiguous interconnection between electronic counters and target units based on nuclear photographic emulsion films have been developed. The application to the OPERA experiment, that aims at detecting oscillations between mu neutrino and tau neutrino in the CNGS neutrino beam, is reported in this paper. In order to reduce background due to latent tracks collected before installation in the detector, on-site large-scale treatments of the emulsions ("refreshing") have been applied. Changeable Sheet (CSd) packages, each made of a doublet of emulsion films, have been designed, assembled and coupled to the OPERA target units ("ECC bricks"). A device has been built to print X-ray spots for accurate interconnection both within the CSd and between the CSd and the related ECC brick. Sample emulsion films have been extensively scanned with state-of-the-art automated optical microscopes. Efficient track-matching and powerful background rejection have been achieved in tests with electronic...

  20. Fluctuations observed in NBI heated Doublet III divertor discharges

    International Nuclear Information System (INIS)

    Konoshima, Shigeru; Aikawa, Hiroshi; Azumi, Masafumi

    1983-10-01

    A specific type of activity associated with fairly large pulsive energy loss has been observed, predominantly during improved confinement (H-mode) discharges in the NBI heated Doublet III tokamak. Large repetitive bursts of edge recycling light with 2-5ms duration and --10ms intervals appear in the course of increasing βsub(p). The amount of energy released by a single burst is estimated to be at least 2-3% of stored energy. As a result of these periodic energy losses, attained values of plasma energy is evaluated to be depressed as much as 10%. Prior to a burst, large m=n=0 magnetic field oscillations of --20kHz were observed with highly peaked distribution near the divertor region. No other particular activities which might be responsible for either the confinement deterioration or improvement have been found throughout the entire operational space. (author)

  1. Impurity studies and discharge cleaning in Doublet III

    Energy Technology Data Exchange (ETDEWEB)

    Marcus, F.B.

    1979-10-01

    The goal of present and next generation tokamak experiments is to produce high-density, high-purity plasmas during high-power, extended-duration discharges. Plasma discharges with Z/sub eff/ values near unity and low concentrations of medium and high-Z metallic impurities have been obtained in Doublet III using a combination of low-power hydrogen discharge cleaning, gas puffing, precise plasma shape and position control, and high-Z limiters. Analysis of the first wall surface and residual gas impurities confirmed that clean conditions have been achieved. The high-Z limiters showed very limited amounts of melting or arcing. The progress of the wall cleaning process was monitored by three diagnostic techniques: Auger electron spectroscopy of metallic samples at the vessel wall, residual gas analysis, and the resistivity of full power discharges.

  2. Reopen parameter regions in two-Higgs doublet models

    Science.gov (United States)

    Staub, Florian

    2018-01-01

    The stability of the electroweak potential is a very important constraint for models of new physics. At the moment, it is standard for Two-Higgs doublet models (THDM), singlet or triplet extensions of the standard model to perform these checks at tree-level. However, these models are often studied in the presence of very large couplings. Therefore, it can be expected that radiative corrections to the potential are important. We study these effects at the example of the THDM type-II and find that loop corrections can revive more than 50% of the phenomenological viable points which are ruled out by the tree-level vacuum stability checks. Similar effects are expected for other extension of the standard model.

  3. Top-bottom doublet in the sphaleron background

    CERN Document Server

    Moreno, J M; Quirós, Mariano

    1995-01-01

    We consider the top-bottom doublet in the background of the sphaleron for the realistic case of large non-degeneracy of fermion masses, in particular m_b=5 GeV and m_t=175 GeV. We propose an axially symmetric (r,\\theta)-dependent ansatz for fermion fields and investigate the effects of the non-degeneracy on them. The exact solution is described, with an error less than 0.01\\%, by a set of ten radial functions. We also propose an approximate solution, in the m_b/m_t\\rightarrow 0 limit, with an error {\\cal O}(m_b/m_t). We have found that the effects of non-degeneracy provide a \\theta-dependence typically \\sim 10\\%.

  4. Two Higgs doublet models and b → s exclusive decays

    Energy Technology Data Exchange (ETDEWEB)

    Arnan, Pere; Mescia, Federico [Universitat de Barcelona, Departament de Fisica Quantica i Astrofisica (FQA), Institut de Ciencies del Cosmos (ICCUB), Barcelona (Spain); Becirevic, Damir [CNRS, Univ. Paris-Sud, Universite Paris-Saclay, Laboratoire de Physique Theorique, Orsay (France); Sumensari, Olcyr [CNRS, Univ. Paris-Sud, Universite Paris-Saclay, Laboratoire de Physique Theorique, Orsay (France); Universidade de Sao Paulo, Instituto de Fisica, Sao Paulo (Brazil)

    2017-11-15

    We computed the leading order Wilson coefficients relevant to all the exclusive b → sl{sup +}l{sup -} decays in the framework of the two Higgs doublet model (2HDM) with a softly broken Z{sub 2} symmetry by including the O(m{sub b}) corrections. We elucidate the issue of appropriate matching between the full and the effective theory when dealing with the (pseudo-)scalar operators for which keeping the external momenta different from zero is necessary. We then make a phenomenological analysis by using the measured B(B{sub s} → μ{sup +}μ{sup -}) and B(B → Kμ{sup +}μ{sup -}){sub high-q{sup 2}}, for which the hadronic uncertainties are well controlled, and we discuss their impact on various types of 2HDM. A brief discussion of the decays with τ-leptons in the final state is provided too. (orig.)

  5. Theory of singlet-doublet excitations in praseodymium

    International Nuclear Information System (INIS)

    Bak, P.

    1975-10-01

    The magnetic excitation spectrum in a paramagnetic singlet-doublet system is calculated using a diagrammatic high density expansion technique. The lowest order diagrams, which correspond to the random phase approximation (RPA), give a detailed description of the wave vector and temperature dependence of the four exciton modes in praseodymium in terms of a Hamiltonian including isotropic Heisenberg exchange interactions and anisotropic, dipolar-like interactions. The leading contributions to the linewidths of the excitations are obtained by extending the 1/Z expansion of the generalized susceptibility propagators one order beyond the random phase approximation. This damping corresponds to spin wave scattering on single-site fluctuations. The theoretical spectral functions are in detailed agreement with experiment

  6. A model with isospin doublet U(1)D gauge symmetry

    Science.gov (United States)

    Nomura, Takaaki; Okada, Hiroshi

    2018-05-01

    We propose a model with an extra isospin doublet U(1)D gauge symmetry, in which we introduce several extra fermions with odd parity under a discrete Z2 symmetry in order to cancel the gauge anomalies out. A remarkable issue is that we impose nonzero U(1)D charge to the Standard Model Higgs, and it gives the most stringent constraint to the vacuum expectation value of a scalar field breaking the U(1)D symmetry that is severer than the LEP bound. We then explore relic density of a Majorana dark matter candidate without conflict of constraints from lepton flavor violating processes. A global analysis is carried out to search for parameters which can accommodate with the observed data.

  7. Leptophobic Z' in models with multiple Higgs doublet fields

    Science.gov (United States)

    Chiang, Cheng-Wei; Nomura, Takaaki; Yagyu, Kei

    2015-05-01

    We study the collider phenomenology of the leptophobic Z' boson from an extra U(1)' gauge symmetry in models with N -Higgs doublet fields. We assume that the Z' boson at tree level has (i) no Z- Z' mixing, (ii) no interaction with the charged leptons, and (iii) no flavour-changing neutral current. Under such a setup, it is shown that in the N = 1 case, all the U(1)' charges of left-handed quark doublets and right-handed up- and down- type quarks are required to be the same, while in the N ≥ 3 case one can take different charges for the three types of quarks. The N = 2 case is not well-defined under the above three requirements. We study the processes ( V = γ , Z and W ±) with the leptonic decays of Z and W ± at the LHC. The most promising discovery channel or the most stringent constraint on the U(1)' gauge coupling constant comes from the Z'γ process below the threshold and from the process above the threshold. Assuming the collision energy of 8 TeV and integrated luminosity of 19.6 fb-1, we find that the constraint from the Z'γ search in the lower mass regime can be stronger than that from the UA2 experiment. In the N ≥ 3 case, we consider four benchmark points for the Z' couplings with quarks. If such a Z' is discovered, a careful comparison between the Z'γ and Z' W signals is crucial to reveal the nature of Z' couplings with quarks. We also present the discovery reach of the Z' boson at the 14-TeV LHC in both N = 1 and N ≥ 3 cases.

  8. chemotherapy patients

    Directory of Open Access Journals (Sweden)

    Katarzyna Augustyniuk

    2016-02-01

    Full Text Available Background . Complementary and alternative medicine (CAM practices for cancer have become popular among oncology patients. An increasing interest in alternative medicine can be explained by the inefficiency of conventional treatment, dissatisfaction with treating patients like objects, and the will to use all available treatment methods. Objectives . The authors assessed how often patients use CAM methods, and which of them are most popular. Material and methods . The study was conducted in Military Hospital no. 109 and the Independent Public Clinical Hospital no. 1 in Szczecin among 100 chemotherapy patients. This survey-based study was performed using an original questionnaire. Results. Most respondents (68% did not use alternative methods to fight the disease. The most popular treatment methods were: herbal medicine (50%, alternative medicine preparations (38% and diet (25%, and the least common: hypnosis (3% and aromatherapy (3%. Analyzed sociodemographic factors had no effects on a choice of a CAM method. Patients obtained information about CAM methods mainly from the Internet (40%, medical staff (37% and literature (31%. Conclusions . 1. Using CAM by patients receiving chemotherapy for neoplasms is quite a common phenomenon. 2. CAM were more often chosen by women. Neither the duration of the disease nor sociodemographic data had effects on making the decision to use CAM methods. 3. The most popular CAM were: herbal medicine, alternative medicine preparations, and diet. 4. Cancer patients should receive special support from nurses and doctors as well as other members of the therapeutic team. Oncology patients should never be left on their own so that they were forced to seek help and support in therapies unconfirmed by scientific investigation.

  9. Malaria chemotherapy.

    Science.gov (United States)

    Winstanley, Peter; Ward, Stephen

    2006-01-01

    Most malaria control strategies today depend on safe and effective drugs, as they have done for decades. But sensitivity to chloroquine, hitherto the workhorse of malaria chemotherapy, has rapidly declined throughout the tropics since the 1980s, and this drug is now useless in many high-transmission areas. New options for resource-constrained governments are few, and there is growing evidence that the burden from malaria has been increasing, as has malaria mortality in Africa. In this chapter, we have tried to outline the main pharmacological properties of current drugs, and their therapeutic uses and limitations. We have summarised the ways in which these drugs are employed, both in the formal health sector and in self-medication. We have briefly touched on the limitations of current drug development, but have tried to pick out a few promising drugs that are under development. Given that Plasmodium falciparum is the organism that kills, and that has developed multi-drug resistance, we have tended to focus upon it. Similarly, given that around 90% of global mortality from malaria occurs in Africa, there is the tendency to dwell on this continent. We give no apology for placing our emphasis upon the use of antimalarial drugs in endemic populations rather than their use for prophylaxis in travellers.

  10. Comparison of an inflammation-based prognostic score (GPS) with performance status (ECOG-ps) in patients receiving palliative chemotherapy for gastroesophageal cancer.

    Science.gov (United States)

    Crumley, Andrew B C; Stuart, Robert C; McKernan, Margaret; McDonald, Alexander C; McMillan, Donald C

    2008-08-01

    The aim of the present study was to compare an inflammation-based prognostic score (Glasgow Prognostic Score, GPS) with performance status (ECOG-ps) in patients receiving platinum-based chemotherapy for palliation of gastroesophageal cancer. Sixty-five patients presenting with gastroesophageal carcinoma to the Royal Infirmary, Glasgow between January 1999 and December 2005 and who received palliative chemotherapy or chemo-radiotherapy were studied. ECOG-ps, C-reactive protein, and albumin were recorded at diagnosis. Patients with both an elevated C-reactive protein (>10 mg/L) and hypoalbuminemia (L) were allocated a GPS of 2. Patients in whom only one of these biochemical abnormalities was present were allocated a GPS of 1 and patients with a normal C-reactive protein and albumin were allocated a score of 0. Toxicity was recorded using the Common Toxicity Criteria. The minimum follow up was 14 months. During the follow-up period, 59 (91%) of the patients died. On univariate and multivariate survival analysis, only the GPS (hazard ratios 1.65, 95% CI 1.10-2.47, P GPS of 0, those patients with a GPS of 1 or 2 required more frequent chemotherapy dose reduction (P GPS, appears to be superior to the subjective assessment of performance status (ECOG-ps) in predicting the response to platinum-based chemotherapy in patients with advanced gastroesophageal cancer.

  11. The value of the combination of hemoglobin, albumin, lymphocyte and platelet in predicting platinum-based chemoradiotherapy response in male patients with esophageal squamous cell carcinoma.

    Science.gov (United States)

    Cong, Lihong; Hu, Likuan

    2017-05-01

    The predictive value of HALP in esophageal cancer is currently unclear. We aimed to evaluate the value of HALP in predicting platinum-based definitive chemoradiotherapy response in male patients with esophageal squamous cell carcinoma. Data from all newly diagnosed patients with esophageal squamous cell carcinoma (ESCC) were collected from January 1, 2010 to December 31, 2014 in Qilu Hospital. The treatment protocol was definitive chemoradiotherapy consisting of docetaxel plus cisplatin or carboplatin. The response assessment of the definitive chemoradiotherapy was based on computed tomography (CT) and barium meal test results. A total of 39 patients were included in the present study. The median value of HALP was 48.34. The chemoradiotherapy response rate of patients in the low HALP value group was 35%, compared with 78.95% of patients in the high HALP group (P=0.010). Additionally, the median progression-free survival in the 2 patient groups was significantly different (10.7 vs. 24.7m, P=0.041). In the multivariate analysis, patients with HALP higher than 48.34 had longer progression-free survival than patients with HALP of 48.34 or less (HR 2.745; 95% CI, 1.176-6.408; P=0.020). However, there was no significant difference for overall survival between the high HALP group and low HALP group. Our data suggested that pretreatment HALP could predict the platinum-based chemoradiotherapy response of tumors and progression free survival in male patients with ESCC. Therefore, HALP could be used in routine clinical practice to guide the therapeutic strategies for individual treatment in patients with ESCC. Copyright © 2017 Elsevier B.V. All rights reserved.

  12. Retrospective analysis of chronomodulated chemotherapy versus conventional chemotherapy with paclitaxel, carboplatin, and 5-fluorouracil in patients with recurrent and/or metastatic head and neck squamous cell carcinoma

    Directory of Open Access Journals (Sweden)

    Chen D

    2013-10-01

    Full Text Available Dan Chen, Jue Cheng, Kai Yang, Yue Ma, Fang Yang Department of Oral and Maxillofacial Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing, People's Republic of China Background: Chronomodulated chemotherapy has emerged as a new therapy as a result of recent studies focusing on the biological clock. It has been demonstrated that combination chronomodulated chemotherapy of platinum-based drugs and 5-fluorouracil (5-Fu can significantly improve efficacy and reduce the incidence of adverse events in patients with metastatic colorectal cancer, as compared with conventional chemotherapy. However, the results may be different in different tumors. Recurrent and metastatic head and neck squamous cell carcinoma (HNSCC is very difficult to treat, with an extremely unfavorable prognosis. So far, no report is available on chronomodulated chemotherapy for HNSCC. Methods: Retrospective analyses were made on 49 patients with local recurrent and/or metastatic HNSCC who underwent palliative treatments with paclitaxel, carboplatin, and 5-Fu. The patients were divided into a chronomodulated chemotherapy group (28 patients and a conventional chemotherapy group (21 patients according to their administration times. The two groups were compared for tumor objective response rate, overall survival (OS, progression-free survival (PFS, and the incidence of adverse events. Results: The tumor objective response rate and patients' OS were significantly higher and longer in the chronomodulated chemotherapy group than in the conventional chemotherapy group (71.43% versus 42.86%, respectively, P0.05. The global incidence of adverse events in the chronomodulated chemotherapy group was significantly lower than that in the conventional chemotherapy group (46.43% versus 76.19%, P<0.05, with significantly lower incidence of grade 3–4 adverse events (7.14% versus 33.33%, P<0.05. Conclusion: Chronomodulated chemotherapy with paclitaxel, carboplatin, and

  13. Muon g−2 in the aligned two Higgs doublet model

    Energy Technology Data Exchange (ETDEWEB)

    Han, Tao [Department of Physics and Astronomy, University of Pittsburgh,Pittsburgh, PA 15260 (United States); Physics Department, Collaborative Innovation Center of Quantum Matter, Tsinghua University,Beijing 100084 (China); Korea Institute for Advanced Study,Seoul 130-722 (Korea, Republic of); Kang, Sin Kyu [School of Liberal Arts, Seoul National University of Science and Technology,Seoul 139-743 (Korea, Republic of); Sayre, Joshua [Department of Physics and Astronomy, University of Pittsburgh,Pittsburgh, PA 15260 (United States)

    2016-02-16

    We study the Two-Higgs-Doublet Model with the aligned Yukawa sector (A2HDM) in light of the observed excess measured in the muon anomalous magnetic moment. We take into account the existing theoretical and experimental constraints with up-to-date values and demonstrate that a phenomenologically interesting region of parameter space exists. With a detailed parameter scan, we show a much larger region of viable parameter space in this model beyond the limiting case Type X 2HDM as obtained before. It features the existence of light scalar states with masses 3 GeV≲m{sub H}≲50 GeV, or  10 GeV≲m{sub A}≲130 GeV, with enhanced couplings to tau leptons. The charged Higgs boson is typically heavier, with 200 GeV≲m{sub H{sup +}}≲630 GeV. The surviving parameter space is forced into the CP-conserving limit by EDM constraints. Some Standard Model observables may be significantly modified, including a possible new decay mode of the SM-like Higgs boson to four taus. We comment on future measurements and direct searches for those effects at the LHC as tests of the model.

  14. Performance of Doublet III neutral beam injector cryopumping system

    International Nuclear Information System (INIS)

    Langhorn, A.R.; Kim, J.; Tupper, M.L.; Williams, J.P.; Fasolo, J.

    1984-01-01

    The Doublet III neutral beam injector system is based on three beamlines; each beamline employs two 80 kV/80 A hydrogen ion sources. Two liquid helium (LHe) cooled cryopanel arrays were designed as an integral part of the beamline in order to provide high differential pumping of hydrogen gas along the beamline. The cryopanel arrays consist of a front (nearer to the torus) disk panel (3 m 2 each side) with liquid nitrogen (LN 2 ) cooled chevrons and a rear cylindrical panel of modified Santeler panels (8 m 2 ) which also employs LN 2 cooled surfaces shielding LHe cooled surfaces. These cryopanels are piped in series. The LHe delivery is based on a closed-loop, forced-flow scheme intended for variable panel temperatures (3.7 to 4.3 K). It uses small tubes for mechanical flexibility and thermal resiliency providing ease of economic defrosting. The cryogenic system consists of a liquefier (100 l/h), a large Dewar, a heat exchanger, and a liquid ring pump. Three beamlines are serviced simultaneously by the system. Pumping speeds measured locally at ionization gauges, were well in excess of the 1.4 x 10 6 l/s design goal

  15. Let there be light from a second light Higgs doublet

    Science.gov (United States)

    Haisch, Ulrich; Malinauskas, Augustinas

    2018-03-01

    In this article, we demonstrate that the unexpected peak at around 95 GeV as seen recently by CMS in the di-photon final state can be explained within the type-I two-Higgs-doublet model by means of a moderately-to-strongly fermiophobic CP-even Higgs H. Depending on the Higgs mass spectrum, the production of such a H arises dominantly from vector boson fusion or through a cascade in either pp\\to t\\overline{t} with \\overset{(-)}{t}\\to {H}^{±}\\overset{(-)}{b}\\to {W}^{± *}H\\overset{(-)}{b} or pp → A with A → W ∓ H ± → W ∓ W ± H or via pp → W ± ∗ → H ± H. In this context, we also discuss other Higgs anomalies such as the LEP excess in Higgsstrahlung and the observation of enhanced rates in t\\overline{t}h at both the Tevatron and the LHC, showing that parameters capable of explaining the CMS di-photon signal can address the latter deviations as well. The Higgs spectra that we explore comprise masses between 80 GeV and 350 GeV. While at present all constraints from direct and indirect searches for spin-0 resonances can be shown to be satisfied for such light Higgses, future LHC data will be able to probe the parameter space that leads to a simultaneous explanation of the discussed anomalies.

  16. Radiative electroweak breaking with pseudo Goldstone Higgs doublets

    International Nuclear Information System (INIS)

    Ananthanarayan, B.; Shafi, Q.

    1996-01-01

    We consider a realistic example of supersymmetric grand unification based on SU(3) c xSU(3) L xSU(3) R in which the electroweak (EW) Higgs doublets are open-quote open-quote light close-quote close-quote as a consequence of the open-quote open-quote pseudo Goldstone close-quote close-quote mechanism. We discuss radiative EW breaking in this model, exploring in particular the open-quote open-quote small close-quote close-quote (order unity) and open-quote open-quote large close-quote close-quote (≅m t /m b ) tanβ regions by studying the variations of r 2 (≡μ 1,2 2 /μ 2 3 ), where μ 1,2,3 2 are the well-known MSSM parameters evaluated at the GUT scale. For |r| sufficiently close to unity the quantity tanβ can be of order unity, but the converse is not always true. copyright 1996 The American Physical Society

  17. Dark matter physics in neutrino specific two Higgs doublet model

    Energy Technology Data Exchange (ETDEWEB)

    Baek, Seungwon; Nomura, Takaaki [School of Physics, Korea Institute for Advanced Study,85 Hoegiro, Dongdaemun-gu, Seoul 02455 (Korea, Republic of)

    2017-03-10

    Although the seesaw mechanism is a natural explanation for the small neutrino masses, there are cases when the Majorana mass terms for the right-handed neutrinos are not allowed due to symmetry. In that case, if neutrino-specific Higgs doublet is introduced, neutrinos become Dirac particles and their small masses can be explained by its small VEV. We show that the same symmetry, which we assume a global U(1){sub X}, can also be used to explain the stability of dark matter. In our model, a new singlet scalar breaks the global symmetry spontaneously down to a discrete Z{sub 2} symmetry. The dark matter particle, lightest Z{sub 2}-odd fermion, is stabilized. We discuss the phenomenology of dark matter: relic density, direct detection, and indirect detection. We find that the relic density can be explained by a novel Goldstone boson channel or by resonance channel. In the most region of parameter space considered, the direct detections is suppressed well below the current experimental bound. Our model can be further tested in indirect detection experiments such as FermiLAT gamma ray searches or neutrinoless double beta decay experiments.

  18. Looking for New Naturally Aligned Higgs Doublets at the LHC

    CERN Document Server

    Pilaftsis, Apostolos

    2015-10-30

    Since the current LHC Higgs data suggest the couplings of the observed 125 GeV Higgs boson to be close to the Standard Model (SM) expectations, any extended Higgs sector must lead to the so-called SM alignment limit, where one of the Higgs bosons behaves exactly like that of the SM. In the context of the Two Higgs Doublet Model (2HDM), this alignment is often associated with either decoupling of the heavy Higgs sector or accidental cancellations in the 2HDM potential. We present a novel symmetry justification for 'natural' alignment without necessarily decoupling or fine-tuning. We show that there exist only three different symmetry realizations of the natural alignment scenario in 2HDM. We analyze new collider signals for the heavy Higgs sector in the natural alignment limit, which dominantly lead to third-generation quarks in the final state and can serve as a useful observational tool during the Run-II phase of the LHC.

  19. Derivative interactions and perturbative UV contributions in N Higgs doublet models

    Energy Technology Data Exchange (ETDEWEB)

    Kikuta, Yohei [KEK Theory Center, KEK, Tsukuba (Japan); The Graduate University for Advanced Studies, Department of Particle and Nuclear Physics, Tsukuba (Japan); Yamamoto, Yasuhiro [Universidad de Granada, Deportamento de Fisica Teorica y del Cosmos, Facultad de Ciencias and CAFPE, Granada (Spain)

    2016-05-15

    We study the Higgs derivative interactions on models including arbitrary number of the Higgs doublets. These interactions are generated by two ways. One is higher order corrections of composite Higgs models, and the other is integration of heavy scalars and vectors. In the latter case, three point couplings between the Higgs doublets and these heavy states are the sources of the derivative interactions. Their representations are constrained to couple with the doublets. We explicitly calculate all derivative interactions generated by integrating out. Their degrees of freedom and conditions to impose the custodial symmetry are discussed. We also study the vector boson scattering processes with a couple of two Higgs doublet models to see experimental signals of the derivative interactions. They are differently affected by each heavy field. (orig.)

  20. Real time acquisition, processing, and archiving of Doublet III diagram data employing table driven software

    International Nuclear Information System (INIS)

    Glad, A.; Henline, P.; Gross, L.; McHarg, B.

    1979-11-01

    This paper describes the diagnostic data acquisition, processing and archiving computer system for the Doublet III fusion research device. This paper's emphasis is mainly on the software, but provides a description of the hardware configuration

  1. Role of chemotherapy and targeted therapy in early-stage non-small cell lung cancer.

    Science.gov (United States)

    Nagasaka, Misako; Gadgeel, Shirish M

    2018-01-01

    Adjuvant platinum based chemotherapy is accepted as standard of care in stage II and III non-small cell lung cancer (NSCLC) patients and is often considered in patients with stage IB disease who have tumors ≥ 4 cm. The survival advantage is modest with approximately 5% at 5 years. Areas covered: This review article presents relevant data regarding chemotherapy use in the perioperative setting for early stage NSCLC. A literature search was performed utilizing PubMed as well as clinical trial.gov. Randomized phase III studies in this setting including adjuvant and neoadjuvant use of chemotherapy as well as ongoing trials on targeted therapy and immunotherapy are also discussed. Expert commentary: With increasing utilization of screening computed tomography scans, it is possible that the percentage of early stage NSCLC patients will increase in the coming years. Benefits of adjuvant chemotherapy in early stage NSCLC patients remain modest. There is a need to better define patients most likely to derive survival benefit from adjuvant therapy and spare patients who do not need adjuvant chemotherapy due to the toxicity of such therapy. Trials for adjuvant targeted therapy, including adjuvant EGFR-TKI trials and trials of immunotherapy drugs are ongoing and will define the role of these agents as adjuvant therapy.

  2. The inert doublet model: a new archetype of WIMP dark matter?

    International Nuclear Information System (INIS)

    Tytgat, M Hg

    2008-01-01

    The Inert Doublet Model (IDM) is a two doublet extension of the Higgs-Brout-Englert sector of the Standard Model with a Z2 symmetry in order to prevent FCNC. If the Z2 symmetry is not spontaneously broken, the lightest neutral extra scalar is a dark matter candidate. We briefly review the phenomenology of the model, emphasizing its relevance for the issue of Electroweak Symmetry Breaking (EWSB) and the prospects for detection of dark matter

  3. Penguin effects induced by the two-Higgs-doublet model and charmless B-meson decays

    International Nuclear Information System (INIS)

    Davies, A.J.; Joshi, G.C.; Matsuda, M.

    1991-03-01

    Nonstandard physical effects through the penguin diagram induced by the charged Higgs scalar contribution in the two-Higgs-doublet model are analysed. The non-leptonic β-decay processes including the non-standard two-Higgs-doublet contribution are compared with the standard model results, which arise from the magnetic gluon transition term. The charged Higgs contribution gives a sizable enhancement to the branching fractions of β-meson charmless decay. 13 refs., 4 figs

  4. Bladder cancer: the combination of chemotherapy and irradiation in the treatment of patients with muscle-invading tumors

    International Nuclear Information System (INIS)

    Shipley, William U.; Zietman, Anthony L.

    1995-01-01

    In the USA the recommended treatment for patients with muscle-invading transitional cell cancer of the bladder is usually radical cystectomy. Conservative surgery (transurethral resection and partial cystectomy), irradiation, and cis-platinum based systemic chemotherapy are, however, each effective for some patients. Although they provide the opportunity for bladder preservation, each modality, when used alone, is inferior to radical cystectomy in terms of local control and, perhaps, survival. Initial response and local control rates are improved when a multimodality approach is used. Up to 85% of patients selected for bladder sparing therapy on the basis of their initial response to chemo-radiation may keep their bladders. This figure could increase further when other powerful prognostic factors, such as the presence of hydronephrosis or carcinoma in situ, are taken into account in initial patient selection. Deferring the patient from immediate cystectomy does not appear to compromise survival. The most appropriate sequencing of radiation and chemotherapy is yet to be established. Concomitant cis-platinum and irradiation improves local control and bladder preservation when compared with irradiation alone but does not decrease the metastatic rate. It is hoped that the well recognized activity of cis-platinum based combination chemotherapy in advanced disease will translate into effective eradication of micrometastatic disease (known to be present in up to 40% of patients at diagnosis). This has yet to be clearly demonstrated in a randomized trial. The addition of combination chemotherapy to radiation does not increase bladder morbidity but carries a considerable systemic risk. Thus, despite promising phase II studies, until a survival benefit is proven in a randomized trial, neoadjuvant or adjuvant combination chemotherapy in conjunction with irradiation should continue to be regarded as experimental

  5. Switch maintenance chemotherapy using S-1 with or without bevacizumab in patients with advanced non-small cell lung cancer: a phase II study.

    Science.gov (United States)

    Niho, Seiji; Ohe, Yuichiro; Ohmatsu, Hironobu; Umemura, Shigeki; Matsumoto, Shingo; Yoh, Kiyotaka; Goto, Koichi

    2017-06-01

    We conducted this single-institute; prospective, non-randomized parallel two-arm phase II study to evaluate the efficacy and safety of switch maintenance chemotherapy with S-1 after induction therapy with a platinum-based regimen in patients with advanced non-small cell lung cancer (NSCLC). Patients not showing disease progression after induction platinum-based chemotherapy received S-1 at the dose of 40mg/m 2 twice daily for 14 consecutive days, every three weeks, with or without bevacizumab (Bev) at the dose of 15mg/kg. In cases where the induction chemotherapy regimen contained Bev, Bev was used as continuation maintenance chemotherapy where appropriate. The efficacy/toxicity of switch maintenance chemotherapy with S-1 and S-1+Bev was evaluated separately. The primary end point of this study was the treatment success rate at three months after the start of S-1 treatment. Between July 2010 and January 2014, 79 patients were enrolled, of which 78 were found to be eligible for inclusion in this study. The treatment success rate at three months was 28.2% (90% confidence interval (CI), 7.1-17.1%) in the S-1 group and 64.1% (90% CI, 50.0-76.8%) in the S-1+Bev group. The primary endpoint was met in the S-1+Bev group. The median PFS and OS were 2.6 months and 11.0 months in the S-1 group, and 4.6 months and 19.9 months in the S-1+Bev group, respectively. The most common grade three toxicity was neutropenia (10% incidence in the S-1+Bev group). There were no cases of febrile neutropenia. Switch maintenance chemotherapy with S-1 in combination with continuation maintenance chemotherapy with bevacizumab yielded modest efficacy with mild and acceptable toxicities. Copyright © 2017. Published by Elsevier B.V.

  6. Passive athermalization of doublets in 8-13 micron waveband

    Science.gov (United States)

    Schuster, Norbert

    2014-10-01

    Passive athermalization of lenses has become a key-technology for automotive and other outdoor applications using modern uncooled 25, 17 and 12 micron pixel pitch bolometer arrays. Typical pixel counts for thermal imaging are 384x288 (qVGA), 640x480 (VGA), and 1024x768 (XGA). Two lens arrangements (called Doublets) represent a cost effective way to satisfy resolution requirements of these detectors with F-numbers 1.4 or faster. Thermal drift of index of refraction and the geometrical changes (in lenses and housing) versus temperature defocus the initial image plane from the detector plane. The passive athermalization restricts this drop of spatial resolution in a wide temperature range (typically -40°C…+80°C) to an acceptable value without any additional external refocus. In particular, lenses with long focal lengths and high apertures claim athermalization. A careful choice of lens and housing materials and a sophistical dimensioning lead to three different principles of passivation: The Passive Mechanical Athermalization (PMA) shifts the complete lens cell, the Passive Optical and Mechanical Athermalization (POMA) shifts only one lens inside the housing, the Passive Optical Athermalization (POA) works without any mechanism. All three principles will be demonstrated for a typical narrow-field lens (HFOV about 12°) with high aperture (aperture based F-number 1.3) for the actual uncooled reference detector (17micron VGA). Six design examples using different combinations of lens materials show the impact on spatial lens resolution, on overall length, and on weight. First order relations are discussed. They give some hints for optimization solutions. Pros and cons of different passive athermalization principles are evaluated in regards of housing design, availability of materials and costing. Examples with a convergent GASIR®1-lens in front distinguish by best resolution, short overall length, and lowest weight.

  7. Chemotherapy to Treat Cancer

    Science.gov (United States)

    Chemotherapy is a type of cancer treatment that uses drugs to kill cancer cells. Learn how chemotherapy works against cancer, why it causes side effects, and how it is used with other cancer treatments.

  8. Severe difficulties with word recognition in noise after platinum chemotherapy in childhood, and improvements with open-fitting hearing-aids.

    Science.gov (United States)

    Einarsson, Einar-Jón; Petersen, Hannes; Wiebe, Thomas; Fransson, Per-Anders; Magnusson, Måns; Moëll, Christian

    2011-10-01

    To investigate word recognition in noise in subjects treated in childhood with chemotherapy, study benefits of open-fitting hearing-aids for word recognition, and investigate whether self-reported hearing-handicap corresponded to subjects' word recognition ability. Subjects diagnosed with cancer and treated with platinum-based chemotherapy in childhood underwent audiometric evaluations. Fifteen subjects (eight females and seven males) fulfilled the criteria set for the study, and four of those received customized open-fitting hearing-aids. Subjects with cisplatin-induced ototoxicity had severe difficulties recognizing words in noise, and scored as low as 54% below reference scores standardized for age and degree of hearing loss. Hearing-impaired subjects' self-reported hearing-handicap correlated significantly with word recognition in a quiet environment but not in noise. Word recognition in noise improved markedly (up to 46%) with hearing-aids, and the self-reported hearing-handicap and disability score were reduced by more than 50%. This study demonstrates the importance of testing word recognition in noise in subjects treated with platinum-based chemotherapy in childhood, and to use specific custom-made questionnaires to evaluate the experienced hearing-handicap. Open-fitting hearing-aids are a good alternative for subjects suffering from poor word recognition in noise.

  9. Reference peak method for analysis of doublets in gamma-ray spectrometry used in neutron activation analysis

    International Nuclear Information System (INIS)

    Wasek, M.; Cichowlas, A.; Sterlinski, S.; Dybczynski, R.

    2000-01-01

    A simple algebraic method for the quantitative analysis of doublets in gamma-ray spectra from HPGe detectors is presented. The calculation algorithm is accomplished using the Microsoft Excel program. The method does not require any assumptions regarding the shape of the peaks in the spectrum. The possibilities of quantitative analysis of doublets of various intensity ration and separation of ots components are discussed in detail. The practical examples proved the usefulness the method also for the analysis of the closed doublets. (author)

  10. Inert doublet dark matter with an additional scalar singlet and 125 GeV Higgs boson

    Energy Technology Data Exchange (ETDEWEB)

    Dutta Banik, Amit; Majumdar, Debasish [Saha Institute of Nuclear Physics, Astroparticle Physics and Cosmology Division, Kolkata (India)

    2014-11-15

    In this work we consider a model for particle dark matter where an extra inert Higgs doublet and an additional scalar singlet is added to the Standard Model (SM) Lagrangian. The dark matter candidate is obtained from only the inert doublet. The stability of this one component dark matter is ensured by imposing a Z{sub 2} symmetry on this additional inert doublet. The additional singlet scalar has a vacuum expectation value (VEV) and mixes with the Standard Model Higgs doublet, resulting in two CP even scalars h{sub 1} and h{sub 2}. We treat one of these scalars, h{sub 1}, to be consistent with the SM Higgs-like boson of mass around 125 GeV reported by the LHC experiment. These two CP even scalars contribute to the annihilation cross section of this inert doublet dark matter, resulting in a larger dark matter mass region that satisfies the observed relic density. We also investigate the h{sub 1} → γγ and h{sub 1} → γ Z processes and compared these with LHC results. This is also used to constrain the dark matter parameter space in the present model. We find that the dark matter candidate in the mass region 60-80 GeV (m{sub 1} = 125 GeV, mass of h{sub 1}) satisfies the recent bound from LUX direct detection experiment. (orig.)

  11. Separation of the 1+/1− parity doublet in 20Ne

    Directory of Open Access Journals (Sweden)

    J. Beller

    2015-02-01

    Full Text Available The (J,T=(1,1 parity doublet in 20Ne at 11.26 MeV is a good candidate to study parity violation in nuclei. However, its energy splitting is known with insufficient accuracy for quantitative estimates of parity violating effects. To improve on this unsatisfactory situation, nuclear resonance fluorescence experiments using linearly and circularly polarized γ-ray beams were used to determine the energy difference of the parity doublet ΔE=E(1−−E(1+=−3.2(±0.7stat(−1.2+0.6sys keV and the ratio of their integrated cross sections Is,0(+/Is,0(−=29(±3stat(−7+14sys. Shell-model calculations predict a parity-violating matrix element having a value in the range 0.46–0.83 eV for the parity doublet. The small energy difference of the parity doublet makes 20Ne an excellent candidate to study parity violation in nuclear excitations. Keywords: Parity doublet, Parity violation

  12. Concomitant Radiotherapy and Chemotherapy for High-Risk Nonmelanoma Skin Carcinomas of the Head and Neck

    Directory of Open Access Journals (Sweden)

    Smith Apisarnthanarax

    2011-01-01

    Full Text Available Background. To report on the use and feasibility of a multimodality approach using concomitant radiotherapy and chemotherapy in patients with high-risk nonmelanoma skin carcinoma (NMSC of the head and neck. Methods. Records of patients with NMSC of the head and neck who received concomitant CRT at the University of North Carolina between 2001 and 2007 were reviewed. Results. Fifteen identified patients had at least one of the following high-risk factors: T4 disease (93%, unresectability (60%, regional nodal involvement (40%, and/or recurrence (47%. Ten patients were treated in the definitive setting and five in the postoperative setting. Platinum based chemotherapy was given in 14 (93% patients. Ten of fifteen (67% patients completed all planned chemotherapy treatments, and thirteen patients (87% completed at least 80% of planned chemotherapy. Mild radiation dermatitis occurred in all patients and reached grade 3 in 13% of patients. No patients experienced grade 4 or 5 toxicity. With a median followup of 31 months in surviving patients, the 2-year actuarial locoregional control and relapse-free survival were 79% and 49%, respectively. Conclusions. Definitive or postoperative chemoradiotherapy for patients with locally advanced or regionally metastasized NMSC of the head and neck appears feasible with acceptable toxicities and favorable locoregional control.

  13. Pre-exenterative chemotherapy, a novel therapeutic approach for patients with persistent or recurrent cervical cancer

    Directory of Open Access Journals (Sweden)

    Uribe Jesus

    2005-09-01

    Full Text Available Abstract Background Most cervical cancer patients with pelvic recurrent or persistent disease are not candidates for exenteration, therefore, they only receive palliative chemotherapy. Here we report the results of a novel treatment modality for these patients pre-exenterative chemotherapy- under the rational that the shrinking of the pelvic tumor would allow its resection. Methods Patients with recurrent or persistent disease and no evidence of systemic disease, considered not be candidates for pelvic exenteration because of the extent of pelvic tumor, received 3-courses of platinum-based chemotherapy. Response was evaluated by CT scan and bimanual pelvic examination; however the decision to perform exenteration relied on the physical findings. Toxicity to chemotherapy was evaluated with standard criteria. Survival was analyzed with the Kaplan-Meier method. Results Seventeen patients were studied. The median number of chemotherapy courses was 4. There were 9 patients who responded to chemotherapy, evaluated by bimanual examination and underwent pelvic exenteration. Four of them had pathological complete response. Eight patients did not respond and were not subjected to surgery. One patient died due to exenteration complications. At a median follow-up of 11 months, the median survival for the whole group was 11 months, 3 months in the non-operated and 32 months in those subjected to exenteration. Conclusion Pre-exenterative chemotherapy is an alternative for cervical cancer patients that are no candidates for exenteration because of the extent of the pelvic disease. Its place in the management of recurrent disease needs to be investigated in randomized studies, however, its value for offering long-term survival in some of these patients with no other option than palliative care must be stressed.

  14. Critical Assessment of TD-DFT for Excited States of Open-Shell Systems: I. Doublet-Doublet Transitions.

    Science.gov (United States)

    Li, Zhendong; Liu, Wenjian

    2016-01-12

    A benchmark set of 11 small radicals is set up to assess the performance of time-dependent density functional theory (TD-DFT) for the excited states of open-shell systems. Both the unrestricted (U-TD-DFT) and spin-adapted (X-TD-DFT) formulations of TD-DFT are considered. For comparison, the well-established EOM-CCSD (equation-of-motion coupled-cluster with singles and doubles) is also used. In total, 111 low-lying singly excited doublet states are accessed by all the three approaches. Taking the MRCISD+Q (multireference configuration interaction with singles and doubles plus the Davidson correction) results as the benchmark, it is found that both U-TD-DFT and EOM-CCSD perform well for those states dominated by singlet-coupled single excitations (SCSE) from closed-shell to open-shell, open-shell to vacant-shell, or closed-shell to vacant-shell orbitals. However, for those states dominated by triplet-coupled single excitations (TCSE) from closed-shell to vacant-shell orbitals, both U-TD-DFT and EOM-CCSD fail miserably due to severe spin contaminations. In contrast, X-TD-DFT provides balanced descriptions of both SCSE and TCSE. As far as the functional dependence is concerned, it is found that, when the Hartree-Fock ground state does not suffer from the instability problem, both global hybrid (GH) and range-separated hybrid (RSH) functionals perform grossly better than pure density functionals, especially for Rydberg and charge-transfer excitations. However, if the Hartree-Fock ground state is instable or nearly instable, GH and RSH tend to underestimate severely the excitation energies. The SAOP (statistically averaging of model orbital potentials) performs more uniformly than any other density functionals, although it generally overestimates the excitation energies of valence excitations. Not surprisingly, both EOM-CCSD and adiabatic TD-DFT are incapable of describing excited states with substantial double excitation characters.

  15. Classification of finite reparametrization symmetry groups in the three-Higgs-doublet model

    International Nuclear Information System (INIS)

    Ivanov, Igor P.; Vdovin, E.

    2013-01-01

    Symmetries play a crucial role in electroweak symmetry breaking models with non-minimal Higgs content. Within each class of these models, it is desirable to know which symmetry groups can be implemented via the scalar sector. In N-Higgs-doublet models, this classification problem was solved only for N=2 doublets. Very recently, we suggested a method to classify all realizable finite symmetry groups of Higgs-family transformations in the three-Higgs-doublet model (3HDM). Here, we present this classification in all detail together with an introduction to the theory of solvable groups, which play the key role in our derivation. We also consider generalized-CP symmetries, and discuss the interplay between Higgs-family symmetries and CP-conservation. In particular, we prove that presence of the Z 4 symmetry guarantees the explicit CP-conservation of the potential. This work completes classification of finite reparametrization symmetry groups in 3HDM. (orig.)

  16. Physiological consequences of doublet discharges on motoneuronal firing and motor unit force

    Directory of Open Access Journals (Sweden)

    Włodzimierz eMrówczyński

    2015-03-01

    Full Text Available The double discharges are observed at the onset of contractions of mammalian motor units (MUs, especially during their recruitment to strong or fast movements. Doublets lead to MU force increase and improve ability of muscles to maintain high force during prolonged contractions. In this review we discuss an ability to produce doublets by fast and slow motoneurons (MNs, their influence on the course of action potential afterhyperpolarization as well as its role in modulation of the initial stage of the firing pattern of MNs. In conclusion, a generation of doublets is an important strategy of motor control, responsible for fitting the motoneuronal firing rate to the optimal for MUs at the start of their contraction, necessary for increment of muscle force.

  17. The influence of facies heterogeneity on the doublet performance in low-enthalpy geothermal sedimentary reservoirs

    DEFF Research Database (Denmark)

    Crooijmans, R. A.; Willems, C. J L; Nick, Hamid

    2016-01-01

    A three-dimensional model is used to study the influence of facies heterogeneity on energy production under different operational conditions of low-enthalpy geothermal doublet systems. Process-based facies modelling is utilised for the Nieuwerkerk sedimentary formation in the West Netherlands Basin...... and the energy recovery rate for different discharge rates and the production temperature (Tmin) above which the doublet is working. With respect to the results, we propose a design model to estimate the life time and energy recovery rate of the geothermal doublet. The life time is estimated as a function of N....../G, Tmin and discharge rate, while the design model for the energy recovery rate is only a function of N/G and Tmin. Both life time and recovery show a positive relation with an increasing N/G. Further our results suggest that neglecting details of process-based facies modelling may lead to significant...

  18. Autler-Townes doublet and electromagnetically induced transparency resonance probed by an ultrashort pulse train

    International Nuclear Information System (INIS)

    Soares, A A; De Araujo, Luis E E

    2010-01-01

    We study theoretically the interaction between an ultrashort pulse train and a three-level atom driven by a cw laser. We show that the pulse train can be employed to observe spectra of Autler-Townes doublet and electromagnetically induced transparency resonance that are time and frequency resolved. The observation of subnatural linewidth features associated with the electromagnetically induced transparency resonance is described. The temporal evolution of electromagnetically induced transparency of the pulse train is shown to exhibit new and different features compared to that of the related phenomenon of coherent population trapping. By matching the tooth separation of the frequency comb associated with the pulse train to that of the Autler-Townes doublet, quantum beats between the doublet components can be induced. We show that coherent accumulation of excitation plays a major role in the two studied phenomena.

  19. CP violation in the two-doublet Higgs sector of the MSSM

    International Nuclear Information System (INIS)

    Akhmetzyanova, Eh.N.; Dolgopolov, M.V.; Dubinin, M.N.

    2006-01-01

    Models with extended two-doublet Higgs sector are discussed in view of using their particular features to find out which sources of CP violation could take place in nature. It is considered the effective two-Higgs-doublet potential with complex parameters, when the CP invariance is broken both explicitly and spontaneously. For case of the two-doublet Higgs sector of the minimal supersymmetric model, when CP invariance is violated by the interactions of Higgs fields with the third generation of scalar quarks, the Higgs bosons mass spectrum in the case of maximal CP mixing is calculated which is significantly different from CP-conserving case. The phenomenological consequences for the Higgs mass spectrum in the decoupling regime and for the strong mixing case are considered [ru

  20. Operator-generated command language for computer control of Doublet III

    International Nuclear Information System (INIS)

    Drobnis, D.; Petersen, P.

    1982-02-01

    The Control System for Doublet III consists of a medium-sized minicomputer system, with several keyboards and color alphanumeric CRTs for interactive operator interface to a large distributed CAMAC I/O system. Under normal operating conditions, however, all of the sequential and decision-making operations necessary to prepare each tokamak shot are performed directly by the computer, executing a set of Procedures coded in a convenient command language. Most of these Procedures have been developed by the Doublet III operators themselves, and are maintained, altered, and augmented as required without programmer attention. In effect, the Procedures have become a high-level tokamak Command Language

  1. Penguin effects induced by the two-Higgs-doublet model and charmless B-meson decays

    International Nuclear Information System (INIS)

    Davies, A.J.; Joshi, G.C.; Matsuda, M.

    1991-01-01

    Nonstandard physical effects through the penguin diagram induced by the charged Higgs scalar contribution in the two-Higgs-doublet model are analysed. Since non-leptonic B-decay processes to final states consisting of s+s+anti s are induced only through the penguin diagram they are important tests of such contributions. We compare these decays including the non-standard two-Higgs-doublet contribution with the standard model results, which arise from the magnetic gluon transistion term. The charged Higgs contribution can give a sizable enhancement to the branching fraction of B-meson charmless decay. (orig.)

  2. Conceptual design summary for modifying Doublet III to a large dee-shaped configuration

    International Nuclear Information System (INIS)

    Davis, L.G.; Gallix, R.; Luxon, J.L.; Mahdavi, M.A.; Puhn, F.A.; Rock, P.J.; Wesley, J.C.

    1983-05-01

    The Doublet III tokamak is to be reconfigured by replacing its indented (doublet) vacuum vessel with a larger one of a dee-shaped cross section. This change will permit significantly larger elongated plasmas than is presently possible and will allow higher plasma current (up to 5 MA) and anticipated longer confinement time. Reactor relevant values of stable beta and plasma pressure are predicted. This modification, while resulting in a significant change in capability, utilizes most of the existing coils, structure, systems and facility

  3. Scalable UWB photonic generator based on the combination of doublet pulses.

    Science.gov (United States)

    Moreno, Vanessa; Rius, Manuel; Mora, José; Muriel, Miguel A; Capmany, José

    2014-06-30

    We propose and experimentally demonstrate a scalable and reconfigurable optical scheme to generate high order UWB pulses. Firstly, various ultra wideband doublets are created through a process of phase-to-intensity conversion by means of a phase modulation and a dispersive media. In a second stage, doublets are combined in an optical processing unit that allows the reconfiguration of UWB high order pulses. Experimental results both in time and frequency domains are presented showing good performance related to the fractional bandwidth and spectral efficiency parameters.

  4. Search for a lighter Higgs boson in Two Higgs Doublet Models

    Energy Technology Data Exchange (ETDEWEB)

    Cacciapaglia, Giacomo; Deandrea, Aldo; Gascon-Shotkin, Suzanne; Corre, Solène Le; Lethuillier, Morgan [University Lyon, Université Claude Bernard Lyon 1, CNRS/IN2P3, UMR5822 IPNL,4, rue E. Fermi, Villeurbanne, F-69622 (France); Tao, Junquan [Institute High Energy Physics, Chinese Academy of Sciences,P.O. Box 918, Beijing, 100049 (China)

    2016-12-15

    We consider present constraints on Two Higgs Doublet Models, both from the LHC at Run 1 and from other sources in order to explore the possibility of constraining a neutral scalar or pseudo-scalar particle lighter than the 125 GeV Higgs boson. Such a lighter particle is not yet completely excluded by present data. We show with a simplified analysis that some new constraints could be obtained at the LHC if such a search is performed by the experimental collaborations, which we therefore encourage to continue carrying out light diphoton resonance searches at √s=13 TeV in the context of Two Higgs Doublet Models.

  5. Possible incorporation of a dee-shaped vacuum vessel in Doublet III

    International Nuclear Information System (INIS)

    Davis, L.; Rawls, J.M.

    1979-11-01

    The design of Doublet III allows relative straightforward incorporation of any of a number of possible dee-configuration vacuum vessels that can serve as relevant size tests of reactor regime devices. Configurations simulating those of JET, ETF and INTOR with plasma areas larger than TFTR can be attained with significant physics parameter results. Such modifications to Doublet III could be incorporated into planned upgrade activites with operations beginning in 1984, early enough to influence the designs of ETF and INTOR and test the scaling laws, poloidal coil system, and impurity control systems proposed for these ignition devices

  6. Design, construction and commissioning of a simple, low cost permanent magnet quadrupole doublet

    International Nuclear Information System (INIS)

    Conard, E.M.; Parcell, S.K.; Arnott, D.W.

    1999-01-01

    In the framework of new beam line developments at the Australian National Medical Cyclotron, a permanent magnet quadrupole doublet was designed and built entirely in house. The design proceeded from the classical work by Halbach et al. but emphasised the 'low cost' aspect by using simple rectangular NdFeB blocks and simple assembly techniques. Numerical simulations using the (2-D) Gemini code were performed to check the field strength and homogeneity predictions of analytical calculations. This paper gives the reasons for the selection of a permanent magnet, the design and construction details of the quadrupole doublet and its field measurement results. (authors)

  7. Analysis of adverse events of renal impairment related to platinum-based compounds using the Japanese Adverse Drug Event Report database.

    Science.gov (United States)

    Naganuma, Misa; Motooka, Yumi; Sasaoka, Sayaka; Hatahira, Haruna; Hasegawa, Shiori; Fukuda, Akiho; Nakao, Satoshi; Shimada, Kazuyo; Hirade, Koseki; Mori, Takayuki; Yoshimura, Tomoaki; Kato, Takeshi; Nakamura, Mitsuhiro

    2018-01-01

    Platinum compounds cause several adverse events, such as nephrotoxicity, gastrointestinal toxicity, myelosuppression, ototoxicity, and neurotoxicity. We evaluated the incidence of renal impairment as adverse events are related to the administration of platinum compounds using the Japanese Adverse Drug Event Report database. We analyzed adverse events associated with the use of platinum compounds reported from April 2004 to November 2016. The reporting odds ratio at 95% confidence interval was used to detect the signal for each renal impairment incidence. We evaluated the time-to-onset profile of renal impairment and assessed the hazard type using Weibull shape parameter and used the applied association rule mining technique to discover undetected relationships such as possible risk factor. In total, 430,587 reports in the Japanese Adverse Drug Event Report database were analyzed. The reporting odds ratios (95% confidence interval) for renal impairment resulting from the use of cisplatin, oxaliplatin, carboplatin, and nedaplatin were 2.7 (2.5-3.0), 0.6 (0.5-0.7), 0.8 (0.7-1.0), and 1.3 (0.8-2.1), respectively. The lower limit of the reporting odds ratio (95% confidence interval) for cisplatin was >1. The median (lower-upper quartile) onset time of renal impairment following the use of platinum-based compounds was 6.0-8.0 days. The Weibull shape parameter β and 95% confidence interval upper limit of oxaliplatin were impairment during cisplatin use in real-world setting. The present findings demonstrate that the incidence of renal impairment following cisplatin use should be closely monitored when patients are hypertensive or diabetic, or when they are co-administered furosemide, loxoprofen, or pemetrexed. In addition, healthcare professionals should closely assess a patient's background prior to treatment.

  8. Chemotherapy disruption of efficient radiotherapy

    International Nuclear Information System (INIS)

    Nervi, C.; Friedman, M.

    1974-01-01

    Studies on the use of chemotherapy in combination with radiotherapy are reviewed. Some topics discussed are: indications for the use of combined chemotherapy and radiotherapy; improvement of the therapeutic ratio following the use of methotrexate; advantages of preirradiation and postirradiation chemotherapy; side effects following simultaneous chemotherapy and radiotherapy; and effects of chemotherapy on cure rate of radiosensitive and radioresistant tumors. (U.S.)

  9. Aberrant DNA damage response pathways may predict the outcome of platinum chemotherapy in ovarian cancer.

    Directory of Open Access Journals (Sweden)

    Dimitra T Stefanou

    Full Text Available Ovarian carcinoma (OC is the most lethal gynecological malignancy. Despite the advances in the treatment of OC with combinatorial regimens, including surgery and platinum-based chemotherapy, patients generally exhibit poor prognosis due to high chemotherapy resistance. Herein, we tested the hypothesis that DNA damage response (DDR pathways are involved in resistance of OC patients to platinum chemotherapy. Selected DDR signals were evaluated in two human ovarian carcinoma cell lines, one sensitive (A2780 and one resistant (A2780/C30 to platinum treatment as well as in peripheral blood mononuclear cells (PBMCs from OC patients, sensitive (n = 7 or resistant (n = 4 to subsequent chemotherapy. PBMCs from healthy volunteers (n = 9 were studied in parallel. DNA damage was evaluated by immunofluorescence γH2AX staining and comet assay. Higher levels of intrinsic DNA damage were found in A2780 than in A2780/C30 cells. Moreover, the intrinsic DNA damage levels were significantly higher in OC patients relative to healthy volunteers, as well as in platinum-sensitive patients relative to platinum-resistant ones (all P<0.05. Following carboplatin treatment, A2780 cells showed lower DNA repair efficiency than A2780/C30 cells. Also, following carboplatin treatment of PBMCs ex vivo, the DNA repair efficiency was significantly higher in healthy volunteers than in platinum-resistant patients and lowest in platinum-sensitive ones (t1/2 for loss of γH2AX foci: 2.7±0.5h, 8.8±1.9h and 15.4±3.2h, respectively; using comet assay, t1/2 of platinum-induced damage repair: 4.8±1.4h, 12.9±1.9h and 21.4±2.6h, respectively; all P<0.03. Additionally, the carboplatin-induced apoptosis rate was higher in A2780 than in A2780/C30 cells. In PBMCs, apoptosis rates were inversely correlated with DNA repair efficiencies of these cells, being significantly higher in platinum-sensitive than in platinum-resistant patients and lowest in healthy volunteers (all P<0.05. We conclude

  10. Chemotherapy-induced hyaluronan production: a novel chemoresistance mechanism in ovarian cancer

    International Nuclear Information System (INIS)

    Ricciardelli, Carmela; Ween, Miranda P; Lokman, Noor A; Tan, Izza A; Pyragius, Carmen E; Oehler, Martin K

    2013-01-01

    Hyaluronan (HA) an important component of the extracellular matrix, has been linked to tumor progression and drug resistance in several malignancies. However, limited data is available for ovarian cancer. This study investigated the role of hyaluronan (HA) and a potential link between the HA-CD44 pathway and membrane ATP binding cassette (ABC) transporter proteins in ovarian cancer chemoresistance. We investigated the ability of HA to block the cytotoxic effects of the chemotherapy drug carboplatin, and to regulate the expression of ABC transporters in ovarian cancer cells. We also examined HA serum levels in ovarian cancer patients prior to and following chemotherapy and assessed its prognostic relevance. HA increased the survival of carboplatin treated ovarian cancer cells expressing the HA receptor, CD44 (OVCAR-5 and OV-90). Carboplatin significantly increased expression of HAS2, HAS3 and ABCC2 and HA secretion in ovarian cancer cell conditioned media. Serum HA levels were significantly increased in patients following platinum based chemotherapy and at both 1st and 2nd recurrence when compared with HA levels prior to treatment. High serum HA levels (>50 μg/ml) prior to chemotherapy treatment were associated with significantly reduced progression-free (P = 0.014) and overall survival (P = 0.036). HA production in ovarian cancer cells was increased in cancer tissues collected following chemotherapy treatment and at recurrence. Furthermore HA treatment significantly increased the expression of ABC drug transporters (ABCB3, ABCC1, ABCC2, and ABCC3), but only in ovarian cancer cells expressing CD44. The effects of HA and carboplatin on ABC transporter expression in ovarian cancer cells could be abrogated by HA oligomer treatment. Importantly, HA oligomers increased the sensitivity of chemoresistant SKOV3 cells to carboplatin. Our findings indicate that carboplatin chemotherapy induces HA production which can contribute to chemoresistance by regulating ABC

  11. FN-2HDM: Two Higgs Doublet Models with Froggatt-Nielsen symmetry

    Energy Technology Data Exchange (ETDEWEB)

    Dery, Avital; Nir, Yosef [Department of Particle Physics and Astrophysics, Weizmann Institute of Science, Herzl 234, Rehovot 76100 (Israel)

    2017-04-03

    We embed Two Higgs Doublet Models (2HDMs) in the Froggatt Nielsen (FN) framework. We find that the approximate FN symmetry predicts i) approximate Natural Flavor Conservation (NFC) of Types II or IV in the Yukawa sector, and ii) approximate Peccei-Quinn (PQ) symmetry in the scalar sector. We discuss the phenomenological consequences of these features.

  12. Self-Sustained Oscillatory Sliding Movement of Doublet Microtubules and Flagellar Bend Formation.

    Directory of Open Access Journals (Sweden)

    Sumio Ishijima

    Full Text Available It is well established that the basis for flagellar and ciliary movements is ATP-dependent sliding between adjacent doublet microtubules. However, the mechanism for converting microtubule sliding into flagellar and ciliary movements has long remained unresolved. The author has developed new sperm models that use bull spermatozoa divested of their plasma membrane and midpiece mitochondrial sheath by Triton X-100 and dithiothreitol. These models enable the observation of both the oscillatory sliding movement of activated doublet microtubules and flagellar bend formation in the presence of ATP. A long fiber of doublet microtubules extruded by synchronous sliding of the sperm flagella and a short fiber of doublet microtubules extruded by metachronal sliding exhibited spontaneous oscillatory movements and constructed a one beat cycle of flagellar bending by alternately actuating. The small sliding displacement generated by metachronal sliding formed helical bends, whereas the large displacement by synchronous sliding formed planar bends. Therefore, the resultant waveform is a half-funnel shape, which is similar to ciliary movements.

  13. Doublet channel neutron-deuteron scattering in leading order effective field theory

    OpenAIRE

    B. BlankleiderFlinders U.; J. Gegelia(INFN)

    2015-01-01

    The doublet channel neutron-deuteron scattering amplitude is calculated in leading order effective field theory (EFT). It is shown that this amplitude does not depend on a constant contact interaction three-body force. Satisfactory agreement with available data is obtained when only two-body forces are included.

  14. THE Na 8200 Å DOUBLET AS AN AGE INDICATOR IN LOW-MASS STARS

    International Nuclear Information System (INIS)

    Schlieder, Joshua E.; Simon, Michal; Lépine, Sébastien; Rice, Emily; Fielding, Drummond; Tomasino, Rachael

    2012-01-01

    We investigate the use of the gravity sensitive neutral sodium (Na I) doublet at 8183 Å and 8195 Å (Na 8200 Å doublet) as an age indicator for M dwarfs. We measured the Na doublet equivalent width (EW) in giants, old dwarfs, young dwarfs, and candidate members of the β Pic moving group using medium-resolution spectra. Our Na 8200 Å doublet EW analysis shows that the feature is useful as an approximate age indicator in M-type dwarfs with (V – K s ) ≥ 5.0, reliably distinguishing stars older and younger than 100 Myr. A simple derivation of the dependence of the Na EW on temperature and gravity supports the observational results. An analysis of the effects of metallicity shows that this youth indicator is best used on samples with similar metallicity. The age estimation technique presented here becomes useful in a mass regime where traditional youth indicators are increasingly less reliable, is applicable to other alkali lines, and will help identify new low-mass members in other young clusters and associations.

  15. Positional stability experiment and analysis of elongated plasmas in Doublet III

    International Nuclear Information System (INIS)

    Yokomizo, Hideaki

    1984-04-01

    Control systems of the plasma position and shape on Doublet III are explained and experimental results of vertical stability of elongated plasmas are reviewed. Observed results of the vertical instability are qualitatively compared with the predictions from the simplified model and quantitatively compared with the numerical calculations based on a more realistic model. Experiments are in reasonable agreement with the theoretical analyses. (author)

  16. Nonclassical Effects of a Four-Level Excited-Doublet Atom Model

    International Nuclear Information System (INIS)

    Zhang Jiansong; Xu Jingbo

    2006-01-01

    We adopt a dynamical algebraic method to study a four-level excited-doublet atom model and obtain the explicit expressions of the time-evolution operator and the density operator for the system. The nonclassical effects of the system, such as collapses and revivals of the atomic inversion and squeezing of the radiation field, are also discussed.

  17. A model for quasi parity-doublet spectra with strong coriolis mixing

    International Nuclear Information System (INIS)

    Minkov, N.; Drenska, S.; Strecker, M.

    2013-01-01

    The model of coherent quadrupole and octupole motion (CQOM) is combined with the reflection-asymmetric deformed shell model (DSM) in a way allowing fully microscopic description of the Coriolis decoupling and K-mixing effects in the quasi parity-doublet spectra of odd-mass nuclei. In this approach the even-even core is considered within the CQOM model, while the odd nucleon is described within DSM with pairing interaction. The Coriolis decoupling/mixing factors are calculated through a parity-projection of the single-particle wave function. Expressions for the Coriolis mixed quasi parity-doublet levels are obtained in the second order of perturbation theory, while the K-mixed core plus particle wave function is obtained in the first order. Expressions for the B(E1), B(E2) and B(E3) reduced probabilities for transitions within and between different quasi-doublets are obtained by using the total K-mixed wave function. The model scheme is elaborated in a form capable of describing the yrast and non-yrast quasi parity-doublet spectra in odd-mass nuclei. (author)

  18. Selection of doublet cellular patterns in directional solidification through spatially periodic perturbations

    International Nuclear Information System (INIS)

    Losert, W.; Stillman, D.A.; Cummins, H.Z.; Kopczynski, P.; Rappel, W.; Karma, A.

    1998-01-01

    Pattern formation at the solid-liquid interface of a growing crystal was studied in directional solidification using a perturbation technique. We analyzed both experimentally and numerically the stability range and dynamical selection of cellular arrays of 'doublets' with asymmetric tip shapes, separated by alternate deep and shallow grooves. Applying an initial periodic perturbation of arbitrary wavelength to the unstable planar interface allowed us to force the interface to evolve into doublet states that would not otherwise be dynamically accessible from a planar interface. We determined systematically the ranges of wavelength corresponding to stable singlets, stable doublets, and transient unstable patterns. Experimentally, this was accomplished by applying a brief UV light pulse of a desired spatial periodicity to the planar interface during the planar-cellular transient using the model alloy Succinonitrile-Coumarin 152. Numerical simulations of the nonlinear evolution of the interface were performed starting from a small sinusoidal perturbation of the steady-state planar interface. These simulations were carried out using a computationally efficient phase-field symmetric model of directional solidification with recently reformulated asymptotics and vanishing kinetics [A. Karma and W.-J. Rappel, Phys. Rev. E 53 R3017 (1996); Phys. Rev. Lett. 77, 4050 (1996); Phys. Rev. E 57, 4323 (1998)], which allowed us to simulate spatially extended arrays that can be meaningfully compared to experiments. Simulations and experiments show remarkable qualitative agreement in the dynamic evolution, steady-state structure, and instability mechanisms of doublet cellular arrays. copyright 1998 The American Physical Society

  19. THE Na 8200 Angstrom-Sign DOUBLET AS AN AGE INDICATOR IN LOW-MASS STARS

    Energy Technology Data Exchange (ETDEWEB)

    Schlieder, Joshua E.; Simon, Michal [Department of Physics and Astronomy, Stony Brook University, Stony Brook, NY 11794 (United States); Lepine, Sebastien; Rice, Emily [Department of Astrophysics, American Museum of Natural History, Central Park West at 79th Street, New York, NY 10024 (United States); Fielding, Drummond [Department of Physics and Astronomy, Johns Hopkins University, 366 Bloomberg Center, 3400 North Charles Street, Baltimore, MD 21218 (United States); Tomasino, Rachael, E-mail: michal.simon@stonybrook.edu, E-mail: schlieder@mpia-hd.mpg.de, E-mail: lepine@amnh.org, E-mail: erice@amnh.org, E-mail: dfieldi1@jhu.edu, E-mail: tomas1r@cmich.edu [Department of Physics, Central Michigan University, Mount Pleasant, MI 48859 (United States)

    2012-05-15

    We investigate the use of the gravity sensitive neutral sodium (Na I) doublet at 8183 Angstrom-Sign and 8195 Angstrom-Sign (Na 8200 Angstrom-Sign doublet) as an age indicator for M dwarfs. We measured the Na doublet equivalent width (EW) in giants, old dwarfs, young dwarfs, and candidate members of the {beta} Pic moving group using medium-resolution spectra. Our Na 8200 A doublet EW analysis shows that the feature is useful as an approximate age indicator in M-type dwarfs with (V - K{sub s}) {>=} 5.0, reliably distinguishing stars older and younger than 100 Myr. A simple derivation of the dependence of the Na EW on temperature and gravity supports the observational results. An analysis of the effects of metallicity shows that this youth indicator is best used on samples with similar metallicity. The age estimation technique presented here becomes useful in a mass regime where traditional youth indicators are increasingly less reliable, is applicable to other alkali lines, and will help identify new low-mass members in other young clusters and associations.

  20. Postoperative Chemotherapy for Medulloblastoma

    Directory of Open Access Journals (Sweden)

    J Gordon Millichap

    2005-03-01

    Full Text Available The survival rate and cognitive function of 43 children, age <3 years, with medulloblastoma treated with intensive postoperative chemotherapy alone, without radiotherapy, were determined at the University of Wurzburg and other centers in Germany Chemotherapy consisted of three two-month cycles of cyclophosphamide, methotrexate, vincristine, carboplatin, and etoposide.

  1. Multi-Higgs doublet models: physical parametrization, sum rules and unitarity bounds

    Science.gov (United States)

    Bento, Miguel P.; Haber, Howard E.; Romão, J. C.; Silva, João P.

    2017-11-01

    If the scalar sector of the Standard Model is non-minimal, one might expect multiple generations of the hypercharge-1/2 scalar doublet analogous to the generational structure of the fermions. In this work, we examine the structure of a Higgs sector consisting of N Higgs doublets (where N ≥ 2). It is particularly convenient to work in the so-called charged Higgs basis, in which the neutral Higgs vacuum expectation value resides entirely in the first Higgs doublet, and the charged components of remaining N - 1 Higgs doublets are mass-eigenstate fields. We elucidate the interactions of the gauge bosons with the physical Higgs scalars and the Goldstone bosons and show that they are determined by an N × 2 N matrix. This matrix depends on ( N - 1)(2 N - 1) real parameters that are associated with the mixing of the neutral Higgs fields in the charged Higgs basis. Among these parameters, N - 1 are unphysical (and can be removed by rephasing the physical charged Higgs fields), and the remaining 2( N - 1)2 parameters are physical. We also demonstrate a particularly simple form for the cubic interaction and some of the quartic interactions of the Goldstone bosons with the physical Higgs scalars. These results are applied in the derivation of Higgs coupling sum rules and tree-level unitarity bounds that restrict the size of the quartic scalar couplings. In particular, new applications to three Higgs doublet models with an order-4 CP symmetry and with a Z_3 symmetry, respectively, are presented.

  2. Microdose-Induced Drug-DNA Adducts as Biomarkers of Chemotherapy Resistance in Humans and Mice.

    Science.gov (United States)

    Zimmermann, Maike; Wang, Si-Si; Zhang, Hongyong; Lin, Tzu-Yin; Malfatti, Michael; Haack, Kurt; Ognibene, Ted; Yang, Hongyuan; Airhart, Susan; Turteltaub, Kenneth W; Cimino, George D; Tepper, Clifford G; Drakaki, Alexandra; Chamie, Karim; de Vere White, Ralph; Pan, Chong-Xian; Henderson, Paul T

    2017-02-01

    We report progress on predicting tumor response to platinum-based chemotherapy with a novel mass spectrometry approach. Fourteen bladder cancer patients were administered one diagnostic microdose each of [ 14 C]carboplatin (1% of the therapeutic dose). Carboplatin-DNA adducts were quantified by accelerator mass spectrometry in blood and tumor samples collected within 24 hours, and compared with subsequent chemotherapy response. Patients with the highest adduct levels were responders, but not all responders had high adduct levels. Four patient-derived bladder cancer xenograft mouse models were used to test the possibility that another drug in the regimen could cause a response. The mice were dosed with [ 14 C]carboplatin or [ 14 C]gemcitabine and the resulting drug-DNA adduct levels were compared with tumor response to chemotherapy. At least one of the drugs had to induce high drug-DNA adduct levels or create a synergistic increase in overall adducts to prompt a corresponding therapeutic response, demonstrating proof-of-principle for drug-DNA adducts as predictive biomarkers. Mol Cancer Ther; 16(2); 376-87. ©2016 AACR. ©2016 American Association for Cancer Research.

  3. Chemotherapy in advanced ovarian cancer: four systematic meta-analyses of individual patient data from 37 randomized trials. Advanced Ovarian Cancer Trialists' Group.

    Science.gov (United States)

    Aabo, K.; Adams, M.; Adnitt, P.; Alberts, D. S.; Athanazziou, A.; Barley, V.; Bell, D. R.; Bianchi, U.; Bolis, G.; Brady, M. F.; Brodovsky, H. S.; Bruckner, H.; Buyse, M.; Canetta, R.; Chylak, V.; Cohen, C. J.; Colombo, N.; Conte, P. F.; Crowther, D.; Edmonson, J. H.; Gennatas, C.; Gilbey, E.; Gore, M.; Guthrie, D.; Yeap, B. Y.

    1998-01-01

    The purpose of this systematic study was to provide an up to date and reliable quantitative summary of the relative benefits of various types of chemotherapy (non-platinum vs platinum, single-agent vs combination and carboplatin vs cisplatin) in the treatment of advanced ovarian cancer. Also, to investigate whether well-defined patient subgroups benefit more or less from cisplatin- or carboplatin-based therapy. Meta-analyses were based on updated individual patient data from all available randomized controlled trials (published and unpublished), including 37 trials, 5667 patients and 4664 deaths. The results suggest that platinum-based chemotherapy is better than non-platinum therapy, show a trend in favour of platinum combinations over single-agent platinum, and suggest that cisplatin and carboplatin are equally effective. There is no good evidence that cisplatin is more or less effective than carboplatin in any particular subgroup of patients. Images Figure 1 Figure 2 Figure 3 PMID:9836481

  4. Chiral doublet bands in odd-A nuclei 103,105Rh

    International Nuclear Information System (INIS)

    Qi Bin; Wang Shouyu; Zhang Shuangquan; Meng Jie

    2010-01-01

    Spontaneous chiral symmetry breaking is a phenomenon of general interest in chemistry, biology and particle physics. Since the pioneering work of nuclear chirality in 1997 [1] , much effort has been devoted to further explore this interesting phenomenon. Following the observation of chiral doublet bands in N = 75 isotones [2] more candidates have been reported over more than 20 nuclei experimentally in A∼100, 130 and 190 mass regions including odd-odd, odd-A and even-even nuclei. However, the identification and the intrinsic mechanism of candidate chiral doublet bands are still under debate. Although various versions of particle rotor model (PRM) and titled axis cranking model (TAC) had been applied to study chiral bands, the essential starting point for understanding their properties is based on the ideal picture, i.e. one particle and one hole coupled with a γ = 30 rigid triaxial rotor. On the other hand, from the investigation of semiclassical TAC based on the mean field, it is shown that the chiral doublet bands in the real nuclei are not always consistent with the static chirality, but mixed with the character of dynamic chirality. Thus it is necessary to construct a fully quantal model for the description of chiral doublet bands in the real nuclei, which is aimed to understand the properties of chiral doublet bands in real nuclei, and to present clearly the picture and character of chiral motion [3] . Recently, we have developed the multi-particle multi-hole coupled with the triaxial rotor model, which is able to describe the nuclear rotation related to many valence nucleons. Adopting this model, chirality in odd-A nuclei 103,105 Rh with πg 9/2 -1 ⊗νh 11/2 2 configuration and in odd-A nucleus 135 Nd with πh 11/2 2 ⊗νh 11/2 1 configuration [4] are studied in a fully quantal approach. For the chiral doublet bands, the observed energies and the B(M1) and B(E2) values are reproduced very well. Root mean square values of the angular momentum components

  5. Induction chemotherapy combined with three-dimensional conformal radiation therapy for locally advanced non-small cell lung cancer

    International Nuclear Information System (INIS)

    Zheng Aiqing; Yu Jinming; Zhao Xianguang; Wang Xuetao; Wei Guangsheng

    2005-01-01

    Objective: To evaluate the effect and complication of induction chemotherapy combined with three-dimensional conformal radiation therapy (3DCRT) for locally advanced non small cell lung cancer (NSCLC). Methods: Ninety-two such patients were randomized into radiation therapy alone group(RT-, 50 patients) and induction chemotherapy combined radiotherapy group (CMT-, 42 patients). The induction chemotherapy consisted of 2-4 cycles of platinum-based regimen. Results: The overall median survival time was 15 months with 12 months in the RT group and 18 months in the CMT group (P=0.014) respectively. The 1-year overall survival rates were 48.6% and 71.2% in RT and CMT group, respectively (P=0.004). The 2-year survival rates were 20.8% and 37.6% in RT and CMT group, respectively (P=0.041). Treatment was well tolerated and the toxicities were similar in either group. Conclusion: The addition of induction chemotherapy to 3DCRT takes a survival advantage over 3DCRT alone for Stage III NSCLC without increasing toxicities. (authors)

  6. Chemotherapy in eye cancer

    African Journals Online (AJOL)

    is a drug used in a wide range of cancers, which produces ... lesions. In a 10-year retrospective review of .... disease and focal chemotherapy for selected high-risk ... of focal drug delivery methods to reduce recurrence .... the protein tubulin.

  7. Prevent Infections During Chemotherapy

    Centers for Disease Control (CDC) Podcasts

    This podcast discusses the importance of preventing infections in cancer patients who are undergoing chemotherapy. Dr. Lisa Richardson, CDC oncologist, talks about a new Web site for cancer patients and their caregivers.

  8. Restrictions on two Higgs doublet models and CP violation at the unification scale

    International Nuclear Information System (INIS)

    Athanasiu, G.G.

    1987-04-01

    Bounds on charged Higgs masses and couplings in models with two Higgs doublets are examined that came from CP violation in the neutral K system. Bounds on charged Higgs masses and couplings in two Higgs doublet models are also obtained from their effects on neutral-B-meson mixing. The bounds are found to be comparable to those obtained with additional assumptions from the neutral K system. The three generation phase invariant measure of CP violation is shown to satisfy a simple and solvable renormalization group equation. Its value is seen to fall by four to eight orders of magnitude between the weak and grand unification scales in the standard model, as well as in its two Higgs and supersymmetric extensions

  9. Investigations on a Q0 Doublet Optics for the LHC Luminosity Upgrade

    CERN Document Server

    Laface, E; Scandale, Walter; Wildner, E

    2008-01-01

    The Q0 scheme of the LHC insertion region is based on the introduction of a doublet of quadrupoles at 13 m from the IP. We present here the doublet optics and the magnets layout such as gradients, lengths, positions and apertures. In this scheme we show the gain in luminosity and chromaticity, with respect to a nominal layout with $\\beta^{*}$ = 0.25 m (i.e. LHC phase 1 upgrade) and $\\beta^{*} = 0.15 m, due to a smaller beta-max. We show the alignment tolerance and the energy deposition issues, in Q0A-Q0B. We also consider shielding the magnets with liners. The capability of Q0 optics to limit the b function could be exploited after the LHC Phase 1 upgrade in order to reduce the $\\beta^{*}$ below 0.25 m, leaving the upgraded triplet unchanged

  10. High-scale validity of a two-Higgs-doublet scenario: metastability included

    Energy Technology Data Exchange (ETDEWEB)

    Chakrabarty, Nabarun; Mukhopadhyaya, Biswarup [Harish-Chandra Research Institute, Regional Centre for Accelerator-based Particle Physics, Allahabad (India)

    2017-03-15

    We identify regions in a Type-II two-Higgs-doublet model which correspond to a metastable electroweak vacuum with lifetime larger than the age of the universe. We analyse scenarios which retain perturbative unitarity up to grand unification and Planck scales. Each point in the parameter space is restricted using data from the Large Hadron Collider (LHC) as well as flavour and precision electroweak constraints. We find that substantial regions of the parameter space are thus identified as corresponding to metastability, which complement the allowed regions for absolute stability, for top quark mass at the high as well as low end of its currently allowed range. Thus, a two-Higgs-doublet scenario with the electroweak vacuum, either stable or metastable, can sail through all the way up to the Planck scale without facing any contradiction. (orig.)

  11. The Higgs vacuum uplifted. Revisiting the electroweak phase transition with a second Higgs doublet

    Energy Technology Data Exchange (ETDEWEB)

    Dorsch, G.C. [Deutsches Elektronen-Synchrotron (DESY), Hamburg (Germany); Huber, S.J. [Sussex Univ., Brighton (United Kingdom). Dept. of Physics and Astronomy; Mimasu, K. [Sussex Univ., Brighton (United Kingdom). Dept. of Physics and Astronomy; Louvain Univ. Catholique, Louvain-la-Neuve (Belgium). Center for Cosmology, Particle Physics and Phenomenology; No, J.M. [King' s College, London (United Kingdom). Dept. of Physics; Sussex Univ., Brighton (United Kingdom). Dept. of Physics and Astronomy

    2017-05-25

    The existence of a second Higgs doublet in Nature could lead to a cosmological first order electroweak phase transition and explain the origin of the matter-antimatter asymmetry in the Universe. We explore the parameter space of such a two-Higgs-doublet-model and show that a first order electroweak phase transition strongly correlates with a significant uplifting of the Higgs vacuum w.r.t. its Standard Model value. We then obtain the spectrum and properties of the new scalars H{sub 0}, A{sub 0} and H{sup ±} that signal such a phase transition, showing that the decay A{sub 0}→H{sub 0}Z at the LHC and a sizable deviation in the Higgs self-coupling λ{sub hhh} from its SM value are sensitive indicators of a strongly first order electroweak phase transition in the 2HDM.

  12. Radiative neutrino mass and Majorana dark matter within an inert Higgs doublet model

    Science.gov (United States)

    Ahriche, Amine; Jueid, Adil; Nasri, Salah

    2018-05-01

    We consider an extension of the standard model (SM) with an inert Higgs doublet and three Majorana singlet fermions to address both origin and the smallness of neutrino masses and dark matter (DM) problems. In this setup, the lightest Majorana singlet fermion plays the role of DM candidate and the model parameter space can be accommodated to avoid different experimental constraints such as lepton flavor violating processes and electroweak precision tests. The neutrino mass is generated at one-loop level a la Scotogenic model and its smallness is ensured by the degeneracy between the C P -odd and C P -even scalar members of the inert doublet. Interesting signatures at both leptonic and hadronic colliders are discussed.

  13. A rotated transmission grating spectrometer for detecting spectral separation of doublet Na

    Energy Technology Data Exchange (ETDEWEB)

    Santosa, Ignatius Edi [Department of Physics Education, Sanata Dharma University, Paingan Maguwohardjo Depok Sleman, Yogyakarta 55281, Indonesia edi@usd.ac.id (Indonesia)

    2015-04-16

    Transmission gratings are usually used in a spectrometer for measuring the wavelength of light. In the common design, the position of the grating is perpendicular to the incident light. In order to increase the angular dispersion, in contrary to the common design, in this experiment the transmission grating was rotated. Due to the non-zero incident angle, the diffracted light was shifted. This rotated transmission grating spectrometer has been used to determine the separation of doublet Na. In this experiment, the diffraction angle was measured at various incident angles. The spectral separation of doublet Na was identified from the difference in the diffraction angle of two spectral lines. This spectral separation depends on the incident angle, the grating constant and the order of diffraction. As the effect of increasing the incident angle, a significant increase of the spectral separation can be achieved up to three fold.

  14. Higgs bosons in the two-doublet model with CP violation

    International Nuclear Information System (INIS)

    Akhmetzyanova, E.; Dolgopolov, M.; Dubinin, M.

    2005-01-01

    We consider the effective two-Higgs-doublet potential with complex parameters, when the CP invariance is broken both explicitly and spontaneously. The diagonal mass term in the local minimum of the potential is constructed for the physical basis of Higgs fields, keeping explicitly the limiting case of CP conservation, if the parameters are taken real. For the special case of the two-doublet Higgs sector of the minimal supersymmetric model, when CP invariance is violated by the Higgs bosons interaction with scalar quarks of the third generation, we calculate by means of the effective potential method the Higgs boson masses and evaluate the two-fermion Higgs boson decay widths and the widths of rare one-loop-mediated decays H→γγ, H→gg

  15. A rotated transmission grating spectrometer for detecting spectral separation of doublet Na

    International Nuclear Information System (INIS)

    Santosa, Ignatius Edi

    2015-01-01

    Transmission gratings are usually used in a spectrometer for measuring the wavelength of light. In the common design, the position of the grating is perpendicular to the incident light. In order to increase the angular dispersion, in contrary to the common design, in this experiment the transmission grating was rotated. Due to the non-zero incident angle, the diffracted light was shifted. This rotated transmission grating spectrometer has been used to determine the separation of doublet Na. In this experiment, the diffraction angle was measured at various incident angles. The spectral separation of doublet Na was identified from the difference in the diffraction angle of two spectral lines. This spectral separation depends on the incident angle, the grating constant and the order of diffraction. As the effect of increasing the incident angle, a significant increase of the spectral separation can be achieved up to three fold

  16. CP properties of symmetry-constrained two-Higgs-doublet models

    CERN Document Server

    Ferreira, P M; Nachtmann, O; Silva, Joao P

    2010-01-01

    The two-Higgs-doublet model can be constrained by imposing Higgs-family symmetries and/or generalized CP symmetries. It is known that there are only six independent classes of such symmetry-constrained models. We study the CP properties of all cases in the bilinear formalism. An exact symmetry implies CP conservation. We show that soft breaking of the symmetry can lead to spontaneous CP violation (CPV) in three of the classes.

  17. Enhanced nuclear magnetic resonance in a non-magnetic cubic doublet

    International Nuclear Information System (INIS)

    Veenendaal, E.J.

    1982-01-01

    In this thesis two lanthanide compounds are studied which show enhanced nuclear magnetism at low temperatures: Rb 2 NaHoF 6 and CsNaHoF 6 . Chapter II gives a description of the 4 He-circulating refrigerator, which was built to provide the low temperatures required for the polarization of the enhanced nuclear moments. This type of dilution refrigerator was chosen because of its simple design and large cooling power. Chapter III is devoted to a comparison of the different types of dilution refrigerators. A theoretical discussion is given of their performance, starting from the differential equations, which govern the temperature distribution in the refrigerator. In chapter IV the actual performance of the refrigerator, described in chapter II is discussed. In chapter V a description of the NMR-apparatus, developed for very-low-temperature NMR experiments is given. In chapter VI experimental results on the compound Rb 2 NaHoF 6 are presented. The CEF-ground state of this compound is probably the non-magnetic doublet GAMMA 3 , but at a temperature of 170 K a structural phase transition lowers the crystal symmetry from cubic to tetragonal and the doublet is split into two singlets. In chapter VII specific heat, (enhanced) nuclear magnetic resonance and magnetization measurements on the compound Cs 2 NaHoF 6 are presented which also has a GAMMA 3 -doublet ground state. In zero magnetic field the degeneracy of the doublet is removed at a temperature of 393 mK, where a phase transition is induced by quadrupolar interactions. (Auth.)

  18. Design and expression of a retro doublet of cecropin with enhanced activity

    OpenAIRE

    Díaz, Mauricio; Arenas, Gloria; Marshall, Sergio H

    2008-01-01

    Novel doublet molecules of cecropin A from Drosophila melanogaster were designed and constructed combining the regular (CECdir) with the inverted (CECret) coding sequence of the standard CEC A1 gene resulting in the following configurations: CECdir-CECret and CECret-CECdir. These two recombinant molecules were generated using a three-primer driven PCR reaction yielding composite single functional aminoacidic molecules with the coding sequences of CECdir linked in frame with the coding sequenc...

  19. The strange quark contribution to the neutron electric dipole moment in multi-Higgs doublet models

    International Nuclear Information System (INIS)

    He, Xiao Gang; McKeller, H.J.; Pakvasa, S.

    1990-09-01

    The strange quark contribution to the neutron electric dipole moment was studied and compared with other contributions in multi-Higgs doublet models. It was found that the strange quark contribution is significant because the strange quark color dipole moment is larger than that of the down (up) quark by a factor m s /m d (m s /m u ). In the case of neutral Higgs it can be the dominant contribution to the neutron electric dipole moment. 18 refs

  20. Photoluminescence Detected Doublet Structure in the Integer and Fractional Quantum Hall Regime

    International Nuclear Information System (INIS)

    Kim, Yongmin; Munteanu, F.M.; Perry, C.H.; Reno, J.L.; Rickel, D.G.; Simmons, J.A.

    1999-01-01

    We present here the results of polarized magneto-photoluminescence measurements on a high mobility single-heterojunction. The presence of a doublet structure over a large magnetic field range (2>v>l/6) is interpreted as possible evidence for the existence of a magneto-roton minima of the charged density waves. This is understood as an indication of strong electronic correlation even in the case of the IQHE limit

  1. Doublet Pulse Coherent Laser Radar for Tracking of Resident Space Objects

    Science.gov (United States)

    2014-09-01

    any other provision of law, no person shall be subject to a penalty for failing to comply with a collection of information if it does not display a...tracking 10 cm2 cross section targets in LEO as well as tracking near Earth objects (NEOs) such as meteoroids, and asteroids may well be possible...using short pulsewidth doublet pulse coherent ladar technique offers a means for precision tracking. The technique offers best of both worlds ; precise

  2. Inert two-Higgs-doublet model strongly coupled to a non-Abelian vector resonance

    Science.gov (United States)

    Rojas-Abatte, Felipe; Mora, Maria Luisa; Urbina, Jose; Zerwekh, Alfonso R.

    2017-11-01

    We study the possibility of a dark matter candidate having its origin in an extended Higgs sector which, at least partially, is related to a new strongly interacting sector. More concretely, we consider an i2HDM (i.e., a Type-I two Higgs doublet model supplemented with a Z2 under which the nonstandard scalar doublet is odd) based on the gauge group S U (2 )1×S U (2 )2×U (1 )Y . We assume that one of the scalar doublets and the standard fermion transform nontrivially under S U (2 )1 while the second doublet transforms under S U (2 )2. Our main hypothesis is that standard sector is weakly coupled while the gauge interactions associated to the second group is characterized by a large coupling constant. We explore the consequences of this construction for the phenomenology of the dark matter candidate and we show that the presence of the new vector resonance reduces the relic density saturation region, compared to the usual i2DHM, in the high dark matter mass range. In the collider side, we argue that the mono-Z production is the channel which offers the best chances to manifest the presence of the new vector field. We study the departures from the usual i2HDM predictions and show that the discovery of the heavy vector at the LHC is challenging even in the mono-Z channel since the typical cross sections are of the order of 10-2 fb .

  3. Resuscitation of the three-scalar doublet model with spontaneous CP violation

    International Nuclear Information System (INIS)

    Branco, G.C.; Buras, A.J.; Gerard, J.M.

    1985-01-01

    We show that the three-scalar doublet model with spontaneous CP violation and natural flavor conservation can be made consistent with the recent measurements of epsilon'/epsilon provided an interesting hierarchy among the vacuum expectation values present in the model is assumed. Simultaneously ΔM(Ksub(L)-Ksub(S)), the epsilon parameter and the electric dipole moment of the neutron are consistent with the experimental data. (orig.)

  4. Lepton Flavor Violation in the Two Higgs Doublet Model using g-2 muon factor

    International Nuclear Information System (INIS)

    Diaz, Rodolfo A.; Martinez, R.; Rodriguez, J.-Alexis; Tuiran, E.

    2002-01-01

    Current experimental data from the g-2 muon factor, seems to show the necessity of physics beyond the Standard Model (SM), since the difference between SM and experimental predictions is approximately 2.6σ. In the framework of the General Two Higgs Doublet Model (2HDM), we calculate the muon anomalous magnetic moment to get lower and upper bounds for the Flavour Changing (FC) Yukawa couplings in the leptonic sector

  5. A doublet of 3" cylindrical silicon drift detectors in the CERES/NA45 experiment

    CERN Document Server

    Faschingbauer, U; Baur, R; Ceretto, F; Drees, A; Fraenkel, Zeev; Fuchs, C; Gatti, E; Glässel, P; Hemberger, M; Pérez de los Heros, C; Hess, F; Holl, P; Irmscher, D; Jacob, C; Kemmer, J; Minaev, Yu I; Panebratsev, Yu A; Pfeiffer, A; Ravinovich, I; Razin, S V; Rehak, P; Sampietro, M; Schükraft, Jürgen; Shimansky, S S; Socol, E; Specht, H J; Tel-Zur, G; Tserruya, Itzhak; Ullrich, T S; Voigt, C A; Wurm, J P; Yurevich, V I

    1995-01-01

    We report on the performance of a doublet of 3" cylindrical silicon drift detectors installed as an upgrade of the CERES/NA45 electron pair spectrometer for the Pb-beam at the CERN SPS. The silicon detectors provide external particle tracking and background rejection of conversions and close Dalitz pairs. Results on vertex reconstruction and rejection from Pb test-run in 1994 are presented.

  6. Pseudo-Goldstone Higgs Doublets from Non-Vectorlike Grand Unified Higgs Sector

    CERN Document Server

    Hernández, A E Cárcamo

    2016-01-01

    We present a novel way of realizing the pseudo-Nambu-Goldstone boson mechanism for the doublet-triplet splitting in supersymmetric grand unified theories. The global symmetries of the Higgs sector are attributed to a non-vectorlike Higgs content, which is consistent with unbroken supersymmetry in a scenario with flat extra dimensions and branes. We also show how in such a model one can naturally obtain a realistic pattern for the Standard Model fermion masses and mixings.

  7. Dark Matter candidate in Inert Doublet Model with additional local gauge symmetry U (1)

    International Nuclear Information System (INIS)

    Gaitán, R.; De Oca, J.H. Montes; Garcés, E. A.; Cabral-Rosetti, L. G.

    2016-01-01

    We consider the Inert Doublet Model (IDM) with an additional local gauge symmetry U (1) and a complex singlet scalar to break the symmetry U (1). The continuous symmetry U (1) is introduced to control the CP-conserving interaction instead of some discrete symmetries as usually. We present the mass spectrum for neutral scalar and gauge bosons and the values of the charges under U (1) for which the model could have a candidate to dark matter. (paper)

  8. Outgassing measurements and results used in designing the Doublet III Neutral Beam Injector System

    International Nuclear Information System (INIS)

    Yamamoto, R.M.; Harvey, J.

    1979-11-01

    Material vacuum properties played an important part in designing the Neutral Beam Injector System for General Atomic's Doublet III Tokamak. Low operating vacuum tank pressures were desired to keep re-ionization of the Neutral Beam to a minimum. Plasma contamination was also a major concern, hence stringent material impurity constraints were imposed. Outgassing Rate Measurement and Residual Gas Analyses were performed on different types of materials to determine if their vacuum properties were compatible with the Neutral Beam Injector System requirements

  9. New viable region of an inert Higgs doublet dark matter model with scotogenic extension

    Science.gov (United States)

    Borah, Debasish; Gupta, Aritra

    2017-12-01

    We explore the intermediate dark matter mass regime of the inert Higgs doublet model, approximately between 400 and 550 GeV, which is allowed by latest constraints from direct and indirect detection experiments, but the thermal relic abundance remains suppressed. We extend the model by three copies of right-handed neutrinos, odd under the built-in Z2 symmetry of the model. This discrete Z2 symmetry of the model allows these right-handed neutrinos to couple to the usual lepton doublets through the inert Higgs doublet allowing the possibility of radiative neutrino mass in the scotogenic fashion. Apart from generating nonzero neutrino mass, such an extension can also revive the intermediate dark matter mass regime. The late decay of the lightest right-handed neutrino to dark matter makes it possible for the usual thermally underabundant dark matter in this intermediate mass regime to satisfy the correct relic abundance limit. The revival of this wide intermediate mass range can have relevance not only for direct and indirect search experiments but also for neutrino experiments as the long lifetime of the lightest right-handed neutrino also results in almost vanishing lightest neutrino mass.

  10. Vapor deposition on doublet airfoil substrates: Control of coating thickness and microstructure

    Energy Technology Data Exchange (ETDEWEB)

    Rodgers, Theron M.; Zhao, Hengbei; Wadley, Haydn N. G., E-mail: haydn@virginia.edu [Department of Materials Science and Engineering, University of Virginia, 395 McCormick Rd., P.O. Box 400745, Charlottesville, Virginia 22904 (United States)

    2015-11-15

    Gas jet assisted vapor deposition processes for depositing coatings are conducted at higher pressures than conventional physical vapor deposition methods, and have shown promise for coating complex shaped substrates including those with non-line-of-sight (NLS) regions on their surface. These regions typically receive vapor atoms at a lower rate and with a wider incident angular distribution than substrate regions in line-of-sight (LS) of the vapor source. To investigate the coating of such substrates, the thickness and microstructure variation along the inner (curved) surfaces of a model doublet airfoil containing both LS and NLS regions has been investigated. Results from atomistic simulations and experiments confirm that the coating's thickness is thinner in flux-shadowed regions than in other regions for all the coating processes investigated. They also indicated that the coatings columnar microstructure and pore volume fraction vary with surface location through the LS to NLS transition zone. A substrate rotation strategy for optimizing the thickness over the entire doublet airfoil surface was investigated, and led to the identification of a process that resulted in only small variation of coating thickness, columnar growth angle, and pore volume fraction on all doublet airfoil surfaces.

  11. Trilinear Higgs couplings in the two Higgs doublet model with CP violation

    International Nuclear Information System (INIS)

    Osland, Per; Pandita, P. N.; Selbuz, Levent

    2008-01-01

    We carry out a detailed analysis of the general two Higgs doublet model with CP violation. We describe two different parametrizations of this model, and then study the Higgs boson masses and the trilinear Higgs couplings for these two parametrizations. Within a rather general model, we find that the trilinear Higgs couplings have a significant dependence on the details of the model, even when the lightest Higgs boson mass is taken to be a fixed parameter. We include radiative corrections in the one-loop effective potential approximation in our analysis of the Higgs boson masses and the Higgs trilinear couplings. The one-loop corrections to the trilinear couplings of the two Higgs doublet model also depend significantly on the details of the model, and can be rather large. We study quantitatively the trilinear Higgs couplings, and show that these couplings are typically several times larger than the corresponding standard model trilinear Higgs coupling in some regions of the parameter space. We also briefly discuss the decoupling limit of the two Higgs doublet model.

  12. Higgs boson couplings in multi-doublet models with natural flavour conservation

    Directory of Open Access Journals (Sweden)

    Kei Yagyu

    2016-12-01

    Full Text Available We investigate the deviation in the couplings of the standard model (SM like Higgs boson (h with a mass of 125 GeV from the prediction of the SM in multi-doublet models within the framework where flavour changing neutral currents at the tree level are naturally forbidden. After we present the general expressions for the modified gauge and Yukawa couplings for h, we show the correlation between the deviation in the Yukawa coupling for the tau lepton hτ+τ− and that for the bottom quark hbb¯ under the assumption of a non-zero deviation in the hVV (V=W,Z couplings in two Higgs doublet models (2HDMs and three Higgs doublet models (3HDMs as simple examples. We clarify the possible allowed prediction of the deviations in the 3HDMs which cannot be explained in the 2HDMs even taking into account the one-loop electroweak corrections to the Yukawa coupling.

  13. Doublet III limiter performance and implications for mechanical design and material selection for future limiters

    International Nuclear Information System (INIS)

    Sabado, M.M.; Marcus, F.B.; Trester, P.W.; Wesley, J.C.

    1979-10-01

    The plasma limiter system for Doublet III is described. Initially, high-Z materials, Ta-10W for the primary limiter and Mo for the backup limiters, were selected as the most attractive metallic candidates from the standpoint of thermal and structural properties. For the purpose of evaluating the effect of material Z on plasma performance, the nonmagnetic, Ni-base alloy Inconel X-750 was selected for a medium-Z limiter material. Graphite, a low-Z material, will likely be the next limiter material for evaluation. Design and material selection criteria for the different Z ranges are presented. The performance of the high-Z limiters in Doublet III is reviewed for an operation period that included approximately 5000 plasma shots. Changes in surface appearance and metallurgical changes are characterized. Discussion is presented on how and to what extent the high-Z elements affected the performance of the plasma based on theory and measurements in Doublet III. The fabrication processes for the Inconel X-750 limiters are summarized, and, last, observations on early performance of the Inconel limiters are described

  14. Doublet III limiter performance and implications for mechanical design and material selection for future limiters

    Energy Technology Data Exchange (ETDEWEB)

    Sabado, M.M.; Marcus, F.B.; Trester, P.W.; Wesley, J.C.

    1979-10-01

    The plasma limiter system for Doublet III is described. Initially, high-Z materials, Ta-10W for the primary limiter and Mo for the backup limiters, were selected as the most attractive metallic candidates from the standpoint of thermal and structural properties. For the purpose of evaluating the effect of material Z on plasma performance, the nonmagnetic, Ni-base alloy Inconel X-750 was selected for a medium-Z limiter material. Graphite, a low-Z material, will likely be the next limiter material for evaluation. Design and material selection criteria for the different Z ranges are presented. The performance of the high-Z limiters in Doublet III is reviewed for an operation period that included approximately 5000 plasma shots. Changes in surface appearance and metallurgical changes are characterized. Discussion is presented on how and to what extent the high-Z elements affected the performance of the plasma based on theory and measurements in Doublet III. The fabrication processes for the Inconel X-750 limiters are summarized, and, last, observations on early performance of the Inconel limiters are described. (MOW)

  15. The role of neoadjuvant chemotherapy in the management of locally advanced cervix cancer: a systematic review

    Directory of Open Access Journals (Sweden)

    Mohammed Osman

    2014-09-01

    Full Text Available Cervical cancer is the second most common cancer in women. Neoadjuvant chemotherapy for patients with locally advanced cervix cancer has comparable benefits to concurrent chemoradiotherapy (CCRT, but with fewer side effects. This systematic review aims to provide a comprehensive summary of the benefits of neoadjuvant chemotherapy for the management of locally advanced cervix cancer from stage IB2 (tumor >4.0 cm to IIIB (tumor extending to the pelvic wall and/or hydronephrosis. Our primary objective was to assess benefits in terms of survival. The data source included the USA national library of medicine, Medline search, and the National Cancer Institute PDQ Clinical Protocols. Inclusion criteria for consideration in the current systematic review included studies published between January 1997 and December 2012. In terms of histology, they had to be focused on squamous cell carcinoma, adenosquamous carcinoma, and/or adenocarcinoma. Patients should be either chemotherapy naïve or cervix cancer chemotherapy naïve, and have a performance status ≤2. The search in the above-mentioned scientific websites led to identify 49 publications, 19 of which were excluded, as they did not meet the inclusion criteria of this systematic review. Therefore only 30 studies were deemed eligible. Data was collected from 1760 patients enrolled in the current systematic review study. The mean age was 45.2 years. The mean tumor size was 4.7 cm. The most commonly used chemotherapies were cisplatin doublets. Paclitaxel was the most commonly used chemotherapeutic agent in the doublets. The mean chemotherapy cycles were 2.7. After chemotherapy, patients underwent surgery after a mean time of 2.5 weeks. The standard operation was radical hysterectomy with pelvic lymphadenectomy. Chemotherapy achieved an objective response rate of 84%. The 5-year progression-free survival and overall survival were 61.9% and 72.8% respectively. The treatment protocol was associated

  16. Evaluating a Prefabricated Submerged Breakwater and Double-T Sill for Beach Erosion Prevention, Cape May Point, NJ

    National Research Council Canada - National Science Library

    Stauble, Donald K; Giovannozzi, Michael A

    2003-01-01

    ...) and a linear prefabricated concrete sill called the Double-T across the seaward end of two adjacent groin compartments, in order to assess the effectiveness of these structures in retaining sand...

  17. An aCGH classifier derived from BRCA1-mutated breast cancer and benefit of high-dose platinum-based chemotherapy in HER2-negative breast cancer patients

    NARCIS (Netherlands)

    Vollebergh, M. A.; Lips, E. H.; Nederlof, P. M.; Wessels, L. F. A.; Schmidt, M. K.; van Beers, E. H.; Cornelissen, S.; Holtkamp, M.; Froklage, F. E.; de Vries, E. G. E.; Schrama, J. G.; Wesseling, J.; van de Vijver, M. J.; van Tinteren, H.; de Bruin, Michiel; Hauptmann, M.; Rodenhuis, S.; Linn, S. C.

    2011-01-01

    Breast cancer cells deficient for BRCA1 are hypersensitive to agents inducing DNA double-strand breaks (DSB), such as bifunctional alkylators and platinum agents. Earlier, we had developed a comparative genomic hybridisation (CGH) classifier based on BRCA1-mutated breast cancers. We hypothesised

  18. Randomize Trial of Cisplatin plus Gemcitabine with either Sorafenib or Placebo as First-line Therapy for Non-small Cell Lung Cancer

    OpenAIRE

    Yan WANG; Lin WANG; Yutao LIU; Shufei YU; Xiangru ZHANG; Yuankai SHI; Yan SUN

    2011-01-01

    Background and objective Platinum-based chemotherapy doublets reached an efficacy plateau in nonsmall-cell lung cancer (NSCLC). This randomized controlled study prospectively assessed the efficacy and safety of cisplatin plus gemcitabine with either Sorafenib or placebo as first-line therapy for NSCLC. Methods Thirty patients, which were confirmed advanced NSCLC histologically or cytologically, were randomly assigned to receive up to six cycles of cisplatin plus gemcitabine with sorafenib or ...

  19. Irinotecan and Oxaliplatin Might Provide Equal Benefit as Adjuvant Chemotherapy for Patients with Resectable Synchronous Colon Cancer and Liver-confined Metastases: A Nationwide Database Study.

    Science.gov (United States)

    Liang, Yi-Hsin; Shao, Yu-Yun; Chen, Ho-Min; Cheng, Ann-Lii; Lai, Mei-Shu; Yeh, Kun-Huei

    2017-12-01

    Although irinotecan and oxaliplatin are both standard treatments for advanced colon cancer, it remains unknown whether either is effective for patients with resectable synchronous colon cancer and liver-confined metastasis (SCCLM) after curative surgery. A population-based cohort of patients diagnosed with de novo SCCLM between 2004 and 2009 was established by searching the database of the Taiwan Cancer Registry and the National Health Insurance Research Database of Taiwan. Patients who underwent curative surgery as their first therapy followed by chemotherapy doublets were classified into the irinotecan group or oxaliplatin group accordingly. Patients who received radiotherapy or did not receive chemotherapy doublets were excluded. We included 6,533 patients with de novo stage IV colon cancer. Three hundred and nine of them received chemotherapy doublets after surgery; 77 patients received irinotecan and 232 patients received oxaliplatin as adjuvant chemotherapy. The patients in both groups exhibited similar overall survival (median: not reached vs. 40.8 months, p=0.151) and time to the next line of treatment (median: 16.5 vs. 14.3 months, p=0.349) in both univariate and multivariate analyses. Additionally, patients with resectable SCCLM had significantly shorter median overall survival than patients with stage III colon cancer who underwent curative surgery and subsequent adjuvant chemotherapy, but longer median overall survival than patients with de novo stage IV colon cancer who underwent surgery only at the primary site followed by standard systemic chemotherapy (p<0.001). Irinotecan and oxaliplatin exhibited similar efficacy in patients who underwent curative surgery for resectable SCCLM. Copyright© 2017, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

  20. Hyperthermia and chemotherapy agent

    International Nuclear Information System (INIS)

    Roizin-Towle, L.; Hall, E.J.

    1981-01-01

    The use of chemotherapeutic agents for the treatment of cancer dates back to the late 19th century, but the modern era of chemotherapy drugs was ushered in during the 1940's with the development of the polyfunctional alkylating agent. Since then, numerous classes of drugs have evolved and the combined use of antineoplastic agents with other treatment modalities such as radiation or heat, remains a large relatively unexplored area. This approach, combining local hyperthermia with chemotherapy agents affords a measure of targeting and selective toxicity not previously available for drugs. In this paper, the effects of adriamycin, bleomycin and cis-platinum are examined. The adjuvant use of heat may also reverse the resistance of hypoxic cells noted for some chemotherapy agents

  1. Combination Chemotherapy for Influenza

    Directory of Open Access Journals (Sweden)

    Robert G. Webster

    2010-07-01

    Full Text Available The emergence of pandemic H1N1 influenza viruses in April 2009 and the continuous evolution of highly pathogenic H5N1 influenza viruses underscore the urgency of novel approaches to chemotherapy for human influenza infection. Anti-influenza drugs are currently limited to the neuraminidase inhibitors (oseltamivir and zanamivir and to M2 ion channel blockers (amantadine and rimantadine, although resistance to the latter class develops rapidly. Potential targets for the development of new anti-influenza agents include the viral polymerase (and endonuclease, the hemagglutinin, and the non-structural protein NS1. The limitations of monotherapy and the emergence of drug-resistant variants make combination chemotherapy the logical therapeutic option. Here we review the experimental data on combination chemotherapy with currently available agents and the development of new agents and therapy targets.

  2. Chemotherapy in thyroid carcinoma

    International Nuclear Information System (INIS)

    Samuel, A.M.; Shah, D.H.

    1999-01-01

    Chemotherapy alone, either as a single drug or a combination of drugs with or without external radiation (ER) is useful for treatment of locally advanced disease and non iodine concentrating metastasis in differentiated thyroid cancers (DTC). The reported response is not encouraging, but the absence of better alternatives leave no choice for the treatment of such cases. However, for treatment of anaplastic thyroid cancers (ANC), chemotherapy (CT) in combination with ER results in local control. In medullary thyroid cancers (MTC), the results obtained with multimodal treatment are encouraging

  3. Extravasation of chemotherapy

    DEFF Research Database (Denmark)

    Langer, Seppo W

    2010-01-01

    Extravasation of chemotherapy is a feared complication of anticancer therapy. The accidental leakage of cytostatic agents into the perivascular tissues may have devastating short-term and long-term consequences for patients. In recent years, the increased focus on chemotherapy extravasation has led...... to the development of international guidelines that have proven useful tools in daily clinical practice. Moreover, the tissue destruction in one of the most dreaded types of extravasation (ie, anthracycline extravasation) now can effectively be prevented with a specific antidote, dexrazoxane....

  4. Chemotherapy-induced polyneuropathy

    DEFF Research Database (Denmark)

    Zedan, Ahmed; Vilholm, Ole Jakob

    2014-01-01

    Chemotherapy-induced polyneuropathy (CIPN) is a common, but underestimated, clinical challenge. Incidence varies depending on many factors that are equally as important as the type of chemotherapeutic agent itself. Moreover, the assessment of CIPN is still uncertain, as several of the most...... frequently used scales do not rely on a formal neurological evaluation and depend on patients' reports and examiners' interpretations. Therefore, the aim of this MiniReview was to introduce the most common chemotherapies that cause neuropathy, and in addition to this, highlight the most significant...

  5. Tumor response and survival in patients with advanced non-small-cell lung cancer: the predictive value of chemotherapy-induced changes in fibrinogen

    International Nuclear Information System (INIS)

    Zhao, Jun; Zheng, Shuang; Zhou, Qiyin; Li, Heming; Liu, Yunpeng; Qu, Xiujuan; Zhao, Mingfang; Jin, Bo; Yu, Ping; Hu, Xuejun; Teng, Yuee; Zhang, Jingdong; Luo, Ying; Zhang, Lingyun

    2012-01-01

    Hyperfibrinogenemia is a common problem associated with various carcinomas, and is accompanied by hypercoagulablity. In advanced non-small-cell lung cancer (NSCLC) it remains unclear whether or not chemotherapy-induced changes in fibrinogen level relate to chemotherapeutic response and prognosis. The purposes of this study were to: 1) analyze the association between chemotherapy-induced changes in plasma fibrinogen level and the chemotherapeutic response after the first two courses of standard first-line platinum-based chemotherapy; and 2) evaluate the prognostic significance of the basal plasma fibrinogen level in patients with advanced NSCLC. In this retrospective study, the data from 160 patients with advanced NSCLC were collected. The association between the changes in fibrinogen and the response to chemotherapy, or between the pre-and post-chemotherapy fibrinogen levels and patient clinical characteristics, were analyzed using SPSS software. In addition, the prognostic value of pre-chemotherapy fibrinogen levels was assessed. The median pre-chemotherapy plasma fibrinogen level was 4.4 g/L. Pre-chemotherapy plasma fibrinogen levels correlated significantly with gender (p = 0.041). Post-chemotherapy plasma fibrinogen levels correlated with gender (p = 0.023), age (p = 0.018), ECOG (p = 0.002) and tumor response (p = 0.049). Plasma fibrinogen levels markedly decreased after chemotherapy in 98 (61.25 %) patients with pre-chemotherapy hyperfibrinogenemia (p = 0.008); and in this population there was a significant link between the decrease in fibrinogen level, and initial partial response (PR; p = 0.017) and stable disease (SD; p = 0.031). Univariate and multivariate analysis revealed that higher levels of fibrinogen (≥4.4 g/L) and ECOG 1 were positively associated with shorter overall survival (OS). CEA and CA125 also decreased significantly (p =0.015, p =0.000) in DCR group after chemotherapy. This study showed that the reduction in plasma fibrinogen levels

  6. Chemotherapy-induced hypocalcemia.

    Science.gov (United States)

    Ajero, Pia Marie E; Belsky, Joseph L; Prawius, Herbert D; Rella, Vincent

    2010-01-01

    To present a unique case of transient, asymptomatic chemotherapy-induced hypocalcemia not attributable to hypomagnesemia or tumor lysis syndrome and review causes of hypocalcemia related to cancer with and without use of chemotherapy. We present a case detailing the clinical and laboratory findings of a patient who had severe hypocalcemia during chemotherapy and discuss causes of hypocalcemia with an extensive literature review of chemotherapeutic agents associated with this biochemical abnormality. In a 90-year-old man, hypocalcemia developed during 2 courses of chemotherapy for Hodgkin lymphoma, with partial recovery between courses and normal serum calcium 10 months after completion of treatment. Magnesium, vitamin D, and parathyroid hormone levels were low normal. There was no evidence of tumor lysis syndrome. Of the various agents administered, vinca alkaloids seemed the most likely cause. Serial testing suggested that the underlying mechanism may have been acquired, reversible hypoparathyroidism. No other similar case was found in the published literature. The severe hypocalcemia in our patient could not be attributed to hypomagnesemia or tumor lysis syndrome, and it was clearly associated with the timing of his chemotherapeutic regimen. Possibilities include direct parathyroid hormone suppression or alteration of calcium sensing by the chemotherapeutic drugs. Serum calcium surveillance before and during chemotherapeutic management of cancer patients may reveal more instances and provide insight into the exact mechanism of this lesser known yet striking complication.

  7. After chemotherapy - discharge

    Science.gov (United States)

    You had chemotherapy treatment for your cancer. Your risk of infection, bleeding, and skin problems may be high. You may have mouth sores, an upset stomach, and diarrhea. You will probably get tired easily. Your appetite may be poor, but you should be able ...

  8. Role of chemotherapy and molecularly targeted agents in the treatment of adenoid cystic carcinoma of the lacrimal gland.

    Science.gov (United States)

    Le Tourneau, Christophe; Razak, Albiruni R A; Levy, Christine; Calugaru, Valentin; Galatoire, Olivier; Dendale, Rémi; Desjardins, Laurence; Gan, Hui K

    2011-11-01

    Adenoid cystic carcinoma (ACC) is the most common malignant epithelial cancer of the lacrimal gland. Despite a slow rate of growth, ACCs are ultimately associated with poor clinical outcome. Given the rarity of this disease, most recommendations regarding therapy are guided by expert opinion and retrospective data rather than level 1 evidence. Surgery and postoperative radiation therapy are commonly used as initial local treatment. In patients at high risk of recurrence, concomitant platinum-based chemotherapy may be added to postoperative radiotherapy in an attempt to enhance radio-sensitivity. While encouraging responses have been reported with intra-arterial neoadjuvant chemotherapy, this strategy is associated with substantial toxicity and should be considered investigational. For patients with metastatic disease not amenable to surgery or radiotherapy, chemotherapy may have a role based on its modest efficacy in non-lacrimal ACC. Similarly, molecular targeted agents may have a role, although the agents tested to date in non-lacrimal ACC have been disappointing. A better understanding of the biology of ACC will be crucial to the future success of developing targeted agents for this disease.

  9. Study of vibrations and stabilization of linear collider final doublets at the sub-nanometer scale

    International Nuclear Information System (INIS)

    Bolzon, B.

    2007-11-01

    CLIC is one of the current projects of high energy linear colliders. Vertical beam sizes of 0.7 nm at the time of the collision and fast ground motion of a few nanometers impose an active stabilization of the final doublets at a fifth of nanometer above 4 Hz. The majority of my work concerned vibrations and active stabilization study of cantilever and slim beams in order to be representative of the final doublets of CLIC. In a first part, measured performances of different types of vibration sensors associated to an appropriate instrumentation showed that accurate measurements of ground motion are possible from 0.1 Hz up to 2000 Hz on a quiet site. Also, electrochemical sensors answering a priori the specifications of CLIC can be incorporated in the active stabilization at a fifth of nanometer. In a second part, an experimental and numerical study of beam vibrations enabled to validate the efficiency of the numerical prediction incorporated then in the simulation of the active stabilization. Also, a study of the impact of ground motion and of acoustic noise on beam vibrations showed that an active stabilization is necessary at least up to 1000 Hz. In a third part, results on the active stabilization of a beam at its two first resonances are shown down to amplitudes of a tenth of nanometer above 4 Hz by using in parallel a commercial system performing passive and active stabilization of the clamping. The last part is related to a study of a support for the final doublets of a linear collider prototype in phase of finalization, the ATF2 prototype. This work showed that relative motion between this support and the ground is below imposed tolerances (6 nm above 0.1 Hz) with appropriate boundary conditions. (author)

  10. The top right coupling in the aligned two-Higgs-doublet model

    Energy Technology Data Exchange (ETDEWEB)

    Ayala, Cesar [Departament de Física Teòrica, Universitat de València & Instituto de Física Corpuscular (IFIC),Centro Mixto Universitat de València-CSIC,E-46100 Burjassot, València (Spain); Department of Physics, Universidad Técnica Federico Santa María,Casilla 110-V, Valparaíso (Chile); González-Sprinberg, Gabriel A. [Instituto de Física, Facultad de Ciencias, Universidad de la República,Iguá 4225, Montevideo 11600 (Uruguay); Martinez, R. [Departamento de Física, Universidad Nacional de Colombia,Bogotá Distrito Capital (Colombia); Vidal, Jordi [Departament de Física Teòrica, Universitat de València & Instituto de Física Corpuscular (IFIC),Centro Mixto Universitat de València-CSIC,E-46100 Burjassot, València (Spain)

    2017-03-24

    We compute the top quark right coupling in the aligned two-Higgs-doublet model. In the Standard Model the real part of this coupling is dominated by QCD-gluon-exchange diagram, but the imaginary part, instead, is purely electroweak at one loop. Within this model we show that values for the imaginary part of the coupling up to one order of magnitude larger than the electroweak prediction can be obtained. For the real part of the electroweak contribution we find that it can be of the order of 2×10{sup −4}. We also present detailed results of the one loop analytical computation.

  11. A second Higgs doublet in the early universe. Baryogenesis and gravitational waves

    International Nuclear Information System (INIS)

    Dorsch, G.C.; Konstandin, T.; Huber, S.J.; No, J.M.; King's College, London

    2016-11-01

    We show that simple Two Higgs Doublet models still provide a viable explanation for the matter-antimatter asymmetry of the Universe via electroweak baryogenesis, even after taking into account the recent order-of-magnitude improvement on the electron-EDM experimental bound by the ACME Collaboration. Moreover we show that, in the region of parameter space where baryogenesis is possible, the gravitational wave spectrum generated at the end of the electroweak phase transition is within the sensitivity reach of the future space-based interferometer LISA.

  12. Baryogenesis in the two doublet and inert singlet extension of the Standard Model

    DEFF Research Database (Denmark)

    Alanne, Tommi; Kainulainen, Kimmo; Tuominen, Kimmo

    2016-01-01

    We investigate an extension of the Standard Model containing two Higgs doublets and a singlet scalar field (2HDSM). We show that the model can have a strongly first-order phase transition and give rise to the observed baryon asymmetry of the Universe, consistent with all experimental constraints...... with the critical temperature, Tn Tc, which can significantly alter the usual phase-transition pattern in 2HD models with Tn ≈ Tc. Furthermore, the singlet field can be the dark matter particle. However, in models with a strong first-order transition its abundance is typically but a thousandth of the observed dark...... matter abundance....

  13. Three-dimensional heat transfer analysis of the Doublet III beamline calorimeter

    International Nuclear Information System (INIS)

    Kamperschroer, J.H.; Pipkins, J.F.

    1979-10-01

    A general three-dimensional analysis has been formulated to study the flow of heat in a neutral beam calorimeter. The boundary value problem with an arbitrary incident heat flux has been solved using Fourier analysis and Laplace transform techniques. A general solution has been obtained and subsequently studied using numerical techniques as applied to the particular geometry and incident heat flux conditions of the Doublet III injection system. Negligible errors result in unfolding the incident heat flux through the use of thermocouples located near the rear surface, if data taking is initiated at the proper time and proceeds at a sufficiently rapid rate

  14. Hidden U (1 ) gauge symmetry realizing a neutrinophilic two-Higgs-doublet model with dark matter

    Science.gov (United States)

    Nomura, Takaaki; Okada, Hiroshi

    2018-04-01

    We propose a neutrinophilic two-Higgs-doublet model with hidden local U (1 ) symmetry, where active neutrinos are Dirac type, and a fermionic dark matter (DM) candidate is naturally induced as a result of remnant symmetry even after the spontaneous symmetry breaking. In addition, a physical Goldstone boson arises as a consequence of two types of gauge singlet bosons and contributes to the DM phenomenologies as well as an additional neutral gauge boson. Then, we analyze the relic density of DM within the safe range of direct detection searches and show the allowed region of dark matter mass.

  15. Higgs boson pair production at the photon linear collider in the two Higgs doublet model

    International Nuclear Information System (INIS)

    Asakawa, Eri; Harada, Daisuke; Okada, Yasuhiro; Kanemura, Shinya; Tsumura, Koji

    2009-02-01

    We calculate the cross section of the lightest Higgs boson pair production at the Photon Linear Collider in the two Higgs doublet model. We focus on the scenario in which the lightest Higgs boson has the standard model like couplings to gauge bosons. We take into account the one-loop correction to the hhh coupling as well as additional one-loop diagrams due to charged bosons to the γγ → hh helicity amplitudes. We discuss the impact of these corrections on the hhh coupling measurement at the Photon Linear Collider. (author)

  16. Measuring the separation of the sodium D-doublet with a Michelson interferometer

    Science.gov (United States)

    D'Anna, M.; Corridoni, T.

    2018-01-01

    Revisiting a method proposed by Fizeau in 1862, in this paper we measure the separation of the Na-doublet (the wavelength difference {{Δ }}λ between the two emission D-lines of the sodium spectrum) with a didactical Michelson interferometer. We describe the setup, how the measurements have been done and develop a mathematical model in order to explain the principal features of the collected data. Discussing the limits of this model, we suggest further experimental and theoretical extensions of the experience, also focusing on the didactical aspects to show how this experiment could bring advanced modern physics topics into high schools.

  17. A second Higgs doublet in the early universe. Baryogenesis and gravitational waves

    Energy Technology Data Exchange (ETDEWEB)

    Dorsch, G.C.; Konstandin, T. [Deutsches Elektronen-Synchrotron (DESY), Hamburg (Germany); Huber, S.J. [Sussex Univ., Brighton (United Kingdom). Dept. of Physics and Astronomy; No, J.M. [Sussex Univ., Brighton (United Kingdom). Dept. of Physics and Astronomy; King' s College, London (United Kingdom). Dept. of Physics

    2016-11-15

    We show that simple Two Higgs Doublet models still provide a viable explanation for the matter-antimatter asymmetry of the Universe via electroweak baryogenesis, even after taking into account the recent order-of-magnitude improvement on the electron-EDM experimental bound by the ACME Collaboration. Moreover we show that, in the region of parameter space where baryogenesis is possible, the gravitational wave spectrum generated at the end of the electroweak phase transition is within the sensitivity reach of the future space-based interferometer LISA.

  18. A second Higgs doublet in the early universe: baryogenesis and gravitational waves

    Energy Technology Data Exchange (ETDEWEB)

    Dorsch, G.C.; Konstandin, T. [DESY, Notkestraße 85, D-22607 Hamburg (Germany); Huber, S.J.; No, J.M., E-mail: glauber.dorsch@desy.de, E-mail: s.huber@sussex.ac.uk, E-mail: thomas.konstandin@desy.de, E-mail: jose_miguel.no@kcl.ac.uk [Department of Physics and Astronomy, University of Sussex, Brighton BN1 9QH (United Kingdom)

    2017-05-01

    We show that simple Two Higgs Doublet models might still provide a viable explanation for the matter-antimatter asymmetry of the Universe via electroweak baryogenesis, even after taking into account the recent order-of-magnitude improvement on the electron-EDM experimental bound by the ACME Collaboration. Moreover we show that, in the region of parameter space where baryogenesis may be possible, the gravitational wave spectrum generated at the end of the electroweak phase transition is within the sensitivity reach of the future space-based interferometer LISA.

  19. Status of the charged Higgs boson in two Higgs doublet models

    Science.gov (United States)

    Arbey, A.; Mahmoudi, F.; Stål, O.; Stefaniak, T.

    2018-03-01

    The existence of charged Higgs boson(s) is inevitable in models with two (or more) Higgs doublets. Hence, their discovery would constitute unambiguous evidence for new physics beyond the Standard Model (SM). Taking into account all relevant results from direct charged and neutral Higgs boson searches at LEP and the LHC, as well as the most recent constraints from flavour physics, we present a detailed analysis of the current phenomenological status of the charged Higgs sector in a variety of well-motivated two Higgs doublet models (2HDMs). We find that charged Higgs bosons as light as 75 GeV can still be compatible with the combined data, although this implies severely suppressed charged Higgs couplings to all fermions. In more popular models, e.g. the 2HDM of Type II, we find that flavour physics observables impose a combined lower limit on the charged Higgs mass of M_{H^± } ≳ 600 GeV - independent of tan β - which increases to M_{H^± } ≳ 650 GeV for tan β < 1. We furthermore find that in certain scenarios, the signature of a charged Higgs boson decaying into a lighter neutral Higgs boson and a W boson provides a promising experimental avenue that would greatly complement the existing LHC search programme for charged Higgs boson(s).

  20. Collider and dark matter searches in the inert doublet model from Peccei-Quinn symmetry

    Energy Technology Data Exchange (ETDEWEB)

    Alves, Alexandre [Departamento de Ciências Exatas e da Terra, Universidade Federal de São Paulo,Diadema-SP, 09972-270 (Brazil); Camargo, Daniel A.; Dias, Alex G. [Universidade Federal do ABC, Centro de Ciências Naturais e Humanas,09210-580, Santo André-SP (Brazil); Longas, Robinson [Instituto de Física, Universidad de Antioquia,Calle 70 No. 52-21, Medellín (Colombia); Nishi, Celso C. [Universidade Federal do ABC, Centro de Matemática, Computação e Cognição Naturais,09210-580, Santo André-SP (Brazil); Queiroz, Farinaldo S. [Max-Planck-Institut fur Kernphysik,Saupfercheckweg 1, 69117 Heidelberg (Germany)

    2016-10-04

    Weakly Interacting Massive Particles (WIMPs) and axions are arguably the most compelling dark matter candidates in the literature. Could they coexist as dark matter particles? More importantly, can they be incorporated in a well motivated framework in agreement with experimental data? In this work, we show that this two component dark matter can be realized in the Inert Doublet Model in an elegant and natural manner by virtue of the spontaneous breaking of a Peccei-Quinn U(1){sub PQ} symmetry into a residual ℤ{sub 2} symmetry. The WIMP stability is guaranteed by the ℤ{sub 2} symmetry and a new dark matter component, the axion, arises. There are two interesting outcomes: (i) vector-like quarks needed to implement the Peccei-Quinn symmetry in the model may act as a portal between the dark sector and the SM fields with a supersymmetry-type phenomenology at colliders; (ii) two-component Inert Doublet Model re-opens the phenomenologically interesting 100–500 GeV mass region. We show that the model can successfully realize a two component dark matter framework and at the same time avoid low and high energy physics constraints such as monojet and dijet plus missing energy, as well as indirect and direct dark matter detection bounds.

  1. Spatial Distribution of Ground water Level Changes Induced by the 2006 Hengchun Earthquake Doublet

    Directory of Open Access Journals (Sweden)

    Yeeping Chia

    2009-01-01

    Full Text Available Water-level changes were ob served in 107 wells at 67 monitoring stations in the southern coastal plain of Tai wan during the 2006 Mw 7.1 Hengchun earthquake doublet. Two consecutive coseismic changes induced by the earth quake doublet can be observed from high-frequency data. Obervations from multiple-well stations indicate that the magnitude and direction of coseismic change may vary in wells of different depths. Coseismic rises were dominant on the south east side of the costal plain; whereas, coseismic falls prevailed on the north west side. In the transition zone, rises appeared in shallow wells whilst falls were evident in deep wells. As coseismic ground water level changes can reflect the tectonic strain field, tectonic extension likely dominates the deep subsurface in the transition area, and possibly in the en tire southern coastal plain. The coseismic rises in water level showed a tendency to de crease with distance from the hypocenter, but no clear trend was found for the coseismic falls.

  2. Effects of Constant and Doublet Frequency Electrical Stimulation Patterns on Force Production of Knee Extensor Muscles.

    Directory of Open Access Journals (Sweden)

    Carole Cometti

    Full Text Available This study compared knee extensors' neuromuscular fatigue in response to two 30-minute stimulation patterns: constant frequency train (CFT and doublet frequency train (DFT. Fifteen men underwent two separate sessions corresponding to each pattern. Measurements included torque evoked by each contraction and maximal voluntary contractions (MVC measured before and immediately after the stimulation sessions. In addition, activation level and torque evoked during doublets (Pd and tetanic contractions at 80-Hz (P80 and 20-Hz (P20 were determined in six subjects. Results indicated greater mean torque during the DFT stimulation session as compared with CFT. But, no difference was obtained between the two stimulation patterns for MVC and evoked torque decreases. Measurements conducted in the subgroup depicted a significant reduction of Pd, P20 and P80. Statistical analyses also revealed bigger P20 immediate reductions after CFT than after DFT. We concluded that DFT could be a useful stimulation pattern to produce and maintain greater force with quite similar fatigue than CFT.

  3. Sensitive criterion for chirality; Chiral doublet bands in 104Rh59

    International Nuclear Information System (INIS)

    Koike, T.; Starosta, K.; Vaman, C.; Ahn, T.; Fossan, D.B.; Clark, R.M.; Cromaz, M.; Lee, I.Y.; Macchiavelli, A.O.

    2003-01-01

    A particle plus triaxial rotor model was applied to odd-odd nuclei in the A ∼ 130 region in order to study the unique parity πh11/2xνh11/2 rotational bands. With maximum triaxiality assumed and the intermediate axis chosen as the quantization axis for the model calculations, the two lowest energy eigenstates of a given spin have chiral properties. The independence of the quantity S(I) on spin can be used as a new criterion for chirality. In addition, a diminishing staggering amplitude of S(I) with increasing spin implies triaxiality in neighboring odd-A nuclei. Chiral quartet bases were constructed specifically to examine electromagnetic properties for chiral structures. A set of selection rules unique to chirality was derived. Doublet bands built on the πg9/2xνh11/2 configuration have been discovered in odd-odd 104Rh using the 96Zr(11B, 3n) reaction. Based on the discussed criteria for chirality, it is concluded that the doublet bands observed in 104Rh exhibit characteristic chiral properties suggesting a new region of chirality around A ∼110. In addition, magnetic moment measurements have been performed to test the πh11/2xνh11/2 configuration in 128Cs and the πg9/2xνh11/2 configuration in 104Rh

  4. A search for neutral Higgs bosons in the MSSM and models with two scalar field doublets

    CERN Document Server

    Ackerstaff, K.; Allison, John; Altekamp, N.; Anderson, K.J.; Anderson, S.; Arcelli, S.; Asai, S.; Ashby, S.F.; Axen, D.; Azuelos, G.; Ball, A.H.; Barberio, E.; Barlow, Roger J.; Bartoldus, R.; Batley, J.R.; Baumann, S.; Bechtluft, J.; Behnke, T.; Bell, Kenneth Watson; Bella, G.; Bentvelsen, S.; Bethke, S.; Betts, S.; Biebel, O.; Biguzzi, A.; Bird, S.D.; Blobel, V.; Bloodworth, I.J.; Bobinski, M.; Bock, P.; Bonacorsi, D.; Boutemeur, M.; Braibant, S.; Brigliadori, L.; Brown, Robert M.; Burckhart, H.J.; Burgard, C.; Burgin, R.; Capiluppi, P.; Carnegie, R.K.; Carter, A.A.; Carter, J.R.; Chang, C.Y.; Charlton, David G.; Chrisman, D.; Clarke, P.E.L.; Cohen, I.; Conboy, J.E.; Cooke, O.C.; Couyoumtzelis, C.; Coxe, R.L.; Cuffiani, M.; Dado, S.; Dallapiccola, C.; Dallavalle, G.Marco; Davis, R.; De Jong, S.; del Pozo, L.A.; de Roeck, A.; Desch, K.; Dienes, B.; Dixit, M.S.; Doucet, M.; Duchovni, E.; Duckeck, G.; Duerdoth, I.P.; Eatough, D.; Estabrooks, P.G.; Etzion, E.; Evans, H.G.; Evans, M.; Fabbri, F.; Fanfani, A.; Fanti, M.; Faust, A.A.; Feld, L.; Fiedler, F.; Fierro, M.; Fischer, H.M.; Fleck, I.; Folman, R.; Fong, D.G.; Foucher, M.; Furtjes, A.; Futyan, D.I.; Gagnon, P.; Gary, J.W.; Gascon, J.; Gascon-Shotkin, S.M.; Geddes, N.I.; Geich-Gimbel, C.; Geralis, T.; Giacomelli, G.; Giacomelli, P.; Giacomelli, R.; Gibson, V.; Gibson, W.R.; Gingrich, D.M.; Glenzinski, D.; Goldberg, J.; Goodrick, M.J.; Gorn, W.; Grandi, C.; Gross, E.; Grunhaus, J.; Gruwe, M.; Hajdu, C.; Hanson, G.G.; Hansroul, M.; Hapke, M.; Hargrove, C.K.; Hart, P.A.; Hartmann, C.; Hauschild, M.; Hawkes, C.M.; Hawkings, R.; Hemingway, R.J.; Herndon, M.; Herten, G.; Heuer, R.D.; Hildreth, M.D.; Hill, J.C.; Hillier, S.J.; Hobson, P.R.; Hocker, James Andrew; Homer, R.J.; Honma, A.K.; Horvath, D.; Hossain, K.R.; Howard, R.; Huntemeyer, P.; Hutchcroft, D.E.; Igo-Kemenes, P.; Imrie, D.C.; Ishii, K.; Jawahery, A.; Jeffreys, P.W.; Jeremie, H.; Jimack, M.; Joly, A.; Jones, C.R.; Jones, M.; Jost, U.; Jovanovic, P.; Junk, T.R.; Kanzaki, J.; Karlen, D.; Kartvelishvili, V.; Kawagoe, K.; Kawamoto, T.; Kayal, P.I.; Keeler, R.K.; Kellogg, R.G.; Kennedy, B.W.; Kirk, J.; Klier, A.; Kluth, S.; Kobayashi, T.; Kobel, M.; Koetke, D.S.; Kokott, T.P.; Kolrep, M.; Komamiya, S.; Kowalewski, Robert V.; Kress, T.; Krieger, P.; von Krogh, J.; Kyberd, P.; Lafferty, G.D.; Lahmann, R.; Lai, W.P.; Lanske, D.; Lauber, J.; Lautenschlager, S.R.; Lawson, I.; Layter, J.G.; Lazic, D.; Lee, A.M.; Lefebvre, E.; Lellouch, D.; Letts, J.; Levinson, L.; List, B.; Lloyd, S.L.; Loebinger, F.K.; Long, G.D.; Losty, M.J.; Ludwig, J.; Lui, D.; Macchiolo, A.; Macpherson, A.; Mannelli, M.; Marcellini, S.; Markopoulos, C.; Markus, C.; Martin, A.J.; Martin, J.P.; Martinez, G.; Mashimo, T.; Mattig, Peter; McDonald, W.John; McKenna, J.; Mckigney, E.A.; McMahon, T.J.; McPherson, R.A.; Meijers, F.; Menke, S.; Merritt, F.S.; Mes, H.; Meyer, J.; Michelini, A.; Mihara, S.; Mikenberg, G.; Miller, D.J.; Mincer, A.; Mir, R.; Mohr, W.; Montanari, A.; Mori, T.; Nagai, K.; Nakamura, I.; Neal, H.A.; Nellen, B.; Nisius, R.; O'Neale, S.W.; Oakham, F.G.; Odorici, F.; Ogren, H.O.; Oh, A.; Oldershaw, N.J.; Oreglia, M.J.; Orito, S.; Palinkas, J.; Pasztor, G.; Pater, J.R.; Patrick, G.N.; Patt, J.; Perez-Ochoa, R.; Petzold, S.; Pfeifenschneider, P.; Pilcher, J.E.; Pinfold, J.; Plane, David E.; Poffenberger, P.; Poli, B.; Posthaus, A.; Rembser, C.; Robertson, S.; Robins, S.A.; Rodning, N.; Roney, J.M.; Rooke, A.; Rossi, A.M.; Routenburg, P.; Rozen, Y.; Runge, K.; Runolfsson, O.; Ruppel, U.; Rust, D.R.; Sachs, K.; Saeki, T.; Sahr, O.; Sang, W.M.; Sarkisian, E.K.G.; Sbarra, C.; Schaile, A.D.; Schaile, O.; Scharf, F.; Scharff-Hansen, P.; Schieck, J.; Schleper, P.; Schmitt, B.; Schmitt, S.; Schoning, A.; Schroder, Matthias; Schumacher, M.; Schwick, C.; Scott, W.G.; Shears, T.G.; Shen, B.C.; Shepherd-Themistocleous, C.H.; Sherwood, P.; Siroli, G.P.; Sittler, A.; Skillman, A.; Skuja, A.; Smith, A.M.; Snow, G.A.; Sobie, R.; Soldner-Rembold, S.; Springer, Robert Wayne; Sproston, M.; Stephens, K.; Steuerer, J.; Stockhausen, B.; Stoll, K.; Strom, David M.; Strohmer, R.; Szymanski, P.; Tafirout, R.; Talbot, S.D.; Taras, P.; Tarem, S.; Teuscher, R.; Thiergen, M.; Thomson, M.A.; von Torne, E.; Torrence, E.; Towers, S.; Trigger, I.; Trocsanyi, Z.; Tsur, E.; Turcot, A.S.; Turner-Watson, M.F.; Ueda, I.; Utzat, P.; Van Kooten, Rick J.; Vannerem, P.; Verzocchi, M.; Vikas, P.; Vokurka, E.H.; Voss, H.; Wackerle, F.; Wagner, A.; Ward, C.P.; Ward, D.R.; Watkins, P.M.; Watson, A.T.; Watson, N.K.; Wells, P.S.; Wermes, N.; White, J.S.; Wilson, G.W.; Wilson, J.A.; Wyatt, T.R.; Yamashita, S.; Yekutieli, G.; Zacek, V.; Zer-Zion, D.

    1998-01-01

    A search is described for the neutral Higgs bosons h^0 and A^0 predicted by models with two scalar field doublets and, in particular, the Minimal Supersymmetric Standard Model (MSSM). The search in the Z^0 h^0 and h^0 A^0 production channels is based on data corresponding to an integrated luminosity of 25 pb^{-1} from e^+e^- collisions at centre-of-mass energies between 130 and 172GeV collected with the OPAL detector at LEP. The observation of a number of candidates consistent with Standard Model background expectations is used in combination with earlier results from data collected at the Z^0 resonance to set limits on m_h and m_A in general models with two scalar field doublets and in the MSSM. For example, in the MSSM, for tan(beta) > 1, minimal and maximal scalar top quark mixing and soft SUSY-breaking masses of 1 TeV, the 95% confidence level limits m_h > 59.0 GeV and m_A > 59.5 GeV are obtained. For the first time, the MSSM parameter space is explored in a detailed scan.

  5. Status of the charged Higgs boson in two Higgs doublet models

    International Nuclear Information System (INIS)

    Arbey, A.; Mahmoudi, F.; Stefaniak, T.; Staal, O.

    2018-01-01

    The existence of charged Higgs boson(s) is inevitable in models with two (or more) Higgs doublets. Hence, their discovery would constitute unambiguous evidence for new physics beyond the Standard Model (SM). Taking into account all relevant results from direct charged and neutral Higgs boson searches at LEP and the LHC, as well as the most recent constraints from flavour physics, we present a detailed analysis of the current phenomenological status of the charged Higgs sector in a variety of well-motivated two Higgs doublet models (2HDMs). We find that charged Higgs bosons as light as 75 GeV can still be compatible with the combined data, although this implies severely suppressed charged Higgs couplings to all fermions. In more popular models, e.g. the 2HDM of Type II, we find that flavour physics observables impose a combined lower limit on the charged Higgs mass of M H ± > or similar 600 GeV - independent of tan β - which increases to M H ± > or similar 650 GeV for tan β < 1. We furthermore find that in certain scenarios, the signature of a charged Higgs boson decaying into a lighter neutral Higgs boson and a W boson provides a promising experimental avenue that would greatly complement the existing LHC search programme for charged Higgs boson(s). (orig.)

  6. Baryogenesis in the two doublet and inert singlet extension of the Standard Model

    Energy Technology Data Exchange (ETDEWEB)

    Alanne, Tommi [CP" 3-Origins, University of Southern Denmark,Campusvej 55, DK-5230 Odense M (Denmark); Kainulainen, Kimmo [Department of Physics, University of Jyväskylä,P.O. Box 35 (YFL), FI-40014 Jyväskylä (Finland); Helsinki Institute of Physics, University of Helsinki,P.O. Box 64, FI-00014 Helsinki (Finland); Tuominen, Kimmo [Department of Physics, University of Helsinki,P.O. Box 64, FI-00014 Helsinki (Finland); Helsinki Institute of Physics, University of Helsinki,P.O. Box 64, FI-00014 Helsinki (Finland); Vaskonen, Ville [Department of Physics, University of Jyväskylä,P.O. Box 35 (YFL), FI-40014 Jyväskylä (Finland); Helsinki Institute of Physics, University of Helsinki,P.O. Box 64, FI-00014 Helsinki (Finland)

    2016-08-25

    We investigate an extension of the Standard Model containing two Higgs doublets and a singlet scalar field (2HDSM). We show that the model can have a strongly first-order phase transition and give rise to the observed baryon asymmetry of the Universe, consistent with all experimental constraints. In particular, the constraints from the electron and neutron electric dipole moments are less constraining here than in pure two-Higgs-doublet model (2HDM). The two-step, first-order transition in 2HDSM, induced by the singlet field, may lead to strong supercooling and low nucleation temperatures in comparison with the critical temperature, T{sub n}≪T{sub c}, which can significantly alter the usual phase-transition pattern in 2HD models with T{sub n}≈T{sub c}. Furthermore, the singlet field can be the dark matter particle. However, in models with a strong first-order transition its abundance is typically but a thousandth of the observed dark matter abundance.

  7. Liposome-encapsulated chemotherapy

    DEFF Research Database (Denmark)

    Børresen, B.; Hansen, A. E.; Kjær, A.

    2018-01-01

    Cytotoxic drugs encapsulated into liposomes were originally designed to increase the anticancer response, while minimizing off-target adverse effects. The first liposomal chemotherapeutic drug was approved for use in humans more than 20years ago, and the first publication regarding its use...... to inherent issues with the enhanced permeability and retention effect, the tumour phenomenon which liposomal drugs exploit. This effect seems very heterogeneously distributed in the tumour. Also, it is potentially not as ubiquitously occurring as once thought, and it may prove important to select patients...... not resolve the other challenges that liposomal chemotherapy faces, and more work still needs to be done to determine which veterinary patients may benefit the most from liposomal chemotherapy....

  8. Combined radiotherapy-chemotherapy

    International Nuclear Information System (INIS)

    Steel, G.G.

    1989-01-01

    This paper presents the clinically confirmed benefits of combined chemotherapy-radiotherapy. They have been found in a small group of diseases that respond to chemotherapy alone. According to the author, only when a drug or drug combination has the ability to eradicate occult disease or substantially to reduce the size of objectively measurable disease is there likely to be an demonstrable benefit from its use in conjunction with radiotherapy. It is the author's belief that the immediate future lies in selecting drugs and patients in which a good chemotherapeutic response can be expected, avoiding drugs that seriously enhance radiation damage to normal tissues and keeping drug and radiation treatments far enough apart in time to minimize interactions

  9. The inert doublet model in the light of Fermi-LAT gamma-ray data: a global fit analysis

    Science.gov (United States)

    Eiteneuer, Benedikt; Goudelis, Andreas; Heisig, Jan

    2017-09-01

    We perform a global fit within the inert doublet model taking into account experimental observables from colliders, direct and indirect dark matter searches and theoretical constraints. In particular, we consider recent results from searches for dark matter annihilation-induced gamma-rays in dwarf spheroidal galaxies and relax the assumption that the inert doublet model should account for the entire dark matter in the Universe. We, moreover, study in how far the model is compatible with a possible dark matter explanation of the so-called Galactic center excess. We find two distinct parameter space regions that are consistent with existing constraints and can simultaneously explain the excess: One with dark matter masses near the Higgs resonance and one around 72 GeV where dark matter annihilates predominantly into pairs of virtual electroweak gauge bosons via the four-vertex arising from the inert doublet's kinetic term. We briefly discuss future prospects to probe these scenarios.

  10. Extending two Higgs doublet models for two-loop neutrino mass generation and one-loop neutrinoless double beta decay

    Energy Technology Data Exchange (ETDEWEB)

    Liu, Zhen, E-mail: liu-zhen@sjtu.edu.cn; Gu, Pei-Hong, E-mail: peihong.gu@sjtu.edu.cn

    2017-02-15

    We extend some two Higgs doublet models, where the Yukawa couplings for the charged fermion mass generation only involve one Higgs doublet, by two singlet scalars respectively carrying a singly electric charge and a doubly electric charge. The doublet and singlet scalars together can mediate a two-loop diagram to generate a tiny Majorana mass matrix of the standard model neutrinos. Remarkably, the structure of the neutrino mass matrix is fully determined by the symmetric Yukawa couplings of the doubly charged scalar to the right-handed leptons. Meanwhile, a one-loop induced neutrinoless double beta decay can arrive at a testable level even if the electron neutrino has an extremely small Majorana mass. We also study other experimental constraints and implications including some rare processes and Higgs phenomenology.

  11. Sizable NSI from the SU(2){sub L} scalar doublet-singlet mixing and the implications in DUNE

    Energy Technology Data Exchange (ETDEWEB)

    Forero, David V. [Center for Neutrino Physics, Virginia Tech,Blacksburg, VA, 24061 (United States); Huang, Wei-Chih [Fakultät für Physik, Technische Universität Dortmund,Dortmund, 44221 (Germany)

    2017-03-03

    We propose a novel and simple mechanism where sizable effects of non-standard interactions (NSI) in neutrino propagation are induced from the mixing between an electrophilic second Higgs doublet and a charged singlet. The mixing arises from a dimensionful coupling of the scalar doublet and singlet to the standard model Higgs boson. In light of the small mass, the light mass eigenstate from the doublet-singlet mixing can generate much larger NSI than those induced by the heavy eigenstate. We show that a sizable NSI ε{sub eτ} (∼0.3) can be attained without being excluded by a variety of experimental constraints. Furthermore, we demonstrate that NSI can mimic effects of the Dirac CP phase in the neutrino mixing matrix but they can potentially be disentangled by future long-baseline neutrino experiments, such as the Deep Underground Neutrino Experiment (DUNE).

  12. Extending two Higgs doublet models for two-loop neutrino mass generation and one-loop neutrinoless double beta decay

    Directory of Open Access Journals (Sweden)

    Zhen Liu

    2017-02-01

    Full Text Available We extend some two Higgs doublet models, where the Yukawa couplings for the charged fermion mass generation only involve one Higgs doublet, by two singlet scalars respectively carrying a singly electric charge and a doubly electric charge. The doublet and singlet scalars together can mediate a two-loop diagram to generate a tiny Majorana mass matrix of the standard model neutrinos. Remarkably, the structure of the neutrino mass matrix is fully determined by the symmetric Yukawa couplings of the doubly charged scalar to the right-handed leptons. Meanwhile, a one-loop induced neutrinoless double beta decay can arrive at a testable level even if the electron neutrino has an extremely small Majorana mass. We also study other experimental constraints and implications including some rare processes and Higgs phenomenology.

  13. The inert doublet model in the light of Fermi-LAT gamma-ray data: a global fit analysis

    Energy Technology Data Exchange (ETDEWEB)

    Eiteneuer, Benedikt; Heisig, Jan [RWTH Aachen University, Institute for Theoretical Particle Physics and Cosmology, Aachen (Germany); Goudelis, Andreas [UMR 7589 CNRS and UPMC, Laboratoire de Physique Theorique et Hautes Energies (LPTHE), Paris (France)

    2017-09-15

    We perform a global fit within the inert doublet model taking into account experimental observables from colliders, direct and indirect dark matter searches and theoretical constraints. In particular, we consider recent results from searches for dark matter annihilation-induced gamma-rays in dwarf spheroidal galaxies and relax the assumption that the inert doublet model should account for the entire dark matter in the Universe. We, moreover, study in how far the model is compatible with a possible dark matter explanation of the so-called Galactic center excess. We find two distinct parameter space regions that are consistent with existing constraints and can simultaneously explain the excess: One with dark matter masses near the Higgs resonance and one around 72 GeV where dark matter annihilates predominantly into pairs of virtual electroweak gauge bosons via the four-vertex arising from the inert doublet's kinetic term. We briefly discuss future prospects to probe these scenarios. (orig.)

  14. Prevent Infections During Chemotherapy

    Centers for Disease Control (CDC) Podcasts

    2011-10-24

    This podcast discusses the importance of preventing infections in cancer patients who are undergoing chemotherapy. Dr. Lisa Richardson, CDC oncologist, talks about a new Web site for cancer patients and their caregivers.  Created: 10/24/2011 by National Center for Chronic Disease Prevention and Health Promotion (NCCDPHP), Division of Cancer Prevention and Control (DCPC).   Date Released: 10/24/2011.

  15. Full dose CHOP chemotherapy

    International Nuclear Information System (INIS)

    Tominaga, Shinichi; Kondo, Makoto; Ando, Yutaka; Yamashita, Shoji; Uematsu, Minoru; Shigematsu, Naoyuki; Nishiguchi, Iku; Hashimoto, Shozo

    1985-01-01

    Since 1982, we have performed 125 courses of CHOP chemotherapy for 27 patients of malignancy, adhering to the original regimen as strictly as possible. CHOP chemotherapy consisted of Cyclophosphamide 750 mg/m 2 , iv, on day 1; Adriamycin 50 mg/m 2 , iv, on day 1; Vincristine 1.4 mg/m 2 , iv, on day 1 (maximum single dose 2.0 mg) and Prednisolone 50 mg/m 2 , po, day 1 through 5. The cycle was repeated every 21 days. As side effects, myelosuppression, hair loss, fever, nausea, vomiting, liver dysfunction, stomatitis, neuropathy, herpes zoster, arrhythmia and hemorrhagic cystitis were seen. Due to myelosuppression, twenty patients experienced febrile episodes at each nadir of WBC counts on 40 courses. However, any febrile patient did not have life threatening infection. Other side effects were also reversible. The radiotherapy of most patients was carried out as initially scheduled, except for 3 patients in whom irradiation was interrupted due to severe stomatitis or herpes zoster. We consider that CHOP chemotherapy is excellent in feasibility even when combined with radiotherapy. (author)

  16. Concurrent radiotherapy and chemotherapy

    International Nuclear Information System (INIS)

    Fu, K.K.

    1985-01-01

    The principal objective of combining chemotherapy with radiotherapy (XRT) for the treatment of advanced head and neck cancer is to improve the therapeutic ratio through the enhancement of local control and reduction of distant metastases without excessively enhancing normal tissue effects. Improved tumour control can result from sole additivity of either therapy or direct interactions between drug and radiation leading to increased tumour cell kill. Chemotherapy may sensitize the cells to radiation, interfere with repair of sublethal or potentially lethal radiation damage, induce cell synchrony, and reduce tumour mass leading to reoxygenation and decreased fraction of resistant hypoxic cells. Radiation may improve drug accessibility to tumour cells and reduce tumour volume leading to increased cell proliferation and chemosensitivity. If the enhanced effects of combined therapy are purely additive, then the two modalities can be administered either sequentially or concurrently with the same results. However, if the enhanced effects result from the direct interaction between drug and radiation, it is necessary that the two modalities be administered concurrently and in close temporal proximity. This review summarizes the results of clinical studies in which chemotherapy was administered concurrently during the course of radiotherapy for patients with previously untreated advanced squamous cell carcinoma in the head and neck

  17. The Features of Moessbauer Spectra of Hemoglobins: Approximation by Superposition of Quadrupole Doublets or by Quadrupole Splitting Distribution?

    International Nuclear Information System (INIS)

    Oshtrakh, M. I.; Semionkin, V. A.

    2004-01-01

    Moessbauer spectra of hemoglobins have some features in the range of liquid nitrogen temperature: a non-Lorentzian asymmetric line shape for oxyhemoglobins and symmetric Lorentzian line shape for deoxyhemoglobins. A comparison of the approximation of the hemoglobin Moessbauer spectra by a superposition of two quadrupole doublets and by a distribution of the quadrupole splitting demonstrates that a superposition of two quadrupole doublets is more reliable and may reflect the non-equivalent iron electronic structure and the stereochemistry in the α- and β-subunits of hemoglobin tetramers.

  18. An overview of neoadjuvant chemotherapy in the multimodality treatment of malignant pleural mesothelioma.

    Science.gov (United States)

    Pasello, G; Ceresoli, G L; Favaretto, A

    2013-02-01

    Malignant Pleural Mesothelioma (MPM) is an aggressive tumour with poor prognosis and increasing incidence in industrialized countries because of the previous widespread exposure to asbestos fibres and to the long lag period from time of exposure and the diagnosis of the disease. MPM shows high refractoriety to systemic treatment, single-modality treatment was generally ineffective and did not achieve higher results than supportive care. The incidence of local and distant recurrences after surgery remains high and that was the reason for many centres to perform combined treatments. In the attempt of reducing the incidence of local recurrences, a multimodality approach with surgery followed by adjuvant radiotherapy was explored. Extrapleural pneumonectomy (EPP) allows higher doses of radiotherapy to the whole hemithorax by avoiding pulmonary toxicity and the results of this approach is a significant reduction of loco-regional relapses; although, extrathoracic metastasis represent a major problem in the management of the disease because of the impact on overall survival. The success with surgical resection after neoadjuvant chemotherapy in stage IIIA lung cancer has been the impetus for several groups to apply this strategy in MPM aiming at reducing the incidence of distant relapse after surgery. Platinum-based chemotherapy plus gemcitabine or pemetrexed for 3-4 cycles followed by surgery and postoperative high-dose radiotherapy showed the best results in terms of overall and progression free survival. This review will focus on the main clinical studies and overview the results of different chemotherapy regimens in the neoadjuvant treatment of MPM. Copyright © 2012 Elsevier Ltd. All rights reserved.

  19. NRF2 Pathway Activation and Adjuvant Chemotherapy Benefit in Lung Squamous Cell Carcinoma.

    Science.gov (United States)

    Cescon, David W; She, Desmond; Sakashita, Shingo; Zhu, Chang-Qi; Pintilie, Melania; Shepherd, Frances A; Tsao, Ming-Sound

    2015-06-01

    Genomic profiling of lung squamous cell carcinomas (SCC) has identified NRF2 pathway alterations, which activate oxidative response pathways, in one third of tumors. Preclinical data suggest these tumors may be resistant to platinum-based chemotherapy. We evaluated the clinical relevance of these findings and assessed whether NRF2 activation predicts benefit from adjuvant chemotherapy in SCC. Logistic regression (LR) and significance analysis of microarrays (SAM) were applied to all 104 TCGA (The Cancer Genome Atlas) SCC cases that had microarray gene expression and mutation data to identify genes associated with somatic NRF2 pathway alterations. The resulting signature (NRF2(ACT)) was tested in 3 independent SCC datasets to evaluate its prognostic and predictive effects. IHC and sequencing for NRF2 and KEAP1 were evaluated in one cohort (n = 43) to assess the relationship between gene expression, mutational status, and protein expression. Twenty-eight genes were identified by overlap between LR (291 genes) and SAM (30 genes), and these consistently separated SCC into 2 groups in all datasets, corresponding to putatively NRF pathway-activated and wild-type (WT) tumors. NRF2(ACT) was not prognostic. However, improved survival with adjuvant chemotherapy in the JBR.10-randomized trial appears limited to patients with the WT signature (HR 0.32, P = 0.16; NRF2(ACT) HR 2.28, P = 0.48; interaction P = 0.15). NRF2(ACT) was highly correlated with mutations in NRF2 and KEAP1, and with high NRF2 protein expression. A gene expression signature of NRF2 pathway activation is associated with benefit from adjuvant cisplatin/vinorelbine in SCC. Patients with NRF2 pathway-activating somatic alterations may have reduced benefit from this therapy. ©2015 American Association for Cancer Research.

  20. Adjuvant chemotherapy for osteosarcoma.

    Science.gov (United States)

    Eilber, F R; Rosen, G

    1989-08-01

    From this review of chemotherapy trials, several observations can be made. Osteosarcoma is a complex disease involving multiple histologies, each with a different prognosis. Prognostic factors that have been shown to be important include anatomic location of the primary tumor, stage at presentation (patients with metastatic or local recurrent disease fair far worse than those with primary disease), age at onset (children fair worse than the teenager with osteosarcoma), and location within the extremity (patients with more distal tumors fairing better than patients with more proximal tumors). There is convincing evidence for the efficacy of chemotherapeutic agents such as methotrexate in high doses (at least 8 g/m2 for adults, 12 g/m2 for children), Adriamycin, and cisplatin. The combination of Adriamycin and cisplatin appears to be more beneficial relative to either one of these agents alone. The efficacy of the combination of BCD as a triple-drug regimen, although useful in several different trials, has not been convincingly shown. Finally, from several of the recent randomized trials, it appears, that chemotherapeutic regimens containing an Adriamycin and cisplatin combination appear to be superior to those that do not include this combination. However, these observations are made from a historical perspective and have not been conclusively proven by randomized prospective investigations. The observations concerning the natural history of the disease and the activity of various chemotherapeutic agents suggest certain clinical practice algorithms. Essential staging procedures would include a bone scan looking for multifocal or metastatic disease, and CT scans of the chest looking for metastases to the lung. From all studies, it is apparent that surgery is mandatory for the primary tumor and should be an integral portion of all treatment methods. Chemotherapy should be considered for all patients with osteosarcoma, and the essential drugs in the regimen appear at

  1. A tale of twin Higgs: natural twin two Higgs doublet models

    International Nuclear Information System (INIS)

    Yu, Jiang-Hao

    2016-01-01

    In original twin Higgs model, vacuum misalignment between electroweak and new physics scales is realized by adding explicit ℤ 2 breaking term. Introducing additional twin Higgs could accommodate spontaneous ℤ 2 breaking, which explains origin of this misalignment. We introduce a class of twin two Higgs doublet models with most general scalar potential, and discuss general conditions which trigger electroweak and ℤ 2 symmetry breaking. Various scenarios on realising the vacuum misalignment are systematically discussed in a natural composite two Higgs double model framework: explicit ℤ 2 breaking, radiative ℤ 2 breaking, tadpole-induced ℤ 2 breaking, and quartic-induced ℤ 2 breaking. We investigate the Higgs mass spectra and Higgs phenomenology in these scenarios.

  2. tbW anomalous couplings in the Two Higgs Doublet Model

    Energy Technology Data Exchange (ETDEWEB)

    Arhrib, Abdesslam; Jueid, Adil [Département de Mathématiques, Faculté des Sciences et Techniques,Université Abdelmalek Essaadi,B. 416, Tangier (Morocco)

    2016-08-11

    We make a complete one loop calculation of the tbW couplings in the Two Higgs Doublet Model. We evaluate both the anomalous couplings g{sub L} and g{sub R} as well as left handed and right handed component of tbW. The computation is done in the Feynman gauge using the on-shell scheme renormalization for the Standard Model wave functions and parameters. We first show that the relative corrections to these anomalous couplings are rather small in most regions of the parameter space. We then analyze the effects of these anomalous couplings on certain observables such as top quark polarization in single top production through t−channel as well as W{sup ±} boson helicity fractions in top decay.

  3. C P -violation in the two Higgs doublet model: From the LHC to EDMs

    Science.gov (United States)

    Chen, Chien-Yi; Li, Hao-Lin; Ramsey-Musolf, Michael

    2018-01-01

    We study the prospective sensitivity to C P -violating two Higgs doublet models from the 14 TeV LHC and future electric dipole moment (EDM) experiments. We concentrate on the search for a resonant heavy Higgs that decays to a Z boson and a SM-like Higgs h , leading to the Z (ℓℓ)h (b b ¯ ) final state. The prospective LHC reach is analyzed using the Boosted Decision Tree method. We illustrate the complementarity between the LHC and low energy EDM measurements and study the dependence of the physics reach on the degree of deviation from the alignment limit. In all cases, we find that there exists a large part of parameter space that is sensitive to both EDMs and LHC searches.

  4. Effect of CP violation in the singlet-doublet dark matter model

    Directory of Open Access Journals (Sweden)

    Tomohiro Abe

    2017-08-01

    Full Text Available We revisit the singlet-doublet dark matter model with a special emphasis on the effect of CP violation on the dark matter phenomenology. The CP violation in the dark sector induces a pseudoscalar interaction of a fermionic dark matter candidate with the SM Higgs boson. The pseudoscalar interaction helps the dark matter candidate evade the strong constraints from the dark matter direct detection experiments. We show that the model can explain the measured value of the dark matter density even if dark matter direct detection experiments do not observe any signal. We also show that the electron electric dipole moment is an important complement to the direct detection for testing this model. Its value is smaller than the current upper bound but within the reach of future experiments.

  5. One-loop contributions to neutral minima in the inert doublet model

    Energy Technology Data Exchange (ETDEWEB)

    Ferreira, P.M. [Instituto Superior de Engenharia de Lisboa - ISEL,1959-007 Lisboa (Portugal); Centro de Física Teórica e Computacional - FCUL,Universidade de Lisboa, R. Ernesto de Vasconcelos, 1749-016 Lisboa (Portugal); Świeżewska, Bogumiła [Faculty of Physics, University of Warsaw,Pasteura 5, 02-093 Warsaw (Poland)

    2016-04-15

    The vacuum structure of the inert doublet model is analysed at the one-loop level using the effective potential formalism, to verify the validity of tree-level predictions for the properties of the global minimum. An inert minimum (with massive fermions) and an inert-like minimum (with massless fermions) can coexist at tree level. But the one-loop analysis reveals that the allowed parameter space for the coexistence of more than one minimum is larger than the tree-level expected one. It is also shown that for some choices of parameters, the global minimum found at the one-loop level may be inert (or inert-like), contrary to what the tree-level analysis indicates.

  6. Instrumentation and control of the Doublet III Neutral Beam Injector System

    Energy Technology Data Exchange (ETDEWEB)

    Kohli, J.C.; Moore, C.D.; Drobnis, D.D.; Elischer, V.P.; Kilgore, R.; Uber, D.

    1980-03-01

    The hardware and software required for the operation of the Doublet III Neutral Beam Injector System (NBIS) are described. Development and implementation of this Instrumentation and Control System was divided between the major participants - General Atomic Company and Lawrence Berkeley Laboratory. The subdivision of responsibilities and the coordination of the participants' activities are described with reference to hardware and software requirements in support of the entire system. Included are a description of the operators' consoles, the interlock system and the CAMAC system. One feature of the control software is source modeling. This feature includes feedback on a shot to shot basis and adaptive control. Adaptive control permits the computer system to automatically adjust parameters after a shot, and to control the system to automatically compensate for time varying NBIS components. The Neutral Beam Power Supply features power supply modeling, fiber optic transmission of analog signals and digital control of power supply power-up/interlocks.

  7. Theory of radiative muon capture with applications to nuclear spin and isospin doublets

    International Nuclear Information System (INIS)

    Hwang, W.P.; Primakoff, H.

    1978-01-01

    A theory of radiative muon capture, with applications to nuclear spin and isospin doublets, is formulated on the basis of the conservation of the hadronic electromagnetic current, the conservation of the hadronic weak polar currents, the partial conservation of the hadronic weak axial-vector current, the SU(2) x SU(2) current algebra for the various hadronic current, and a simplifying dynamical approximation for the hadron-radiating part of the transition amplitude: the ''linearity hypothesis''. The resultant total transition amplitude, which also includes the muon-radiating part, is worked out explicitly and applied to treat the processes μ - p → ν/sub μ/nγ and μ - 3 He → ν/sub μ/ 3 Hγ

  8. A tale of twin Higgs: natural twin two Higgs doublet models

    Energy Technology Data Exchange (ETDEWEB)

    Yu, Jiang-Hao [Amherst Center for Fundamental Interactions, Department of Physics,University of Massachusetts Amherst,710 North Pleasant St., Amherst, MA 01002 (United States)

    2016-12-28

    In original twin Higgs model, vacuum misalignment between electroweak and new physics scales is realized by adding explicit ℤ{sub 2} breaking term. Introducing additional twin Higgs could accommodate spontaneous ℤ{sub 2} breaking, which explains origin of this misalignment. We introduce a class of twin two Higgs doublet models with most general scalar potential, and discuss general conditions which trigger electroweak and ℤ{sub 2} symmetry breaking. Various scenarios on realising the vacuum misalignment are systematically discussed in a natural composite two Higgs double model framework: explicit ℤ{sub 2} breaking, radiative ℤ{sub 2} breaking, tadpole-induced ℤ{sub 2} breaking, and quartic-induced ℤ{sub 2} breaking. We investigate the Higgs mass spectra and Higgs phenomenology in these scenarios.

  9. Two Higgs Doublet Model and Model Independent Interpretation of Neutral Higgs Boson Searches

    CERN Document Server

    Abbiendi, G.; Ainsley, C.; Akesson, P.F.; Alexander, G.; Allison, John; Anderson, K.J.; Arcelli, S.; Asai, S.; Ashby, S.F.; Axen, D.; Azuelos, G.; Bailey, I.; Ball, A.H.; Barberio, E.; Barlow, Roger J.; Baumann, S.; Behnke, T.; Bell, Kenneth Watson; Bella, G.; Bellerive, A.; Benelli, G.; Bentvelsen, S.; Bethke, S.; Biebel, O.; Bloodworth, I.J.; Boeriu, O.; Bock, P.; Bohme, J.; Bonacorsi, D.; Boutemeur, M.; Braibant, S.; Bright-Thomas, P.; Brigliadori, L.; Brown, Robert M.; Burckhart, H.J.; Cammin, J.; Capiluppi, P.; Carnegie, R.K.; Carter, A.A.; Carter, J.R.; Chang, C.Y.; Charlton, David G.; Clarke, P.E.L.; Clay, E.; Cohen, I.; Cooke, O.C.; Couchman, J.; Couyoumtzelis, C.; Coxe, R.L.; Csilling, A.; Cuffiani, M.; Dado, S.; Dallavalle, G.Marco; Dallison, S.; de Roeck, A.; de Wolf, E.; Dervan, P.; Desch, K.; Dienes, B.; Dixit, M.S.; Donkers, M.; Dubbert, J.; Duchovni, E.; Duckeck, G.; Duerdoth, I.P.; Estabrooks, P.G.; Etzion, E.; Fabbri, F.; Fanti, M.; Feld, L.; Ferrari, P.; Fiedler, F.; Fleck, I.; Ford, M.; Frey, A.; Furtjes, A.; Futyan, D.I.; Gagnon, P.; Gary, J.W.; Gaycken, G.; Geich-Gimbel, C.; Giacomelli, G.; Giacomelli, P.; Glenzinski, D.; Goldberg, J.; Grandi, C.; Graham, K.; Gross, E.; Grunhaus, J.; Gruwe, M.; Gunther, P.O.; Hajdu, C.; Hanson, G.G.; Hansroul, M.; Hapke, M.; Harder, K.; Harel, A.; Harin-Dirac, M.; Hauke, A.; Hauschild, M.; Hawkes, C.M.; Hawkings, R.; Hemingway, R.J.; Hensel, C.; Herten, G.; Heuer, R.D.; Hill, J.C.; Hocker, James Andrew; Hoffman, Kara Dion; Homer, R.J.; Honma, A.K.; Horvath, D.; Hossain, K.R.; Howard, R.; Huntemeyer, P.; Igo-Kemenes, P.; Ishii, K.; Jacob, F.R.; Jawahery, A.; Jeremie, H.; Jones, C.R.; Jovanovic, P.; Junk, T.R.; Kanaya, N.; Kanzaki, J.; Karapetian, G.; Karlen, D.; Kartvelishvili, V.; Kawagoe, K.; Kawamoto, T.; Keeler, R.K.; Kellogg, R.G.; Kennedy, B.W.; Kim, D.H.; Klein, K.; Klier, A.; Kluth, S.; Kobayashi, T.; Kobel, M.; Kokott, T.P.; Komamiya, S.; Kowalewski, Robert V.; Kress, T.; Krieger, P.; von Krogh, J.; Kuhl, T.; Kupper, M.; Kyberd, P.; Lafferty, G.D.; Landsman, H.; Lanske, D.; Lawson, I.; Layter, J.G.; Leins, A.; Lellouch, D.; Letts, J.; Levinson, L.; Liebisch, R.; Lillich, J.; List, B.; Littlewood, C.; Lloyd, A.W.; Lloyd, S.L.; Loebinger, F.K.; Long, G.D.; Losty, M.J.; Lu, J.; Ludwig, J.; Macchiolo, A.; Macpherson, A.; Mader, W.; Marcellini, S.; Marchant, T.E.; Martin, A.J.; Martin, J.P.; Martinez, G.; Mashimo, T.; Mattig, Peter; McDonald, W.John; McKenna, J.; McMahon, T.J.; McPherson, R.A.; Meijers, F.; Mendez-Lorenzo, P.; Menges, W.; Merritt, F.S.; Mes, H.; Michelini, A.; Mihara, S.; Mikenberg, G.; Miller, D.J.; Mohr, W.; Montanari, A.; Mori, T.; Nagai, K.; Nakamura, I.; Neal, H.A.; Nisius, R.; O'Neale, S.W.; Oakham, F.G.; Odorici, F.; Ogren, H.O.; Oh, A.; Okpara, A.; Oreglia, M.J.; Orito, S.; Pasztor, G.; Pater, J.R.; Patrick, G.N.; Patt, J.; Pfeifenschneider, P.; Pilcher, J.E.; Pinfold, J.; Plane, David E.; Poli, B.; Polok, J.; Pooth, O.; Przybycien, M.; Quadt, A.; Rembser, C.; Renkel, P.; Rick, H.; Rodning, N.; Roney, J.M.; Rosati, S.; Roscoe, K.; Rossi, A.M.; Rozen, Y.; Runge, K.; Runolfsson, O.; Rust, D.R.; Sachs, K.; Saeki, T.; Sahr, O.; Sarkisyan, E.K.G.; Sbarra, C.; Schaile, A.D.; Schaile, O.; Scharff-Hansen, P.; Schroder, Matthias; Schumacher, M.; Schwick, C.; Scott, W.G.; Seuster, R.; Shears, T.G.; Shen, B.C.; Shepherd-Themistocleous, C.H.; Sherwood, P.; Siroli, G.P.; Skuja, A.; Smith, A.M.; Snow, G.A.; Sobie, R.; Soldner-Rembold, S.; Spagnolo, S.; Sproston, M.; Stahl, A.; Stephens, K.; Stoll, K.; Strom, David M.; Strohmer, R.; Stumpf, L.; Surrow, B.; Talbot, S.D.; Tarem, S.; Taylor, R.J.; Teuscher, R.; Thiergen, M.; Thomas, J.; Thomson, M.A.; Torrence, E.; Towers, S.; Toya, D.; Trefzger, T.; Trigger, I.; Trocsanyi, Z.; Tsur, E.; Turner-Watson, M.F.; Ueda, I.; Vachon, B.; Vannerem, P.; Verzocchi, M.; Voss, H.; Vossebeld, J.; Waller, D.; Ward, C.P.; Ward, D.R.; Watkins, P.M.; Watson, A.T.; Watson, N.K.; Wells, P.S.; Wengler, T.; Wermes, N.; Wetterling, D.; White, J.S.; Wilson, G.W.; Wilson, J.A.; Wyatt, T.R.; Yamashita, S.; Zacek, V.; Zer-Zion, D.

    2001-01-01

    Searches for the neutral Higgs bosons h0 and A0, are used to obtain limits on the Type II Two Higgs Doublet Model (2HDM(II)) with no CP-violation in the Higgs sector and no additional particles besides the five Higgs bosons. The analysis combines approximately 170 pb-1 of data collected with the OPAL detector at sqrt{s} ~ 189 GeV with previous runs at sqrt{s} ~ mZ and sqrt{s} ~ 183 GeV. The searches are sensitive to the h0, A0 -> qq, gg, tau+tau- and h0 -> A0A0 decay modes of the Higgs bosons. For the first time, the 2HDM(II) parameter space is explored in a detailed scan, and new flavour independent analyses are applied to examine regions in which the neutral Higgs bosons decay predominantly into light quarks or gluons. Model-independent limits are also given.

  10. Perturbation constraint on particle masses in the Weinberg-Salam model with two massless Higgs doublets

    International Nuclear Information System (INIS)

    Inoue, Kenzo; Nakano, Yoshimasa; Kakuto, Akira.

    1980-01-01

    The Weinberg-Salam model with two Higgs doublets is investigated. The spontaneous breakdown of the gauge symmetry is assumed to be produced by the Coleman-Weinberg mechanism, keeping gauge hierarchies in grand unified theories in mind. A discrete symmetry is introduced to secure flavor-diagonal Yukawa interactions of neutral Higgs bosons and the absence of the axion. Bounds on various masses are obtained by imposing coupling constants to lie in a finite range for the validity of the perturbation theory. It will be found that there must be at least one Higgs boson whose mass is lighter than 40 GeV, in order to satisfy the perturbation constraint at the unification mass scale in grand unified theories. (author)

  11. Dobletes etimológicos en fraseología / Etymological doublets in phraseology

    Directory of Open Access Journals (Sweden)

    Oksana Gorelova

    2010-07-01

    Full Text Available RESUMEN: El artículo analiza un grupo de frases proverbiales españolas que proceden de un mismo étimo latino pero que entraron en la lengua española por dos vías diferentes: la escrita y la hablada, lo que permite llegar a la conclusión de que en el sistema fraseológico español existen dobletes etimológicos.ABSTRACT: The article analyses a group of Spanish proverbial sayings that originate in the same Latin etymon but entered the Spanish language though two two different routes - the written one and the spoken one. This allows us draw conclusions about the existence of etymological doublets in the Spanish phraseological system.

  12. Exploring collider aspects of a neutrinophilic Higgs doublet model in multilepton channels

    Science.gov (United States)

    Huitu, Katri; Kärkkäinen, Timo J.; Mondal, Subhadeep; Rai, Santosh Kumar

    2018-02-01

    We consider a neutrinophilic Higgs scenario where the Standard Model is extended by one additional Higgs doublet and three generations of singlet right-handed Majorana neutrinos. Light neutrino masses are generated through mixing with the heavy neutrinos via the Type-I seesaw mechanism when the neutrinophilic Higgs gets a vacuum expectation value (VEV). The Dirac neutrino Yukawa coupling in this scenario can be sizable compared to those in the canonical Type-I seesaw mechanism owing to the small neutrinophilic Higgs VEV giving rise to interesting phenomenological consequences. We have explored various signal regions likely to provide a hint of such a scenario at the LHC as well as at future e+e- colliders. We have also highlighted the consequences of light neutrino mass hierarchies in collider phenomenology that can complement the findings of neutrino oscillation experiments.

  13. Application of an array processor to the analysis of magnetic data for the Doublet III tokamak

    International Nuclear Information System (INIS)

    Wang, T.S.; Saito, M.T.

    1980-08-01

    Discussed herein is a fast computational technique employing the Floating Point Systems AP-190L array processor to analyze magnetic data for the Doublet III tokamak, a fusion research device. Interpretation of the experimental data requires the repeated solution of a free-boundary nonlinear partial differential equation, which describes the magnetohydrodynamic (MHD) equilibrium of the plasma. For this particular application, we have found that the array processor is only 1.4 and 3.5 times slower than the CDC-7600 and CRAY computers, respectively. The overhead on the host DEC-10 computer was kept to a minimum by chaining the complete Poisson solver and free-boundary algorithm into one single-load module using the vector function chainer (VFC). A simple time-sharing scheme for using the MHD code is also discussed

  14. Conformally invariant Inert Higgs doublet model: an unified model for Inflation and Dark matter

    International Nuclear Information System (INIS)

    Das, Moumita; Mohanty, Subhendra

    2012-01-01

    Motivation of our present study is the searching for an unified model which can describe both the inflation as well as dark matter. From particle physics point of view, Higgs can be the most interesting candidate for the scalar field inflation. Conformal coupling of the inflaton with the gravity can generate the density perturbation and we use this idea in a realistic inert Higgs doublet model. We study the loop corrections of this conformally coupled system and in present era there is electroweak symmetry breaking to provide the mass of the particles. Study of the mass spectrum in present era reveals the scalar dark matter with mass 33.7 GeV and lightest Higgs at 125.6 GeV.

  15. Instrumentation and control of the Doublet III Neutral Beam Injector System

    International Nuclear Information System (INIS)

    Kohli, J.C.; Moore, C.D.; Drobnis, D.D.; Elischer, V.P.; Kilgore, R.; Uber, D.

    1980-03-01

    The hardware and software required for the operation of the Doublet III Neutral Beam Injector System (NBIS) are described. Development and implementation of this Instrumentation and Control System was divided between the major participants - General Atomic Company and Lawrence Berkeley Laboratory. The subdivision of responsibilities and the coordination of the participants' activities are described with reference to hardware and software requirements in support of the entire system. Included are a description of the operators' consoles, the interlock system and the CAMAC system. One feature of the control software is source modeling. This feature includes feedback on a shot to shot basis and adaptive control. Adaptive control permits the computer system to automatically adjust parameters after a shot, and to control the system to automatically compensate for time varying NBIS components. The Neutral Beam Power Supply features power supply modeling, fiber optic transmission of analog signals and digital control of power supply power-up/interlocks

  16. Comparison of Theodorsen's Unsteady Aerodynamic Forces with Doublet Lattice Generalized Aerodynamic Forces

    Science.gov (United States)

    Perry, Boyd, III

    2017-01-01

    This paper identifies the unsteady aerodynamic forces and moments for a typical section contained in the NACA Report No. 496, "General Theory of Aerodynamic Instability and the Mechanism of Flutter," by Theodore Theodorsen. These quantities are named Theodorsen's aerodynamic forces (TAFs). The TAFs are compared to the generalized aerodynamic forces (GAFs) for a very high aspect ratio wing (AR = 20) at zero Mach number computed by the doublet lattice method. Agreement between TAFs and GAFs is very-good-to-excellent. The paper also reveals that simple proportionality relationships that are known to exist between the real parts of some GAFs and the imaginary parts of others also hold for the real and imaginary parts of the corresponding TAFs.

  17. Radiative generation of quark masses and mixing angles in the two Higgs doublet model

    International Nuclear Information System (INIS)

    Ibarra, Alejandro; Solaguren-Beascoa, Ana

    2014-01-01

    We present a framework to generate the quark mass hierarchies and mixing angles by extending the Standard Model with one extra Higgs doublet. The charm and strange quark masses are generated by small quantum effects, thus explaining the hierarchy between the second and third generation quark masses. All the mixing angles are also generated by small quantum effects: the Cabibbo angle is generated at zeroth order in perturbation theory, while the remaining off-diagonal entries of the Cabibbo–Kobayashi–Maskawa matrix are generated at first order, hence explaining the observed hierarchy |V ub |,|V cb |≪|V us |. The values of the radiatively generated parameters depend only logarithmically on the heavy Higgs mass, therefore this framework can be reconciled with the stringent limits on flavor violation by postulating a sufficiently large new physics scale

  18. ''Big Dee'' upgrade of the Doublet III diagnostic data acquisition computer system

    International Nuclear Information System (INIS)

    Mcharg, B.B.

    1983-01-01

    The ''Big Dee'' upgrade of the Doublet III tokamak facility will begin operation in 1986 with an initial quantity of data expected to be 10 megabytes per shot and eventually attaining 20-25 megabytes per shot. This is in comparison to the 4-5 megabytes of data currently acquired. To handle this greater quantity of data and to serve physics needs for significantly improved between-shot processing of data will require a substantial upgrade of the existing data acquisition system. The key points of the philosophy that have been adopted for the upgraded system to handle the greater quantity of data are (1) preserve existing hardware, (2) preserve existing software; (3) configure the system in a modular fashion; and (4) distribute the data acquisition over multiple computers. The existing system using ModComp CLASSIC 16 bit minicomputers is capable of handling 5 megabytes of data per shot

  19. Big Dee upgrade of the Doublet III diagnostic data acquisition computer system

    International Nuclear Information System (INIS)

    McHarg, B.B. Jr.

    1983-12-01

    The Big Dee upgrade of the Doublet III tokamak facility will begin operation in 1986 with an initial quantity of data expected to be 10 megabytes per shot and eventually attaining 20 to 25 megabytes per shot. This is in comparison to the 4 to 5 megabytes of data currently acquired. To handle this greater quantity of data and to serve physics needs for significantly improved between-shot processing of data will require a substantial upgrade of the existing data acquisition system. The key points of the philosophy that have been adopted for the upgraded system to handle the greater quantity of data are (1) preserve existing hardware; (2) preserve existing software; (3) configure the system in a modular fashion; and (4) distribute the data acquisition over multiple computers. The existing system using ModComp CLASSIC 16 bit minicomputers is capable of handling 5 megabytes of data per shot

  20. Neutrino masses in RPV models with two pairs of Higgs doublets

    Energy Technology Data Exchange (ETDEWEB)

    Grossman, Yuval [Laboratory for Elementary-Particle Physics, Cornell University,Ithaca, N.Y. (United States); Peset, Clara [Institut de Fisica d’Altes Energies (IFAE), Universitat Autònoma de Barcelona,08193 Bellaterra, Barcelona (Spain)

    2014-04-07

    We study the generation of neutrino masses and mixing in supersymmetric R-parity violating models containing two pairs of Higgs doublets. In these models, new RPV terms H^{sub D{sub 1}}H^{sub D{sub 2}}E^ arise in the superpotential, as well as new soft terms. Such terms give new contributions to neutrino masses. We identify the different parameters and suppression/enhancement factors that control each of these contributions. At tree level, just like in the MSSM, only one neutrino acquires a mass due to neutrino-neutralino mixing. There are no new one loop effects. We study the two loop contributions and find the conditions under which they can be important.

  1. SM with two Higgs doublets: an example of CP-violation without Fermions

    International Nuclear Information System (INIS)

    Cvetic, G.

    1993-01-01

    Some CP-violation effects without fermions in the Standard Model are investigated with two Higgs doublets. First, the mass eigenstates of the physical neutral Higgses are calculated for small but nonzero CP-violation parameter ξ * , and then a ''forward-backward'' asymmetry A fb for the decay H → W + W - Z that would be a signal of CP-violation. The effects are in general small. However, A fb turns out to be a rather clean signal of CP-violation: neither the CP-conserving final state interactions nor the direct production background events contribute to Γ fb . The KM-type CP-violation effects that could in principle also contribute to A fb are negligible. 6 refs

  2. Has the general two-Higgs-doublet model unnatural FCNC suppression? An RGE analysis

    International Nuclear Information System (INIS)

    Cvetic, G.; Hwang, S.S.; Kim, C.S.

    1997-01-01

    There is a widespread belief that the general two-Higgs-doublet model (G2HDM) behaves unnaturally with respect to evolution of the flavor-changing neutral Yukawa coupling parameters (FCNYCP's) - i.e., that the latter, although being suppressed at low energies of probes, in general increase by a large factor as the energy of probes increases. We investigate this, by evolving Yukawa parameters by one-loop renormalization group equations and neglecting contributions of the first quark generation. For patterns of FCNYCP suppression at low energies suggested by existing quark mass hierarchies, FCNYCP's remain remarkably stable (suppressed) up to energies very close to the Landau pole. This indicates that G2HDM preserves FCNYCP suppression, for reasonably chosen patterns of that suppression at low energies. (author)

  3. Agnostic stacking of intergalactic doublet absorption: measuring the Ne VIII population

    Science.gov (United States)

    Frank, Stephan; Pieri, Matthew M.; Mathur, Smita; Danforth, Charles W.; Shull, J. Michael

    2018-05-01

    We present a blind search for doublet intergalactic metal absorption with a method dubbed `agnostic stacking'. Using a forward-modelling framework, we combine this with direct detections in the literature to measure the overall metal population. We apply this novel approach to the search for Ne VIII absorption in a set of 26 high-quality COS spectra. We probe to an unprecedented low limit of log N>12.3 at 0.47≤z ≤1.34 over a path-length Δz = 7.36. This method selects apparent absorption without requiring knowledge of its source. Stacking this mixed population dilutes doublet features in composite spectra in a deterministic manner, allowing us to measure the proportion corresponding to Ne VIII absorption. We stack potential Ne VIII absorption in two regimes: absorption too weak to be significant in direct line studies (12.3 13.7). We do not detect Ne VIII absorption in either regime. Combining our measurements with direct detections, we find that the Ne VIII population is reproduced with a power-law column density distribution function with slope β = -1.86 ^{+0.18 }_{ -0.26} and normalization log f_{13.7} = -13.99 ^{+0.20 }_{ -0.23}, leading to an incidence rate of strong Ne VIII absorbers dn/dz =1.38 ^{+0.97 }_{ -0.82}. We infer a cosmic mass density for Ne VIII gas with 12.3 value significantly lower that than predicted by recent simulations. We translate this density into an estimate of the baryon density Ωb ≈ 1.8 × 10-3, constituting 4 per cent of the total baryonic mass.

  4. Relative brightness of the O+(2 D-2 P) doublets in low-energy aurorae

    International Nuclear Information System (INIS)

    Whiter, D. K.; Lanchester, B. S.; Gustavsson, B.; Jallo, N. I. B.; Jokiaho, O.; Dahlgren, H.; Ivchenko, N.

    2014-01-01

    The ratio of the emission line doublets from O + at 732.0 nm (I 732 ) and 733.0 nm (I 733 ) has been measured in auroral conditions of low-energy electron precipitation from Svalbard (78.°20 north, 15.°83 east). Accurate determination of R = I 732 /I 733 provides a powerful method for separating the density of the O + 2 P 1 /2,3 /2 o levels in modeling of the emissions from the doublets. A total of 383 spectra were included from the winter of 2003-2004. The value obtained is R = I 732 /I 733 = 1.38 ± 0.02, which is higher than theoretical values for thermal equilibrium in fully ionized plasma, but is lower than reported measurements by other authors in similar auroral conditions. The continuity equations for the densities of the two levels are solved for different conditions, in order to estimate the possible variations of R. The results suggest that the production of ions in the two levels from O ( 3 P 1 ) and O ( 3 P 2 ) does not follow the statistical weights, unlike astrophysical calculations for plasmas in nebulae. The physics of auroral impact ionization may account for this difference, and therefore for the raised value of R. In addition, the auroral solution of the densities of the ions, and thus of the value of R, is sensitive to the temperature of the neutral atmosphere. Although the present work is a statistical study, it shows that it is necessary to determine whether there are significant variations in the ratio resulting from non-equilibrium conditions, from auroral energy deposition, large electric fields, and changes in temperature and composition.

  5. Restrictions on two Higgs doublet models and CP violation at the unification scale

    International Nuclear Information System (INIS)

    Athanasiu, G.G.

    1987-01-01

    In Part I we examine bounds from CP violation in the neutral K system on charged Higgs masses and couplings in models with two Higgs doublets. While CP violation is still due only to a non-zero phase in the Kobayashi-Maskawa matrix, there are additional short-distance contributions involving charged Higgs exchange rather than W boson exchange. By having CP violation in the mass matrix, but not in the kaon to two pions decay amplitude, largely due to Higgs exchange, it is possible to obtain a small value of ε'/ε. In Part II we obtain bounds on charged-Higgs-boson masses and couplings in two Higgs doublet models from their effects on neutral-B-meson mixing. The bounds are comparable to those obtained with additional assumptions from the neutral-K-system. Neutral-Higgs-boson effects on the spectrum and wave functions of tt bound states are examined in the same model. In the future they could lead to restrictions on, or discovery of, the corresponding neutral Higgs bosons if they have relatively low masses and enhanced couplings. Finally, in Part III, the three generation phase invariant measure of CP violation is shown to satisfy a simple and solvable renormalization group equation. Its value falls by four to eight orders of magnitude between the weak and grand unification scales in the standard model, as well as in its two Higgs and supersymmetric extensions. Such a small value of CP violation at the grand unification scale can pose a problem for baryogenesis; this avoided if there are heavy quarks with masses close to their fixed points

  6. Renormalization schemes for the Two-Higgs-Doublet Model and applications to h → WW/ZZ → 4 fermions

    DEFF Research Database (Denmark)

    Altenkamp, Lukas; Dittmaier, Stefan; Rzehak, Heidi

    2017-01-01

    We perform the renormalization of different types of Two-Higgs-Doublet Models for the calculation of observables at next-to-leading order. In detail, we suggest four different renormalization schemes based on on-shell renormalization conditions as far as possible and on M S ¯ prescriptions for th...

  7. Separate μ- and e-lepton numbers non-conservation in the Weinberg model with two higgs doublets

    International Nuclear Information System (INIS)

    Branco, G.C.

    1977-03-01

    It is shown that in the Weinberg-Salam model with two Higgs doublets, one is naturally led to the violation of separate μ and e-lepton numbers. The branching ratio for μ → eγ is found to be comparable to the present experimental limit. (orig.) [de

  8. Mass terms of CP-violating Weinberg three-Higgs-doublet model at a charge-breaking vacuum

    International Nuclear Information System (INIS)

    Zarrinkamar, S.; Hassanabadi, H.; Rajabi, A.A.

    2010-01-01

    Weinberg three-Higgs-doublet model attracts interest in many aspects including the study of CP-violation as well as calculating the muon transverse polarization and neutron electric dipole moment. In the present work, we calculate the mass terms of CP-violating Weinberg 3HDM at a charge-breaking vacuum using an elaborate basis. (author)

  9. Two-Higgs-doublet-portal dark-matter models in light of direct search and LHC data

    Energy Technology Data Exchange (ETDEWEB)

    Chang, Chia-Feng [Department of Physics and Center for Theoretical Sciences, National Taiwan University,No. 1, Sec. 4, Roosevelt Rd., Taipei 106, Taiwan (China); He, Xiao-Gang [Department of Physics and Center for Theoretical Sciences, National Taiwan University,No. 1, Sec. 4, Roosevelt Rd., Taipei 106, Taiwan (China); INPAC, Department of Physics and Astronomy, Shanghai Jiao Tong University,800 Dongchuan Rd., Minhang, Shanghai 200240 (China); Physics Division, National Center for Theoretical Sciences,No. 101, Sec. 2, Kuang Fu Rd., Hsinchu 300, Taiwan (China); Tandean, Jusak [Department of Physics and Center for Theoretical Sciences, National Taiwan University,No. 1, Sec. 4, Roosevelt Rd., Taipei 106, Taiwan (China); Physics Division, National Center for Theoretical Sciences,No. 101, Sec. 2, Kuang Fu Rd., Hsinchu 300, Taiwan (China)

    2017-04-19

    We explore simple Higgs-portal models of dark matter (DM) with spin 1/2, 3/2, and 1, respectively, applying to them constraints from the LUX and PandaX-II direct detection experiments and from LHC measurements on the 125-GeV Higgs boson. With only one Higgs doublet, we find that the spin-1/2 DM having a purely scalar effective coupling to the doublet is viable only in a narrow range of mass near the Higgs pole, whereas the vector DM is still allowed if its mass is also close to the Higgs pole or exceeds 1.4 TeV, both in line with earlier analyses. Moreover, the spin-3/2 DM is in a roughly similar situation to the spin-1/2 DM, but has surviving parameter space which is even more restricted. We also consider the two-Higgs-doublet extension of each of the preceding models, assuming that the expanded Yukawa sector is that of the two-Higgs-doublet model of type II. We show that in these two-Higgs-doublet-portal models significant portions of the DM mass regions excluded in the simplest scenarios by direct search bounds can be reclaimed due to suppression of the effective DM interactions with nucleons at some ratios of the CP-even Higgs bosons’ couplings to the up and down quarks. The regained parameter space contains areas which can yield a DM-nucleon scattering cross-section that is far less than its current experimental limit or even goes below the neutrino-background floor.

  10. SINGLE AGENT DOCETAXEL AS SECOND- LINE CHEMOTHERAPY FOR PRETREATED PATIENTS WITH RECURRENT NON- SMALL CELL LUNG CANCER

    Directory of Open Access Journals (Sweden)

    Deyan N. Davidov

    2013-04-01

    Full Text Available Objective: Single agent Docetaxel is a standard therapy for patients with non- small cell lung cancer after the failure of platinum- containing regimens. The aim of this study was to explore the efficacy and safety of Docetaxel monotherapy as second- line chemotherapy in pretreated patient with inoperable non- small cell lung cancer. Methods: From January 2005 to May 2008 thirty- six consecutive patients with locally advanced or metastatic morphologically proven stage IIIB/ IV non- small cell lung cancer entered the study after failure of previous platinum- based regimens. Treatment schedule consist of Docetaxel 75 mg/m2 administered every three weeks with repetition after 21 days with Dexamethasone premedication. Results: Overall response rate, median time to progression and median survival was 16,6 %, 4,5 months and 5,6 months respectively. The main hematological toxicity was neutropenia. Conclusions: That data suggest that single agent Docetaxel remain reasonable choices for the chemotherapy in pretreated patients with non- small cell lung cancer.

  11. Preliminary evaluation of a predictive blood assay to identify patients at high risk of chemotherapy-induced nausea.

    Science.gov (United States)

    Kutner, Thomas; Kunkel, Emily; Wang, Yue; George, Kyle; Zeger, Erik L; Ali, Zonera A; Prendergast, George C; Gilman, Paul B; Wallon, U Margaretha

    2017-02-01

    The aim of this study was to test a new blood-based assay for its ability to predict delayed chemotherapy-induced nausea. Blood drawn from consented patients prior to receiving their first platinum-based therapy was tested for glutathione recycling capacity and normalized to total red cell numbers. This number was used to predict nausea and then compared to patient reported outcomes using the Rotterdam Symptom Check List and medical records. We show that the pathways involved in the glutathione recycling are stable for at least 48 h and that the test was able to correctly classify the risk of nausea for 89.1 % of the patients. The overall incidence of nausea was 21.9 % while women had an incidence of 29.6 %. This might be the first objective test to predict delayed nausea for cancer patients receiving highly emetogenic chemotherapy. We believe that this assay could better guide clinicians in their efforts to provide optimal patient-oriented care.

  12. Physical exercise during adjuvant chemotherapy

    NARCIS (Netherlands)

    van Waart, H.

    2017-01-01

    This thesis evaluates the effect of physical exercise during chemotherapy. In chapter two the study design, rationale and methods of the Physical exercise during Adjuvant Chemotherapy Study (PACES) are described. Chapter three presents the effects of the randomized controlled trial evaluating a

  13. Status epilepticus associated with platinum chemotherapy in a patient with cervical cancer: a case report

    International Nuclear Information System (INIS)

    Holman, Laura L.; Ren, Yulan; Westin, Shannon N.

    2015-01-01

    While peripheral neuropathy is a common side effect of platinum-based chemotherapy, central nervous system (CNS) toxicity, such as encephalopathy or seizures, appears to be rare. This manuscript describes the only reported case of nonconvulsive status epilepticus associated with cisplatin in a cervical cancer patient who does not have other underlying medical conditions. The patient is a 54-year-old Chinese female with recurrent stage IIIB moderately differentiated squamous cell carcinoma of the cervix who was being treated with cisplatin and topotecan. During the sixth cycle of this regimen, the patient presented with mental status changes. While imaging and laboratory values were within normal limits, the patient’s EEG revealed nonconvulsive status epilepticus. After appropriate intervention, she made a complete recovery with no further seizures. The patient currently remains on antiepileptic therapy, but is no longer receiving cisplatin. Patients who present with new onset seizures should primarily be evaluated for underlying medical conditions. Among patients who are suspected to have CNS side effects associated with platinum use, we recommend avoidance of platinum agents in future chemotherapeutic regimens. Although rare, providers should be aware of the potential for CNS toxicity associated with this drug class

  14. Chromonychia Secondary to Chemotherapy

    Directory of Open Access Journals (Sweden)

    Marien Lopes

    2013-06-01

    Full Text Available Chemotherapy drugs can affect the skin and its appendages. Several clinical presentations can be observed, depending on the affected structure. The most common dermatological side effect is chromonychia. The main causative agents are: (1 cyclophosphamide, which can provoke a diffuse, black pigmentation, longitudinal striae and dark grey pigmentation located proximally on the nails; (2 doxorubicin, which promotes dark brown bands alternating with white striae and dark brown pigmentation in transverse bands, and (3 hydroxyurea, which produces a distal, diffuse, dark brown pigmentation. In the majority of cases, the effects are reversible after the suspension of the causative agent for a few months. We report a patient who developed chromonychia while undergoing treatment with cyclophosphamide, vincristine, doxorubicin, dexamethasone, methotrexate and cytarabine for acute lymphocytic leukemia.

  15. Changes in cross-sectional area of pulmonary vessels on chest computed tomography after chemotherapy in patients with advanced non-squamous non-small-cell lung cancer.

    Science.gov (United States)

    Karayama, Masato; Inui, Naoki; Kusagaya, Hideki; Suzuki, Seiichiro; Inoue, Yusuke; Enomoto, Noriyuki; Fujisawa, Tomoyuki; Nakamura, Yutaro; Suda, Takafumi

    2016-05-01

    Chemotherapy is associated with a risk of vascular damage. Novel anti-angiogenic agents, which can directly affect tumor angiogenesis, are increasingly being used. However, the effects of these agents on normal vasculature are not well understood. Here, we evaluated the effects of chemotherapy in general, and the anti-angiogenic agent bevacizumab, more specifically, on the pulmonary vasculature in patients with advanced non-squamous non-small-cell lung cancer (NSCLC). For this, we used the cross-sectional area of pulmonary vessels (CSA), which is an easily measurable indicator of small pulmonary vasculature on non-contrast chest computed tomography (CT). We retrospectively reviewed CT scans of the lungs of 75 chemo-naïve patients with advanced non-squamous NSCLC, for measurement of CSA, before and after first-line platinum-based chemotherapy, using a semi-automatic image-processing program. Measured vessels were classified in two groups: small vessels with CSA area (%CSAsmall-diameter vessels, with a significant decrease in %CSAsmall pulmonary vascular damage. Use of bevacizumab does not enhance the reduction in area of pulmonary vessels.

  16. Generation of doublet spectral lines at self-seeded X-ray FELs

    Energy Technology Data Exchange (ETDEWEB)

    Geloni, Gianluca [European XFEL GmbH, Hamburg (Germany); Kocharyan, Vitali; Saldin, Evgeni [Deutsches Elektronen-Synchrotron (DESY), Hamburg (Germany)

    2010-11-15

    Self-seeding schemes, consisting of two undulators with a monochromator in between, aim to reduce the bandwidth of SASE X-ray FELs. We recently proposed to use a new method of monochromatization exploiting a single crystal in Braggtransmission geometry for self-seeding in the hard X-ray range. The obvious and technically possible extension is to use such kind of monochromator setup with two -or more- crystals arranged in a series to spectrally filter the SASE radiation at two -or more- closely-spaced wavelengths within the FEL gain band. This allows for the production of doublet- or multiplet-spectral lines. Applications exist over a broad range of hard X-ray wavelengths involving any process where there is a large change in cross section over a narrow wavelength range, as in multiple wavelength anomalous diffraction techniques (MAD). In this paper we consider the simultaneous operation of the LCLS hard X-ray FEL at two closely spaced wavelengths. We present simulation results for the LCLS baseline, and we show that this method can produce fully coherent radiation shared between two longitudinal modes. Mode spacing can be easily tuned within the FEL gain band, i.e. within 10 eV. An interesting aspect of the proposed scheme is a way of modulating the electron bunch at optical frequencies without a seed quantum laser. In fact, the XFEL output intensity contains an oscillating ''mode-beat'' component whose frequency is related to the frequency difference between the pair of longitudinal modes considered. Thus, at saturation one obtains FEL-induced modulations of energy loss and energy spread in the electron bunch at optical frequency. These modulations can be converted into density modulation at the same optical frequency with the help of a weak chicane installed behind the baseline undulator. Powerful coherent radiation can then be generated with the help of an optical transition radiation (OTR) station,which have important applications. In this paper we briefly

  17. Three-dimensional magnetotelluric imaging of the 1997 Kagoshima earthquake doublet, Southwest Japan

    Science.gov (United States)

    Asamori, K.; Makuuchi, A.; Umeda, K.

    2013-12-01

    The 1997 Kagoshima earthquake doublet struck on unrecognized active faults lacking clear surface expression where very few large earthquakes have occurred. Two shallow moderate earthquakes occurred in the northwestern part of Kagoshima province, on March 26 (Mw 6.1) and May 13 (Mw 6.0) in 1997, both followed by intensive aftershock sequences. Aftershock distribution of the 1997 earthquake doublet reflects complicated rupture process attributed to the geological (rheological) conditions and coupling of hydraulic pressure as well as tectonic shear stress. For advanced understanding of dynamic interactions between fluids and faulting, it is imperative to obtain three-dimensional (3-D) images of the electrical resistivity structure around the seismogenic faults. In this study, we conduct magnetotelluric (MT) soundings in and around the source region of the 1997 Kagoshima earthquake sequence and perform a 3-D inversion of wideband MT data above a depth of 30 km. MT stations were deployed around the aftershock area of the 1997 Kagoshima earthquake. All of 42 MT sites were set up in the land area. The data were collected using five component (three magnetic and two telluric components) wide-band MT instruments (Phoenix MTU-5 system) in February, 2013. The data were acquired in the frequency range from 0.000343 to 320 Hz. The recording duration ranged from 2 to 8 days. As the cultural noises severely affect the measurements, the time series analysis focused on the nocturnal data when there were fewer noise. A simultaneous remote reference measurement was carried out at the Sawauchi site (1300 km northeast of the study area). Using the remote reference technique (Gamble et al., 1979), we were able to reduce the unfavorable cultural noises. The observed apparent resistivity and phase data were inverted simultaneously using the 3-D inversion code of Sasaki (2004). In this inversion, the 3-D blocks were set up in the crust and upper mantle. These block size in the horizontal

  18. Generation of doublet spectral lines at self-seeded X-ray FELs

    International Nuclear Information System (INIS)

    Geloni, Gianluca; Kocharyan, Vitali; Saldin, Evgeni

    2010-11-01

    Self-seeding schemes, consisting of two undulators with a monochromator in between, aim to reduce the bandwidth of SASE X-ray FELs. We recently proposed to use a new method of monochromatization exploiting a single crystal in Braggtransmission geometry for self-seeding in the hard X-ray range. The obvious and technically possible extension is to use such kind of monochromator setup with two -or more- crystals arranged in a series to spectrally filter the SASE radiation at two -or more- closely-spaced wavelengths within the FEL gain band. This allows for the production of doublet- or multiplet-spectral lines. Applications exist over a broad range of hard X-ray wavelengths involving any process where there is a large change in cross section over a narrow wavelength range, as in multiple wavelength anomalous diffraction techniques (MAD). In this paper we consider the simultaneous operation of the LCLS hard X-ray FEL at two closely spaced wavelengths. We present simulation results for the LCLS baseline, and we show that this method can produce fully coherent radiation shared between two longitudinal modes. Mode spacing can be easily tuned within the FEL gain band, i.e. within 10 eV. An interesting aspect of the proposed scheme is a way of modulating the electron bunch at optical frequencies without a seed quantum laser. In fact, the XFEL output intensity contains an oscillating ''mode-beat'' component whose frequency is related to the frequency difference between the pair of longitudinal modes considered. Thus, at saturation one obtains FEL-induced modulations of energy loss and energy spread in the electron bunch at optical frequency. These modulations can be converted into density modulation at the same optical frequency with the help of a weak chicane installed behind the baseline undulator. Powerful coherent radiation can then be generated with the help of an optical transition radiation (OTR) station,which have important applications. In this paper we briefly

  19. Chemotherapy and targeted therapy in advanced biliary tract carcinoma: a pooled analysis of clinical trials.

    Science.gov (United States)

    Eckel, Florian; Schmid, Roland M

    2014-01-01

    In biliary tract cancer, gemcitabine platinum (GP) doublet palliative chemotherapy is the current standard treatment. The aim of this study was to analyze recent trials, even those small and nonrandomized, and identify superior new regimens. Trials published in English between January 2000 and January 2014 were analyzed, as well as ASCO abstracts from 2010 to 2013. In total, 161 trials comprising 6,337 patients were analyzed. The pooled results of standard therapy GP (no fluoropyrimidine, F, or other drug) were as follows: the median response rate (RR), tumor control rate (TCR), time to tumor progression (TTP) and overall survival (OS) were 25.9 and 63.5%, and 5.3 and 9.5 months, respectively. GFP triplets as well as G-based chemotherapy plus targeted therapy were significantly superior to GP concerning tumor control (TCR, TTP) and OS, with no difference in RR. Triplet combinations of GFP as well as G-based chemotherapy with (predominantly EGFR) targeted therapy are most effective concerning tumor control and survival.

  20. Detecting acute neurotoxicity during platinum chemotherapy by neurophysiological assessment of motor nerve hyperexcitability

    International Nuclear Information System (INIS)

    Hill, Andrew; Bergin, Peter; Hanning, Fritha; Thompson, Paul; Findlay, Michael; Damianovich, Dragan; McKeage, Mark J

    2010-01-01

    Platinum-based drugs, such as cisplatin and oxaliplatin, are well-known for inducing chronic sensory neuropathies but their acute and motor neurotoxicities are less well characterised. Use was made of nerve conduction studies and needle electromyography (EMG) to assess motor nerve excitability in cancer patients during their first treatment cycle with platinum-based chemotherapy in this study. Twenty-nine adult cancer patients had a neurophysiological assessment either before oxaliplatin plus capecitabine, on days 2 to 4 or 14 to 20 after oxaliplatin plus capecitabine, or on days 2 to 4 after carboplatin plus paclitaxel or cisplatin, undertaken by a neurophysiologist who was blinded to patient and treatment details. Patients completed a symptom questionnaire at the end of the treatment cycle. Abnormal spontaneous high frequency motor fibre action potentials were detected in 100% of patients (n = 6) and 72% of muscles (n = 22) on days 2 to 4 post-oxaliplatin, and in 25% of patients (n = 8) and 13% of muscles (n = 32) on days 14 to 20 post-oxaliplatin, but in none of the patients (n = 14) or muscles (n = 56) tested prior to oxaliplatin or on days 2 to 4 after carboplatin plus paclitaxel or cisplatin. Repetitive compound motor action potentials were less sensitive and less specific than spontaneous high frequency motor fibre action potentials for detection of acute oxaliplatin-induced motor nerve hyperexcitability but were present in 71% of patients (n = 7) and 32% of muscles (n = 32) on days 2 to 4 after oxaliplatin treatment. Acute neurotoxicity symptoms, most commonly cold-induced paraesthesiae and jaw or throat tightness, were reported by all patients treated with oxaliplatin (n = 22) and none of those treated with carboplatin plus paclitaxel or cisplatin (n = 6). Abnormal spontaneous high frequency motor fibre activity is a sensitive and specific endpoint of acute oxaliplatin-induced motor nerve hyperexcitability, detectable on EMG on days 2 to 4 post

  1. Detecting acute neurotoxicity during platinum chemotherapy by neurophysiological assessment of motor nerve hyperexcitability

    Directory of Open Access Journals (Sweden)

    Hill Andrew

    2010-08-01

    Full Text Available Abstract Background Platinum-based drugs, such as cisplatin and oxaliplatin, are well-known for inducing chronic sensory neuropathies but their acute and motor neurotoxicities are less well characterised. Use was made of nerve conduction studies and needle electromyography (EMG to assess motor nerve excitability in cancer patients during their first treatment cycle with platinum-based chemotherapy in this study. Methods Twenty-nine adult cancer patients had a neurophysiological assessment either before oxaliplatin plus capecitabine, on days 2 to 4 or 14 to 20 after oxaliplatin plus capecitabine, or on days 2 to 4 after carboplatin plus paclitaxel or cisplatin, undertaken by a neurophysiologist who was blinded to patient and treatment details. Patients completed a symptom questionnaire at the end of the treatment cycle. Results Abnormal spontaneous high frequency motor fibre action potentials were detected in 100% of patients (n = 6 and 72% of muscles (n = 22 on days 2 to 4 post-oxaliplatin, and in 25% of patients (n = 8 and 13% of muscles (n = 32 on days 14 to 20 post-oxaliplatin, but in none of the patients (n = 14 or muscles (n = 56 tested prior to oxaliplatin or on days 2 to 4 after carboplatin plus paclitaxel or cisplatin. Repetitive compound motor action potentials were less sensitive and less specific than spontaneous high frequency motor fibre action potentials for detection of acute oxaliplatin-induced motor nerve hyperexcitability but were present in 71% of patients (n = 7 and 32% of muscles (n = 32 on days 2 to 4 after oxaliplatin treatment. Acute neurotoxicity symptoms, most commonly cold-induced paraesthesiae and jaw or throat tightness, were reported by all patients treated with oxaliplatin (n = 22 and none of those treated with carboplatin plus paclitaxel or cisplatin (n = 6. Conclusions Abnormal spontaneous high frequency motor fibre activity is a sensitive and specific endpoint of acute oxaliplatin-induced motor nerve

  2. Concurrent Chemotherapy and Intensity-Modulated Radiotherapy for Locoregionally Advanced Laryngeal and Hypopharyngeal Cancers

    International Nuclear Information System (INIS)

    Lee, Nancy Y.; O'Meara, William; Chan, Kelvin; Della-Bianca, Cesar; Mechalakos, James G.; Zhung, Joanne; Wolden, Suzanne L.; Narayana, Ashwatha; Kraus, Dennis; Shah, Jatin P.; Pfister, David G.

    2007-01-01

    Purpose: To perform a retrospective review of laryngeal/hypopharyngeal carcinomas treated with concurrent chemotherapy and intensity-modulated radiotherapy (IMRT). Methods and Materials: Between January 2002 and June 2005, 20 laryngeal and 11 hypopharyngeal carcinoma patients underwent IMRT with concurrent platinum-based chemotherapy; most patients had Stage IV disease. The prescription of the planning target volume for gross, high-risk, and low-risk subclinical disease was 70, 59.4, and 54 Gy, respectively. Acute/late toxicities were retrospectively scored using the Common Toxicity Criteria scale. The 2-year local progression-free, regional progression-free, laryngectomy-free, distant metastasis-free, and overall survival rates were calculated using the Kaplan-Meier method. Results: The median follow-up of the living patients was 26 months (range, 17-58 months). The 2-year local progression-free, regional progression-free, laryngectomy-free, distant metastasis-free, and overall survival rate was 86%, 94%, 89%, 92%, and 63%, respectively. Grade 2 mucositis or higher occurred in 48% of patients, and all experienced Grade 2 or higher pharyngitis during treatment. Xerostomia continued to decrease over time from the end of RT, with none complaining of Grade 2 toxicity at this analysis. The 2-year post-treatment percutaneous endoscopic gastrostomy-dependency rate for those with hypopharyngeal and laryngeal tumors was 31% and 15%, respectively. The most severe late complications were laryngeal necrosis, necrotizing fascitis, and a carotid rupture resulting in death 3 weeks after salvage laryngectomy. Conclusion: These preliminary results have shown that IMRT achieved encouraging locoregional control of locoregionally advanced laryngeal and hypopharyngeal carcinomas. Xerostomia improved over time. Pharyngoesophageal stricture with percutaneous endoscopic gastrostomy dependency remains a problem, particularly for patients with hypopharyngeal carcinoma and, to a lesser

  3. Chemotherapy-related leukopenia as a biomarker predicting survival outcomes in locally advanced cervical cancer.

    Science.gov (United States)

    Bogani, Giorgio; Sabatucci, Ilaria; Maltese, Giuseppa; Lecce, Francesca; Signorelli, Mauro; Martinelli, Fabio; Chiappa, Valentina; Indini, Alice; Leone Roberti Maggiore, Umberto; Borghi, Chiara; Fucà, Giovanni; Ditto, Antonino; Raspagliesi, Francesco; Lorusso, Domenica

    2017-01-01

    To investigate the impact of hematologic toxicity and leukopenia in locally advanced cervical cancer patients undergoing neoadjuvant chemotherapy (NACT). Data of consecutive patients undergoing platinum-based NACT followed by surgery were retrospectively searched in order to evaluate the impact of chemotherapy-related toxicity on survival outcomes. Toxicity was graded per the Common Terminology Criteria for Adverse Events (CTCAEv.4.03). Survival outcomes were evaluated using Kaplan-Meir and Cox hazard models. Overall, 126 patients were included. Among those, 94 (74.6%) patients experienced grade2+ hematologic toxicity; while, grade2+ non-hematologic toxicity occurred in 11 (8.7%) patients. After a median follow-up of 37.1 (inter-quartile range, 12-57.5) months, 21 (16.6%) patients experienced recurrence. Via multivariate analysis, no factor was independently associated with disease-free survival; while a trend toward worse prognosis was observed for patients experiencing grade2+ leukopenia at cycle-3 (HR:3.13 (95%CI: 0.94, 10.3); p=0.06). Similarly, grade2+ leukopenia (HR:9.98 (95%CI: 1.14, 86.6); p=0.03), lymph-node positivity (HR:14.6 (95%CI:1.0, 214.4); p=0.05) and vaginal involvement (HR:5.81 (95%CI:1.43, 23.6); p=0.01) impacted on overall survival, at multivariate analysis. Magnitude of leukopenia correlated with survival (p<0.001). Although, our data have to be confirmed by prospective investigations, the present study shows an association between the occurrence of leukopenia and survival outcomes. NACT-related immunosuppression might reduce the response against the tumor, thus promoting cancer progression. Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

  4. Almost-commutative geometries beyond the standard model: III. Vector doublets

    International Nuclear Information System (INIS)

    Squellari, Romain; Stephan, Christoph A

    2007-01-01

    We will present a new extension of the standard model of particle physics in its almost-commutative formulation. This extension has as its basis the algebra of the standard model with four summands (Iochum et al 2004 J. Math. Phys. 45 5003 (Preprint hep-th/0312276), Jureit J-H and Stephan C 2005 J. Math. Phys. 46 043512 (Preprint hep-th/0501134), Schuecker T 2005 Krajewski diagrams and spin lifts Preprint hep-th/0501181, Jureit et al 2005 J. Math. Phys. 46 072303 (Preprint hep-th/0503190), Jureit J-H and Stephan C 2006 On a classification of irreducible almost commutative geometries: IV (Preprint hep-th/0610040)), and enlarges only the particle content by an arbitrary number of generations of left-right symmetric doublets which couple vectorially to the U(1) Y x SU(2) w subgroup of the standard model. As in the model presented in Stephan (2007 Almost-commutative geometries beyond the standard model: II. New Colours Preprint hep-th/0706.0595), which introduced particles with a new colour, grand unification is no longer required by the spectral action. The new model may also possess a candidate for dark matter in the hundred TeV mass range with neutrino-like cross section

  5. Constraining Proton Lifetime in SO(10) with Stabilized Doublet-Triplet Splitting

    Energy Technology Data Exchange (ETDEWEB)

    Babu, K.S.; /Oklahoma State U.; Pati, Jogesh C.; /SLAC; Tavartkiladze, Zurab; /Oklahoma State U. /Tbilisi, Inst. Phys.

    2011-06-28

    We present a class of realistic unified models based on supersymmetric SO(10) wherein issues related to natural doublet-triplet (DT) splitting are fully resolved. Using a minimal set of low dimensional Higgs fields which includes a single adjoint, we show that the Dimopoulos-Wilzcek mechanism for DT splitting can be made stable in the presence of all higher order operators without having pseudo-Goldstone bosons and flat directions. The {mu} term of order TeV is found to be naturally induced. A Z{sub 2}-assisted anomalous U(1){sub A} gauge symmetry plays a crucial role in achieving these results. The threshold corrections to {alpha}{sub 3}(M{sub Z}), somewhat surprisingly, are found to be controlled by only a few effective parameters. This leads to a very predictive scenario for proton decay. As a novel feature, we find an interesting correlation between the d = 6 (p {yields} e{sup +}{pi}{sup 0}) and d = 5 (p {yields} {bar {nu}}K{sup +}) decay amplitudes which allows us to derive a constrained upper limit on the inverse rate of the e{sup +}{pi}{sup 0} mode. Our results show that both modes should be observed with an improvement in the current sensitivity by about a factor of five to ten.

  6. Review of the conceptual design of a Doublet fusion experimental power reactor

    International Nuclear Information System (INIS)

    Baker, C.C.

    1976-01-01

    The results of a two-year, conceptual design study of a fusion experimental power reactor (EPR) are presented. For this study, the primary objectives of the EPR are to obtain plasma ignition conditions and produce net electrical power. The design features a Doublet plasma configuration with a major radius of 4.5 m. The average plasma beta is 10 percent which yields a thermonuclear power level of 410 MW during a 105-sec burn period. With a duty factor of 0.84, the gross electrical output is 124 MW(e) while the net output is 37 MW(e). The design features a 25-cm-thick, helium-cooled, modular, stainless-steel blanket with a 1-cm-thick, silicon carbide first wall. Sufficient shielding is provided to permit contact maintenance outside the shield envelope within 24 hr after shutdown. An overall plant concept has been developed including a superheated steam cycle power conversion system. Preliminary cost estimates and construction schedules have also been developed. 3 refs

  7. Interference contributions to gluon initiated heavy Higgs production in the Two-Higgs-Doublet Model

    International Nuclear Information System (INIS)

    Greiner, Nicolas

    2016-03-01

    We discuss the production of a heavy neutral Higgs boson of a CP-conserving Two-Higgs-Doublet Model in gluon fusion and its decay into a four-fermion final state, gg(→VV)→e + e - π + π - /e + e - ν l anti ν l . We investigate the interference contributions to invariant mass distributions of the four-fermion final state and other relevant kinematical observables. The relative importance of the different contributions is quantified for the process in the on-shell approximation, gg→ZZ. We show that interferences of the heavy Higgs with the light Higgs boson and background contributions are essential for a correct description of the differential cross section. Even though they contribute below O(10%) to those heavy Higgs signal cross sections, to which the experiments at the Large Hadron Collider were sensitive in its first run, we find that they are sizeable in certain regions of the parameter space that are relevant for future heavy Higgs boson searches. In fact, the interference contributions can significantly enhance the experimental sensitivity to the heavy Higgs boson.

  8. CP violation in a multi-Higgs-doublet model with flavor-changing neutral currents

    International Nuclear Information System (INIS)

    Deshpande, N.G.; He, X.

    1994-01-01

    We study CP violation in multi-Higgs-doublet model based on a S 3 xZ 3 horizontal symmetry where the CKM phase is not the principal source of CP violation. We consider two mechanisms for CP violation in this model: (a) CP violation due to complex Yukawa couplings, and (b) CP violation due to scalar-pseudoscalar Higgs boson mixings. Both mechanisms can explain the observed CP violation in the neutral kaon system. ε'/ε due to neutral Higgs boson exchange is small in both mechanisms, but charged Higgs boson contributions can be as large as 10 -4 for (a) and 10 -3 for (b). CP violation in the neutral B system is, however, quite different from the minimal standard model. The neutron electric dipole moment can be as large as the present experimental bound, and can be used to constrain charged Higgs boson masses. The electron EDM is one order of magnitude below the experimental bound in case (b) and smaller in case (a)

  9. High density low-q discharges with D-shaped plasmas in Doublet III

    International Nuclear Information System (INIS)

    Nagami, Masayuki; Yoshida, Hidetoshi; Shinya, Kichiro; Yokomizo, Hideaki; Shimada, Michiya; Ioki, Kimihiro; Izumi, Shigeru; Kitsunezaki, Masao; Jahns, G.

    1981-07-01

    The maximum plasma current in Doublet III is found to be limited by disruptions when the limiter safety factor is approximately 2. However, due to the strong toroidal and shaping field effect on rotational transform at the outer plasma edge associated with a D-shape formation having a vertical elongation of 1.5, the safety factor q sub(a) * estimated from simple geometric considerations for D-shaped plasmas corresponds to values as low as 1.5. These discharges operate stably with considerably higher plasma current than most reactor design studies assume. These low-q discharges show excellent plasma performance: very flat spatial electron temperature progiles, high density operation with anti n sub(e)R/B sub(T) up to 7.8, and good energy confinement producing a volume average β of up to 1% with ohmic heating only. This operational regime appears to be applicable to future high β tokamaks with D-shaped cross section. (author)

  10. Function and operation of the Doublet III E-coil vacuum breaker system

    International Nuclear Information System (INIS)

    Callis, R.W.; Jackson, G.; DeGrassie, J.; Peterson, P.; LeVine, F.

    1979-11-01

    The ohmic heating system for the Doublet III fusion research device at General Atomic is required to provide the voltage for the initial breakdown phase (there is no preionization) along with the energy to drive the plasma current to a value of 2.5 MA or greater. This requires a peak one turn voltage of 250 volts (16 kV across coil terminals) and a magnetic flux swing of 5 volt-seconds (peak coil current of 110 kA). This voltage and flux swing is accomplished by reverse biasing the ohmic heating coil (E-coil) where, upon reaching a value of 110 ka the coil current is interrupted and commutated into a RC network producing 16 kV across the coil. The interrruption of the E-coil current is accomplished by the use of an array of vacuum circuit breakers (VCB's) and a counter plus network. A description is given of the ohmic heating circuit and the performance of the vacuum circuit breaker array and its counter pulse system

  11. Exploring the Inert Doublet Model through the dijet plus missing transverse energy channel at the LHC

    Directory of Open Access Journals (Sweden)

    P. Poulose

    2017-02-01

    Full Text Available In this study of the Inert Doublet Model (IDM, we propose that the dijet + missing transverse energy channel at the Large Hadron Collider (LHC will be an effective way of searching for the scalar particles of the IDM. This channel receives contributions from gauge boson fusion, and t-channel production, along with contributions from H+ associated production. We perform the analysis including study of the Standard Model (SM background with assumed systematic uncertainty, and optimise the selection criteria employing suitable cuts on the kinematic variables to maximise the signal significance. We find that with high luminosity option of the LHC, this channel has the potential to probe the IDM in the mass range of up to about 400 GeV, which is not accessible through other leptonic channels. In a scenario with light dark matter of mass about 65 GeV, charged Higgs in the mass range of around 200 GeV provides the best possibility with a signal significance of about 2σ at an integrated luminosity of about 3000 fb−1.

  12. Radiative corrections to the triple Higgs coupling in the inert Higgs doublet model

    International Nuclear Information System (INIS)

    Arhrib, Abdesslam; Benbrik, Rachid; Falaki, Jaouad El; Jueid, Adil

    2015-01-01

    We investigate the implication of the recent discovery of a Higgs-like particle in the first phase of the LHC Run 1 on the Inert Higgs Doublet Model (IHDM). The determination of the Higgs couplings to SM particles and its intrinsic properties will get improved during the new LHC Run 2 starting this year. The new LHC Run 2 would also shade some light on the triple Higgs coupling. Such measurement is very important in order to establish the details of the electroweak symmetry breaking mechanism. Given the importance of the Higgs couplings both at the LHC and e + e − Linear Collider machines, accurate theoretical predictions are required. We study the radiative corrections to the triple Higgs coupling hhh and to hZZ, hWW couplings in the context of the IHDM. By combining several theoretical and experimental constraints on parameter space, we show that extra particles might modify the triple Higgs coupling near threshold regions. Finally, we discuss the effect of these corrections on the double Higgs production signal at the e + e − LC and show that they can be rather important.

  13. Tectonic Implication of the 5th March 2005, Doublet Earthquake in Ilan, Taiwan

    Directory of Open Access Journals (Sweden)

    En-Chao Yeh

    2016-01-01

    Full Text Available The 5th March 2005 earthquake doublet focal mechanism was determined as strike-slip faulting from Harvard and BATS moment tensor inversion. However, based on first motion polarities, the first shock has a normal focal mechanism (Wu et al. 2008a. This discrepancy has caused a debate over the focal mechanism solution because different focal mechanisms have different tectonic implications. Based on the dislocation determination from Global Position System (GPS measurements, we find this event includes both tensile and strike-slip components. This finding illustrates the reason for the differences in the determined focal mechanisms using two different types of seismic data and analyzing methods. Field mapping and microstructure examination results indicate that the ductile deformation around the study area was characterized by the evolution from transpression to transtension with a predominant strike-slip component, but present-day active structures may be dominated by normal faulting. Thus, the active tensile slip result determined from dislocation modeling strongly suggests that the back arc extension of the Okinawa trough influences the stress state in this region, and changes the major transtension from strike-slip faulting to normal faulting.

  14. Mass matrix ansatz and lepton flavor violation in the two-Higgs doublet model-III

    International Nuclear Information System (INIS)

    Diaz-Cruz, J.L.; Noriega-Papaqui, R.; Rosado, A.

    2004-01-01

    Predictive Higgs-boson-fermion couplings can be obtained when a specific texture for the fermion mass matrices is included in the general two-Higgs doublet model. We derive the form of these couplings in the charged lepton sector using a Hermitian mass matrix ansatz with four-texture zeros. The presence of unconstrained phases in the vertices φ i l i l j modifies the pattern of flavor-violating Higgs boson interactions. Bounds on the model parameters are obtained from present limits on rare lepton flavor-violating processes, which could be extended further by the search for the decay τ→μμμ and μ-e conversion at future experiments. The signal from Higgs boson decays φ i →τμ could be searched for at the CERN Large Hadron Collider, while e-μ transitions could produce a detectable signal at a future eμ collider, through the reaction e + μ - →h 0 →τ + τ -

  15. Status of the Inert Doublet Model and the role of multileptons at the LHC

    Energy Technology Data Exchange (ETDEWEB)

    Gustafsson, Michael [Univ. Libre de Bruxelles (Belgium). Service de Physique Theorique; Rydbeck, Sara [Deutsches Elektronen-Synchrotron (DESY), Hamburg (Germany); Lopez-Honorez, Laura [Max-Planck-Institut fuer Kernphysik, Heidelberg (Germany); Lundstroem, Erik [AlbaNova Univ., Stockholm (Sweden). The Oskar Klein Centre

    2012-06-15

    A possible feature of the Inert Doublet Model (IDM) is to provide a dark matter candidate together with an alteration of both direct and indirect collider constraints that allow for a heavy Higgs boson. We study the IDM in light of recent results from Higgs searches at the Large Hadron Collider (LHC) in combination with dark matter direct-detection limits from the XENON experiment. We ask under what conditions the IDM can still accommodate a heavy Higgs boson. We find that IDM scenarios with a Higgs boson in the mass range 160 to 600 GeV are ruled out only when all experimental constraints are combined. For models explaining only a fraction of the DM the limits are weakened, and IDMs with a heavy Higgs are allowed. We discuss the prospects for future detection of such IDM scenarios in the four-lepton plus missing energy channel at the LHC. This signal can show up in the first year of running at {radical}(s)=14 TeV, and we present detector-level studies for a few benchmark models. (orig.)

  16. Stability analysis for the Big Dee upgrade of the Doublet III tokamak

    International Nuclear Information System (INIS)

    Helton, F.J.; Luxon, J.L.

    1987-01-01

    Ideal magnetohydrodynamic stability analysis has been carried out for configurations expected in the Big Dee tokamak, an upgrade of the Doublet III tokamak into a non-circular cross-section device which began operation early in 1986. The results of this analysis support theoretical predictions as follows: Since the maximum value of beta stable to ballooning and Mercier modes, which we denote β c , increases with inverse aspect ratio, elongation and triangularity, the Big Dee is particularly suited to obtain high values of β c and there exist high β c Big Dee equilibria for large variations in all relevant plasma parameters. The beta limits for the Big Dee are consistent with established theory as summarized in present scaling laws. High beta Big Dee equilibria are continuously accessible when approached through changes in all relevant input parameters and are structurally stable with respect to variations of input plasma parameters. Big Dee beta limits have a smooth dependence on plasma parameters such as β p and elongation. These calculations indicate that in the actual running of the device the Big Dee high beta equilibria should be smoothly accessible. Theory predicts that the limiting plasma parameters, such as beta, total plasma current and plasma pressure, which can be obtained within the operating limits of the Big Dee are reactor relevant. Thus the Big Dee should be able to use its favourable ideal MHD scaling and controlled plasma shaping to attain reactor relevant parameters in a moderate sized device. (author)

  17. Simplified dark matter models with two Higgs doublets. I. Pseudoscalar mediators

    Energy Technology Data Exchange (ETDEWEB)

    Bauer, Martin [Heidelberg Univ. (Germany). Inst. fuer Theoretische Physik; Haisch, Ulrich [Oxford Univ. (United Kingdom). Rudolf Peierls Centre for Theoretical Physics; CERN, Geneva (Switzerland). Theoretical Physics Dept.; Kahlhoefer, Felix [Deutsches Elektronen-Synchrotron (DESY), Hamburg (Germany)

    2017-01-15

    We study a new class of renormalisable simplified models for dark matter searches at the LHC that are based on two Higgs doublet models with an additional pseudoscalar mediator. In contrast to the spin-0 simplified models employed in analyses of Run I data these models are self-consistent, unitary and bounds from Higgs physics typically pose no constraints. Predictions for various missing transverse energy (E{sub T,miss}) searches are discussed and the reach of the 13 TeV LHC is explored. It is found that the proposed models provide a rich spectrum of complementary observables that lead to non-trivial constraints. We emphasise in this context the sensitivity of the t anti t+E{sub T,miss}, mono-Z and mono-Higgs channels, which yield stronger limits than mono-jet searches in large parts of the parameter space. Constraints from spin-0 resonance searches, electroweak precision measurements and flavour observables are also derived and shown to provide further important handles to constraint and to test the considered dark matter models.

  18. Ideal-MHD beta limits: scaling laws and comparison with Doublet III high-beta plasmas

    International Nuclear Information System (INIS)

    Bernard, L.C.; Bhadra, D.K.; Helton, F.J.; Lao, L.L.; Todd, T.N.

    1983-06-01

    Doublet III (DIII) recently has achieved a value for #betta#, the ratio of volume averaged plasma to magnetic pressure, of 4.5%. This #betta# value is in the range required for an economically attractive tokamak reactor, and also close to the relevant limit predicted by ideal-MHD theory. It is therefore of great interest to assess the validity of the theory by comparison with experiment and thus to have a basis for the prediction of future reactor performance. A large variety of plasma shapes have been obtained in DIII. These shapes can be divided into two classes: (1) limiter discharges, and (2) diverted discharges, which are of great interest because of their good confinement in the H-mode operation. We derive simple scaling laws from the variation of optimized ideal-MHD beta limits (#betta#/sub c/) with plasma shape parameters. The current profile is optimized for fixed plasma shapes, separately for the high-n (ballooning) and the low-n (kink) modes. Results are presented in the form of suitability normalized curves of #betta# versus poloidal beta, #betta#/sub p/, for both ballooning and kink modes in order to simultaneously compare all the DIII experimental data

  19. Higgs pair production in the CP-violating two-Higgs-doublet model

    Science.gov (United States)

    Bian, Ligong; Chen, Ning; Jiang, Yun

    2017-12-01

    The SM-like Higgs pair production is discussed in the framework of the general CP-violating two-Higgs-doublet model, where we find that the CP-violating mixing angles can be related to the Higgs self-couplings. Therefore, the future experimental searches for Higgs boson pairs can be constrained by the improved precision of the electric dipole moment measurements. Based on a series of constraints of the SM-like Higgs boson signal fits, the perturbative unitarity and stability bounds to the Higgs potential, and the most recent LHC searches for heavy Higgs bosons, we suggest a set of benchmark models for the future high-energy collider searches for Higgs pair production. The e+e- colliders operating at s = (500GeV,1 TeV) are capable of measuring the Higgs cubic self-couplings of the benchmark models directly. We also estimate the cross sections of the resonance contributions to the Higgs pair productions for the benchmark models at the future LHC and SppC/FCC-hh runs.

  20. Heat flux to the limiter during disruptions and neutral beam injection in Doublet-III

    International Nuclear Information System (INIS)

    Hino, T.; DeGrassie, J.; Taylor, T.S.; Hopkins, G.; Meyer, C.; Petrie, T.W.; Kahn, C.L.; Ejima, S.

    1984-01-01

    The heat flux to the Doublet-III primary limiter has been monitored during plasma disruptions and during neutral beam injection. The surface temperature of the movable TiC-coated graphite limiter was measured with an Inframetrics thermal imaging system and a suitably filtered silicon photodiode spot detector. In addition, the floating electric potential of the limiter with respect to the vacuum vessel was measured. The heat pulse duration to the limiter was measured by the spot detector with a time response of x approx.= 10 μs and these times were correlated with the plasma parameters. In limiter discharges, 20% of the plasma kinetic stored energy goes to the limiter during disruptions. The power balance during disruptions is also discussed. During neutral beam injection, the limiter is not heated uniformly; the ion drift side receives much more thermal flux than the electron drift side. The fraction of beam power going to the limiter is as high as approx.= 35% in normal limiter discharges. (orig.)

  1. Studies on divertor effects by means of the Doublet-III high-temperature plasma device

    International Nuclear Information System (INIS)

    Shimada, Michiya

    1982-12-01

    The diverter action on impurity removal, helium ash compression and radiative cooling was studied in Doublet-3, placing emphasis on the applicability to reacting plasma grade devices such as Intor. The following principal results were obtained with a single-null poloidal diverter without the diverter chamber and the diverter throat (referred to as ''open diverter''), and the diverter coils being installed outside the vacuum chamber. The diverter reduced metallic impurities in the central plasma volume, carbon influx and radiation loss, and changed a typically peaked radiation power profile to a hollow profile. In helium-seeded diverter discharge, helium gas pressure near the diverter rose with the increase of main plasma density, and the pressure was high enough to demonstrate the possibility of helium ash exhaust in a diverted tokamak. The radiation power in the diverter volume significantly increased with the increasing main plasma density to as much as 50 % of the input ohmic power. The remote radiation cooling reduced the thermal load on the diverter plate, and the electron temperature near the diverter plate was cooled down. The source of this remote radiative cooling power was the mixture of line radiation of hydrogen neutral and oxygen. (Kako, I.)

  2. Rotation and rotation-vibration spectroscopy of the 0+-0- inversion doublet in deuterated cyanamide.

    Science.gov (United States)

    Kisiel, Zbigniew; Kraśnicki, Adam; Jabs, Wolfgang; Herbst, Eric; Winnewisser, Brenda P; Winnewisser, Manfred

    2013-10-03

    The pure rotation spectrum of deuterated cyanamide was recorded at frequencies from 118 to 649 GHz, which was complemented by measurement of its high-resolution rotation-vibration spectrum at 8-350 cm(-1). For D2NCN the analysis revealed considerable perturbations between the lowest Ka rotational energy levels in the 0(+) and 0(-) substates of the lowest inversion doublet. The final data set for D2NCN exceeded 3000 measured transitions and was successfully fitted with a Hamiltonian accounting for the 0(+) ↔ 0(-) coupling. A smaller data set, consisting only of pure rotation and rotation-vibration lines observed with microwave techniques was obtained for HDNCN, and additional transitions of this type were also measured for H2NCN. The spectroscopic data for all three isotopic species were fitted with a unified, robust Hamiltonian allowing confident prediction of spectra well into the terahertz frequency region, which is of interest to contemporary radioastronomy. The isotopic dependence of the determined inversion splitting, ΔE = 16.4964789(8), 32.089173(3), and 49.567770(6) cm(-1), for D2NCN, HDNCN, and H2NCN, respectively, is found to be in good agreement with estimates from a simple reduced quartic-quadratic double minimum potential.

  3. High scale impact in alignment and decoupling in two-Higgs-doublet models

    Science.gov (United States)

    Basler, Philipp; Ferreira, Pedro M.; Mühlleitner, Margarete; Santos, Rui

    2018-05-01

    The two-Higgs-doublet model (2HDM) provides an excellent benchmark to study physics beyond the Standard Model (SM). In this work, we discuss how the behavior of the model at high-energy scales causes it to have a scalar with properties very similar to those of the SM—which means the 2HDM can be seen to naturally favor a decoupling or alignment limit. For a type II 2HDM, we show that requiring the model to be theoretically valid up to a scale of 1 TeV, by studying the renormalization group equations (RGE) of the parameters of the model, causes a significant reduction in the allowed magnitude of the quartic couplings. This, combined with B -physics bounds, forces the model to be naturally decoupled. As a consequence, any nondecoupling limits in type II, like the wrong-sign scenario, are excluded. On the contrary, even with the very constraining limits for the Higgs couplings from the LHC, the type I model can deviate substantially from alignment. An RGE analysis similar to that made for type II shows, however, that requiring a single scalar to be heavier than about 500 GeV would be sufficient for the model to be decoupled. Finally, we show that the 2HDM is stable up to the Planck scale independently of which of the C P -even scalars is the discovered 125 GeV Higgs boson.

  4. Two-loop corrections to the ρ parameter in Two-Higgs-Doublet models

    Energy Technology Data Exchange (ETDEWEB)

    Hessenberger, Stephan; Hollik, Wolfgang [Max-Planck-Institut fuer Physik (Werner-Heisenberg-Institut), Muenchen (Germany)

    2017-03-15

    Models with two scalar doublets are among the simplest extensions of the Standard Model which fulfill the relation ρ = 1 at lowest order for the ρ parameter as favored by experimental data for electroweak observables allowing only small deviations from unity. Such small deviations Δρ originate exclusively from quantum effects with special sensitivity to mass splittings between different isospin components of fermions and scalars. In this paper the dominant two-loop electroweak corrections to Δρ are calculated in the CP-conserving THDM, resulting from the top-Yukawa coupling and the self-couplings of the Higgs bosons in the gauge-less limit. The on-shell renormalization scheme is applied. With the assumption that one of the CP-even neutral scalars represents the scalar boson observed by the LHC experiments, with standard properties, the two-loop non-standard contributions in Δρ can be separated from the standard ones. These contributions are of particular interest since they increase with mass splittings between non-standard Higgs bosons and can be additionally enhanced by tanβ and λ{sub 5}, an additional free coefficient of the Higgs potential, and can thus modify the one-loop result substantially. Numerical results are given for the dependence on the various non-standard parameters, and the influence on the calculation of electroweak precision observables is discussed. (orig.)

  5. Leptophilic neutral Higgs bosons in two Higgs doublet model at a linear collider

    Energy Technology Data Exchange (ETDEWEB)

    Hashemi, Majid [Shiraz University, Physics Department, College of Sciences, Shiraz (Iran, Islamic Republic of)

    2017-05-15

    This paper addresses the question of the observability of neutral Higgs bosons through the leptonic decay in a two Higgs doublet model (2HDM). Both scalar and pseudo-scalar Higgs bosons (H, A) are considered. The model is set to type IV to enhance the leptonic decay. In such a scenario, a signal production process like e{sup +}e{sup -} → A{sup 0}H{sup 0} → ττμμ or μμττ would provide a clear signal on top of the background in a di-muon invariant mass distribution far from the Z boson pole mass. The analysis is based on a τ-id algorithm which preselects events if they have two τ jets by requiring a hadronic τ decay. Several benchmark points are defined for the search, requiring a linear collider operating at √(s) = 0.5 and 1 TeV. It is shown that the signal can be observed on top of the background in all benchmark points at an integrated luminosity of 1000 fb{sup -1}. (orig.)

  6. Maximally Symmetric Two Higgs Doublet Model with Natural Standard Model Alignment

    CERN Document Server

    Dev, P S Bhupal

    2014-01-01

    We study the Higgs mass spectrum as predicted by a Maximally Symmetric Two Higgs Doublet Model (MS-2HDM) potential based on the SO(5) group, softly broken by bilinear Higgs mass terms. We show that the lightest Higgs sector resulting from this MS-2HDM becomes naturally aligned with that of the Standard Model (SM), independently of the charged Higgs boson mass and $\\tan \\beta$. In the context of Type-II 2HDM, SO(5) is the simplest of the three possible symmetry realizations of the scalar potential that can naturally lead to the SM alignment. Nevertheless, renormalization group effects due to the hypercharge gauge coupling $g'$ and third-generation Yukawa couplings may break sizeably this SM alignment, along with the custodial symmetry inherited by the SO(5) group. Using the current Higgs signal strength data from the LHC, which disfavour large deviations from the SM alignment limit, we derive lower mass bounds on the heavy Higgs sector as a function of $\\tan\\beta$, which can be stronger than the existing limit...

  7. Doublet tracer tests to determine the contaminant flushing properties of a municipal solid waste landfill.

    Science.gov (United States)

    Woodman, N D; Rees-White, T C; Beaven, R P; Stringfellow, A M; Barker, J A

    2017-08-01

    This paper describes a programme of research investigating horizontal fluid flow and solute transport through saturated municipal solid waste (MSW) landfill. The purpose is to inform engineering strategies for future contaminant flushing. Solute transport between injection/abstraction well pairs (doublets) is investigated using three tracers over five separate tests at well separations between 5m and 20m. Two inorganic tracers (lithium and bromide) were used, plus the fluorescent dye tracer, rhodamine-WT. There was no evidence for persistent preferential horizons or pathways at the inter-well scale. The time for tracer movement to the abstraction wells varied with well spacing as predicted for a homogeneous isotropic continuum. The time for tracer movement to remote observation wells was also as expected. Mobile porosity was estimated as ~0.02 (~4% of total porosity). Good fits to the tracer breakthrough data were achieved using a dual-porosity model, with immobile regions characterised by block diffusion timescales in the range of about one to ten years. This implies that diffusional exchanges are likely to be very significant for engineering of whole-site contaminant flushing and possibly rate-limiting. Copyright © 2017. Published by Elsevier B.V.

  8. Searches for Dark Matter via Mono-W Production in Inert Doublet Model at the LHC

    Science.gov (United States)

    Wan, Neng; Li, Niu; Zhang, Bo; Yang, Huan; Zhao, Min-Fu; Song, Mao; Li, Gang; Guo, Jian-You

    2018-05-01

    The Inert Doublet Model (IDM) is one of the many beyond Standard Model scenarios with an extended scalar sector, which provide a suitable dark matter particle candidate. Dark matter associated visible particle production at high energy colliders provides a unique way to determine the microscopic properties of the dark matter particle. In this paper, we investigate that the mono-W + missing transverse energy production at the Large Hadron Collider (LHC), where W boson decay to a lepton and a neutrino. We perform the analysis for the signal of mono-W production in the IDM and the Standard Model (SM) backgrounds, and the optimized criteria employing suitable cuts are chosen in kinematic variables to maximize signal significance. We also investigate the discovery potential in several benchmark scenarios at the 14 TeV LHC. When the light Z2 odd scalar higgs of mass is about 65 GeV, charged Higgs is in the mass range from 120 GeV to 250 GeV, it provides the best possibility with a signal significance of about 3σ at an integrated luminosity of about 3000 fb‑1. Supported by the National Natural Science Foundation of China under Grant Nos. 11205003, 11305001, 11575002, the Key Research Foundation of Education Ministry of Anhui Province of China under Grant Nos. KJ2017A032, KJ2016A749, KJ2013A260, and Natural Science Foundation of West Anhui University under Grant No. WXZR201614

  9. A very light CP-odd scalar in the Two-Higgs-Doublet Model

    CERN Document Server

    Larios, F; Yuan, C P; CERN. Geneva

    2001-01-01

    We show that a general two-Higgs-doublet model (THDM) with a very light CP-odd scalar (A) can be compatible with the rho parameter, Br(b --> s\\gamma), R_b, A_b, (g-2) of muon, Br(Upsilon --> A gamma), and the direct search via the Yukawa process at LEP. For its mass around 0.2 GeV, the muon (g-2) and Br(Upsilon --> A \\gamma) data require tan(beta) to be about 1. Consequently, A can behave like a fermiophobic CP-odd scalar and predominantly decay into a photon pair ("gamma gamma"), which registers in detectors of high energy collider experiments as a single photon signature when the momentum of A is large. We compute the partial decay width of Z --> A A A and the production rate of f \\bar{f} --> Z A A --> Z +"gamma gamma", f^' {\\bar f} --> W^{\\pm} A A --> W^\\pm + "gamma gamma" and f \\bar f --> H^+ H^- --> W^+ W^- A A --> W^+ W^- + "gamma gamma" at high energy colliders such as LEP, Tevatron, LHC, and future Linear Colliders. Other production mechanisms of a light A, such as gg --> h --> AA --> "gamma gamma", a...

  10. Acute emesis: moderately emetogenic chemotherapy

    DEFF Research Database (Denmark)

    Herrstedt, Jørn; Rapoport, Bernardo; Warr, David

    2011-01-01

    This paper is a review of the recommendations for the prophylaxis of acute emesis induced by moderately emetogenic chemotherapy as concluded at the third Perugia Consensus Conference, which took place in June 2009. The review will focus on new studies appearing since the Second consensus conference...... receiving multiple cycles of moderately emetogenic chemotherapy will be reviewed. Consensus statements are given, including optimal dose and schedule of serotonin(3) receptor antagonists, dexamethasone, and neurokinin(1) receptor antagonists. The most significant recommendations (and changes since the 2004...... version of the guidelines) are as follows: the best prophylaxis in patients receiving moderately emetogenic chemotherapy (not including a combination of an anthracycline plus cyclophosphamide) is the combination of palonosetron and dexamethasone on the day of chemotherapy, followed by dexamethasone...

  11. Uterine/Endometrial Cancer: Chemotherapy

    Science.gov (United States)

    ... with Your Treatment Team Treatment Surgery Surgical Staging Pathology of Ovarian Cancer Chemotherapy Radiation Therapy Hormone Therapy ... 20, 2016 January 17, 2017 February 21, 2017 March 22, 2017 April 18, 2017 May 16, 2017 ...

  12. Toward a theory of the initiation of cancer by alpha, beta, and x radiation: the twin doublet model

    International Nuclear Information System (INIS)

    Marshall, J.H.; Pagnamenta, A.

    1979-01-01

    Information concerning the basic mechanics of interaction of radiation with matter at both the cellular and the molecular levels may now be sufficient to allow an extension of the cellular model of cancer induction to the level of individual particle tracks, ionizations, and particular bonds in the DNA molecule. The Doublet model appears promising as a candidate for the initial damage to DNA involved in cell killing, mutation, and a single cancer initiation

  13. Thermal stress analysis and the effect of temperature dependence of material properties on Doublet III limiter design

    International Nuclear Information System (INIS)

    McKelvey, T.E.; Koniges, A.E.; Marcus, F.; Sabado, M.; Smith, R.

    1979-10-01

    Temperature and thermal stress parametric design curves are presented for two materials selected for Doublet III primary limiter applications. INC X-750 is a candidate for the medium Z limiter design and ATJ graphite for the low Z design. The dependence of significant material properties on temperature is shown and the impact of this behavior on the decision to actively or passively cool the limiter is discussed

  14. Higgs particle production at LEP in multi-doublet scenarios with hierarchy of the vacuum expectation values

    International Nuclear Information System (INIS)

    Kalinowski, J.; Pokorski, S.

    1989-01-01

    We discuss the production at LEP of Higgs particles in multi-doublet scenarios with a hierarchy of the vacuum expectation values ν 2 /ν 1 ≅m t /m b . The cross sections are similar or larger than for the standard Higgs boson of the same mass but the signature is different. Events with four b-jets are the only important signature of such Higgs particles. (orig.)

  15. Electric dipole moments of charged leptons in the split fermion scenario in the two Higgs doublet model

    International Nuclear Information System (INIS)

    Iltan, E.O.

    2005-01-01

    We predict the charged lepton electric dipole moments in the split fermion scenario in the framework of the two Higgs doublet model. We observe that the numerical value of the muon (tau) electric dipole moment is of the order of the magnitude of 10 -22 e cm (10 -20 e cm) and there is an enhancement in the case of two extra dimensions, especially for the tau lepton electric dipole moment. (orig.)

  16. Global fits of the two-loop renormalized Two-Higgs-Doublet model with soft Z 2 breaking

    Science.gov (United States)

    Chowdhury, Debtosh; Eberhardt, Otto

    2015-11-01

    We determine the next-to-leading order renormalization group equations for the Two-Higgs-Doublet model with a softly broken Z 2 symmetry and CP conservation in the scalar potential. We use them to identify the parameter regions which are stable up to the Planck scale and find that in this case the quartic couplings of the Higgs potential cannot be larger than 1 in magnitude and that the absolute values of the S-matrix eigenvalues cannot exceed 2 .5 at the electroweak symmetry breaking scale. Interpreting the 125 GeV resonance as the light CP -even Higgs eigenstate, we combine stability constraints, electroweak precision and flavour observables with the latest ATLAS and CMS data on Higgs signal strengths and heavy Higgs searches in global parameter fits to all four types of Z 2 symmetry. We quantify the maximal deviations from the alignment limit and find that in type II and Y the mass of the heavy CP -even ( CP -odd) scalar cannot be smaller than 340 GeV (360 GeV). Also, we pinpoint the physical parameter regions compatible with a stable scalar potential up to the Planck scale. Motivated by the question how natural a Higgs mass of 125 GeV can be in the context of a Two-Higgs-Doublet model, we also address the hierarchy problem and find that the Two-Higgs-Doublet model does not offer a perturbative solution to it beyond 5 TeV.

  17. Magnitude of Higgs-boson-exchange CP violation in two-doublet models with large tanβ

    International Nuclear Information System (INIS)

    Barr, S.M.

    1993-01-01

    CP violation in neutral Higgs-boson exchange is studied in two-doublet models in an expansion in (1/tan 2 β). The typical magnitude of various CP-violating quantities is found for large tanβ. In particular the electric dipole moment (EDM) of the electron and the coefficient c S of the CP-violating electron-nucleon scalar-pseudoscalar operator are examined and it is found that in a simple class of two-doublet models c S /d e is typically O(tan 2 β). Therefore c S is more important than d e for the EDM's of diamagnetic atoms and molecules (Hg, Xe, TlF) typically if tanβ approx-gt 5, and for paramagnetic atoms (Cs, Tl) if tanβ approx-gt 15. The dependence on tanβ of the various contributions to the neutron EDM including the Weinberg three-gluon operator, and the dependence on tanβ of the top-quark EDM are also discussed. Supersymmetric and three-doublet models are also considered

  18. Influence of comorbidity on survival, toxicity and health-related quality of life in patients with advanced non-small-cell lung cancer receiving platinum-doublet chemotherapy

    DEFF Research Database (Denmark)

    Grønberg, Bjørn H; Sundstrøm, Stein; Kaasa, Stein

    2010-01-01

    /LC13. RESULTS: Data from 402 of the 436 of the patients enrolled onto the phase III trial were analysed. The patients with severe comorbidity had similar survival as other patients (6.9 versus 8.1months; p=.34), similar frequency of neutropenia (48% versus 42%; p=.16), but experienced more...

  19. Long-term results of intensity-modulated radiotherapy concomitant with chemotherapy for hypopharyngeal carcinoma aimed at laryngeal preservation

    Directory of Open Access Journals (Sweden)

    Tseng Szu-Wen

    2010-03-01

    Full Text Available Abstract Background The objective of this retrospective study is to investigate laryngeal preservation and long-term treatment results in hypopharyngeal carcinoma treated with intensity-modulated radiotherapy (IMRT combined with chemotherapy. Methods Twenty-seven patients with hypopharyngeal carcinoma (stage II-IV were enrolled and underwent concurrent chemoradiotherapy. The chemotherapy regimens were monthly cisplatin and 5-fluorouracil for six patients and weekly cisplatin for 19 patients. All patients were treated with IMRT with simultaneous integrated boost technique. Acute and late toxicities were recorded based on CTCAE 3.0 (Common Terminology Criteria for Adverse Events. Results The median follow-up time for survivors was 53.0 months (range 36-82 months. The initial complete response rate was 85.2%, with a laryngeal preservation rate of 63.0%. The 5-year functional laryngeal, local-regional control, disease-free and overall survival rates were 59.7%, 63.3%, 51.0% and 34.8%, respectively. The most common greater than or equal to grade 3 acute and late effects were dysphagia (63.0%, 17 of 27 patients and laryngeal stricture (18.5%, 5 of 27 patients, respectively. Patients belonging to the high risk group showed significantly higher risk of tracheostomy compared to the low risk group (p = 0.014. Conclusions After long-term follow-up, our results confirmed that patients with hypopharyngeal carcinoma treated with IMRT concurrent with platinum-based chemotherapy attain high functional laryngeal and local-regional control survival rates. However, the late effect of laryngeal stricture remains a problem, particularly for high risk group patients.

  20. A shallow crustal earthquake doublet from the Trans-Mexican volcanic belt (Central Mexico)

    Science.gov (United States)

    Quintanar, L.; Rodríguez-González, M.; Campos-Enríquez, O.

    2003-04-01

    The trans-Mexican volcanic belt is an active volcanic arc related to subduction along the Middle America trench and characterized by shallow seismicity and synvolcanic to postvolcanic extensional arc-parallel faulting. The Mezquital graben is a major intra-arc basin of the central trans-Mexican volcanic belt. A doublet of moderate shallow shocks occurred in March and October 1976 in the region of this graben. These earthquakes were recorded by the Mexican National Seismological network, in particular by the Bosch-Omori seismograph (T_0 = 18 s) at the Tacubaya Observatory in Mexico City. We have carefully relocated the two main shocks and their major aftershocks by reading the original records and using a modified crustal velocity model for this region. A difference of ˜50 km is observed between the locations reported by the Mexican Seismological Service and those obtained in this study, which are additionally supported by the damage distribution of these earthquakes. A first motion analysis, based on regional and teleseismic records, defines for the March and October shocks normal fault mechanisms, characterized by E-W striking fault planes, which coincides with the orientation of the master faults of the Mezquital graben. After calculating the instrumental response, the source parameters were obtained from the Bosch-Omori seismograph records by body-wave modeling. For the March earthquake, we estimate a seismic moment of 4.5×1023 dyne-cm (equivalent to M_w=5.0) and a stress drop of 0.7 MPa assuming a circular rupture model (radius = 3 km). Given the poor quality of the Bosch-Omori record for the October earthquake, we used the comparison, between both events, of long-period (T=20 sec) teleseismic records at 2 stations to obtain its corresponding source parameters. By assuming a similar stress drop as for the March event, we obtain a M_0 of 5.6×1023 dyne-cm and M_w = 5.1 with a rupture length of 6.5 km. According to gravity data, the regional E-W faults are

  1. The effect of a single blade limiter on energetic neutral beam particles in Doublet III

    International Nuclear Information System (INIS)

    Petrie, T.W.; Armentrout, C.; Burrell, K.H.; Hino, T.; Kahn, C.; Kim, J.; Lohr, J.; Rottler, L.; Schissel, D.; St John, H.

    1984-01-01

    Energetic beam ion collisions with the main limiter can be a significant power loss process under certain operating conditions in Doublet III. Futhermore, these collisions may cause measurable damage to the limiter itself. Under low current and low toroidal field conditions (e.g., Isub(p) = 290 kA and Bsub(T) = 6.3 kG), 20-38% of the inferred absorbed beam power may be deposited directly on the ion drift side of the limiter by the beam ions. However, for higher plasma current and toroidal fields (e.g., Isub(p) = 480 kA and Bsub(t) = 15 kG), the fraction of inferred absorbed beam power deposited on the limiter is reduced to < 10%. Monte Carlo code simulations show that this loss of beam power is primarily a result of the large poloidal and toroidal gyro-orbits of the energetic beam ions. Other factors which may enhance beam ion losses to the limiter are (1) large separation distances between the primary limiter and the (outboard) vacuum vessel wall, and (2) plasma density buildup near the plasma edge during high gas puff operation. In addition, our data suggests enhanced plasma density and recycling near the limiter. This localized density can cause appreciable premature ionizations of the incoming beam neutrals and thus reduce the effective plasma heating of the beamline which is immediately upcurrent of the limiter. The prematurely-ionized beam particles from this adjacent beamline are responsible for much of the damage to the ion drift side of the limiter. We have found that under certain operating conditions (1) the direct beam heating of the limiter is 50% greater and (2) the stored plasma energy is 10% less when the beamline immediately upcurrent of the limiter heats the plasma. Thus, the relative positions of the limiters to the beamlines are important in designing future tokamaks. (orig.)

  2. Chemotherapy and quality of life in NSCLC PS 2 patients

    DEFF Research Database (Denmark)

    Helbekkmo, Nina; Strøm, Hans H; Sundstrøm, Stein H

    2009-01-01

    , fatigue, dyspnea, sleeping problems and appetite loss in comparison to the PS 0/1 group. CONCLUSIONS: PS 2 NSCLC patients seem to achieve valuable HRQOL benefits from platinum-based combination therapy. Prospective clinical studies with predefined HRQOL outcomes in PS 2 patients are needed to confirm...

  3. In Silico Oncology: Quantification of the In Vivo Antitumor Efficacy of Cisplatin-Based Doublet Therapy in Non-Small Cell Lung Cancer (NSCLC) through a Multiscale Mechanistic Model

    Science.gov (United States)

    Kolokotroni, Eleni; Dionysiou, Dimitra; Veith, Christian; Kim, Yoo-Jin; Franz, Astrid; Grgic, Aleksandar; Bohle, Rainer M.; Stamatakos, Georgios

    2016-01-01

    The 5-year survival of non-small cell lung cancer patients can be as low as 1% in advanced stages. For patients with resectable disease, the successful choice of preoperative chemotherapy is critical to eliminate micrometastasis and improve operability. In silico experimentations can suggest the optimal treatment protocol for each patient based on their own multiscale data. A determinant for reliable predictions is the a priori estimation of the drugs’ cytotoxic efficacy on cancer cells for a given treatment. In the present work a mechanistic model of cancer response to treatment is applied for the estimation of a plausible value range of the cell killing efficacy of various cisplatin-based doublet regimens. Among others, the model incorporates the cancer related mechanism of uncontrolled proliferation, population heterogeneity, hypoxia and treatment resistance. The methodology is based on the provision of tumor volumetric data at two time points, before and after or during treatment. It takes into account the effect of tumor microenvironment and cell repopulation on treatment outcome. A thorough sensitivity analysis based on one-factor-at-a-time and latin hypercube sampling/partial rank correlation coefficient approaches has established the volume growth rate and the growth fraction at diagnosis as key features for more accurate estimates. The methodology is applied on the retrospective data of thirteen patients with non-small cell lung cancer who received cisplatin in combination with gemcitabine, vinorelbine or docetaxel in the neoadjuvant context. The selection of model input values has been guided by a comprehensive literature survey on cancer-specific proliferation kinetics. The latin hypercube sampling has been recruited to compensate for patient-specific uncertainties. Concluding, the present work provides a quantitative framework for the estimation of the in-vivo cell-killing ability of various chemotherapies. Correlation studies of such estimates with

  4. In Silico Oncology: Quantification of the In Vivo Antitumor Efficacy of Cisplatin-Based Doublet Therapy in Non-Small Cell Lung Cancer (NSCLC through a Multiscale Mechanistic Model.

    Directory of Open Access Journals (Sweden)

    Eleni Kolokotroni

    2016-09-01

    Full Text Available The 5-year survival of non-small cell lung cancer patients can be as low as 1% in advanced stages. For patients with resectable disease, the successful choice of preoperative chemotherapy is critical to eliminate micrometastasis and improve operability. In silico experimentations can suggest the optimal treatment protocol for each patient based on their own multiscale data. A determinant for reliable predictions is the a priori estimation of the drugs' cytotoxic efficacy on cancer cells for a given treatment. In the present work a mechanistic model of cancer response to treatment is applied for the estimation of a plausible value range of the cell killing efficacy of various cisplatin-based doublet regimens. Among others, the model incorporates the cancer related mechanism of uncontrolled proliferation, population heterogeneity, hypoxia and treatment resistance. The methodology is based on the provision of tumor volumetric data at two time points, before and after or during treatment. It takes into account the effect of tumor microenvironment and cell repopulation on treatment outcome. A thorough sensitivity analysis based on one-factor-at-a-time and latin hypercube sampling/partial rank correlation coefficient approaches has established the volume growth rate and the growth fraction at diagnosis as key features for more accurate estimates. The methodology is applied on the retrospective data of thirteen patients with non-small cell lung cancer who received cisplatin in combination with gemcitabine, vinorelbine or docetaxel in the neoadjuvant context. The selection of model input values has been guided by a comprehensive literature survey on cancer-specific proliferation kinetics. The latin hypercube sampling has been recruited to compensate for patient-specific uncertainties. Concluding, the present work provides a quantitative framework for the estimation of the in-vivo cell-killing ability of various chemotherapies. Correlation studies of

  5. Study of vibrations and stabilization of linear collider final doublets at the sub-nanometer scale; Etude des vibrations et de la stabilisation a l'echelle sous-nanometrique des doublets finaux d'un collisionneur lineaire

    Energy Technology Data Exchange (ETDEWEB)

    Bolzon, B

    2007-11-15

    CLIC is one of the current projects of high energy linear colliders. Vertical beam sizes of 0.7 nm at the time of the collision and fast ground motion of a few nanometers impose an active stabilization of the final doublets at a fifth of nanometer above 4 Hz. The majority of my work concerned vibrations and active stabilization study of cantilever and slim beams in order to be representative of the final doublets of CLIC. In a first part, measured performances of different types of vibration sensors associated to an appropriate instrumentation showed that accurate measurements of ground motion are possible from 0.1 Hz up to 2000 Hz on a quiet site. Also, electrochemical sensors answering a priori the specifications of CLIC can be incorporated in the active stabilization at a fifth of nanometer. In a second part, an experimental and numerical study of beam vibrations enabled to validate the efficiency of the numerical prediction incorporated then in the simulation of the active stabilization. Also, a study of the impact of ground motion and of acoustic noise on beam vibrations showed that an active stabilization is necessary at least up to 1000 Hz. In a third part, results on the active stabilization of a beam at its two first resonances are shown down to amplitudes of a tenth of nanometer above 4 Hz by using in parallel a commercial system performing passive and active stabilization of the clamping. The last part is related to a study of a support for the final doublets of a linear collider prototype in phase of finalization, the ATF2 prototype. This work showed that relative motion between this support and the ground is below imposed tolerances (6 nm above 0.1 Hz) with appropriate boundary conditions. (author)

  6. Chemotherapy for carcinoma of stomach

    International Nuclear Information System (INIS)

    Salek, T.

    2011-01-01

    Of all patients with gastric cancer 80 % to 90 % are either diagnosed at an advanced stage when the tumour is inoperable, or develop a recurrence within five years after surgery. Chemotherapy clearly improves survival in comparison to best supportive care only. No chemotherapy regimen showed a survival benefit better than 5-fluorouracil alone in a phase III trial for advanced gastric cancer in 1990s, and several new cytotoxic agents became available in late 1990s. Thereafter, a couple of phase III trials supported the substitution of infusional 5-fluorouracil by orally administered agents and the replacement of cisplatin by oxaliplatin in early 2000s. Trastuzumab has succeeded in showing a survival benefit for patients with Her-2 positive gastric cancer which accounts for about 10 - 20 % of the cancer. This means that the door is opened to the new era of chemotherapy with molecular target agents and with individualization for advanced gastric cancer. (author)

  7. Adjuvant chemotherapy and cancer cure

    International Nuclear Information System (INIS)

    Bertino, J.R.

    1983-01-01

    The use of chemotherapy as an adjuvant to surgery and/or radiotherapy is well founded in experimental tumor systems and appears to be effective in patients in some circumstances. It is clear from both clinical and experimental studies that (1) the dose is important, (2) the earlier chemotherapy is started after primary therapy the better, and (3) combination chemotherapy may be more effective than single-agent treatment. The better the estimation of risk of recurrence, the better the assessment of the risk-benefit ratio with adjuvant therapy. Salvage therapy as well as relative risk of recurrence are considerations in the choice of patients to be treated. Finally, some evidence is presented to indicate that alkylating agents may not be necessary in combination regimens for adjuvant therapy if effective antimetabolite combinations are available

  8. Corneal Confocal Microscopy Detects Small Fibre Neuropathy in Patients with Upper Gastrointestinal Cancer and Nerve Regeneration in Chemotherapy Induced Peripheral Neuropathy.

    Directory of Open Access Journals (Sweden)

    Maryam Ferdousi

    Full Text Available There are multiple neurological complications of cancer and its treatment. This study assessed the utility of the novel non-invasive ophthalmic technique of corneal confocal microscopy in identifying neuropathy in patients with upper gastrointestinal cancer before and after platinum based chemotherapy. In this study, 21 subjects with upper gastrointestinal (oesophageal or gastric cancer and 21 healthy control subjects underwent assessment of neuropathy using the neuropathy disability score, quantitative sensory testing for vibration perception threshold, warm and cold sensation thresholds, cold and heat induced pain thresholds, nerve conduction studies and corneal confocal microscopy. Patients with gastro-oesophageal cancer had higher heat induced pain (P = 0.04 and warm sensation (P = 0.03 thresholds with a significantly reduced sural sensory (P<0.01 and peroneal motor (P<0.01 nerve conduction velocity, corneal nerve fibre density (CNFD, nerve branch density (CNBD and nerve fibre length (CNFL (P<0.0001. Furthermore, CNFD correlated significantly with the time from presentation with symptoms to commencing chemotherapy (r = -0.54, P = 0.02, and CNFL (r = -0.8, P<0.0001 and CNBD (r = 0.63, P = 0.003 were related to the severity of lymph node involvement. After the 3rd cycle of chemotherapy, there was no change in any measure of neuropathy, except for a significant increase in CNFL (P = 0.003. Corneal confocal microscopy detects a small fibre neuropathy in this cohort of patients with upper gastrointestinal cancer, which was related to disease severity. Furthermore, the increase in CNFL after the chemotherapy may indicate nerve regeneration.

  9. Scaling of energy confinement with minor radius, current and density in Doublet III Ohmically heated plasmas

    International Nuclear Information System (INIS)

    Ejima, S.; Petrie, T.W.; Riviere, A.C.

    1982-01-01

    The dependence of plasma energy confinement on minor radius, density and plasma current is described for Ohmically heated near-circular plasmas in Doublet III. A wide range of parameters is used for the study of scaling laws; the plasma minor radius defined by the flux surface in contact with limiter is varied by a factor of 2 (a = 44, 32, and 23 cm), the line average plasma density, nsub(e)-bar, is varied by a factor of 20 from 0.5 to 10 x 10 13 cm -3 (nsub(e)-bar R 0 /Bsub(T) = 0.3 to 6 x 10 14 cm -2 .kG -1 ) and the plasma current, I, is varied by a factor of 6 from 120 to 718 kA. The range of the limiter safety factor, qsub(L), is from 2 to 12. - For plasmas with a = 23 and 32 cm, the scaling law at low nsub(e)-bar for the gross electron energy confinement time can be written as (s, cm) tausub(Ee)sup(G) approx.= 3.6 x 10 -19 nsub(e)-bar a 2 qsub(c)sup(3/4), where qsub(c) = 2πa 2 Bsub(T)/μ 0 IR 0 . For the 44-cm plasmas, tausub(Ee)sup(G) is about 1.8 times less than predicted by this scaling, possibly owing to the change in limiter configuration and small plasma-wall separation and/or the aspect ratio change. At high nsub(e)-bar, tausub(Ee)sup(G) saturates and in many cases decreases with nsub(e)-bar but increases with I in a classical-like manner. The dependence of tausub(Ee)sup(G) on a is considerably weakened. The confinement behaviour can be explained by taking an ion thermal conductivity 2 to 7 times that given by Hinton-Hazeltine's neoclassical theory with a lumped-Zsub(eff) impurity model. Within this range the enhancement factor increases with a or a/R 0 . The electron thermal conductivity evaluated at half-temperature radius where most of the thermal insulation occurs sharply increases with average current density within that radius, but does not depend on a within the uncertainties of the measurements. (author)

  10. Main line maser emission in the OH ground state Λdoublet as a result of overlapping far infrared transitions

    International Nuclear Information System (INIS)

    Pelling, M.

    1977-01-01

    Transitions 2πsub(1/2), j = 5/2, F = 3 → 2πsub(3/2), j = 3/2, F = 2 and 2πsub(1/2), j = 5/2, F = 2 → 2πsub(3/2), J = 3/2, F = 1 have overlapping Doppler line wings at a kinetic temperature of 100 K. This alters the transport of radiation in each line from that which would occur in the absence of line overlap. As a result, the upper levels of the ground state Λ-doublet become overpopulated. (author)

  11. Neutrinophilic two Higgs doublet model with dark matter under an alternative U(1)_{B-L} gauge symmetry

    Science.gov (United States)

    Nomura, Takaaki; Okada, Hiroshi

    2018-03-01

    We propose a Dirac type active neutrino with rank two mass matrix and a Majorana fermion dark matter candidate with an alternative local U(1)_{B-L} extension of neutrinophilic two Higgs doublet model. Our dark matter candidate can be stabilized due to charge assignment under the gauge symmetry without imposing extra discrete Z_2 symmetry and the relic density is obtained from an Z' boson exchanging process. Taking into account collider constraints on the Z' boson mass and coupling, we estimate the relic density.

  12. B → nK* and B → φKS Decays in the Two Higgs Doublet Model III

    International Nuclear Information System (INIS)

    Shuai-Wei, Wang; Tai-Ping, Song; Lin-Xia, Lü

    2008-01-01

    Using the QCD factorization approach, we investigate the large branching ratios of B →φ K s decays and tjhe S φKs anomaly of B →K s decay in the two Higgs doublet model III. With the contributions of flavour-changing neutral current mediated by the neutral Higgs bosons H 0 , h 0 and A 0 at the tree level, we provide a coherent resolution to these anomalies within the constrained parameter spaces, which are 120 bs λ ss | <136. This will be really interesting in searching for the signs of new physics. (the physics of elementary particles and fields)

  13. B→ηK* and B→φKs decays in the two Higgs doublet model III

    International Nuclear Information System (INIS)

    Wang Shuaiwei; Song Taiping; Lv Linxia

    2008-01-01

    Using the QCD factorization approach, we investigate the large branching ratios of B→ηK * decays and the S φK s anomaly of B→φK s decay in the two Higgs doublet model III. With the contributions of flavour-changing neutral current mediated by the neutral Higgs bosons H 0 , h 0 and A 0 at the tree level, we provide a coherent resolution to these anomalies within the constrained parameter spaces, which are 120 bs λ ss |<136. This will be really interesting in searching for the signs of new physics. (authors)

  14. Electric dipole moments of charged leptons and lepton flavor violating interactions in the general two Higgs doublet model

    International Nuclear Information System (INIS)

    Iltan, E. O.

    2001-01-01

    We calculate the electric dipole moment of the electron using the experimental result of the muon electric dipole moment and upper limit of the BR(μ->eγ) in the framework of the general two Higgs doublet model. Our prediction is 10 -32 ecm, which lies in the experimental current limits. Further, we obtain constraints for the Yukawa couplings {bar ξ} N,τe D and {bar ξ} N,τμ D . Finally, we present an expression which connects the BR(τ->μγ) and the electric dipole moment of the τ lepton and study the relation between these physical quantities

  15. Managing Chemotherapy Side Effects: Bleeding Problems

    Science.gov (United States)

    ... C ancer I nstitute Managing Chemotherapy Side Effects Bleeding Problems “My nurse said that chemotherapy could make ... with a clean cloth. Keep pressing until the bleeding stops. If you bruise: Put ice on the ...

  16. Fertility preservation after chemotherapy for Hodgkin lymphoma

    NARCIS (Netherlands)

    van der Kaaij, Marleen A. E.; van Echten-Arends, Jannie; Simons, Arnold H. M.; Kluin-Nelemans, Hanneke C.

    2010-01-01

    Treatment for Hodgkin lymphoma can negatively affect fertility. This review summarizes data on fertility after chemotherapy in adult patients. Alkylating chemotherapy, especially if containing procarbazine and/or cyclophosphamide, is most harmful to gonadal functioning. Alkylating regimens cause

  17. Chemotherapy-associated recurrent pneumothoraces in lymphangioleiomyomatosis.

    LENUS (Irish Health Repository)

    Kelly, Emer

    2012-02-01

    Lymphangioleiomyomatosis is a rare cause of pneumothorax in women. We present the case of a 48-year-old woman with lymphangioleiomyomatosis, who had never had a pneumothorax prior to commencing chemotherapy for breast cancer. During chemotherapy she developed 3 pneumothoraces and 2 episodes of pneumomediastinum. We suggest that the pneumothoraces were caused by the chemotherapy. To our knowledge, this is the first reported case of chemotherapy triggering pneumothoraces in a woman with lymphangioleiomyomatosis.

  18. Managing Chemotherapy Side Effects: Constipation

    Science.gov (United States)

    N ational C ancer I nstitute Managing Chemotherapy Side Effects Constipation Take these steps: Eat high-fiber foods such as: ● ● Whole-grain breads and cereals ● ● Fruits and vegetables ● ● Nuts and seeds Turn this ...

  19. Arterial occlusion precipitated by cisplatinbased chemotherapy

    OpenAIRE

    Joseph, D.; Dubashi, B.; Karthikeyan, B.; Jain, A.

    2010-01-01

    Cisplatin-based therapy is curative in testicular cancer. Adverse effects of cisplatin-based chemotherapy include dose-dependent myelosuppression, nephrotoxicity, neurotoxicity, and ototoxicity. By contrast, chemotherapy-associated vascular complications are unpredictable. Few incidents of digital gangrene with cisplatin have been reported. Here, we present a patient who developed arterial occlusion leading to gangrene of the toe after cisplatinbased chemotherapy.

  20. Chemotherapy for bladder cancer: treatment guidelines for neoadjuvant chemotherapy, bladder preservation, adjuvant chemotherapy, and metastatic cancer

    DEFF Research Database (Denmark)

    Sternberg, Cora N; Donat, S Machele; Bellmunt, Joaquim

    2007-01-01

    To determine the optimal use of chemotherapy in the neoadjuvant, adjuvant, and metastatic setting in patients with advanced urothelial cell carcinoma, a consensus conference was convened by the World Health Organization (WHO) and the Société Internationale d'Urologie (SIU) to critically review...

  1. Direct and indirect singlet scalar dark matter detection in the lepton-specific two-Higgs-doublet model

    International Nuclear Information System (INIS)

    Boucenna, M. S.; Profumo, S.

    2011-01-01

    A recent study of gamma-ray data from the Galactic center motivates the investigation of light (∼7-10 GeV) particle dark matter models featuring tau-lepton pairs as dominant annihilation final state. The lepton-specific two-Higgs-doublet model provides a natural framework where light, singlet scalar dark matter can pair-annihilate dominantly into tau leptons. We calculate the nucleon-dark matter cross section for singlet scalar dark matter within the lepton-specific two-Higgs-doublet model framework, and compare with recent results from direct detection experiments. We study how direct dark matter searches can be used to constrain the dark matter interpretation of gamma-ray observations, for different dominant annihilation final states. We show that models exist with the correct thermal relic abundance that could fit the claimed gamma-ray excess from the Galactic center region and have direct detection cross sections of the order of what is needed to interpret recent anomalous events reported by direct detection experiments.

  2. The broad Brillouin doublet and CP of KTaO3, second sound vs. Two-phonon difference scattering

    International Nuclear Information System (INIS)

    Farhi, E.; Tagantsev, A.K.; Hehlen, B.; Courtens, E.; Boatner, L.A.

    1999-01-01

    Complete text of publication follows. Low-T Brillouin spectra of the incipient ferroelectric KTaO 3 exhibit a broad central peak (CP) (1), and some additional broad Brillouin doublet (BD) (2), that can both relate to phonon-density fluctuations (3). Starting from extensive new high resolution neutron scattering measurements in pure crystals, low lying phonon sheets were modelled in the central part of Brillouin zone. Such a parameterisation was then used in order to analyse those up-mentioned unusual features in teens of two-phonon mechanisms (4). Numerical evaluations show that transverse acoustic (TA) phonons whose normal damping is faster than the BD frequency (Γ DB > ω DB ) may produce hydrodynamic second sound (propagation of heat). Moreover, two-phonon difference scattering from low damping thermal TA phonons ((Γ DB DB ) can contribute to the spectra with either a sharp or a broader BD, depending on the phonon group velocity and phonon-sheet anisotropy. The position of the doublet is consistent with both mechanisms, but comparing the computed anisotropies with experimental Brillouin and neutron scattering data, one favours the second process. (author)

  3. Chemotherapy-induced Spontaneous Pneumothorax: Case Series

    Directory of Open Access Journals (Sweden)

    Een Hendarsih

    2016-09-01

    The mechanism of pneumothorax following chemotherapy is not clearly understood yet, however, several hypotheses have been considered: 1 the rupture of a subpleural bulla after chemotherapy; 2 the rupture of an emphysematous bulla in an over expanded portion of the lung which is partially obstructed by a neoplasm; 3 tumor lyses or necrosis due to cytotoxic chemotherapy directly induces the formation of fistula. Dyspnea and chest pain suddenly appear during successful chemotherapy for metastatic chemosensitive tumors should alert the physician to the possibility of SP. The treatment is directed toward lung re-expansion. Chemotherapy induced pneumothorax should be considered as oncologic emergency.

  4. Whole abdomen radiation therapy after a short chemotherapy course and second-look laparotomy in advanced ovarian cancer

    International Nuclear Information System (INIS)

    Franchin, G.; Tumolo, S.; Scarabelli, C.; De Paoli, A.; Boz, G.; Crivellari, D.; Arcicasa, M.; Bortolus, R.; Gobitti, C.; Minatel, E.

    1991-01-01

    From April 1983 through December 1989, 42 consecutive patients with diagnosis of epithelial ovarian carcinoma were initially managed by aggressive surgery and three courses of endoperitoneal cis-platinum-based chemotherapy followed by an alternating combination chemotherapy and second-look laparotomy. Patients with residual tumor less than or equal to 2 cm subsequently received whole abdominal radiation therapy (WAR). Twenty-eight patients (42% with no residual disease, 21% with microscopic disease, and 36% with residual disease less than 2 cm) were eligible for WAR. WAR was delivered using an open-field technique up to 22 Gy in 20 fractions followed by a pelvic boost of 18 Gy in 10 fractions. The kidneys were shielded posteriorly at 1100 cGy; hepatic shields were not added. One patient did not complete WAR for lung metastases after 5 radiotherapy fractions. The complete treatment program lasted 8 months (range, 6.8-11). The median follow-up of the 28 patients entered into the study was 50 months. Eight patients are alive and disease-free at 5 years. The overall and disease-free survival rates at 5 years are 45 and 30%, respectively. All but 2 patients relapsed within the abdominopelvic cavity and 3 developed brain metastases. Toxic effects, during WAR, required treatment interruption in all but 4 patients: 3 developed a small bowel obstruction requiring surgery and 1 died of surgical complications in complete remission. The poor disease-free survival and the severe toxicity encountered have been valid indications that WAR should be discontinued as a treatment modality in advanced ovarian cancer at the authors department

  5. Cancer cell adaptation to chemotherapy

    International Nuclear Information System (INIS)

    Di Nicolantonio, Federica; Johnson, Penny; Somers, Shaw S; Toh, Simon; Higgins, Bernie; Lamont, Alan; Gulliford, Tim; Hurren, Jeremy; Yiangou, Constantinos; Cree, Ian A; Mercer, Stuart J; Knight, Louise A; Gabriel, Francis G; Whitehouse, Pauline A; Sharma, Sanjay; Fernando, Augusta; Glaysher, Sharon; Di Palma, Silvana

    2005-01-01

    Tumor resistance to chemotherapy may be present at the beginning of treatment, develop during treatment, or become apparent on re-treatment of the patient. The mechanisms involved are usually inferred from experiments with cell lines, as studies in tumor-derived cells are difficult. Studies of human tumors show that cells adapt to chemotherapy, but it has been largely assumed that clonal selection leads to the resistance of recurrent tumors. Cells derived from 47 tumors of breast, ovarian, esophageal, and colorectal origin and 16 paired esophageal biopsies were exposed to anticancer agents (cisplatin; 5-fluorouracil; epirubicin; doxorubicin; paclitaxel; irinotecan and topotecan) in short-term cell culture (6 days). Real-time quantitative PCR was used to measure up- or down-regulation of 16 different resistance/target genes, and when tissue was available, immunohistochemistry was used to assess the protein levels. In 8/16 paired esophageal biopsies, there was an increase in the expression of multi-drug resistance gene 1 (MDR1) following epirubicin + cisplatin + 5-fluorouracil (ECF) chemotherapy and this was accompanied by increased expression of the MDR-1 encoded protein, P-gp. Following exposure to doxorubicin in vitro, 13/14 breast carcinomas and 9/12 ovarian carcinomas showed >2-fold down-regulation of topoisomerase IIα (TOPOIIα). Exposure to topotecan in vitro, resulted in >4-fold down-regulation of TOPOIIα in 6/7 colorectal tumors and 8/10 ovarian tumors. This study suggests that up-regulation of resistance genes or down-regulation in target genes may occur rapidly in human solid tumors, within days of the start of treatment, and that similar changes are present in pre- and post-chemotherapy biopsy material. The molecular processes used by each tumor appear to be linked to the drug used, but there is also heterogeneity between individual tumors, even those with the same histological type, in the pattern and magnitude of response to the same drugs. Adaptation

  6. Effects of induction docetaxel, platinum, and fluorouracil chemotherapy in patients with stage III or IVA/B nasopharyngeal cancer treated with concurrent chemoradiation therapy: Final results of 2 parallel phase 2 clinical trials.

    Science.gov (United States)

    Kong, Lin; Zhang, Youwang; Hu, Chaosu; Guo, Ye; Lu, Jiade J

    2017-06-15

    The effects of docetaxel, platinum, and fluorouracil (TPF) induction chemotherapy plus concurrent chemoradiotherapy (CCRT) on locoregionally advanced nasopharyngeal cancer (NPC) are unclear. This study examined the long-term outcomes of the addition of this regimen to CCRT for stage III and IVA/B NPC. Two parallel, single-arm phase 2 trials were performed synchronously to evaluate the efficacy and toxicity of TPF-based induction chemotherapy in patients with stage III or IVA/B NPC. The induction chemotherapy, which preceded standard intensity-modulated radiation therapy/platinum-based chemoradiation, consisted of 3 cycles of docetaxel (75 mg/m 2 on day 1), cisplatin (75 mg/m 2 on day 1), and a continuous infusion of fluorouracil (500 mg/m 2 /d on days 1-5) every 4 weeks. The primary endpoint for both trials was 5-year overall survival (OS). Between January 2007 and July 2010, 52 eligible patients with stage III NPC and 64 eligible patients with nonmetastatic stage IV NPC were accrued to the 2 trials. With a median follow-up of 67 months, the 5-year OS, progression-free survival, distant metastasis-free survival, and local progression-free survival (LPFS) rates were all improved in comparison with historical benchmarks for patients with stage III or IVA/IVB NPC. Multivariate analyses indicated that T and N classifications (T1/T2 vs T3/T4 and N3 vs N0-N2) were the only significant prognosticators for OS. The number of induction chemotherapy cycles was the only significant prognostic factor for predicting LPFS. TPF-based induction chemotherapy appears to significantly improve outcomes in comparison with historical data when it is administered before CCRT for locoregionally advanced NPC. A phase 3 trial is currently being performed to confirm this benefit. Cancer 2017;123:2258-2267. © 2017 American Cancer Society. © 2017 American Cancer Society.

  7. The Use of Source-Sink and Doublet Distributions Extended to the Solution of Boundary-Value Problems in Supersonic Flow

    Science.gov (United States)

    Heaslet, Max A; Lomax, Harvard

    1948-01-01

    A direct analogy is established between the use of source-sink and doublet distributions in the solution of specific boundary-value problems in subsonic wing theory and the corresponding problems in supersonic theory. The correct concept of the "finite part" of an integral is introduced and used in the calculation of the improper integrals associated with supersonic doublet distributions. The general equations developed are shown to include several previously published results and particular examples are given for the loading on rolling and pitching triangular wings with supersonic leading edges.

  8. Experimental studies on cancer chemotherapy

    International Nuclear Information System (INIS)

    1976-08-01

    The further development of the chemotherapy of cancer in the experimental and clinical fields necessitates a profound knowledge of its chemical, biochemical and pharmacological fundamentals and the mechanism of physiological and pathological growth processes. The 'Arbeitsgemeinschaft Zytostatika' includes chemists, biochemists, pharmacologists, molecular biologists, physicians and immunologists of various scientific institutes and clinics in the Federal Republic of Germany and in West Berlin. It is their aim to carry out basic research as well as clinical-orientated research in the field of the chemotherapy of cancer. In the 15 years of cooperation, fundamental knowledge was gained, especially in the field of the cytotoxic specificity and cancerotoxic selectivity of alkylating cytostatics. New cytostatics with a greater oncostatic selectivity and an altered spectrum of activity were tested and greater knowledge was won on the molecular-biological prerequisites of a rational drug design. (orig.) [de

  9. [Chemotherapy and women fertility preservation].

    Science.gov (United States)

    Gauthier, Tristan; Piver, Pascal; Durand, Lise-Marie; Donadel, Lorène; Pech, Jean-Christophe; Roux, Christophe; Aubard, Yves

    2010-01-01

    Agressive chemotherapy can lead to premature ovarian failure and loss of fertility in women and children. Embryo cryopreservation is an established clinical procedure of fertility preservation but with several limitations. Others options are available. Cryopreservation ovarian cortex tissu have to be suggested in case of high gonadotoxic treatment. It doesn't require puberty and delay in initiation of chemotherapy. The first birth in France after orthotopic graft of ovarian tissu thawed have been recently described with a promising process. Oocyte cryopreservation is available for women without partner but the experience is limited. Gonadotrophin-releasing hormone (GnRH) agonist therapy as ovarian protectants seem interesting. Follicular growth and maturation in vitro are still experimental. Copyright 2010 Elsevier Masson SAS. All rights reserved.

  10. Chemotherapy for advanced gastric cancer.

    Science.gov (United States)

    Wagner, Anna Dorothea; Syn, Nicholas Lx; Moehler, Markus; Grothe, Wilfried; Yong, Wei Peng; Tai, Bee-Choo; Ho, Jingshan; Unverzagt, Susanne

    2017-08-29

    Gastric cancer is the fifth most common cancer worldwide. In "Western" countries, most people are either diagnosed at an advanced stage, or develop a relapse after surgery with curative intent. In people with advanced disease, significant benefits from targeted therapies are currently limited to HER-2 positive disease treated with trastuzumab, in combination with chemotherapy, in first-line. In second-line, ramucirumab, alone or in combination with paclitaxel, demonstrated significant survival benefits. Thus, systemic chemotherapy remains the mainstay of treatment for advanced gastric cancer. Uncertainty remains regarding the choice of the regimen. To assess the efficacy of chemotherapy versus best supportive care (BSC), combination versus single-agent chemotherapy and different chemotherapy combinations in advanced gastric cancer. We searched the Cochrane Central Register of Controlled Trials, MEDLINE and Embase up to June 2016, reference lists of studies, and contacted pharmaceutical companies and experts to identify randomised controlled trials (RCTs). We considered only RCTs on systemic, intravenous or oral chemotherapy versus BSC, combination versus single-agent chemotherapy and different chemotherapy regimens in advanced gastric cancer. Two review authors independently identified studies and extracted data. A third investigator was consulted in case of disagreements. We contacted study authors to obtain missing information. We included 64 RCTs, of which 60 RCTs (11,698 participants) provided data for the meta-analysis of overall survival. We found chemotherapy extends overall survival (OS) by approximately 6.7 months more than BSC (hazard ratio (HR) 0.3, 95% confidence intervals (CI) 0.24 to 0.55, 184 participants, three studies, moderate-quality evidence). Combination chemotherapy extends OS slightly (by an additional month) versus single-agent chemotherapy (HR 0.84, 95% CI 0.79 to 0.89, 4447 participants, 23 studies, moderate-quality evidence), which is

  11. Metastatic hidradenocarcinoma: Surgery and chemotherapy.

    Science.gov (United States)

    Amel, Trabelsi; Olfa, Gharbi; Faten, Hammedi; Makrem, Hochlef; Slim, Ben Ahmed; Moncef, Mokni

    2009-12-01

    Hidradenocarcinoma is a rare carcinoma of high malignant potential. It most metastasizes to regional lymph nodes and distant viscera. We report a case of 52-year-old woman who presented with an invasive hidradenocarcinoma of the finger, treated with surgical excision. The patient presented with skin and lymph node metastases four years after, treated by chemotherapy. Hidradenocarcinoma is an aggressive tumor. It seems important to use adjuvant therapies particularly for recurrent and metastatic forms.

  12. Metastatic hidradenocarcinoma: Surgery and chemotherapy

    OpenAIRE

    Trabelsi Amel; Gharbi Olfa; Hammedi Faten; Hochlef Makrem; Ben Ahmed Slim; Mokni Moncef

    2009-01-01

    Context: Hidradenocarcinoma is a rare carcinoma of high malignant potential. It most metastasizes to regional lymph nodes and distant viscera. Case report: We report a case of 52-year-old woman who presented with an invasive hidradenocarcinoma of the finger, treated with surgical excision. The patient presented with skin and lymph node metastases four years after, treated by chemotherapy. Conclusion: Hidradenocarcinoma is an aggressive tumor. It seems important to use adjuvant therapies parti...

  13. [Exploration of the Care Needs of Post-Chemotherapy Lung Cancer Patients and Related Factors].

    Science.gov (United States)

    Chiu, Hui-Ying; Lin, Yu-Hua; Wang, Chin-Chou; Chen, Wan-Yi; Chang, Huang-Chih; Lin, Meng-Chih

    2016-06-01

    Chemotherapy (CT) is the first priority treatment for advanced stage lung cancer. However, symptom distress, impaired ability to conduct daily activities, and post-CT care needs are potential side effects of CT. To explore the factors related to the care needs of post-chemotherapy lung cancer patients. A cross-sectional study was used. One hundred and twenty-one adult patients who had been diagnosed with advanced-stage lung cancer and who had undergone CT using the Platinum and Docetaxel doublet regimen were recruited from a medical center in southern Taiwan. The instruments used included a nursing care needs survey, symptoms distress scale, daily activity interference scale, and patient characteristics datasheet. Participants self-prioritized their emergency management, health consultation, and emotional support activities based on their perceived care needs. The top three post-CT symptoms in terms of severity were: fatigue, appetite change, and sleep disorder. Primary disruptions in daily activities during the post-CT period related to: holding social activities, work, and stair climbing. Significant and positive correlations were found among daily activity interference (r = .30, p needs. The regression model indicated daily activity interference as a predictor of care needs, accounting for 10.7% of the total variance. These results highlight the relationships among care needs, symptom distress, and daily activity interference in post-chemotherapy lung-cancer patients. The present study provides a reference for nursing care to reduce the symptom distress, to enhance the performance of daily activities, and to meet the care needs of lung-cancer patients.

  14. THE PHYSICAL ORIGIN AND THE DIAGNOSTIC POTENTIAL OF THE SCATTERING POLARIZATION IN THE Li I RESONANCE DOUBLET AT 6708 A

    International Nuclear Information System (INIS)

    Belluzzi, Luca; Landi Degl'Innocenti, Egidio; Trujillo Bueno, Javier

    2009-01-01

    High-sensitivity measurements of the linearly polarized solar limb spectrum produced by scattering processes in quiet regions of the solar atmosphere showed that the Q/I profile of the lithium doublet at 6708 A has an amplitude ∼10 -4 and a curious three-peak structure, qualitatively similar to that found and confirmed by many observers in the Na I D 2 line. Given that a precise measurement of the scattering polarization profile of the lithium doublet lies at the limit of the present observational possibilities, it is worthwhile to clarify the physical origin of the observed polarization, its diagnostic potential, and what kind of Q/I shapes can be expected from theory. To this end, we have applied the quantum theory of atomic level polarization taking into account the hyperfine structure of the two stable isotopes of lithium, as well as the Hanle effect of a microturbulent magnetic field of arbitrary strength. We find that quantum interferences between the sublevels pertaining to the upper levels of the D 2 and D 1 line transitions of lithium do not cause any observable effect on the emergent Q/I profile. Our theoretical calculations show that only two Q/I peaks can be expected, with the strongest one caused by the D 2 line of 7 Li I and the weakest one due to the D 2 line of 6 Li I. Interestingly, we find that these two peaks in the theoretical Q/I profile stand out clearly only when the kinetic temperature of the thin atmospheric region that produces the emergent spectral line radiation is lower than 4000 K. The fact that such a thin atmospheric region is located around a height of 200 km in standard semi-empirical models, where the kinetic temperature is about 5000 K, leads us to suggest that the most likely Q/I profile produced by the Sun in the lithium doublet should be slightly asymmetric and dominated by the 7 Li I peak.

  15. Phylogenetic analysis of the core histone doublet and DNA topo II genes of Marseilleviridae: evidence of proto-eukaryotic provenance.

    Science.gov (United States)

    Erives, Albert J

    2017-11-28

    While the genomes of eukaryotes and Archaea both encode the histone-fold domain, only eukaryotes encode the core histone paralogs H2A, H2B, H3, and H4. With DNA, these core histones assemble into the nucleosomal octamer underlying eukaryotic chromatin. Importantly, core histones for H2A and H3 are maintained as neofunctionalized paralogs adapted for general bulk chromatin (canonical H2 and H3) or specialized chromatin (H2A.Z enriched at gene promoters and cenH3s enriched at centromeres). In this context, the identification of core histone-like "doublets" in the cytoplasmic replication factories of the Marseilleviridae (MV) is a novel finding with possible relevance to understanding the origin of eukaryotic chromatin. Here, we analyze and compare the core histone doublet genes from all known MV genomes as well as other MV genes relevant to the origin of the eukaryotic replisome. Using different phylogenetic approaches, we show that MV histone domains encode obligate H2B-H2A and H4-H3 dimers of possible proto-eukaryotic origin. MV core histone moieties form sister clades to each of the four eukaryotic clades of canonical and variant core histones. This suggests that MV core histone moieties diverged prior to eukaryotic neofunctionalizations associated with paired linear chromosomes and variant histone octamer assembly. We also show that MV genomes encode a proto-eukaryotic DNA topoisomerase II enzyme that forms a sister clade to eukaryotes. This is a relevant finding given that DNA topo II influences histone deposition and chromatin compaction and is the second most abundant nuclear protein after histones. The combined domain architecture and phylogenomic analyses presented here suggest that a primitive origin for MV histone genes is a more parsimonious explanation than horizontal gene transfers + gene fusions + sufficient divergence to eliminate relatedness to eukaryotic neofunctionalizations within the H2A and H3 clades without loss of relatedness to each of

  16. A search for Higgs bosons h and A of a two doublet model is performed using ALEPH; Recherche des bosons de Higgs neutres d`un modele a deux doublets avec le detecteur ALEPH au LEP

    Energy Technology Data Exchange (ETDEWEB)

    Simion, S.

    1995-04-01

    A search of Higgs bosons h and A of a two-doublet model is performed. We analyse the data collected by ALEPH till 1993, corresponding to a luminosity of 63.4 pb{sup 1} at the Z peak. The {tau}{sup +}{tau}{sup -}q anti q and b anti b b anti b final states are mainly considered. The section criteria are available, thus improving the sensitivity of the analysis. Assuming m{sub h} = m{sub A} = 45 GeV, an upper limit of O.324 pb on the {pi}{sup +}{pi}{sup -}q anti q cross section is derived. The four-b final state selection is based on b-hadron lifetime, using the two-dimensional readout from the vertex detector. We analyse 1.53 million hadronic Z`s without any evidence for a signal (313 events seen, 270+-17 expected from the background, with 24% efficiency for m{sub h} = m{sub A} = 45 GeV.). Searches for the standard Model Higgs boson are interpreted in the framework of a two-doublet model. The decay of the lightest scalar h into a AA pair is also considered. No signal is found and the regions excluded in the (m{sub h} -m{sub A}) and (m{sub A} - tan {beta}) planes of the MSSM are presented. Influence of stop mixing is discussed. Assuming m{sub top} 170 GeV, universal quark masses m{sub Q} = 1 TeV, no stop mixing, and tan {beta} > 1, a 95% lower limit on m{sub A} equal to 45.5 GeV is derived. (authors). 60 refs., 93 figs., 15 tabs.

  17. Efficacy and Safety of rh-Endostatin Combined with Chemotherapy 
versus Chemotherapy Alone for Advanced NSCLC: A Meta-analysis Review

    Directory of Open Access Journals (Sweden)

    Jinzhong ZHANG

    2011-05-01

    thrombocytopenia (OR=0.78, 95%CI: 0.19-3.16 and radiation esophagitis (OR=1.00, 95%CI: 0.40-2.49 were similar in the NPE plus RT arm compared with those in the NP plus RT arm. Conclusion In the treatment of advanced NSCLC, rh-endostatin in combination with platinum-based chemotherapy improve the response rate without obviously raised side effects, however, when radiotherapy are added to NPE arm or NP arm, the response rates have a similar outcome. Owing to the small sample size and poor quality of included trials, more well-designed double-blinded randomized controlled trials should be performed.

  18. Activity of chemotherapy in mucinous ovarian cancer with a recurrence free interval of more than 6 months: results from the SOCRATES retrospective study

    International Nuclear Information System (INIS)

    Pignata, Sandro; Ghezzi, Fabio; Manzione, Luigi; Lauria, Rossella; Breda, Enrico; Alletti, Desiderio Gueli; Ballardini, Michela; Lombardi, Alessandra Vernaglia; Sorio, Roberto; Mangili, Giorgia; Priolo, Domenico; Ferrandina, Gabriella; Magni, Giovanna; Morabito, Alessandro; Scarfone, Giovanna; Scollo, Paolo; Odicino, Franco; Cormio, Gennaro; Katsaros, Dionyssios; Villa, Antonella; Mereu, Liliana

    2008-01-01

    Mucinous ovarian carcinoma have a poorer prognosis compared with other histological subtypes. The aim of this study was to evaluate, retrospectively, the activity of chemotherapy in patients with platinum sensitive recurrent mucinous ovarian cancer. The SOCRATES study retrospectively assessed the pattern of care of a cohort of patients with recurrent platinum-sensitive ovarian cancer observed in the years 2000–2002 in 37 Italian centres. Data were collected between April and September 2005. Patients with recurrent ovarian cancer with > 6 months of platinum free interval were considered eligible. Twenty patients with mucinous histotype and 388 patients with other histotypes were analyzed. At baseline, mucinous tumours differed from the others for an higher number of patients with lower tumor grading (p = 0.0056) and less advanced FIGO stage (p = 0.025). At time of recurrence, a statistically significant difference was found in performance status (worse in mucinous, p = 0.024). About 20% of patients underwent secondary cytoreduction in both groups, but a lower number of patients were optimally debulked in the mucinous group (p = 0.03). Patients with mucinous cancer received more frequently single agent platinum than platinum based-combination therapy or other non-platinum schedules as second line therapy (p = 0.026), with a response rate lower than in non-mucinous group (36.4% vs 62.6%, respectively, p = 0.04). Median time to progression and overall survival were worse for mucinous ovarian cancer. Finally, mucinous cancer received a lower number of chemotherapy lines (p = 0.0023). This analysis shows that platinum sensitive mucinous ovarian cancer has a poor response to chemotherapy. Studies dedicated to this histological subgroup are needed

  19. Activity of chemotherapy in mucinous ovarian cancer with a recurrence free interval of more than 6 months: results from the SOCRATES retrospective study

    Energy Technology Data Exchange (ETDEWEB)

    Pignata, Sandro [Istituto Nazionale Tumori, Napoli (Italy); Ghezzi, Fabio [Università dell' Insubria Clinica Ginecologia e Ostetrica, Varese (Italy); Manzione, Luigi [Azienda Ospedaliera S. Carlo, Oncologia Medica, Potenza (Italy); Lauria, Rossella [Università Federico II, Oncologia Medica, Napoli (Italy); Breda, Enrico [Ospedale S. Giovanni-Fatebene Fratelli-Isola Tiberina, Oncologia Medica, Roma (Italy); Alletti, Desiderio Gueli [A.O. Vincenzo Cervello, Ostetricia e Ginecologia, Palermo (Italy); Ballardini, Michela [Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori - IRST, Meldola (FC) (Italy); Lombardi, Alessandra Vernaglia [Casa di cura Malzoni, Ginecologia Oncologica, Avellino (Italy); Sorio, Roberto [CRO AVIANO, Oncologia Medica, Aviano (Italy); Mangili, Giorgia [Ospedale S. Raffaele, Ginecologia Oncologica Medica, Milano (Italy); Priolo, Domenico [Ospedale S. Vincenzo, Oncologia Medica, Taormina (Italy); Ferrandina, Gabriella [Policlinico Agostino Gemelli, Ginecologia Oncologica, Roma (Italy); Magni, Giovanna [QBGROUP spa, Padova (Italy); Morabito, Alessandro [Istituto Nazionale Tumori, Napoli (Italy); Scarfone, Giovanna [Ospedale Maggiore Policlinico, Mangiagalli e Regina Elena, Clinica Ostetrico-Ginecologica, Milano (Italy); Scollo, Paolo [A.O. S. Cannizzaro, Ginecologia ed Ostetricia, Catania (Italy); Odicino, Franco [A.O. Spedali Civili-Università degli Studi di Brescia, II Ginecologia ed Ostetricia, Brescia (Italy); Cormio, Gennaro [Azienda Ospedaliera Policlinico, II Ginecologia e Ostetricia, Bari (Italy); Katsaros, Dionyssios [Azienda Ospedaliera O.I.R.M.-S. Anna, Ginecologica Oncologica, Università di Torino (Italy); Villa, Antonella [Ospedali Riuniti di Bergamo, U.O. di Ginecologia, Bergamo (Italy); Mereu, Liliana [Ospedale Policlinico S. Matteo, Ostetrica e Ginecologica, Pavia (Italy)

    2008-09-01

    Mucinous ovarian carcinoma have a poorer prognosis compared with other histological subtypes. The aim of this study was to evaluate, retrospectively, the activity of chemotherapy in patients with platinum sensitive recurrent mucinous ovarian cancer. The SOCRATES study retrospectively assessed the pattern of care of a cohort of patients with recurrent platinum-sensitive ovarian cancer observed in the years 2000–2002 in 37 Italian centres. Data were collected between April and September 2005. Patients with recurrent ovarian cancer with > 6 months of platinum free interval were considered eligible. Twenty patients with mucinous histotype and 388 patients with other histotypes were analyzed. At baseline, mucinous tumours differed from the others for an higher number of patients with lower tumor grading (p = 0.0056) and less advanced FIGO stage (p = 0.025). At time of recurrence, a statistically significant difference was found in performance status (worse in mucinous, p = 0.024). About 20% of patients underwent secondary cytoreduction in both groups, but a lower number of patients were optimally debulked in the mucinous group (p = 0.03). Patients with mucinous cancer received more frequently single agent platinum than platinum based-combination therapy or other non-platinum schedules as second line therapy (p = 0.026), with a response rate lower than in non-mucinous group (36.4% vs 62.6%, respectively, p = 0.04). Median time to progression and overall survival were worse for mucinous ovarian cancer. Finally, mucinous cancer received a lower number of chemotherapy lines (p = 0.0023). This analysis shows that platinum sensitive mucinous ovarian cancer has a poor response to chemotherapy. Studies dedicated to this histological subgroup are needed.

  20. Activity of chemotherapy in mucinous ovarian cancer with a recurrence free interval of more than 6 months: results from the SOCRATES retrospective study

    Directory of Open Access Journals (Sweden)

    Alletti Desiderio

    2008-09-01

    Full Text Available Abstract Background Mucinous ovarian carcinoma have a poorer prognosis compared with other histological subtypes. The aim of this study was to evaluate, retrospectively, the activity of chemotherapy in patients with platinum sensitive recurrent mucinous ovarian cancer. Methods The SOCRATES study retrospectively assessed the pattern of care of a cohort of patients with recurrent platinum-sensitive ovarian cancer observed in the years 2000–2002 in 37 Italian centres. Data were collected between April and September 2005. Patients with recurrent ovarian cancer with > 6 months of platinum free interval were considered eligible. Results Twenty patients with mucinous histotype and 388 patients with other histotypes were analyzed. At baseline, mucinous tumours differed from the others for an higher number of patients with lower tumor grading (p = 0.0056 and less advanced FIGO stage (p = 0.025. At time of recurrence, a statistically significant difference was found in performance status (worse in mucinous, p = 0.024. About 20% of patients underwent secondary cytoreduction in both groups, but a lower number of patients were optimally debulked in the mucinous group (p = 0.03. Patients with mucinous cancer received more frequently single agent platinum than platinum based-combination therapy or other non-platinum schedules as second line therapy (p = 0.026, with a response rate lower than in non-mucinous group (36.4% vs 62.6%, respectively, p = 0.04. Median time to progression and overall survival were worse for mucinous ovarian cancer. Finally, mucinous cancer received a lower number of chemotherapy lines (p = 0.0023. Conclusion This analysis shows that platinum sensitive mucinous ovarian cancer has a poor response to chemotherapy. Studies dedicated to this histological subgroup are needed.

  1. Activity of chemotherapy in mucinous ovarian cancer with a recurrence free interval of more than 6 months: results from the SOCRATES retrospective study

    Science.gov (United States)

    Pignata, Sandro; Ferrandina, Gabriella; Scarfone, Giovanna; Scollo, Paolo; Odicino, Franco; Cormio, Gennaro; Katsaros, Dionyssios; Villa, Antonella; Mereu, Liliana; Ghezzi, Fabio; Manzione, Luigi; Lauria, Rossella; Breda, Enrico; Alletti, Desiderio Gueli; Ballardini, Michela; Lombardi, Alessandra Vernaglia; Sorio, Roberto; Mangili, Giorgia; Priolo, Domenico; Magni, Giovanna; Morabito, Alessandro

    2008-01-01

    Background Mucinous ovarian carcinoma have a poorer prognosis compared with other histological subtypes. The aim of this study was to evaluate, retrospectively, the activity of chemotherapy in patients with platinum sensitive recurrent mucinous ovarian cancer. Methods The SOCRATES study retrospectively assessed the pattern of care of a cohort of patients with recurrent platinum-sensitive ovarian cancer observed in the years 2000–2002 in 37 Italian centres. Data were collected between April and September 2005. Patients with recurrent ovarian cancer with > 6 months of platinum free interval were considered eligible. Results Twenty patients with mucinous histotype and 388 patients with other histotypes were analyzed. At baseline, mucinous tumours differed from the others for an higher number of patients with lower tumor grading (p = 0.0056) and less advanced FIGO stage (p = 0.025). At time of recurrence, a statistically significant difference was found in performance status (worse in mucinous, p = 0.024). About 20% of patients underwent secondary cytoreduction in both groups, but a lower number of patients were optimally debulked in the mucinous group (p = 0.03). Patients with mucinous cancer received more frequently single agent platinum than platinum based-combination therapy or other non-platinum schedules as second line therapy (p = 0.026), with a response rate lower than in non-mucinous group (36.4% vs 62.6%, respectively, p = 0.04). Median time to progression and overall survival were worse for mucinous ovarian cancer. Finally, mucinous cancer received a lower number of chemotherapy lines (p = 0.0023). Conclusion This analysis shows that platinum sensitive mucinous ovarian cancer has a poor response to chemotherapy. Studies dedicated to this histological subgroup are needed. PMID:18761742

  2. Gauge invariant Barr-Zee type contributions to fermionic EDMs in the two-Higgs doublet models

    International Nuclear Information System (INIS)

    Abe, Tomohiro; Hisano, Junji; Kitahara, Teppei; Tobioka, Kohsaku

    2014-01-01

    We calculate all gauge invariant Barr-Zee type contributions to fermionic electric dipole moments (EDMs) in the two-Higgs doublet models (2HDM) with softly broken Z 2 symmetry. We start by studying the tensor structure of h→VV′ part in the Barr-Zee diagrams, and we calculate the effective couplings in a gauge invariant way by using the pinch technique. Then we calculate all Barr-Zee diagrams relevant for electron and neutron EDMs. We make bounds on the parameter space in type-I, type-II, type-X, and type-Y 2HDMs. The electron and neutron EDMs are complementary to each other in discrimination of the 2HDMs. Type-II and type-X 2HDMs are strongly constrained by recent ACME experiment’s result, and future experiments of electron and neutron EDMs may search O(10) TeV physics

  3. A measurement of the radiative widths of the 16.6-16.9 MeV doublet in 8Be

    International Nuclear Information System (INIS)

    Nathan, Alan Marc

    1975-01-01

    The isovector M1 decay rates of the 16.6-16.9 MeV 2+ doublet in 8 Be to the 2.9 MeV 2+ first excited state have been measured. The total rate summed over both levels is found to be Γ mi = 4.94+0.80 eV. This allows a determination of the weak magnetism form factor b which is proportional to Γ mi 1/2 . If this result is compared with the result of a recent teta-alpha angular correlation measurement in the beta decays of the analogue 8 Li and 8 B ground states to the same final state, a model independent test of the Conserved Vector Current theory is possible. It is shown that the existing data are consistent with both CVC and the nonexistence of a 2. class induced tensor form factor. (author)

  4. Minkowski space structure of the Higgs potential in the two-Higgs-doublet model. II. Minima, symmetries, and topology

    International Nuclear Information System (INIS)

    Ivanov, I. P.

    2008-01-01

    We continue to explore the consequences of the recently discovered Minkowski space structure of the Higgs potential in the two-Higgs-doublet model. Here, we focus on the vacuum properties. The search for extrema of the Higgs potential is reformulated in terms of 3-quadrics in the 3+1-dimensional Minkowski space. We prove that 2HDM cannot have more than two local minima in the orbit space and that a twice-degenerate minimum can arise only via spontaneous violation of a discrete symmetry of the Higgs potential. Investigating topology of the 3-quadrics, we give concise criteria for existence of noncontractible paths in the Higgs orbit space. We also study explicit symmetries of the Higgs potential/Lagrangian and their spontaneous violation from a wider perspective than usual

  5. Next-to-leading order unitarity fits in Two-Higgs-Doublet models with soft ℤ{sub 2} breaking

    Energy Technology Data Exchange (ETDEWEB)

    Cacchio, Vincenzo; Chowdhury, Debtosh; Eberhardt, Otto [Istituto Nazionale di Fisica Nucleare, Sezione di Roma,Piazzale Aldo Moro 2, I-00185 Roma (Italy); Murphy, Christopher W. [Scuola Normale Superiore,Piazza dei Cavalieri 7, I-56126 Pisa (Italy)

    2016-11-07

    We fit the next-to-leading order unitarity conditions to the Two-Higgs-Doublet model with a softly broken ℤ{sub 2} symmetry. In doing so, we alleviate the existing uncertainty on how to treat higher order corrections to quartic couplings of its Higgs potential. A simplified approach to implementing the next-to-leading order unitarity conditions is presented. These new bounds are then combined with all other relevant constraints, including the complete set of LHC Run I data. The upper 95% bounds we find are 4.2 on the absolute values of the quartic couplings, and 235 GeV (100 GeV) for the mass degeneracies between the heavy Higgs particles in the type I (type II) scenario. In type II, we exclude an unbroken ℤ{sub 2} symmetry with a probability of 95%. All fits are performed using the open-source code HEPfit.

  6. Relative brightness of the O{sup +}({sup 2} D-{sup 2} P) doublets in low-energy aurorae

    Energy Technology Data Exchange (ETDEWEB)

    Whiter, D. K. [Finnish Meteorological Institute, Erik Palménin Aukio 1, FI-00560 Helsinki (Finland); Lanchester, B. S.; Gustavsson, B.; Jallo, N. I. B.; Jokiaho, O.; Dahlgren, H. [School of Physics and Astronomy, University of Southampton, SO17 1BJ (United Kingdom); Ivchenko, N., E-mail: daniel.whiter@fmi.fi [Royal Institute of Technology (KTH), Teknikringen 31, SE-100 44 Stockholm (Sweden)

    2014-12-10

    The ratio of the emission line doublets from O{sup +} at 732.0 nm (I {sub 732}) and 733.0 nm (I {sub 733}) has been measured in auroral conditions of low-energy electron precipitation from Svalbard (78.°20 north, 15.°83 east). Accurate determination of R = I {sub 732}/I {sub 733} provides a powerful method for separating the density of the O{sup +} {sup 2} P{sub 1} {sub /2,3} {sub /2}{sup o} levels in modeling of the emissions from the doublets. A total of 383 spectra were included from the winter of 2003-2004. The value obtained is R = I {sub 732}/I {sub 733} = 1.38 ± 0.02, which is higher than theoretical values for thermal equilibrium in fully ionized plasma, but is lower than reported measurements by other authors in similar auroral conditions. The continuity equations for the densities of the two levels are solved for different conditions, in order to estimate the possible variations of R. The results suggest that the production of ions in the two levels from O ({sup 3} P {sub 1}) and O ({sup 3} P {sub 2}) does not follow the statistical weights, unlike astrophysical calculations for plasmas in nebulae. The physics of auroral impact ionization may account for this difference, and therefore for the raised value of R. In addition, the auroral solution of the densities of the ions, and thus of the value of R, is sensitive to the temperature of the neutral atmosphere. Although the present work is a statistical study, it shows that it is necessary to determine whether there are significant variations in the ratio resulting from non-equilibrium conditions, from auroral energy deposition, large electric fields, and changes in temperature and composition.

  7. The Associated Absorption Features in Quasar Spectra of the Sloan Digital Sky Survey. I. Mg II Absorption Doublets

    Science.gov (United States)

    Chen, Zhi-Fu; Huang, Wei-Rong; Pang, Ting-Ting; Huang, Hong-Yan; Pan, Da-Sheng; Yao, Min; Nong, Wei-Jing; Lu, Mei-Mei

    2018-03-01

    Using the SDSS spectra of quasars included in the DR7Q or DR12Q catalogs, we search for Mg II λλ2796, 2803 narrow absorption doublets in the spectra data around Mg II λ2798 emission lines. We obtain 17,316 Mg II doublets, within the redshift range of 0.3299 ≤ z abs ≤ 2.5663. We find that a velocity offset of υ r 6000 km s‑1. If associated Mg II absorbers are defined by υ r present at least one associated Mg II system with {W}{{r}}λ 2796≥slant 0.2 \\mathringA . The fraction of associated Mg II systems with high-velocity outflows correlates with the average luminosities of their central quasars, indicating a relationship between outflows and the quasar feedback power. The υ r distribution of the outflow Mg II absorbers is peaked at 1023 km s‑1, which is smaller than the corresponding value of the outflow C IV absorbers. The redshift number density evolution of absorbers (dn/dz) limited by υ r > ‑3000 km s‑1 differs from that of absorbers constrained by υ r > 2000 km s‑1. Absorbers limited by υ r > 2000 km s‑1 and higher values exhibit profiles similar to dn/dz. In addition, the dn/dz is smaller when absorbers are constrained with larger υ r . The distributions of equivalent widths, and the ratio of {W}rλ 2796/{W}rλ 2803, are the same for associated and intervening systems, and independent of quasar luminosity.

  8. Precision calculations for h → WW/ZZ → 4 fermions in the Two-Higgs-Doublet Model with Prophecy4f

    DEFF Research Database (Denmark)

    Altenkamp, Lukas; Dittmaier, Stefan; Rzehak, Heidi

    2018-01-01

    We have calculated the next-to-leading-order electroweak and QCD corrections to the decay processes h → WW/ZZ → 4 fermions of the light CP-even Higgs boson h of various types of Two-Higgs-Doublet Models (Types I and II, “lepton-specific” and “flipped” models). The input parameters are defined in ...

  9. The relation between well spacing and Net Present Value in fluvial Hot Sedimentary Aquifer geothermal doublets : a West Netherlands Basin case study

    NARCIS (Netherlands)

    Willems, C.J.L.; Goense, T.; Maghami Nick, Hamidreza M.; Bruhn, D.F.

    2016-01-01

    This paper analyzes the relation between well spacing and Net Present Value of a Hot Sedimentary Aquifer geothermal doublet. First, a sensitivity analysis is carried out to evaluate the effect of uncertainty of geological and production parameters on the Net present Value. Second a finite-element

  10. Nanotechnology for Cancer Therapy Based on Chemotherapy

    OpenAIRE

    Chen-Yang Zhao; Rui Cheng; Zhe Yang; Zhong-Min Tian

    2018-01-01

    Chemotherapy has been widely applied in clinics. However, the therapeutic potential of chemotherapy against cancer is seriously dissatisfactory due to the nonspecific drug distribution, multidrug resistance (MDR) and the heterogeneity of cancer. Therefore, combinational therapy based on chemotherapy mediated by nanotechnology, has been the trend in clinical research at present, which can result in a remarkably increased therapeutic efficiency with few side effects to normal tissues. Moreover,...

  11. Overview, prevention and management of chemotherapy extravasation

    OpenAIRE

    Kreidieh, Firas Y; Moukadem, Hiba A; El Saghir, Nagi S

    2016-01-01

    Chemotherapy extravasation remains an accidental complication of chemotherapy administration and may result in serious damage to patients. We review in this article the clinical aspects of chemotherapy extravasation and latest advances in definitions, classification, prevention, management and guidelines. We review the grading of extravasation and tissue damage according to various chemotherapeutic drugs and present an update on treatment and new antidotes including dexrazoxane for anthracycl...

  12. Combined radiotherapy and chemotherapy for head and neck cancer

    International Nuclear Information System (INIS)

    Inuyama, Yukio; Fujii, Masato; Tanaka, Juichi; Takaoka, Tetsuro; Hosoda, Hyonosuke; Kawaura, Mitsuhiro; Toji, Masao

    1988-01-01

    There are 4 modalities of combined radiotherapy and chemotherapy which include (1) concurrent radiotherapy and chemotherapy, (2) sequential use of radiotherapy and chemotherapy (pre-radiation chemotherapy), (3) pre-radiation chemotherapy followed by concurrent radiation and chemotherapy, and (4) alternating use of radiotherapy and chemotherapy based upon Looney's hypothesis. We studied concurrent use of radiotherapy and UFT by means of animal experimentation and clinical trials. The results obtained revealed that UFT was a most suitable agent together with 5-fluorouracil for concurrent application of radiotherapy and chemotherapy. Neo-adjuvant chemotherapy including pre-radiation chemotherapy was also studied in cases of maxillary sinus carcinoma and nasopharyngeal carcinoma. From the results, it seemed desirable to use cisplatin and bleomycin analogs sequentially in combined chemotherapy and radiotherapy. Neo-adjuvant chemotherapy should be studied successively to improve local tumor control rates and prevent distant metastases. For future perspectives, new trials of alternating radiotherapy and chemotherapy based upon Looney's hypothesis seem necessary. (author)

  13. [Oral complications of chemotherapy of malignant neoplasms].

    Science.gov (United States)

    Obralić, N; Tahmiscija, H; Kobaslija, S; Beslija, S

    1999-01-01

    Function and integrity disorders of the oral cavity fall into the most frequent complication of the chemotherapy of leucemias, malignant lymphomas and solid tumors. Complications associated with cancer chemotherapy can be direct ones, resulting from the toxic action of antineoplastic agents on the proliferative lining of the mouth, or indirect, as a result of myelosuppression and immunosuppression. The most frequent oral complications associated with cancer chemotherapy are mucositis, infection and bleeding. The principles of prevention and management of oral complications during cancer chemotherapy are considered in this paper.

  14. Chemotherapy in combined and multimodality treatment

    International Nuclear Information System (INIS)

    Anon.

    1989-01-01

    It is shown that chemotherapy of tumors of various localizations developes intensively in the last few years. It is connected with discovery and adoption of new active antitumoral preparations, such as alkylating preparations, antimetabolites, antitumoral antibiotics, hormonal preparations. To create the rational effective conditions of chemotherapy a study was made on kinetics of tumor gowth, molecular mechanisms of interaction of cytostatics and cells of malignant tumor. Main factors of chemotherapy combination with radiotherapy when treating numerous malignant tumors were considered. Effectiveness of using chemotherapy in combination with other methods of treatment was shown

  15. Chemotherapy

    Science.gov (United States)

    ... Central venous catheter Central venous catheter with a port Percutaneously inserted central catheter (PICC) A central line ... pain or numbness from nerve damage Have a dry mouth , mouth sores, or swelling in the mouth ...

  16. Chemotherapy

    Science.gov (United States)

    ... cause nerve problems and burning, numbness, tingling, or shooting pain in the fingers and toes. Certain types ... more comfortable wearing hats, scarves, or wigs to school or other events. Or, you may look great ...

  17. The inelastic scattering of 2Pi [case (b)] molecules and an understanding of the differing Λ doublet propensities for molecules of π vs π3 orbital occupancy

    International Nuclear Information System (INIS)

    Dagdigian, P.J.; Alexander, M.H.; Liu, K.; Department of Chemistry, University of Maryland, College Park, Maryland 20742; Gas Phase Chemical Dynamics Group, Chemistry Division, Argonne National Laboratory, 9700 South Cass Avenue, Argonne, Illinois 60439)

    1989-01-01

    The quantum formalism for the scattering of a diatomic molecule in a 2 Pi electronic state which is well described by Hund's case (b) limit is investigated here. For a particular JF/sub i/ yields J'F'/sub 1/ transition, quantum interference effects will lead to preferential population of one of the final state Λ doublet levels. The nonstatistical population of final state Λ doublet levels arises from an interference between terms in the expansion of the two electrostatic potential energy surfaces, of A' and A'' reflection symmetry, which describe the interaction between a molecule in a Pi electronic state and a closed-shell partner. The particular Λ doublet level preferred is opposite for molecules of π 1 vs π 3 electron occupancy. The physical origin of this reversal in the Λ doublet propensity is a direct reflection of the fact that for the former the A' potential surface is more repulsive since the sole π electron lies in the triatomic plane in this case, whereas for molecules of π 3 electron occupancy the A' surface is less repulsive than the A'' surface since for the A' surface only one of the three π electrons lies in the triatomic plane. The magnitude of these Λ doublet propensities is illustrated by calculated cross sections for the CH(X 2 Pi)--He system using the ab initio potential energy surfaces calculated by the Argonne theoretical group, and these cross sections are compared to those of the crossed molecular study of Liu and Macdonald [J. Chem. Phys. 61, xxxx (1989)]. A similar analysis is carried out for collisions of a molecule of π 3 electron occupancy and is illustrated by inelastic collisions of OH(X 2 Pi)

  18. Comparison of chemotherapy and hematopoietic stem cell ...

    African Journals Online (AJOL)

    Aims: Chemotherapy is frequently used as a conditioning regimen to destroy malignant marrow cells before transplantation. Xerostomia, dysphagia, altered taste perception, mucositis, soft‑tissue ulceration, and infection are common adverse oral effects of chemotherapy. The study was aimed to compare decayed, missing, ...

  19. Paradox of Prescribing Late Chemotherapy: Oncologists Explain.

    Science.gov (United States)

    Bluhm, Minnie; Connell, Cathleen M; De Vries, Raymond G; Janz, Nancy K; Bickel, Kathleen E; Silveira, Maria J

    2016-12-01

    The value of chemotherapy for patients with cancer in the last weeks of life warrants examination. Late chemotherapy may not improve survival or quality of life but typically precludes hospice enrollment and may result in additional symptoms, increased use of other aggressive treatments, and worsening quality of life. Few studies have explored oncologists' rationales for administering chemotherapy near death. This study examines the self-reported factors that influence oncologists' decisions about late chemotherapy. In-depth individual interviews were conducted with 17 oncologists through a semistructured interview guide. Interviews were audio recorded and transcribed verbatim. Transcripts were coded and analyzed using conventional content analysis, a qualitative method that allows the detection and analysis of patterns in the data. Clinical factors take priority in determining late chemotherapy decisions when clear treatment choices exist. When clinical factors are ambiguous, emotion becomes a highly salient influence. Oncologists view late chemotherapy to be patient driven and use it to palliate emotional distress and maintain patient hope even when physical benefit is unexpected. Oncologists experience unique and difficult challenges when caring for dying patients, including emotionally draining communication, overwhelming responsibility for life/death, limitations of oncology to heal, and prognostic uncertainty. These challenges are also eased by offering late chemotherapy. The findings reveal a nuanced understanding of why oncologists find it difficult to refuse chemotherapy treatment for patients near death. Optimal end-of-life treatment decisions require supportive interventions and system change, both of which must take into account the challenges oncologists face.

  20. A prospective study on concurrent chemotherapy and thoracic three-dimensional radiotherapy for stage IV non-small cell lung cancer (1) -survival and toxicity

    International Nuclear Information System (INIS)

    Su Shengfa; Lu Bing; Zhang Bo; Hu Yinyang; Ouyang Weiwei; Li Huiqin; Wang Gang; Long Jinhua

    2011-01-01

    Objective: To evaluate the overall survival and safety among patients for stage IV non-small cell lung cancer (NSCLC) treated with concurrent chemotherapy and thoracic three-dimensional radiotherapy (CCTTRT). Methods: From Jan. 2003 to July 2010, 201 patients with stage IV NSCLC were included. All patients were treated with CCTTRT. Those patients who received only one cycle chemotherapy were not included in survival analysis,but analysis of toxicity. One hundred and eighty-two patients were eligible for survival analysis. All patients received platinum-based two-drug chemotherapy. The median number of cycles was 4. The median dose to planning target volume of primary tumor (DT PTV ) was 63 Gy. Treatment-related gastrointestinal and hematological toxicity were scored according to WHO criteria. Radiation-related pneumonitis and esophagitis were evaluated according to the National Cancer Institute's Common Terminology Criteria for Adverse Events (CTC) version 3.0. Survival was calculated by Kaplan-Meier method and compared using the Logrank. Cox regression model was used to examine the effect of CCTTRT on overall survival. Results: The follow-up rate of 201 patients was 97.5%. with 201, 170 and 134 patients finished 2 =10.10, P =0.001). For patients eligible for survival analysis and received 4 - 5 cycles of systemic chemotherapy, MST of patients treated with DT PTV ≥63 Gy was significantly longer than those treated with DT PTV 2 =20.48, P =0.000) and 16.1 months vs.8.8 months (χ 2 =11.75, P =0.001)]. For patients with single organ metastasis, MST was 16 months for those treated with DT PTV ≥63 Gy and 9 months for those with DT PTV 2 =10.51, P=0.000); for patients with multiple organ metastasis, it was 11 months and 7 months, respectively (χ 2 =7.90, P =0.005). Multivariate analysis showed that concurrent 4 - 5 cycles chemotherapy and DTPTV ≥63 Gy (β =0.243, P=0.019) and improved KPS (β =1.268, P=0.000) were independent factors for survival. For the whole

  1. Nanotechnology for Cancer Therapy Based on Chemotherapy

    Directory of Open Access Journals (Sweden)

    Chen-Yang Zhao

    2018-04-01

    Full Text Available Chemotherapy has been widely applied in clinics. However, the therapeutic potential of chemotherapy against cancer is seriously dissatisfactory due to the nonspecific drug distribution, multidrug resistance (MDR and the heterogeneity of cancer. Therefore, combinational therapy based on chemotherapy mediated by nanotechnology, has been the trend in clinical research at present, which can result in a remarkably increased therapeutic efficiency with few side effects to normal tissues. Moreover, to achieve the accurate pre-diagnosis and real-time monitoring for tumor, the research of nano-theranostics, which integrates diagnosis with treatment process, is a promising field in cancer treatment. In this review, the recent studies on combinational therapy based on chemotherapy will be systematically discussed. Furthermore, as a current trend in cancer treatment, advance in theranostic nanoparticles based on chemotherapy will be exemplified briefly. Finally, the present challenges and improvement tips will be presented in combination therapy and nano-theranostics.

  2. Chemotherapy alone versus chemotherapy plus radiotherapy for adults with early stage Hodgkin lymphoma (Review)

    DEFF Research Database (Denmark)

    Blank, Oliver; von Tresckow, Bastian; Monsef, Ina

    2017-01-01

    BACKGROUND: Combined modality treatment consisting of chemotherapy followed by localised radiotherapy is the standard treatment for patients with early stage Hodgkin lymphoma (HL). However, due to long- term adverse effects such as secondary malignancies the role of radiotherapy has been questioned...... recently and some clinical study groups advocate chemotherapy only for this indication. OBJECTIVES: To assess the effects of chemotherapy alone compared to chemotherapy plus radiotherapy in adults with early stage HL . SEARCH METHODS: For the or i ginal version of this review, we searched MEDLINE, Embase......-related mortality (RR 0.99; 95% CI 0.14 to 6.90; P = 0.99; low-quality evidence), there is no evidence for a difference between the use of chemotherapy alone and chemotherapy plus radiotherapy. CRR rate was not reported. AUTHORS' CONCLUSIONS: This systematic review compared the effects of chemotherapy alone...

  3. High-dose Extended-Field Irradiation and High-Dose-Rate Brachytherapy With Concurrent Chemotherapy for Cervical Cancer With Positive Para-Aortic Lymph Nodes

    International Nuclear Information System (INIS)

    Kim, Young Seok; Kim, Jong Hoon; Ahn, Seung Do; Lee, Sang-wook; Shin, Seong Soo; Nam, Joo-Hyun; Kim, Young-Tak; Kim, Yong-Man; Kim, Jong-Hyeok; Choi, Eun Kyung

    2009-01-01

    Purpose: To determine the efficacy and toxicity of extended-field radiotherapy (RT) with concurrent platinum-based chemotherapy in patients with uterine cervical carcinoma and positive para-aortic nodes. Methods and Materials: We retrospectively reviewed the results for 33 women with Stage IB-IVB cervical cancer. Each patient had received 59.4 Gy, including a three-dimensional conformal boost to the para-aortic lymph nodes and 41.4-50.4 Gy of external beam radiotherapy to the pelvis. Each patient also underwent six or seven applications of high-dose-rate brachytherapy (median, 5 Gy to point A at each session). Results: The median follow-up period of surviving patients was 39 months. The most common acute toxicity was hematologic, observed in 23 women. Severe acute and late gastrointestinal toxicity was observed in 3 and 4 patients, respectively. More than three-quarters of patients showed a complete response, encompassing the primary mass, metastatic pelvic, and para-aortic lymph nodes. Of the 33 women, 15 had no evidence of disease, 6 had persistent disease, 4 developed in-field failures, and 6 developed distant failures. The 5-year overall and disease-free survival rate was 47% and 42%, respectively. Conclusion: Concurrent chemoradiotherapy with extended-field radiotherapy is feasible in women with uterine cervical carcinoma and positive para-aortic lymph nodes, with acceptable late morbidity and a high survival rate, although it was accompanied by substantial acute toxicity.

  4. Radiation Therapy-First Strategy After Surgery With or Without Adjuvant Chemotherapy in Stage IIIA-N2 Non-Small Cell Lung Cancer.

    Science.gov (United States)

    Lee, Hyun Woo; Noh, O Kyu; Oh, Young-Taek; Choi, Jin-Hyuk; Chun, Mison; Kim, Hwan-Ik; Heo, Jaesung; Ahn, Mi Sun; Park, Seong Yong; Park, Rae Woong; Yoon, Dukyong

    2016-03-01

    Postoperative radiation therapy (PORT) and postoperative chemotherapy (POCT) can be administered as adjuvant therapies in patients with non-small cell lung cancer (NSCLC). The aim of this study was to present the clinical outcomes in patients treated with PORT-first with or without subsequent POCT in stage IIIA-N2 NSCLC. From January 2002 to November 2014, the conditions of 105 patients with stage IIIA-N2 NSCLC who received PORT-first with or without subsequent POCT were analyzed. PORT was initiated within 4 to 6 weeks after surgical resection. Platinum-based POCT was administered 3 to 4 weeks after the completion of PORT. We analyzed the outcomes and the clinical factors affecting survival. Of 105 patients, 43 (41.0%) received POCT with a median of 4 cycles (range, 2-6 cycles). The follow-up times ranged from 3 to 123 months (median, 30 months), and the 5-year overall survival (OS) was 40.2%. The 5-year OS of patients treated with PORT and POCT was significantly higher than that of patients with PORT (61.3% vs 29.2%, Ptreatment of stage IIIA-N2 NSCLC. The benefit of POCT on OS was preserved even in the PORT-first setting. Further studies are warranted to compare the sequencing of PORT and POCT, guaranteeing the proper use of POCT. Copyright © 2016 Elsevier Inc. All rights reserved.

  5. Splenic abscess in cancer chemotherapy.

    Science.gov (United States)

    Ismail, Essadi; El Barni, Rachid; Lahkim, Mohamed; Rokhsi, Redouane; Atmane, Elmehdi; El Fikri, Abdelghani; Bouchama, Rachid; Achour, Abdessamad; Zyani, Mohamed

    2015-11-11

    Splenic abcess is an uncommon complication for cancer treatment. It occurs more frequently in immunocompromised patients. They are characterized by high mortality. The classic triad (fever, pain of the left hypochondrium, and sensitive mass left) is only present in one-third of cases the clinical spectrum ranging from no symptoms to events such as fever, nausea, vomiting, weight loss, abdominal pain left, splenomegaly. Treatment options are limited, but must be discussed and adapted to the patient profile. We report the case of a 62-year-old Arabic male, diagnosed with metastatic lung adenocarcinoma, who, after several cycles of chemotherapy, presented symptoms and signs of splenic abcess. Splenic abcess is rare situation, which must be actively researched, to have access to an optimal therapeutic approach.

  6. The Effect of Consolidation Chemotherapy for LA-NSCLC Patients Receiving Concurrent Chemoradiotherapy

    Directory of Open Access Journals (Sweden)

    Yelda Varol

    2016-09-01

    Full Text Available Aim: The efficacy and safety of consolidation chemotherapy (CCT following concurrent chemoradiotherapy are not adequately established for patients with locally advanced non-small-cell lung cancer (LA-NSCLC. In this context, the present study aims to evaluate the efficacy and toxicity of CCT.Material and Method: We retrospectively analyzed the overall survival (OS and progression-free survival (PFS of 83 LA-NSCLC patients treated with concurrent CRT as an initial treatment with (n:20 or without CCT (n:63. All patients were cytohistologically proven to have NSCLC and diagnosed with clinical Stage III (n:48 for IIIA and n:35 for IIIB according to the staging system published by the American Joint Committee on Cancer (AJCC in 2009. All patients received curative thoracic radiotherapy with concurrent platinum doublet chemotherapy. Results: The mean age of the lung cancer patients was 59 (±7.3; 89.2% were male (n:74,and there were only 9 female patients (10.8%.When we compared the outcome of LA-NSCLC patients treated with CCT (median 10.4 months to the patients treated without CCT (median 13.8 months, the log-rank analysis demonstrated a statistically significant difference for an inferior progression-free survival (p=0.046 in patients receiving CCT. However, no significant association was observed for overall survival (17.4, 21 months, respectively (p>0.05. Patients with CCT presented higher levels of hematological side effects compared with the patients without CCT (p

  7. Scrutinizing the alignment limit in two-Higgs-doublet models. II. mH=125 GeV

    Science.gov (United States)

    Bernon, Jérémy; Gunion, John F.; Haber, Howard E.; Jiang, Yun; Kraml, Sabine

    2016-02-01

    In the alignment limit of a multidoublet Higgs sector, one of the Higgs mass eigenstates aligns in field space with the direction of the scalar field vacuum expectation values, and its couplings approach those of the Standard Model (SM) Higgs boson. We consider C P -conserving two-Higgs-doublet models (2HDMs) of type I and type II near the alignment limit in which the heavier of the two C P -even Higgs bosons, H , is the SM-like state observed with a mass of 125 GeV, and the couplings of H to gauge bosons approach those of the SM. We review the theoretical structure and analyze the phenomenological implications of this particular realization of the alignment limit, where decoupling of the extra states cannot occur given that the lighter C P -even state h must, by definition, have a mass below 125 GeV. For the numerical analysis, we perform scans of the 2HDM parameter space employing the software packages 2hdmc and lilith, taking into account all relevant pre-LHC constraints, constraints from the measurements of the 125 GeV Higgs signal at the LHC, as well as the most recent limits coming from searches for other Higgs-like states. Implications for Run 2 at the LHC, including expectations for observing the other scalar states, are also discussed.

  8. Bs0–B-bars0 mixing within minimal flavor-violating two-Higgs-doublet models

    International Nuclear Information System (INIS)

    Chang, Qin; Li, Pei-Fu; Li, Xin-Qiang

    2015-01-01

    In the “Higgs basis” for a generic 2HDM, only one scalar doublet gets a nonzero vacuum expectation value and, under the criterion of minimal flavor violation, the other one is fixed to be either color-singlet or color-octet, which are named as the type-III and type-C models, respectively. In this paper, the charged-Higgs effects of these two models on B s 0 –B -bar s 0 mixing are studied. First of all, we perform a complete one-loop computation of the electro-weak corrections to the amplitudes of B s 0 –B -bar s 0 mixing. Together with the up-to-date experimental measurements, a detailed phenomenological analysis is then performed in the cases of both real and complex Yukawa couplings of charged scalars to quarks. The spaces of model parameters allowed by the current experimental data on B s 0 –B -bar s 0 mixing are obtained and the differences between type-III and type-C models are investigated, which is helpful to distinguish between these two models

  9. Near-threshold photoionization of the Xe 3d spin-orbit doublet: Relativistic, relaxation, and intershell interaction effects

    International Nuclear Information System (INIS)

    Radojevic, V.; Davidovic, D.M.; Amusia, M.Ya.

    2003-01-01

    Results of calculations of the near-threshold photoionization of the xenon 3d spin-orbit doublet are reported. Our theoretical analysis is undertaken in order to interpret and enlighten the very detailed measurements of this process [A. Kivimaeki et al., Phys. Rev. A 63, 012716 (2001)], which revealed a previously unobserved interesting feature--an additional broad maximum--in the partial xenon 3d 5/2 cross section. This double maximum was not produced by earlier calculations, except in the recent study by Amusia et al. [Phys. Rev. Lett. 88, 093002 (2002)], which, in contrast to the present one, is not ab initio and relativistic in character. The partial photoionization cross sections of 3d 5/2 and 3d 3/2 subshells, photoelectron anisotropy parameters, and spin-polarization parameters that were so far not studied either experimentally or theoretically are calculated. Many-electron correlations, relativistic effects, and relaxation effects of the ionic core in the ionization process are taken into account by using the relativistic random-phase approximation, modified to include the relaxation of the considered subshell

  10. {Delta}r in the Two-Higgs-Doublet Model at full one loop level - and beyond

    Energy Technology Data Exchange (ETDEWEB)

    Lopez-Val, David [Universitaet Heidelberg, Institut fuer Theoretische Physik, Heidelberg (Germany); Sola, Joan [Universitat de Barcelona, Dept. Estructura i Constituents de la Materia, Barcelona, Catalonia (Spain); Institut de Ciencies del Cosmos, Barcelona, Catalonia (Spain)

    2013-04-15

    After the recent discovery of a Higgs-like boson particle at the CERN LHC-collider, it becomes more necessary than ever to prepare ourselves for identifying its standard or non-standard nature. The fundamental parameter {Delta}r, relating the values of the electroweak gauge boson masses and the Fermi constant, is the traditional observable encoding high precision information of the quantum effects. In this work we present a complete quantitative study of {Delta}r in the framework of the general Two-Higgs-Doublet Model (2HDM). While the one-loop analysis of {Delta}r in this model was carried out long ago, in the first part of our work we consistently incorporate the higher order effects that have been computed since then for the SM part of {Delta}r. Within the on-shell scheme, we find typical corrections leading to shifts of {proportional_to}20-40 MeV on the W mass, resulting in a better agreement with its experimentally measured value and in a degree no less significant than in the MSSM case. In the second part of our study we devise a set of effective couplings that capture the dominant higher order genuine 2HDM quantum effects on the {delta}{rho} part of {Delta}r in the limit of large Higgs boson self-interactions. This limit constitutes a telltale property of the general 2HDM which is unmatched by e.g. the MSSM. (orig.)

  11. Δr in the Two-Higgs-Doublet Model at full one loop level - and beyond

    International Nuclear Information System (INIS)

    Lopez-Val, David; Sola, Joan

    2013-01-01

    After the recent discovery of a Higgs-like boson particle at the CERN LHC-collider, it becomes more necessary than ever to prepare ourselves for identifying its standard or non-standard nature. The fundamental parameter Δr, relating the values of the electroweak gauge boson masses and the Fermi constant, is the traditional observable encoding high precision information of the quantum effects. In this work we present a complete quantitative study of Δr in the framework of the general Two-Higgs-Doublet Model (2HDM). While the one-loop analysis of Δr in this model was carried out long ago, in the first part of our work we consistently incorporate the higher order effects that have been computed since then for the SM part of Δr. Within the on-shell scheme, we find typical corrections leading to shifts of ∝20-40 MeV on the W mass, resulting in a better agreement with its experimentally measured value and in a degree no less significant than in the MSSM case. In the second part of our study we devise a set of effective couplings that capture the dominant higher order genuine 2HDM quantum effects on the δρ part of Δr in the limit of large Higgs boson self-interactions. This limit constitutes a telltale property of the general 2HDM which is unmatched by e.g. the MSSM. (orig.)

  12. Measurement of central nickel density in Doublet III plasmas with a soft x-ray diode array

    International Nuclear Information System (INIS)

    Groebner, R.J.; Jahns, G.L.; Ejima, S.; Hsieh, C.L.

    1985-01-01

    An array of soft x-ray diodes has been used to obtain central nickel densities for discharges in the Doublet III tokamak, during operation with an inconel primary limiter, in which nickel L-line radiation dominated the diode signals. The nature of the diode signals is determined primarily by comparison with soft x-ray spectra. The contribution of the continuum portion of the spectra to the central diode signal can be calculated and compared to the observed signal. When the diode signal is dominated by nickel L-line emission, the observed signal is considerably larger than the calculated continuum contribution. Chordal data from the array of diodes are inverted to provide the spatial profile of soft x-ray emission. Because the diodes are absolute detectors of radiation, the soft x-ray emission profile is used to obtain the absolute nickel concentration and density profile in the center of the plasma. A computer code, including over 100 nickel L-line transitions, has been developed to obtain the nickel density. The nickel L-line cooling rate, calculated with the code, is presented. The nickel density obtained by this technique agrees well with that obtained from the K/sub α/ line intensity measured with a soft x-ray spectrometer and that obtained from a bolometric measurement of central radiated power coupled with a coronal equilibrium model of the radiation

  13. Electron impact excitation of the lowest doublet and quartet core-excited autoionizing states in Rb atoms

    International Nuclear Information System (INIS)

    Borovik, A; Roman, V; Zatsarinny, O; Bartschat, K

    2013-01-01

    Electron impact excitation of the (4p 5 5s 2 ) 2 P 3/2,1/2 and (4p 5 4d5s) 4 P 1/2,3/2,5/2 autoionizing states in rubidium atoms was studied experimentally by measuring the ejected-electron excitation functions and theoretically by employing a fully relativistic Dirac B-spline R-matrix (close-coupling) model. The experimental data were collected in an impact energy range from the respective excitation thresholds up to 50 eV with an incident electron energy resolution of 0.2 eV and an observation angle of 54.7°. Absolute values of the excitation cross sections were obtained by normalizing to the theoretical predictions. The observed near-threshold resonance structures were also analysed by comparison with theory. For the 2 P 3/2,1/2 doublet states, a detailed analysis of the R-matrix results reveals that the most intense resonances are related to odd-parity negative-ion states with dominant configurations 4p 5 5s5p 2 and 4p 5 4d5s6s. The measured excitation functions for the 2 P 1/2 and 4 P J states indicate a noticeable cascade population due to the radiative decay from high-lying autoionizing states. A comparative analysis with similar data for other alkali atoms is also presented.

  14. Flavour Independent $h^{0}A^{0}$ Search and Two Higgs Doublet Model Interpretation of Neutral Higgs Boson Searches at LEP

    CERN Document Server

    Abbiendi, G.; Akesson, P.F.; Alexander, G.; Allison, John; Amaral, P.; Anagnostou, G.; Anderson, K.J.; Asai, S.; Axen, D.; Bailey, I.; Barberio, E.; Barillari, T.; Barlow, R.J.; Batley, R.J.; Bechtle, P.; Behnke, T.; Bell, Kenneth Watson; Bell, P.J.; Bella, G.; Bellerive, A.; Benelli, G.; Bethke, S.; Biebel, O.; Boeriu, O.; Bock, P.; Boutemeur, M.; Braibant, S.; Brown, Robert M.; Burckhart, H.J.; Campana, S.; Capiluppi, P.; Carnegie, R.K.; Carter, A.A.; Carter, J.R.; Chang, C.Y.; Charlton, D.G.; Ciocca, C.; Csilling, A.; Cuffiani, M.; Dado, S.; De Roeck, A.; De Wolf, E.A.; Desch, K.; Dienes, B.; Donkers, M.; Dubbert, J.; Duchovni, E.; Duckeck, G.; Duerdoth, I.P.; Etzion, E.; Fabbri, F.; Ferrari, P.; Fiedler, F.; Fleck, I.; Ford, M.; Frey, A.; Gagnon, P.; Gary, John William; Geich-Gimbel, C.; Giacomelli, G.; Giacomelli, P.; Giunta, Marina; Goldberg, J.; Gross, E.; Grunhaus, J.; Gruwe, M.; Gunther, P.O.; Gupta, A.; Hajdu, C.; Hamann, M.; Hanson, G.G.; Harel, A.; Hauschild, M.; Hawkes, C.M.; Hawkings, R.; Hemingway, R.J.; Herten, G.; Heuer, R.D.; Hill, J.C.; Hoffman, Kara Dion; Horvath, D.; Igo-Kemenes, P.; Ishii, K.; Jeremie, H.; Jovanovic, P.; Junk, T.R.; Kanzaki, J.; Karlen, D.; Kawagoe, K.; Kawamoto, T.; Keeler, R.K.; Kellogg, R.G.; Kennedy, B.W.; Kluth, S.; Kobayashi, T.; Kobel, M.; Komamiya, S.; Kramer, T.; Krieger, P.; von Krogh, J.; Kuhl, T.; Kupper, M.; Lafferty, G.D.; Landsman, H.; Lanske, D.; Lellouch, D.; Lettso, J.; Levinson, L.; Lillich, J.; Lloyd, S.L.; Loebinger, F.K.; Lu, J.; Ludwig, A.; Ludwig, J.; Mader, W.; Marcellini, S.; Martin, A.J.; Masetti, G.; Mashimo, T.; Mattig, Peter; McKenna, J.; McPherson, R.A.; Meijers, F.; Menges, W.; Merritt, F.S.; Mes, H.; Meyer, Niels T.; Michelini, A.; Mihara, S.; Mikenberg, G.; Miller, D.J.; Mohr, W.; Mori, T.; Mutter, A.; Nagai, K.; Nakamura, I.; Nanjo, H.; Neal, H.A.; Nisius, R.; O'Neale, S.W.; Oh, A.; Oreglia, M.J.; Orito, S.; Pahl, C.; Pasztor, G.; Pater, J.R.; Pilcher, J.E.; Pinfold, J.; Plane, David E.; Pooth, O.; Przybycien, M.; Quadt, A.; Rabbertz, K.; Rembser, C.; Renkel, P.; Roney, J.M.; Rossi, A.M.; Rozen, Y.; Runge, K.; Sachs, K.; Saeki, T.; Sarkisyan, E.K.G.; Schaile, A.D.; Schaile, O.; Scharff-Hansen, P.; Schieck, J.; Schorner-Sadenius, T.; Schroder, Matthias; Schumacher, M.; Seuster, R.; Shears, T.G.; Shen, B.C.; Sherwood, P.; Skuja, A.; Smith, A.M.; Sobie, R.; Soldner-Rembold, S.; Spano, F.; Stahl, A.; Strom, David M.; Strohmer, R.; Tarem, S.; Tasevsky, M.; Teuscher, R.; Thomson, M.A.; Torrence, E.; Toya, D.; Tran, P.; Trigger, I.; Trocsanyi, Z.; Tsur, E.; Turner-Watson, M.F.; Ueda, I.; Ujvari, B.; Vollmer, C.F.; Vannerem, P.; Vertesi, R.; Verzocchi, M.; Voss, H.; Vossebeld, J.; Ward, C.P.; Ward, D.R.; Watkins, P.M.; Watson, A.T.; Watson, N.K.; Wells, P.S.; Wengler, T.; Wermes, N.; Wilson, G.W.; Wilson, J.A.; Wolf, G.; Wyatt, T.R.; Yamashita, S.; Zer-Zion, D.; Zivkovic, Lidija

    2005-01-01

    Upper limits on the cross-section of the pair-production process e+e- -> h0A0 assuming 100% decays into hadrons, are derived from a new search for the h0A0 -> hadrons topology, independent of the hadronic flavour of the decay products. Searches for the neutral Higgs bosons h0 and A0, are used to obtain constraints on the Type II Two Higgs Doublet Model (2HDM(11)) with no CP violation in the Higgs sector and no additional non Standard Model particles besides the five Higgs bosons. The analysis combines LEP1 and LEP2 data collected with the OPAL detctor up to the highest available centre-of-mass energies. The searches are sensitive to the h0, A0 -> qq, gg,tau+tau- and h0 -> A0A0 decay modes of the Higgs bosons. The 2HDM(II) parameter space is explored in a detailed scan. Large regions of the 2HDM(II) parameter space are excluded at the 95% CL in the (mh, mA), (mh, tanb) and (mA, tanb) planes, using both direct neutral Higgs boson searches and indirect limits derived from Standard Model high precision measuremen...

  15. Exercise and chemotherapy-induced amenorrhea.

    Science.gov (United States)

    Mathis, Katlynn M; Sturgeon, Kathleen M; Winkels, Renate M; Wiskemann, Joachim; Williams, Nancy I; Schmitz, Kathryn

    2018-07-01

    Chemotherapy-induced amenorrhea (CIA) is the temporary or permanent loss of menses experienced by premenopausal women undergoing chemotherapy treatment for cancer. Two possible mechanisms through which chemotherapy induces CIA have been identified: systemic endothelial dysfunction, resulting in decreased blood flow to the ovaries, and increased oxidative stress within the ovaries, both of which are proposed to lead to apoptosis of follicles. Endothelial dysfunction in ovarian arteries in women undergoing or who have undergone chemotherapy treatment is characterized by prothrombotic changes and thickening of the vascular wall. These changes result in occlusion of the blood vessels. Oxidative stress is increased and antioxidants decreased in the ovaries secondary to chemotherapy drugs, specifically cyclophosphamide. It is hypothesized that low to moderate intensity aerobic exercise during chemotherapy may prevent these changes and lessen the risk for developing CIA in premenopausal women. Low to moderate intensity aerobic exercise has been shown to improve endothelial function and blood flow in patients with cardiovascular disease-a disease state characterized by endothelial dysfunction and for which patients who have undergone chemotherapy are at increased risk. In mice, moderate intensity aerobic exercise has been shown to decrease the amount of oxidative stress within the ovaries, and in humans, chronic aerobic exercise has been shown to increase antioxidant production systemically. This hypothesis should be tested in both a mouse model, using sedentary and exercising mice treated with chemotherapy drugs that commonly result in CIA, as well as a human model to determine the effects of low to moderate intensity aerobic exercise on ovarian function in premenopausal women undergoing chemotherapy. Copyright © 2018 Elsevier Ltd. All rights reserved.

  16. Chemotherapy for head and neck cancer

    International Nuclear Information System (INIS)

    Pfister, David G.

    1997-01-01

    Purpose/Objective: The role of chemotherapy in the management of squamous cell carcinoma of the upper aerodigestive tract is undergoing rapid evolution. Historically, the use of chemotherapy was limited to patients with incurable disease who had exhausted all surgical and radiation therapy options. The results of recent randomized trials, however, suggest an increasing role for chemotherapy as part of primary management in patients with unresectable disease; advanced larynx or hypopharynx cancer with the intent of larynx preservation, or advanced nasopharynx cancer. This refresher course will provide a comprehensive overview of the current indications for chemotherapy in the management of these malignancies, and will highlight areas of controversy and future directions of investigation. More specifically, the following areas will be emphasized. 1. The identification of drugs commonly used in the management of head and neck cancer, their customary dosing and side effects. 2. The impact of induction and/or adjuvant chemotherapy combined with surgery and radiation therapy as defined by randomized trials, including a discussion of the Head and Neck Contracts program and the Intergroup adjuvant trial. 3. The development of larynx/function preservation treatment programs, including a review of the Veterans Administration and EORTC larynx preservation studies. 4. The evolving role of chemotherapy as part of innovative combined modality programs, especially in patients with unresectable disease. The rationale and utility of sequential versus concomitant/alternating chemotherapy-radiation strategies, and relevant randomized clinical trials comparing the different strategies will be discussed. 5. The appropriate application of chemotherapy in the palliative setting, including a discussion of the relative merits of single-agent versus combination chemotherapy

  17. Chemotherapy for head and neck cancer

    International Nuclear Information System (INIS)

    Pfister, David G.

    1995-01-01

    Purpose/Objective: The role of chemotherapy in the management of squamous cell carcinoma of the upper aerodigestive tract is undergoing rapid evolution. Historically, the use of chemotherapy was limited to patients with incurable disease who had exhausted all surgical and radiation therapy options. The results of recent randomized trials, however, suggest an increasing role for chemotherapy as part of primary management in patients seeking to avoid potentially morbid surgical procedures or with unresectable disease. This refresher course will provide a comprehensive overview of the current indications for chemotherapy in the management of these malignancies, and will highlight areas of controversy and future directions of investigation. More specifically, the following areas will be emphasized. 1. The identification of drugs commonly used in the management of head and neck cancer, their customary dosing and side effects. 2. The impact of induction and/or adjuvant chemotherapy combined with surgery and radiation therapy as defined by randomized trials, including a discussion of the Head and Neck Contracts program and the Intergroup adjuvant trial. 3. The development of larynx/function preservation treatment programs, including a review of the Memorial Hospital experience with larynx preservation and the Veterans Administration larynx preservation study. 4. The evolving role of chemotherapy as part of innovative combined modality programs, especially in patients with unresectable disease. The rationale and utility of sequential versus concomitant/alternating chemotherapy-radiation strategies, and relevant randomized clinical trials comparing the different strategies will be discussed. 5. The appropriate application of chemotherapy in the palliative setting, including a discussion of the relative merits of single-agent versus combination chemotherapy

  18. Search for Higgs bosons predicted in two-Higgs-doublet models via decays to tau lepton pairs in 1.96 TeV pp collisions.

    Science.gov (United States)

    Aaltonen, T; Adelman, J; Akimoto, T; Alvarez González, B; Amerio, S; Amidei, D; Anastassov, A; Annovi, A; Antos, J; Apollinari, G; Apresyan, A; Arisawa, T; Artikov, A; Ashmanskas, W; Attal, A; Aurisano, A; Azfar, F; Badgett, W; Barbaro-Galtieri, A; Barnes, V E; Barnett, B A; Barria, P; Bartos, P; Bartsch, V; Bauer, G; Beauchemin, P-H; Bedeschi, F; Beecher, D; Behari, S; Bellettini, G; Bellinger, J; Benjamin, D; Beretvas, A; Beringer, J; Bhatti, A; Binkley, M; Bisello, D; Bizjak, I; Blair, R E; Blocker, C; Blumenfeld, B; Bocci, A; Bodek, A; Boisvert, V; Bolla, G; Bortoletto, D; Boudreau, J; Boveia, A; Brau, B; Bridgeman, A; Brigliadori, L; Bromberg, C; Brubaker, E; Budagov, J; Budd, H S; Budd, S; Burke, S; Burkett, K; Busetto, G; Bussey, P; Buzatu, A; Byrum, K L; Cabrera, S; Calancha, C; Campanelli, M; Campbell, M; Canelli, F; Canepa, A; Carls, B; Carlsmith, D; Carosi, R; Carrillo, S; Carron, S; Casal, B; Casarsa, M; Castro, A; Catastini, P; Cauz, D; Cavaliere, V; Cavalli-Sforza, M; Cerri, A; Cerrito, L; Chang, S H; Chen, Y C; Chertok, M; Chiarelli, G; Chlachidze, G; Chlebana, F; Cho, K; Chokheli, D; Chou, J P; Choudalakis, G; Chuang, S H; Chung, K; Chung, W H; Chung, Y S; Chwalek, T; Ciobanu, C I; Ciocci, M A; Clark, A; Clark, D; Compostella, G; Convery, M E; Conway, J; Cordelli, M; Cortiana, G; Cox, C A; Cox, D J; Crescioli, F; Cuenca Almenar, C; Cuevas, J; Culbertson, R; Cully, J C; Dagenhart, D; Datta, M; Davies, T; de Barbaro, P; De Cecco, S; Deisher, A; De Lorenzo, G; Dell'Orso, M; Deluca, C; Demortier, L; Deng, J; Deninno, M; Derwent, P F; Di Canto, A; di Giovanni, G P; Dionisi, C; Di Ruzza, B; Dittmann, J R; D'Onofrio, M; Donati, S; Dong, P; Donini, J; Dorigo, T; Dube, S; Efron, J; Elagin, A; Erbacher, R; Errede, D; Errede, S; Eusebi, R; Fang, H C; Farrington, S; Fedorko, W T; Feild, R G; Feindt, M; Fernandez, J P; Ferrazza, C; Field, R; Flanagan, G; Forrest, R; Frank, M J; Franklin, M; Freeman, J C; Furic, I; Gallinaro, M; Galyardt, J; Garberson, F; Garcia, J E; Garfinkel, A F; Garosi, P; Genser, K; Gerberich, H; Gerdes, D; Gessler, A; Giagu, S; Giakoumopoulou, V; Giannetti, P; Gibson, K; Gimmell, J L; Ginsburg, C M; Giokaris, N; Giordani, M; Giromini, P; Giunta, M; Giurgiu, G; Glagolev, V; Glenzinski, D; Gold, M; Goldschmidt, N; Golossanov, A; Gomez, G; Gomez-Ceballos, G; Goncharov, M; González, O; Gorelov, I; Goshaw, A T; Goulianos, K; Gresele, A; Grinstein, S; Grosso-Pilcher, C; Group, R C; Grundler, U; Guimaraes da Costa, J; Gunay-Unalan, Z; Haber, C; Hahn, K; Hahn, S R; Halkiadakis, E; Han, B-Y; Han, J Y; Happacher, F; Hara, K; Hare, D; Hare, M; Harper, S; Harr, R F; Harris, R M; Hartz, M; Hatakeyama, K; Hays, C; Heck, M; Heijboer, A; Heinrich, J; Henderson, C; Herndon, M; Heuser, J; Hewamanage, S; Hidas, D; Hill, C S; Hirschbuehl, D; Hocker, A; Hou, S; Houlden, M; Hsu, S-C; Huffman, B T; Hughes, R E; Husemann, U; Hussein, M; Huston, J; Incandela, J; Introzzi, G; Iori, M; Ivanov, A; James, E; Jang, D; Jayatilaka, B; Jeon, E J; Jha, M K; Jindariani, S; Johnson, W; Jones, M; Joo, K K; Jun, S Y; Jung, J E; Junk, T R; Kamon, T; Kar, D; Karchin, P E; Kato, Y; Kephart, R; Ketchum, W; Keung, J; Khotilovich, V; Kilminster, B; Kim, D H; Kim, H S; Kim, H W; Kim, J E; Kim, M J; Kim, S B; Kim, S H; Kim, Y K; Kimura, N; Kirsch, L; Klimenko, S; Knuteson, B; Ko, B R; Kondo, K; Kong, D J; Konigsberg, J; Korytov, A; Kotwal, A V; Kreps, M; Kroll, J; Krop, D; Krumnack, N; Kruse, M; Krutelyov, V; Kubo, T; Kuhr, T; Kulkarni, N P; Kurata, M; Kwang, S; Laasanen, A T; Lami, S; Lammel, S; Lancaster, M; Lander, R L; Lannon, K; Lath, A; Latino, G; Lazzizzera, I; LeCompte, T; Lee, E; Lee, H S; Lee, S W; Leone, S; Lewis, J D; Lin, C-S; Linacre, J; Lindgren, M; Lipeles, E; Lister, A; Litvintsev, D O; Liu, C; Liu, T; Lockyer, N S; Loginov, A; Loreti, M; Lovas, L; Lucchesi, D; Luci, C; Lueck, J; Lujan, P; Lukens, P; Lungu, G; Lyons, L; Lys, J; Lysak, R; MacQueen, D; Madrak, R; Maeshima, K; Makhoul, K; Maki, T; Maksimovic, P; Malde, S; Malik, S; Manca, G; Manousakis-Katsikakis, A; Margaroli, F; Marino, C; Marino, C P; Martin, A; Martin, V; Martínez, M; Martínez-Ballarín, R; Maruyama, T; Mastrandrea, P; Masubuchi, T; Mathis, M; Mattson, M E; Mazzanti, P; McFarland, K S; McIntyre, P; McNulty, R; Mehta, A; Mehtala, P; Menzione, A; Merkel, P; Mesropian, C; Miao, T; Miladinovic, N; Miller, R; Mills, C; Milnik, M; Mitra, A; Mitselmakher, G; Miyake, H; Moggi, N; Mondragon, M N; Moon, C S; Moore, R; Morello, M J; Morlock, J; Movilla Fernandez, P; Mülmenstädt, J; Mukherjee, A; Muller, Th; Mumford, R; Murat, P; Mussini, M; Nachtman, J; Nagai, Y; Nagano, A; Naganoma, J; Nakamura, K; Nakano, I; Napier, A; Necula, V; Nett, J; Neu, C; Neubauer, M S; Neubauer, S; Nielsen, J; Nodulman, L; Norman, M; Norniella, O; Nurse, E; Oakes, L; Oh, S H; Oh, Y D; Oksuzian, I; Okusawa, T; Orava, R; Osterberg, K; Pagan Griso, S; Pagliarone, C; Palencia, E; Papadimitriou, V; Papaikonomou, A; Paramonov, A A; Parks, B; Pashapour, S; Patrick, J; Pauletta, G; Paulini, M; Paus, C; Peiffer, T; Pellett, D E; Penzo, A; Phillips, T J; Piacentino, G; Pianori, E; Pinera, L; Pitts, K; Plager, C; Pondrom, L; Poukhov, O; Pounder, N; Prakoshyn, F; Pronko, A; Proudfoot, J; Ptohos, F; Pueschel, E; Punzi, G; Pursley, J; Rademacker, J; Rahaman, A; Ramakrishnan, V; Ranjan, N; Redondo, I; Renton, P; Renz, M; Rescigno, M; Richter, S; Rimondi, F; Ristori, L; Robson, A; Rodrigo, T; Rodriguez, T; Rogers, E; Rolli, S; Roser, R; Rossi, M; Rossin, R; Roy, P; Ruiz, A; Russ, J; Rusu, V; Rutherford, B; Saarikko, H; Safonov, A; Sakumoto, W K; Saltó, O; Santi, L; Sarkar, S; Sartori, L; Sato, K; Savoy-Navarro, A; Schlabach, P; Schmidt, A; Schmidt, E E; Schmidt, M A; Schmidt, M P; Schmitt, M; Schwarz, T; Scodellaro, L; Scribano, A; Scuri, F; Sedov, A; Seidel, S; Seiya, Y; Semenov, A; Sexton-Kennedy, L; Sforza, F; Sfyrla, A; Shalhout, S Z; Shears, T; Shepard, P F; Shimojima, M; Shiraishi, S; Shochet, M; Shon, Y; Shreyber, I; Sinervo, P; Sisakyan, A; Slaughter, A J; Slaunwhite, J; Sliwa, K; Smith, J R; Snider, F D; Snihur, R; Soha, A; Somalwar, S; Sorin, V; Spreitzer, T; Squillacioti, P; Stanitzki, M; St Denis, R; Stelzer, B; Stelzer-Chilton, O; Stentz, D; Strologas, J; Strycker, G L; Suh, J S; Sukhanov, A; Suslov, I; Suzuki, T; Taffard, A; Takashima, R; Takeuchi, Y; Tanaka, R; Tecchio, M; Teng, P K; Terashi, K; Thom, J; Thompson, A S; Thompson, G A; Thomson, E; Tipton, P; Ttito-Guzmán, P; Tkaczyk, S; Toback, D; Tokar, S; Tollefson, K; Tomura, T; Tonelli, D; Torre, S; Torretta, D; Totaro, P; Tourneur, S; Trovato, M; Tsai, S-Y; Tu, Y; Turini, N; Ukegawa, F; Vallecorsa, S; van Remortel, N; Varganov, A; Vataga, E; Vázquez, F; Velev, G; Vellidis, C; Vidal, M; Vidal, R; Vila, I; Vilar, R; Vine, T; Vogel, M; Volobouev, I; Volpi, G; Wagner, P; Wagner, R G; Wagner, R L; Wagner, W; Wagner-Kuhr, J; Wakisaka, T; Wallny, R; Wang, S M; Warburton, A; Waters, D; Weinberger, M; Weinelt, J; Wester, W C; Whitehouse, B; Whiteson, D; Wicklund, A B; Wicklund, E; Wilbur, S; Williams, G; Williams, H H; Wilson, P; Winer, B L; Wittich, P; Wolbers, S; Wolfe, C; Wright, T; Wu, X; Würthwein, F; Xie, S; Yagil, A; Yamamoto, K; Yamaoka, J; Yang, U K; Yang, Y C; Yao, W M; Yeh, G P; Yi, K; Yoh, J; Yorita, K; Yoshida, T; Yu, G B; Yu, I; Yu, S S; Yun, J C; Zanello, L; Zanetti, A; Zhang, X; Zheng, Y; Zucchelli, S

    2009-11-13

    We present the results of a search for Higgs bosons predicted in two-Higgs-doublet models, in the case where the Higgs bosons decay to tau lepton pairs, using 1.8 fb(-1) of integrated luminosity of pp collisions recorded by the CDF II experiment at the Fermilab Tevatron. Studying the mass distribution in events where one or both tau leptons decay leptonically, no evidence for a Higgs boson signal is observed. The result is used to infer exclusion limits in the two-dimensional space of tanbeta versus m(A) (the ratio of the vacuum expectation values of the two Higgs doublets and the mass of the pseudoscalar boson, respectively).

  19. Neoadjuvant chemotherapy in locally advanced colon cancer

    DEFF Research Database (Denmark)

    Jakobsen, Anders; Andersen, Fahimeh; Fischer, Anders

    2015-01-01

    BACKGROUND: Neoadjuvant chemotherapy has proven valuable in several tumors, but it has not been elucidated in colon cancer. The present phase II trial addressed the issue in high-risk patients selected by computed tomography (CT) scan. MATERIAL AND METHODS: Patients with resectable colon cancer...... 32% (p = 0.005) translating into a three-year DFS of 94% versus 63% (p = 0.005). CONCLUSION: Neoadjuvant chemotherapy in colon cancer is feasible and the results suggest that a major part of the patients can be spared adjuvant chemotherapy. Validation in a randomized trial is warranted....

  20. Impact of Metronomic UFT/Cyclophosphamide Chemotherapy and Antiangiogenic Drug Assessed in a New Preclinical Model of Locally Advanced Orthotopic Hepatocellular Carcinoma

    Directory of Open Access Journals (Sweden)

    Terence C. Tang

    2010-03-01

    Full Text Available Hepatocellular carcinoma (HCC is an intrinsically chemotherapy refractory malignancy. Development of effective therapeutic regimens would be facilitated by improved preclinical HCC models. Currently, most models consist of subcutaneous human tumor transplants in immunodeficient mice; however, these do not reproduce the extensive liver disease associated with HCC or metastasize. To address this deficiency, we developed an orthotopic model. Human HCC cells were transfected with the gene encoding secretable β-subunit human choriogonadotropin (β-hCG, which was used as a surrogate marker of tumor burden. The HCC cells were implanted into the left liver lobe of severe combined immunodeficient (SCID mice, after which the efficacy of different therapies was evaluated on established, but liver-confined human Hep3B cell line HCC. Treatments included sorafenib or metronomic chemotherapy using cyclophosphamide (CTX, UFT, an oral 5-fluorouracil prodrug, or doxorubicin either alone or in various combinations, with or without an antiangiogenic agent, DC101, an anti-vascular endothelial growth factor receptor-2 antibody. Sorafenib inhibited tumor growth in a dose-dependent manner but caused severe weight loss in SCID mice, thus necessitating use of DC101 in subsequent experiments. Although less toxicity was observed using either single or doublet metronomic chemotherapy without any added antiangiogenic agent, none, provided survival benefit. In contrast, significantly improved overall survival was observed using various combinations of metronomic chemotherapy regimens such as UFT + CTX with DC101. In conclusion, using this model of liver-confined but advanced HCC suggests that the efficacy of a targeted antiangiogenic drug or metronomic chemotherapy can be mutually enhanced by concurrent combination treatment.

  1. OPTIMAL and ENSURE trials-based combined cost-effectiveness analysis of erlotinib versus chemotherapy for the first-line treatment of Asian patients with non-squamous non-small-cell lung cancer

    Science.gov (United States)

    Zhang, Pengfei; Hutton, David; Li, Qiu

    2018-01-01

    Objectives Erlotinib, the first generation of epidermoid growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI), has been recommended as an essential treatment in patients with non-small-cell lung cancer (NSCLC) with EGFR mutation. Although it has improved progression-free survival (PFS), overall survival (OS) was limited and erlotinib can be expensive. This cost-effectiveness analysis compares erlotinib monotherapy with gemcitabine-included doublet chemotherapy. Setting First-line treatment of Asian patients with NSCLC with EGFR mutation. Methods A Markov model was created based on the results of the ENSURE (NCT01342965) and OPTIMAL (CTONG-0802) trials which evaluated erlotinib and chemotherapy. The model simulates cancer progression and all causes of death. All medical costs were calculated from the perspective of the Chinese healthcare system. Main outcome measures The primary outcomes are costs, quality-adjusted life years (QALYs) and incremental cost-effectiveness ratios (ICERs). Results The combined PFS was 11.81 months and 5.1 months for erlotinib and chemotherapy, respectively, while the OS was reversed at 24.68 months for erlotinib and 26.16 months for chemotherapy. The chemotherapy arm gained 0.13 QALYs compared with erlotinib monotherapy (1.17 QALYs vs 1.04 QALYs), while erlotinib had lower costs ($55 230 vs $77 669), resulting in an ICER of $174 808 per QALY for the chemotherapy arm, which exceeds three times the Chinese GDP per capita. The most influential factors were the health utility of PFS, the cost of erlotinib and the health utility of progressed disease. Conclusion Erlotinib monotherapy may be acceptable as a cost-effective first-line treatment for NSCLC compared with gemcitabine-based chemotherapy. The results were robust to changes in assumptions. Trial registration number NCT01342965 and CTONG-0802. PMID:29654023

  2. Spectral features of the tunneling-induced transparency and the Autler-Townes doublet and triplet in a triple quantum dot.

    Science.gov (United States)

    Luo, Xiao-Qing; Li, Zeng-Zhao; Jing, Jun; Xiong, Wei; Li, Tie-Fu; Yu, Ting

    2018-02-15

    We theoretically investigate the spectral features of tunneling-induced transparency (TIT) and Autler-Townes (AT) doublet and triplet in a triple-quantum-dot system. By analyzing the eigenenergy spectrum of the system Hamiltonian, we can discriminate TIT and double TIT from AT doublet and triplet, respectively. For the resonant case, the presence of the TIT does not exhibit distinguishable anticrossing in the eigenenergy spectrum in the weak-tunneling regime, while the occurrence of double anticrossings in the strong-tunneling regime shows that the TIT evolves to the AT doublet. For the off-resonance case, the appearance of a new detuning-dependent dip in the absorption spectrum leads to double TIT behavior in the weak-tunneling regime due to no distinguished anticrossing occurring in the eigenenergy spectrum. However, in the strong-tunneling regime, a new detuning-dependent dip in the absorption spectrum results in AT triplet owing to the presence of triple anticrossings in the eigenenergy spectrum. Our results can be applied to quantum measurement and quantum-optics devices in solid systems.

  3. Cancer chemotherapy and biotherapy: principles and practice

    National Research Council Canada - National Science Library

    Chabner, Bruce; Longo, Dan L

    2011-01-01

    "Updated to include the newest drugs and those currently in development, Cancer Chemotherapy and Biotherapy, Fifth Edition is a comprehensive reference on the preclinical and clinical pharmacology of anticancer agents...

  4. Managing Chemotherapy Side Effects: Hair Loss (Alopecia)

    Science.gov (United States)

    ... C ancer I nstitute Managing Chemotherapy Side Effects Hair Loss (Alopecia) “Losing my hair was hard at first. ... and anywhere on your body may fall out. Hair loss is called alopecia. When will my hair start ...

  5. Novel Combination Chemotherapy for Localized Ewing Sarcoma

    Science.gov (United States)

    In this clinical trial, researchers will test whether the addition of the drug combination vincristine, topotecan, and cyclophosphamide to a standard chemotherapy regimen improves overall survival in patients with extracranial Ewing

  6. Managing Chemotherapy Side Effects: Nausea and Vomiting

    Science.gov (United States)

    N ational C ancer I nstitute Managing Chemotherapy Side Effects U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Nausea and Vomiting “I take medicine so I won’t feel sick ...

  7. Managing Chemotherapy Side Effects: Swelling (Fluid Retention)

    Science.gov (United States)

    N ational C ancer I nstitute Managing Chemotherapy Side Effects Swelling (Fluid retention) “My hands and feet were swollen and puffy. My nurse helped me understand why I had to stop eating salty ...

  8. Nanoscale drug delivery for targeted chemotherapy.

    Science.gov (United States)

    Xin, Yong; Huang, Qian; Tang, Jian-Qin; Hou, Xiao-Yang; Zhang, Pei; Zhang, Long Zhen; Jiang, Guan

    2016-08-28

    Despite significant improvements in diagnostic methods and innovations in therapies for specific cancers, effective treatments for neoplastic diseases still represent major challenges. Nanotechnology as an emerging technology has been widely used in many fields and also provides a new opportunity for the targeted delivery of cancer drugs. Nanoscale delivery of chemotherapy drugs to the tumor site is highly desirable. Recent studies have shown that nanoscale drug delivery systems not only have the ability to destroy cancer cells but may also be carriers for chemotherapy drugs. Some studies have demonstrated that delivery of chemotherapy via nanoscale carriers has greater therapeutic benefit than either treatment modality alone. In this review, novel approaches to nanoscale delivery of chemotherapy are described and recent progress in this field is discussed. Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

  9. Breast Cancer Chemotherapy and Your Heart

    Science.gov (United States)

    ... of the American Heart Association Cardiology Patient Page Breast Cancer Chemotherapy and Your Heart Christine Unitt , Kamaneh Montazeri , ... Disclosures Footnotes Figures & Tables Info & Metrics eLetters Introduction Breast cancer is the most commonly diagnosed cancer in women. ...

  10. The role of chemotherapy in brain metastases

    International Nuclear Information System (INIS)

    Ohori, Hisatsugu; Takahashi, Shin; Ishioka, Chikashi

    2007-01-01

    Brain metastases are the most common intracranial tumors and their incidence is increasing. Untreated brain metastases have a very poor prognosis with a median survival of 1-2 months. Despite the use of surgery and radiotherapy including whole-brain radiation and stereotactic radiosurgery to locally control brain metastases, survival times for those patients has not improved. Although chemotherapy plays a limited role in the treatment of brain metastases, metastases from lung or breast cancer are often well-controlled by chemotherapy. Accumulating evidence suggest that brain metastases are equally sensitive to chemotherapy as are metastases elsewhere in the body in particular chemotherapy-naive cases. Finally, since nearly a half of patients with brain metastases die from progression of systemic disease, control of systemic disease as well as intracranial disease are both important. (author)

  11. Chemotherapy-induced sclerosing cholangitis

    Energy Technology Data Exchange (ETDEWEB)

    Sandrasegaran, K.; Alazmi, W.M.; Tann, M.; Fogel, E.L.; McHenry, L.; Lehman, G.A

    2006-08-15

    Aim: To review the computed tomography (CT), magnetic resonance imaging (MRI) and cholangiographic findings of chemotherapy-induced sclerosing cholangitis (CISC). Methods: Between January 1995 and December 2004, 11 patients in the endoscopic retrograde cholangiography database were identified with CISC. Twelve CT, four MRI, 69 endoscopic and nine antegrade cholangiographic studies in these patients were reviewed. Serial change in appearance and response to endoscopic treatment were recorded. Results: CISC showed segmental irregular biliary dilatation with strictures of proximal extrahepatic bile ducts. The distal 5 cm of common bile duct was not affected in any patient. CT and MRI findings included altered vascular perfusion of one or more liver segments, liver metastases or peritoneal carcinomatosis. Biliary strictures needed repeated stenting in 10 patients (mean: every 4.7 months). Cirrhosis (n = 1) or confluent fibrosis (n = 0) were uncommon findings. Conclusion: CISC shares similar cholangiographic appearances to primary sclerosing cholangitis (PSC). Unlike PSC, biliary disease primarily involved ducts at the hepatic porta rather than intrahepatic ducts. Multiphasic contrast-enhanced CT or MRI may show evidence of perfusion abnormalities, cavitary liver lesions, or metastatic disease.

  12. Combined chemotherapy including platinum derivatives for medulloblastoma. The usefulness as maintenance chemotherapy

    International Nuclear Information System (INIS)

    Sasaki, Hikaru; Otani, Mitsuhiro; Yoshida, Kazunari; Kagami, Hiroshi; Shimazaki, Kenji; Toya, Shigeo; Kawase, Takeshi

    1997-01-01

    The authors reviewed 24 cerebellar medulloblastoma patients treated at Keio University to determine usefulness of combined chemotherapy including platinum derivatives (cisplatin, carboplatin) as the induction and maintenance treatment. All patients underwent radical surgery and craniospinal irradiation. Ten received adjuvant chemotherapy other than platinum derivatives (mainly with nitrosourea compounds), five were treated by induction and maintenance chemotherapy including platinum derivatives, and nine patients did not undergo chemotherapy. The progression-free survival rate of patients treated with platinum derivatives was better than that of patients treated with other modes of chemotherapy and also that of patients who did not receive chemotherapy. The results were especially good in the case of four patients treated with maintenance chemotherapy consisting of carboplatin and etoposide, two of whom had been free from relapse beyond the risk period of Collins. The occurrences of toxicity in maintenance chemotherapy with carboplatin and etoposide were limited to transient leucopenia. The present study indicates combined chemotherapy including platinum derivatives benefits patients with medulloblastoma, and could be useful, especially as maintenance treatment. (author)

  13. Mechanisms of chemotherapy-induced behavioral toxicities

    Directory of Open Access Journals (Sweden)

    Elisabeth G Vichaya

    2015-04-01

    Full Text Available While chemotherapeutic agents have yielded relative success in the treatment of cancer, patients are often plagued with unwanted and even debilitating side-effects from the treatment which can lead to dose reduction or even cessation of treatment. Common side effects (symptoms of chemotherapy include (i cognitive deficiencies such as problems with attention, memory and executive functioning; (ii fatigue and motivational deficit; and (iii neuropathy. These symptoms often develop during treatment but can remain even after cessation of chemotherapy, severely impacting long-term quality of life. Little is known about the underlying mechanisms responsible for the development of these behavioral toxicities, however, neuroinflammation is widely considered to be one of the major mechanisms responsible for chemotherapy-induced symptoms. Here, we critically assess what is known in regards to the role of neuroinflammation in chemotherapy-induced symptoms. We also argue that, based on the available evidence neuroinflammation is unlikely the only mechanism involved in the pathogenesis of chemotherapy-induced behavioral toxicities. We evaluate two other putative candidate mechanisms. To this end we discuss the mediating role of damage-associated molecular patterns (DAMPs activated in response to chemotherapy-induced cellular damage. We also review the literature with respect to possible alternative mechanisms such as a chemotherapy-induced change in the bioenergetic status of the tissue involving changes in mitochondrial function in relation to chemotherapy-induced behavioral toxicities. Understanding the mechanisms that underlie the emergence of fatigue, neuropathy, and cognitive difficulties is vital to better treatment and long-term survival of cancer patients.

  14. PD-1 and PD-L1 inhibitors after platinum-based chemotherapy or in first-line therapy in cisplatin-ineligible patients: Dramatic improvement of prognosis and overall survival after decades of hopelessness in patients with metastatic urothelial cancer.

    Science.gov (United States)

    Resch, Irene; Shariat, Shahrokh F; Gust, Kilian M

    2018-01-01

    Until recently, there were no true innovations in the management of locally advanced (aUC) and metastatic urothelial cancer (mUC) in the last three decades. Vinflunine has been approved by the EMA (European Medicines Agency) with only limited improvement compared to best supportive care in second line treatment. In addition, gemcitabine/cisplatin has been established as an alternative to methotrexate, vinblastine, doxorubicin, and cisplatin (MVAC). The advent of checkpoint inhibitors (CPI) revolutionized the care of these patients, transforming a unanimously deadly disease into one with hope through sustained disease control. Five immune CPI have recently been approved for aUC/mUC by the US Food and Drug Administration (FDA) including atezolizumab, nivolumab, pembrolizumab, durvalumab and avelumab. All five CPI are FDA-approved as second-line therapy with atezolizumab and pembrolizumab also being approved for first-line therapy in cisplatin-ineligible patients. The rapid acceptance in the treatment algorithm of UC is based on the impressive clinical efficacy of these agents in some patients, combined with their excellent safety profile. These new agents are indeed the most important advancement in UC care. However, the challenge in the age of precision medicine is to identify the patients who are most likely to benefit from CPIs, as the majority of patients do not respond to CPI. Toward this goal, validation of clinical, molecular and imaging biomarkers that serve for prediction and monitoring of treatment response are of central necessity.

  15. Neoadjuvant Chemotherapy for Advanced Epithelial Ovarian Cancer

    International Nuclear Information System (INIS)

    Avendano Juan; Buitrago, Giancarlo; Ramos, Pedro; Suescun Oscar

    2010-01-01

    Objective: To describe the experience at the National Cancer Institute (NCI) on the use of neoadjuvant chemotherapy as primary treatment for epithelial ovarian cancer among patients in stages IIIC and IV. Methods: We conducted a descriptive retrospective study (case series type) of patients diagnosed with epithelial ovarian cancer in stages IIIC and IV, treated at the NCI from January 1, 2003 to December 31,2006, who underwent neoadjuvant chemotherapy as primary treatment. Demographic characteristics and clinical outcomes are described. Results: Seventeen patients who fulfilled the above mentioned criteria were selected. Once neoadjuvant chemotherapy ended, 5 patients (29.4%) achieved complete or partial clinical response; 4 (23.8%) remained in stable condition, and 8 (47.6%) showed signs of progressive illness. Interval debulking surgery was performed on objective response patients. Maximum cytoreduction was achieved in 5 patients (100%); first relapse was reported at month 18 of follow-up; 2 disease-free survivors were identified in December, 2007; 8 (49%) reported some degree of non-severe chemotherapy-related toxicity. No mortality was related to chemotherapy, no post surgical complications were observed and no patient required advanced support management. Conclusions: Neoadjuvant chemotherapy, followed by optimal interval debulking surgery among selected patients, can be an alternative treatment for advanced epithelial ovarian cancer among women with irresecability or the critically ill. Further studies with improved design are required to confirm these findings.

  16. Impact of adjuvant chemotherapy for gliomatosis cerebri

    International Nuclear Information System (INIS)

    Kong, Doo-Sik; Nam, Do-Hyun; Kim, Sung Tae; Lee, Jung-Il; Suh, Yeon-Lim; Lim, Do Hoon; Kim, Won Seog; Kwon, Ki-Hoon; Park, Kwan; Kim, Jong Hyun

    2010-01-01

    Gliomatosis cerebri (GC) is characterized by a diffuse infiltration of tumor cells throughout CNS, however, few details are available about the chemotherapeutic effect on GC. The aim of this study was to investigate its clinical course and to determine the efficacy of chemotherapy for GC. Between Jan. 1999 and Dec. 2004, 37 GC patients were diagnosed by biopsy and treated with radiotherapy in a single institution. To determine the efficacy of chemotherapy for GC, we retrospectively reviewed their clinical courses. The study cohort was divided into 2 groups, those with and without receiving post-radiotherapy adjuvant chemotherapy such as temozolomide or nitrosourea-based chemotherapy. Nineteen patients with adjuvant chemotherapy were assigned to the chemotreatment group and 18 with radiotherapy alone were assigned to the control group. Mean survival for chemotreatment group and control group were 24.2 and 13.1 months, respectively (p = 0.045). Time to progression for these groups were 16.0 and 6.0 months, respectively (p = 0.007). Overall review of the clinical course of patients with GC provided that early appearance of new contrast-enhancing lesions within 6 months from the initial diagnosis and higher histological grade were closely associated with poor survival (p < 0.001 and p = 0.008). Adjuvant chemotherapy following radiotherapy could prolong the survival in patients with GC. In addition, newly developed contrast-enhanced lesions on the follow-up MR images indicate the progression of GC

  17. Cancer occurring after radiotherapy and chemotherapy

    International Nuclear Information System (INIS)

    Holm, L.E.

    1990-01-01

    Radiotherapy and chemotherapy can effectively control cancer but can also cause new cancers to develop as long-term complications. Almost all types of cancer have been associated with radiotherapy. The breast, thyroid, and bone marrow are the organs most susceptible to radiation carcinogenesis. The bone marrow is also most frequently involved by chemotherapy and the leukemia risk is much higher than after radiotherapy. The combination of intensive radiotherapy and chemotherapy is particularly leukemogenic. The latent period between radiotherapy/chemotherapy and the appearance of a second primary cancer ranges from a few years to several decades. The risk for a second primary cancer following radiotherapy or chemotherapy emphasizes the need for life long follow-up of patients receiving such treatments. This is particularly the case in individuals with long life expectancy, for example, patients treated for childhood neoplasms. The benefits of radiotherapy and chemotherapy in oncology exceed the risks for second primary cancers. Efforts should be directed towards identifying those patients who will benefit from the treatments so that only they are exposed to the risk. 33 references

  18. Photon buildup factors of some chemotherapy drugs.

    Science.gov (United States)

    Kavaz, Esra; Ahmadishadbad, Nader; Özdemir, Yüksel

    2015-02-01

    Everyday more and more people are diagnosed with some form of cancer. Some are treatable with chemotherapy alone, while others need radiotherapy and occasionally surgery. Recently, concurrent administration of chemotherapy and radiotherapy has been increasingly used in cancer treatment, leading to improvements in survival as well as quality of life. Accordingly, interaction of chemotherapy drugs with radiation will be meaningful to examine. In the present study, gamma ray energy absorption and exposure of buildup factors were computed using the five-parameter geometric progression (G-P) fitting formula for some chemotherapy drugs in the energy range 0.015-15 MeV, and for penetration depths up to 40 mean free path (mfp). The generated energy absorption (EABF) and exposure buildup factors (EBF) of chemotherapy drugs have been studied as a function of penetration depth and incident photon energy. The significant variations in EABF and EBF for chemotherapy drugs have been observed at the moderate energy region. It has been concluded that the buildup of photons is less in azathioprine and is more in vinblastine compared with other drugs. Buildup factors investigated in the present work could be useful in radiation dosimetry and therapy. Copyright © 2014 Elsevier Masson SAS. All rights reserved.

  19. Quality of life of lung cancer patients receiving outpatient chemotherapy

    OpenAIRE

    MATSUDA, AYAKO; KOBAYASHI, MIKA; SAKAKIBARA, YUMI; TAMAOKA, MEIYO; FURUIYE, MASASHI; INASE, NAOHIKO; MATSUSHIMA, EISUKE

    2011-01-01

    An increasing number of cancer patients receive outpatient chemotherapy as an alternative to inpatient chemotherapy. The aim of this study was to investigate whether quality of life (QOL) during outpatient chemotherapy was better than QOL prior to hospital discharge, and to explore possible related factors prior to hospital discharge that affected the QOL of lung cancer patients who received outpatient chemotherapy. Lung cancer inpatients who were scheduled for outpatient chemotherapy were as...

  20. n-3 polyunsaturated fatty acid supplementation during cancer chemotherapy

    OpenAIRE

    Morland, Sarah Louise; Martins, Karen J.B.; Mazurak, Vera C.

    2016-01-01

    Evidence from several clinical trials suggests that n-3 polyunsaturated fatty acid (n-3 PUFA) supplementation during cancer chemotherapy improves patient outcomes related to chemotherapy tolerability, regardless of the type of chemotherapy used. While the effects of n-3 PUFA supplementation during chemotherapy have been the subject of several reviews, the mechanisms by which n-3 PUFA improve patient responses through improved chemotherapy tolerability are unclear. There are several barriers c...